0001681622-20-000091.txt : 20201026 0001681622-20-000091.hdr.sgml : 20201026 20200922073649 ACCESSION NUMBER: 0001681622-20-000091 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 117 CONFORMED PERIOD OF REPORT: 20200922 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200922 DATE AS OF CHANGE: 20200922 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Varex Imaging Corp CENTRAL INDEX KEY: 0001681622 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC COMPONENTS, NEC [3679] IRS NUMBER: 813434516 STATE OF INCORPORATION: DE FISCAL YEAR END: 1002 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37860 FILM NUMBER: 201187869 BUSINESS ADDRESS: STREET 1: 1678 S. PIONEER ROAD CITY: SALT LAKE CITY STATE: UT ZIP: 84104 BUSINESS PHONE: 801-972-5000 MAIL ADDRESS: STREET 1: 1678 S. PIONEER ROAD CITY: SALT LAKE CITY STATE: UT ZIP: 84104 8-K 1 form8-kcoverxreissued2.htm 8-K Document
falseFY201900016816220.010.01150000000150000000380265973837130538026597383713050.04805P5Y00300000000.010.012000000020000000000P12M0100000550.10.0750.0750.0537.6022.6337.6022.6337.6022.6331.0831.0827.7722.8431.4231.42 0001681622 2018-09-29 2019-09-27 0001681622 2020-09-22 2020-09-22 0001681622 2017-09-30 2018-09-28 0001681622 2016-10-01 2017-09-29 0001681622 2018-09-28 0001681622 2019-09-27 0001681622 2017-09-29 0001681622 2016-09-30 0001681622 us-gaap:CommonStockMember 2018-09-29 2019-09-27 0001681622 us-gaap:CommonStockMember 2017-09-30 2018-09-28 0001681622 us-gaap:CommonStockMember 2017-09-29 0001681622 us-gaap:AdditionalPaidInCapitalMember 2018-09-29 2019-09-27 0001681622 us-gaap:NoncontrollingInterestMember 2017-09-30 2018-09-28 0001681622 us-gaap:ParentMember 2017-09-30 2018-09-28 0001681622 us-gaap:RetainedEarningsMember 2017-09-29 0001681622 us-gaap:AdditionalPaidInCapitalMember 2019-09-27 0001681622 us-gaap:NoncontrollingInterestMember 2017-09-29 0001681622 us-gaap:CommonStockMember 2016-10-01 2017-09-29 0001681622 us-gaap:NoncontrollingInterestMember 2018-09-29 2019-09-27 0001681622 us-gaap:ParentMember 2016-10-01 2017-09-29 0001681622 vrex:NetParentInvestmentMember 2016-09-30 0001681622 us-gaap:RetainedEarningsMember 2016-10-01 2017-09-29 0001681622 us-gaap:AdditionalPaidInCapitalMember 2017-09-30 2018-09-28 0001681622 us-gaap:CommonStockMember 2016-09-30 0001681622 us-gaap:RetainedEarningsMember 2017-09-30 2018-09-28 0001681622 vrex:NetParentInvestmentMember 2016-10-01 2017-09-29 0001681622 vrex:NetParentInvestmentMember 2018-09-28 0001681622 us-gaap:RetainedEarningsMember 2018-09-29 2019-09-27 0001681622 us-gaap:AdditionalPaidInCapitalMember 2017-09-29 0001681622 vrex:NetParentInvestmentMember 2019-09-27 0001681622 us-gaap:NoncontrollingInterestMember 2019-09-27 0001681622 us-gaap:ParentMember 2016-09-30 0001681622 us-gaap:RetainedEarningsMember 2019-09-27 0001681622 us-gaap:CommonStockMember 2018-09-28 0001681622 us-gaap:ParentMember 2018-09-29 2019-09-27 0001681622 us-gaap:ParentMember 2018-09-28 0001681622 us-gaap:ParentMember 2019-09-27 0001681622 us-gaap:RetainedEarningsMember 2016-09-30 0001681622 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-09-30 2018-09-28 0001681622 us-gaap:AdditionalPaidInCapitalMember 2016-10-01 2017-09-29 0001681622 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-10-01 2017-09-29 0001681622 us-gaap:RetainedEarningsMember 2018-09-28 0001681622 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-29 2019-09-27 0001681622 us-gaap:AdditionalPaidInCapitalMember 2016-09-30 0001681622 us-gaap:AdditionalPaidInCapitalMember 2018-09-28 0001681622 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-27 0001681622 us-gaap:NoncontrollingInterestMember 2018-09-28 0001681622 us-gaap:CommonStockMember 2019-09-27 0001681622 vrex:NetParentInvestmentMember 2017-09-29 0001681622 us-gaap:NoncontrollingInterestMember 2016-09-30 0001681622 us-gaap:ParentMember 2017-09-29 0001681622 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-28 0001681622 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-09-29 0001681622 us-gaap:MachineryAndEquipmentMember 2019-09-27 0001681622 us-gaap:MachineryAndEquipmentMember 2018-09-28 0001681622 vrex:BuildingsandLeaseholdImprovementsMember 2019-09-27 0001681622 us-gaap:ConstructionInProgressMember 2019-09-27 0001681622 us-gaap:LandMember 2019-09-27 0001681622 vrex:BuildingsandLeaseholdImprovementsMember 2018-09-28 0001681622 us-gaap:LandMember 2018-09-28 0001681622 us-gaap:ConstructionInProgressMember 2018-09-28 0001681622 vrex:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2017-09-30 2018-09-28 0001681622 vrex:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-09-29 2019-09-27 0001681622 vrex:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2016-10-01 2017-09-29 0001681622 srt:RestatementAdjustmentMember 2017-09-30 2018-09-28 0001681622 srt:MinimumMember 2018-09-29 2019-09-27 0001681622 vrex:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2018-09-29 2019-09-27 0001681622 srt:MaximumMember 2018-09-29 2019-09-27 0001681622 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2019-09-27 0001681622 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2019-03-29 0001681622 us-gaap:BuildingMember 2018-09-29 2019-09-27 0001681622 vrex:VarianMedicalSystemsInc.Member 2017-01-28 0001681622 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2018-09-29 2019-09-27 0001681622 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-12-28 0001681622 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2018-09-29 2019-09-27 0001681622 us-gaap:LandImprovementsMember 2018-09-29 2019-09-27 0001681622 vrex:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2017-09-30 2018-09-28 0001681622 vrex:DirectConversionABMember us-gaap:DevelopedTechnologyRightsMember 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:CustomerRelationshipsMember 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:CustomerRelationshipsMember 2019-04-29 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:DevelopedTechnologyRightsMember 2019-04-29 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:TradeNamesMember 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:OrderOrProductionBacklogMember 2019-04-29 0001681622 vrex:DirectConversionABMember 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:OrderOrProductionBacklogMember 2019-04-29 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:TradeNamesMember 2019-04-29 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:InProcessResearchAndDevelopmentMember 2019-04-29 0001681622 vrex:PerkinElmerInc.Member vrex:IndustrialMember 2017-05-01 2017-09-29 0001681622 vrex:PerkinElmerInc.Member 2017-05-01 2017-09-29 0001681622 vrex:PerkinElmerInc.Member vrex:MedicalMember 2017-05-01 2017-09-29 0001681622 vrex:DirectConversionABMember 2019-04-30 2019-09-27 0001681622 vrex:DirectConversionABMember vrex:IndustrialMember 2019-04-30 2019-09-27 0001681622 vrex:DirectConversionABMember vrex:MedicalMember 2019-04-30 2019-09-27 0001681622 vrex:PerkinElmerInc.Member 2017-05-01 0001681622 vrex:PerkinElmerInc.Member 2017-05-01 2017-05-01 0001681622 vrex:PerkinElmerInc.Member 2016-10-01 2017-09-29 0001681622 vrex:DirectConversionABMember 2019-04-29 2019-04-29 0001681622 vrex:VirtualMediaIntegrationLtd.Member 2018-08-31 2018-08-31 0001681622 vrex:PerkinElmerInc.Member us-gaap:ForeignCountryMember 2017-05-01 0001681622 vrex:DirectConversionABMember 2019-04-30 0001681622 vrex:VirtualMediaIntegrationLtd.Member 2018-08-31 0001681622 vrex:PerkinElmerInc.Member us-gaap:LeaseAgreementsMember 2017-05-01 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:OrderOrProductionBacklogMember 2017-05-01 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:LeaseAgreementsMember 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:TradeNamesMember 2017-05-01 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:OrderOrProductionBacklogMember 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:CustomerRelationshipsMember 2017-05-01 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:DevelopedTechnologyRightsMember 2017-05-01 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:DevelopedTechnologyRightsMember 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:TradeNamesMember 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:CustomerRelationshipsMember 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:InProcessResearchAndDevelopmentMember 2017-05-01 0001681622 vrex:VECImagingGmbHCo.KGMember 2018-11-01 2019-09-27 0001681622 vrex:DpiXHoldingMember us-gaap:EquityMethodInvesteeMember 2019-09-27 0001681622 vrex:VECImagingGmbHCo.KGMember srt:ScenarioForecastMember 2019-12-17 2019-12-17 0001681622 vrex:DpiXHoldingMember us-gaap:EquityMethodInvesteeMember 2018-09-29 2019-09-27 0001681622 vrex:DpiXHoldingMember us-gaap:EquityMethodInvesteeMember 2013-10-01 2013-10-31 0001681622 vrex:DpiXHoldingMember 2019-09-27 0001681622 vrex:DpiXHoldingMember 2018-09-29 2019-09-27 0001681622 vrex:DpiXLLCMember 2019-09-27 0001681622 vrex:CETTEENGmbHMember vrex:VECImagingGmbHCo.KGMember 2019-09-27 0001681622 vrex:DpiXHoldingMember us-gaap:EquityMethodInvesteeMember 2018-09-28 0001681622 vrex:DpiXHoldingMember 2016-10-01 2017-09-29 0001681622 vrex:DpiXHoldingMember 2017-09-30 2018-09-28 0001681622 vrex:DpiXHoldingMember us-gaap:EquityMethodInvesteeMember 2016-10-01 2017-09-29 0001681622 vrex:VECImagingGmbHCo.KGMember 2019-09-27 0001681622 vrex:DpiXHoldingMember vrex:FixedCostCommitmentsMember 2018-09-29 2019-09-27 0001681622 vrex:DpiXHoldingMember 2018-09-28 0001681622 vrex:DpiXHoldingMember us-gaap:EquityMethodInvesteeMember 2017-09-30 2018-09-28 0001681622 vrex:LondonFacilityClosingMember 2017-09-30 2018-09-28 0001681622 vrex:SantaClaraFacilityRelocationMember 2017-09-30 2018-09-28 0001681622 vrex:SantaClaraFacilityRelocationMember 2018-09-29 2019-09-27 0001681622 srt:MinimumMember vrex:SantaClaraFacilityRelocationMember 2019-09-27 0001681622 srt:MaximumMember vrex:SantaClaraFacilityRelocationMember 2019-09-27 0001681622 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:OtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:OtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2018-09-29 2019-09-27 0001681622 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-10-01 2017-09-29 0001681622 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-09-30 2018-09-28 0001681622 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-29 2019-09-27 0001681622 currency:CHF us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-09-27 0001681622 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-09-27 0001681622 currency:JPY us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-09-27 0001681622 currency:EUR us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-09-27 0001681622 currency:CNY us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-09-27 0001681622 currency:CHF us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-09-27 0001681622 currency:EUR us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-09-27 0001681622 currency:CNY us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-09-27 0001681622 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-09-27 0001681622 currency:JPY us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-09-27 0001681622 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-29 2019-09-27 0001681622 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-09-30 2018-09-28 0001681622 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-10-01 2017-09-29 0001681622 us-gaap:SecuredDebtMember 2019-09-27 0001681622 vrex:OtherDebtMember 2019-09-27 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2018-09-29 2019-09-27 0001681622 us-gaap:SecuredDebtMember 2018-09-29 2019-09-27 0001681622 us-gaap:SecuredDebtMember 2018-09-28 0001681622 us-gaap:SecuredDebtMember 2017-09-30 2018-09-28 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2017-09-30 2018-09-28 0001681622 vrex:OtherDebtMember 2018-09-28 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2019-09-27 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2018-09-28 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2018-10-10 0001681622 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:LondonInterbankOfferedRateLIBORMember 2017-05-01 2017-05-01 0001681622 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:BaseRateMember 2017-05-01 2017-05-01 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member vrex:DebtInstrumentRepaymentPeriodOneMember 2017-05-01 2017-05-01 0001681622 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:BaseRateMember 2017-05-01 2017-05-01 0001681622 vrex:RevolvingCreditFacilityMay2017Member 2017-05-01 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member 2017-05-01 2017-05-01 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member vrex:DebtInstrumentRepaymentPeriodThreeMember 2017-05-01 2017-05-01 0001681622 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2017-05-01 2017-05-01 0001681622 vrex:RevolvingCreditFacilityMay2017Member us-gaap:SubsequentEventMember 2019-10-08 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member vrex:DebtInstrumentRepaymentPeriodFiveMember 2017-05-01 2017-05-01 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:LondonInterbankOfferedRateLIBORMember 2017-05-01 2017-05-01 0001681622 vrex:RevolvingCreditFacilityMay2017Member us-gaap:SubsequentEventMember 2019-10-08 2019-10-08 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2018-10-10 2018-10-10 0001681622 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:LondonInterbankOfferedRateLIBORMember 2017-05-01 2017-05-01 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2017-05-01 0001681622 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2017-05-01 2017-05-01 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:FederalFundsEffectiveSwapRateMember 2017-05-01 2017-05-01 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2017-05-01 2017-05-01 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member vrex:DebtInstrumentRepaymentPeriodTwoMember 2017-05-01 2017-05-01 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member vrex:DebtInstrumentRepaymentPeriodFourMember 2017-05-01 2017-05-01 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member vrex:DebtInstrumentRepaymentPeriodFourMember 2017-01-25 2017-01-25 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member vrex:DebtInstrumentRepaymentPeriodTwoMember 2017-01-25 2017-01-25 0001681622 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-27 0001681622 us-gaap:FairValueMeasurementsRecurringMember 2019-09-27 0001681622 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-27 0001681622 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-27 0001681622 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-09-28 0001681622 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-09-28 0001681622 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-09-28 0001681622 us-gaap:FairValueMeasurementsRecurringMember 2018-09-28 0001681622 us-gaap:IntellectualPropertyMember 2018-09-28 0001681622 vrex:CustomerContractsandSupplierRelationshipsMember 2019-09-27 0001681622 us-gaap:DevelopedTechnologyRightsMember 2018-09-28 0001681622 us-gaap:IntellectualPropertyMember 2019-09-27 0001681622 us-gaap:DevelopedTechnologyRightsMember 2019-09-27 0001681622 vrex:CustomerContractsandSupplierRelationshipsMember 2018-09-28 0001681622 vrex:MedicalMember 2018-09-29 2019-09-27 0001681622 vrex:IndustrialMember 2018-09-29 2019-09-27 0001681622 vrex:IndustrialMember 2019-09-27 0001681622 vrex:MedicalMember 2018-09-28 0001681622 vrex:IndustrialMember 2018-09-28 0001681622 vrex:MedicalMember 2019-09-27 0001681622 vrex:JointVentureInSaudiArabiaMember 2018-09-28 0001681622 vrex:MeVisMedicalSolutionsAGMeVisMember 2015-04-30 0001681622 vrex:MeVisMedicalSolutionsAGMeVisMember 2019-09-27 0001681622 vrex:MeVisMedicalSolutionsAGMeVisMember vrex:MeVisMedicalSolutionsAGMeVisMember 2019-09-27 0001681622 vrex:MeVisMedicalSolutionsAGMeVisMember 2015-10-31 0001681622 vrex:MeVisMedicalSolutionsAGMeVisMember 2015-10-01 2015-10-31 0001681622 us-gaap:EmployeeStockMember vrex:A2017ESPPMember 2017-01-01 2017-01-31 0001681622 us-gaap:EmployeeStockOptionMember vrex:A2017ESPPMember 2019-09-27 0001681622 us-gaap:EmployeeStockOptionMember vrex:A2017OmnibusStockPlanMember 2019-09-27 0001681622 us-gaap:EmployeeStockOptionMember 2019-09-27 0001681622 us-gaap:EmployeeStockMember vrex:A2017ESPPMember 2018-09-29 2019-09-27 0001681622 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2018-09-29 2019-09-27 0001681622 us-gaap:EmployeeStockMember vrex:A2017ESPPMember 2017-01-31 0001681622 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:MajorityShareholderMember 2016-10-01 2017-09-29 0001681622 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2018-09-29 2019-09-27 0001681622 us-gaap:EmployeeStockMember 2018-09-29 2018-12-28 0001681622 us-gaap:EmployeeStockMember 2018-09-29 2019-09-27 0001681622 us-gaap:EmployeeStockOptionMember 2018-09-29 2019-09-27 0001681622 us-gaap:EmployeeStockOptionMember 2017-09-30 2017-12-29 0001681622 us-gaap:EmployeeStockOptionMember 2018-09-29 2018-12-28 0001681622 us-gaap:EmployeeStockMember 2017-09-30 2017-12-29 0001681622 us-gaap:CostOfSalesMember 2016-10-01 2017-09-29 0001681622 us-gaap:ResearchAndDevelopmentExpenseMember 2017-09-30 2018-09-28 0001681622 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-09-29 2019-09-27 0001681622 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-10-01 2017-09-29 0001681622 us-gaap:CostOfSalesMember 2018-09-29 2019-09-27 0001681622 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-09-30 2018-09-28 0001681622 us-gaap:ResearchAndDevelopmentExpenseMember 2016-10-01 2017-09-29 0001681622 us-gaap:CostOfSalesMember 2017-09-30 2018-09-28 0001681622 us-gaap:ResearchAndDevelopmentExpenseMember 2018-09-29 2019-09-27 0001681622 srt:MaximumMember 2019-09-27 0001681622 srt:MinimumMember 2019-09-27 0001681622 srt:MaximumMember 2018-09-28 0001681622 srt:MinimumMember 2018-09-28 0001681622 us-gaap:OperatingSegmentsMember 2019-09-27 0001681622 us-gaap:OperatingSegmentsMember vrex:MedicalMember 2019-09-27 0001681622 us-gaap:OperatingSegmentsMember vrex:MedicalMember 2018-09-28 0001681622 us-gaap:OperatingSegmentsMember vrex:IndustrialMember 2019-09-27 0001681622 us-gaap:OperatingSegmentsMember vrex:IndustrialMember 2018-09-28 0001681622 us-gaap:OperatingSegmentsMember 2018-09-28 0001681622 srt:LatinAmericaMember 2018-09-29 2019-09-27 0001681622 us-gaap:EMEAMember 2018-09-29 2019-09-27 0001681622 us-gaap:EMEAMember 2018-09-28 0001681622 srt:LatinAmericaMember 2017-09-30 2018-09-28 0001681622 srt:AsiaPacificMember 2018-09-29 2019-09-27 0001681622 srt:AsiaPacificMember 2016-10-01 2017-09-29 0001681622 srt:AsiaPacificMember 2019-09-27 0001681622 country:US 2019-09-27 0001681622 us-gaap:EMEAMember 2019-09-27 0001681622 country:US 2018-09-29 2019-09-27 0001681622 srt:LatinAmericaMember 2018-09-28 0001681622 country:US 2016-10-01 2017-09-29 0001681622 srt:LatinAmericaMember 2016-10-01 2017-09-29 0001681622 srt:LatinAmericaMember 2019-09-27 0001681622 us-gaap:EMEAMember 2016-10-01 2017-09-29 0001681622 country:US 2018-09-28 0001681622 country:US 2017-09-30 2018-09-28 0001681622 srt:AsiaPacificMember 2018-09-28 0001681622 us-gaap:EMEAMember 2017-09-30 2018-09-28 0001681622 srt:AsiaPacificMember 2017-09-30 2018-09-28 0001681622 vrex:IndustrialMember 2017-09-30 2018-09-28 0001681622 vrex:MedicalMember 2017-09-30 2018-09-28 0001681622 vrex:IndustrialMember 2016-10-01 2017-09-29 0001681622 vrex:MedicalMember 2016-10-01 2017-09-29 0001681622 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2019-09-27 0001681622 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-09-29 2019-09-27 0001681622 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-09-28 0001681622 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-09-27 0001681622 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-09-29 2019-09-27 0001681622 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-09-28 0001681622 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-09-27 0001681622 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-09-28 0001681622 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-09-29 2019-09-27 0001681622 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-09-28 0001681622 2018-09-29 0001681622 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-09-29 0001681622 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2019-09-27 0001681622 2019-09-28 2019-09-27 0001681622 vrex:ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2020-06-09 0001681622 vrex:ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2020-06-09 2020-06-09 0001681622 vrex:ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2020-06-04 0001681622 vrex:ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2020-06-04 2020-06-05 0001681622 us-gaap:SubsequentEventMember 2020-06-04 2020-06-05 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:SubsequentEventMember 2020-06-06 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:SubsequentEventMember 2019-10-08 2019-10-08 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:SubsequentEventMember 2019-10-08 iso4217:USD iso4217:USD xbrli:shares xbrli:pure vrex:member xbrli:shares vrex:entity vrex:employee vrex:segment vrex:derivative iso4217:EUR xbrli:shares vrex:day utreg:Rate


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
  ___________________________________
FORM 8-K
 ___________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 22, 2020
  ___________________________________
VAREX IMAGING CORPORATION
(Exact name of registrant as specified in its charter)
 ___________________________________
Delaware
(State or other jurisdiction of incorporation or organization)
001-37860
 
81-3434516
(Commission File Number)
 
(I.R.S. Employer
Identification Number)
 
 
 
 
1678 S. Pioneer Road,
Salt Lake City,
Utah
 
84104
 
 
 
 
(Zip Code)
Registrant’s telephone number, including area code: (801) 972-5000
Not Applicable
(Former name or former address, if changed since last report)
 ___________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock
VREX
The Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b - 2 of the Securities Exchange Act of 1934. Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 8.01
Other Events

As previously reported within Form 10-Q for the quarter ended July 3, 2020 filed on August 14, 2020 (“Form 10-Q”) Varex Imaging Corporation (the “Company”) experienced reduced demand in the Company’s industrial segment and for certain higher end medical products that negatively impacted revenues and gross margin and as a result of the economic downturn resulting from COVID-19. The Company’s Credit Agreement contains financial covenants, including certain leverage ratio covenants. The Company was in compliance with all financial covenants as of July 3, 2020. However, based on the Company’s current forecasts, it was probable that the Company would be in violation of certain leverage ratio covenants contained in its Credit Agreement within the twelve-month period following the issuance of those financial statements, including as early as the end of the Company's fiscal year end 2020. Failure to comply with the covenants, if not amended or waived, would result in an event of default under the Credit Agreement and the acceleration of the outstanding balance of the loans thereunder and cross defaults and accelerations under other agreements. As a result, the Company’s Form 10-Q reported that these events and conditions raise substantial doubt about the Company’s ability to continue as a going concern within the twelve-month period following the issuance of those financial statements.

In Exhibit 99.1 to this Current Report on Form 8-K (i) the Company, in anticipation of certain financing transactions, updated Note 1 of its consolidated financial statements (“Financial Statements”) in its Annual Report on Form 10-K for the year ended September 27, 2019 (the “2019 Form 10-K”) to add an “Impact of COVID-19” discussion as previously disclosed in the Form 10-Q and updated Note 19 to add a discussion of its debt financing activities since December 20, 2019 and (ii) the Company’s independent registered public accounting firm reissued its report contained in the 2019 Form 10-K to include a paragraph noting management’s conclusion regarding the Company’s ability to continue as a going concern. Other than as described in the preceding sentences, Exhibit 99.1 does not revise, modify, update or otherwise affect the 2019 Form 10-K, including the Financial Statements. This Form 8-K and Exhibit 99.1 should be read in conjunction with our other filings made with the SEC, including, and subsequent to, the date of the 2019 Form 10-K.

Item 9.01
Financial Statements and Exhibits
(d)     Exhibits

Exhibit No.
Description
23.1
99.1
101
The following materials from Varex Imaging Corporation’s Annual Report on Form 10-K for the year ended September 27, 2019, filed with the Securities and Exchange Commission on December 20, 2019, as revised by this Current Report on Form 8-K, formatted in Inline XBRL:
(i)  the Consolidated Statements of Operations of the Company for the years ended September 27, 2019, September 28, 2018 and September 29, 2017;
(ii)  the Consolidated Statements of Comprehensive Income of the Company for the years ended September 27, 2019, September 28, 2018 and September 29, 2017;
(iii)  the Consolidated Balance Sheets of the Company as of September 27, 2019 and September 28, 2018;
(iv)  the Consolidated Statements of Cash Flows of the Company for the years ended September 27, 2019, September 28, 2018 and September 29, 2017;
(v)  the Consolidated Statements of Changes in Shareholders’ Equity of the Company for the years ended September 27, 2019, September 28, 2018 and September 29, 2017; and
(vi)  the Notes to the Consolidated Financial Statements.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)







SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 
 
VAREX IMAGING CORPORATION
 
 
 
Dated: September 22, 2020
By:
/s/ Kimberley E. Honeysett
 
 
Kimberley E. Honeysett
 
 
Senior Vice President, General Counsel and Corporate Secretary


 EX-23.1 2 exhibit231-auditorcons.htm EXHIBIT 23.1 Exhibit


Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (Nos. 333-215770, 333-236487, and 333-215770) of Varex Imaging Corporation of our report dated December 20, 2019, except with respect to our opinion on the consolidated financial statements insofar as it relates to the matters that raise substantial doubt about the Company’s ability to continue as a going concern discussed in Note 1, as to which the date is September 22, 2020, relating to the consolidated financial statements, and the effectiveness of internal control over financial reporting, which appears in this Current Report on Form 8-K.

/s/ PricewaterhouseCoopers LLP
Salt Lake City, Utah
September 22, 2020


EX-99.1 3 exhibit991-financialst.htm EXHIBIT 99.1 Exhibit

PART IV 
Exhibit 99.1
VAREX IMAGING CORPORATION
EXHIBIT 99.1 TO FORM 8-K
FOR THE YEAR ENDED DECEMBER 31, 2019

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS



1



Report of Independent Registered Public Accounting Firm

To the Board of Directors and Stockholders of Varex Imaging Corporation

Opinions on the Financial Statements and Internal Control over Financial Reporting

We have audited the accompanying consolidated balance sheets of Varex Imaging Corporation and its subsidiaries (the “Company”) as of September 27, 2019 and September 28, 2018, and the related consolidated statements of earnings, of comprehensive earnings, of equity and of cash flows for each of the three years in the period ended September 27, 2019, including the related notes (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of September 27, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of September 27, 2019 and September 28, 2018, and the results of its operations and its cash flows for each of the three years in the period ended September 27, 2019 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company did not maintain, in all material respects, effective internal control over financial reporting as of September 27, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO because material weaknesses in internal control over financial reporting existed as of that date related to (i) ineffective risk assessment process to identify and assess the risks in the Company’s business processes, (ii) ineffective control environment as the Company had an insufficient complement of resources with the requisite knowledge and experience to create the proper environment for effective internal control over financial reporting such that corrective activities to the Company’s internal control over financial reporting are appropriately applied, prioritized, and implemented in a timely manner, (iii) ineffective controls related to accounting for revenue, deferred revenue and related accounts receivable, including maintaining effective business process controls to prevent or detect misstatements in the processing of customer transactions, and the effect of the adoption of and continuous accounting for Revenue from Contracts with Customers, (iv) ineffective controls related to accounting for inventory and cost of revenues, including maintaining effective business process controls to prevent or detect misstatements in the accuracy, valuation, presentation and disclosure of inventory, and (v) ineffective controls over the Company’s financial reporting close process to prevent or detect misstatements in the financial statements, including ineffective business performance monitoring review control over the Company’s international entities, ineffective controls related to elimination of intercompany balances, ineffective controls to identify post-close events which occur before the financial statements are available to be issued, and ineffective controls over the review of the statement of cash flows.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. The material weaknesses referred to above are described in Management’s Annual Report on Internal Control Over Financial Reporting (not presented herein) appearing under Item 9A of the Company's 2019 Annual Report on Form 10-K. We considered these material weaknesses in determining the nature, timing, and extent of audit tests applied in our audit of the September 27, 2019 consolidated financial statements, and our opinion regarding the effectiveness of the Company’s internal control over financial reporting does not affect our opinion on those consolidated financial statements.

Substantial Doubt about the Company’s Ability to Continue as a Going Concern
The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, due to the impact of COVID-19, the Company has begun to experience and expects to continue to experience reduced demand in the Company’s industrial segment and for certain higher end medical products which negatively impacts revenues, gross margin, and the other items used to calculate the Company’s financial covenants contained in its Credit Agreement. As a result, it is probable that the Company will be in violation of certain leverage ratio covenants contained in its Credit Agreement within the twelve-month period following the reissuance of these consolidated financial statements, including as early as the end of the Company’s fiscal year end 2020. These events and conditions raise substantial doubt about the Company’s ability to continue as a going concern within the twelve-month period following the issuance of these consolidated financial statements. Management's plans in regard to these matters are also described in Note 1. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Change in Accounting Principle
As discussed in Note 18 to the consolidated financial statements, the Company changed the manner in which it accounts for revenue effective September 29, 2018. This matter is also described in the “Critical Audit Matters” section of our report.

F-1




Basis for Opinions

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in management's report referred to above. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

As described in Management’s Annual Report on Internal Control Over Financial Reporting (not presented herein), management has excluded Direct Conversion AB from its assessment of internal control over financial reporting as of September 27, 2019 because it was acquired by the Company in a purchase business combination during the fiscal year ended September 27, 2019. We have also excluded Direct Conversion AB from our audit of internal control over financial reporting. Direct Conversion AB is a wholly-owned subsidiary whose total assets and total revenues excluded from management’s assessment and our audit of internal control over financial reporting represent 0.8% and 0.8%, respectively, of the related consolidated financial statement amounts as of and for the year ended September 27, 2019.

Definition and Limitations of Internal Control over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.  

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that (i) relate to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

F-2




Consolidated Financial Statements – Impact of Resources and Controls Related to Risk Assessment and Financial Reporting
 
The completeness and accuracy of the consolidated financial statements, including the financial condition, results of operations and cash flows, is dependent on, in part, (i) designing and maintaining monitoring controls related to the identification and assessment of risk in the business process environment, (ii) designing and maintaining financial reporting controls, including information technology general controls, and financial reporting close controls related to review of international operations, intercompany balances, post-close events and the statement of cash flows, and (iii) maintaining sufficient resources to create the proper environment for effective internal control over financial reporting.

The principal considerations for our determination that performing procedures relating to the consolidated financial statements – impact of resources and controls related to risk assessment and financial reporting is a critical matter are there was a high degree of auditor judgment, subjectivity and effort in performing procedures and evaluating audit evidence related to information systems and businesses processes, which affect substantially all financial statement account balances and disclosures. As described above in the “Opinions on the Financial Statements and Internal Control over Financial Reporting” section, material weaknesses were identified as of September 27, 2019 related to (i) ineffective risk assessment, (ii) ineffective control environment, and (iii) the financial reporting close process. Additionally, as previously disclosed by management, material weaknesses related to (i) information technology general controls and (ii) accounting for the Company’s operations in Germany existed during the year ended September 27, 2019.
 
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the financial statements. These procedures included, among others, evaluating the nature and extent of audit procedures performed and evidence obtained. These procedures also included manually testing the completeness and accuracy of system reports or other information generated by the Company's Information Technology (IT) systems.

Revenue Recognition, including Adoption of the New Revenue Accounting Standard

As described in Notes 1 and 18 to the consolidated financial statements, the Company’s consolidated revenue was $780.6 million for the year ended September 27, 2019. As described above, effective September 29, 2018, the Company adopted the new revenue accounting standard. The Company determines revenue recognition through the following steps: identification of the contract, or contracts, with a customer, identification of the performance obligations in the contract, determination of the transaction price, allocation of the transaction price to the performance obligations in the contract, and recognition of revenue when, or as, a performance obligation is satisfied. The Company’s revenues are derived primarily from the sale of hardware and services and are recognized net of any value-added or sales tax and net of sales discounts.
The principal considerations for our determination that performing procedures relating to revenue recognition, including adoption of the new revenue accounting standard, is a critical audit matter are there was a high degree of auditor judgment, subjectivity and effort in performing procedures and in evaluating the audit evidence obtained related to revenue recognition, including the adoption of the new revenue accounting standard. As described above in the “Opinions on the Financial Statements and Internal Control over Financial Reporting” section, a material weakness was identified as of September 27, 2019 related to the accounting for revenue, deferred revenue and related accounts receivable, specifically including the review of the completeness and accuracy of customer order entry, quantity and pricing, and the effect of the adoption of and continuous accounting for revenue from contracts with customers.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included, among others, evaluating management’s process for determining the application of the new revenue accounting standard to the Company’s revenue, evaluating the reasonableness of management’s judgments, and evaluating the impacts of adoption identified by management. Testing management’s application of the new revenue accounting standard included examining revenue arrangements on a test basis, including assessing the terms and conditions of the arrangement and performing procedures to test the adjustments recorded upon adoption. These procedures also included (i) manually testing the completeness and accuracy of system reports or other information generated by the Company’s IT systems and (ii) evaluating the nature and extent of audit procedures performed and evidence obtained.
Inventories
As described in Note 1 to the consolidated financial statements, the Company’s consolidated inventory balance was $248.2 million as of September 27, 2019. The Company values inventories at the lower of cost or net realizable value. Costs include materials, labor and manufacturing overhead and is computed using standard cost (which approximates actual cost) on a first-in-first-out basis. The

F-3



Company evaluates the carrying value of its inventories taking into consideration such factors as historical and anticipated future sales compared to quantities on hand and the prices the Company expects to obtain for products in its various markets. The Company adjusts excess and obsolete inventories to net realizable value and write-downs of excess and obsolete inventories are recorded as a component of cost of revenues.
The principal considerations for our determination that performing procedures relating to inventories is a critical audit matter are there was a high degree of auditor judgment, subjectivity and effort in performing procedures and in evaluating audit evidence related to the existence and valuation of inventory. As described above in the “Opinions on the Financial Statements and Internal Control over Financial Reporting” section, a material weakness was identified as of September 27, 2019 related to accounting for inventory and cost of revenue, specifically including maintaining effective controls related to inventory count procedures, the valuation of inventory at lower of cost and net realizable value, and presentation and disclosure of inventory classifications.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included, among others, performing procedures to test the existence of inventories and evaluating and testing management’s process for determining the valuation of inventories. These procedures also included (i) manually testing the completeness and accuracy of system reports or other information generated by the Company’s IT systems and (ii) evaluating the nature and extent of audit procedures performed and evidence obtained.
Acquisition of Direct Conversion AB – Intangible Assets

As described in Note 2 to the consolidated financial statements, the Company completed the acquisition of Direct Conversion AB for net consideration of $79.4 million in 2019, which resulted in $32.9 million of intangible assets being recorded. Those intangible assets were comprised primarily of developed technology of $18.4 million and customer relationships of $9.0 million. Intangibles were valued primarily using a discounted cash flow, which included estimated revenue growth and discount rate.
The principal considerations for our determination that performing procedures relating to the intangible assets recorded with the acquisition of Direct Conversion AB is a critical audit matter are there was a high degree of auditor judgment and subjectivity in applying procedures relating to the fair value measurement of intangible assets acquired due to the significant judgment by management when developing the fair value of the intangible assets. Significant audit effort was required in performing procedures to evaluate the discounted cash flow, the estimated revenue growth, and the discount rate. The audit effort also involved the use of professionals with specialized skill and knowledge.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the financial statements. These procedures included testing the effectiveness of controls relating to the acquisition accounting, including controls over management’s valuation of intangible assets and controls over development of the assumptions related to the valuation of intangible assets, including discounted cash flow, estimated revenue growth, and the discount rate. These procedures also included, among others (i) reading the purchase agreement, (ii) testing management’s process for estimating the fair value of intangible assets, and (iii) testing the completeness and accuracy of the data used in the discounted cash flow and evaluating the reasonableness of significant assumptions, including the discounted cash flow, the estimated revenue growth and the discount rate. Evaluating the reasonableness of the discounted cash flow, including the revenue growth, involved considering the past performance of the acquired business, as well as economic and industry forecasts, and considering whether they were consistent with evidence obtained in other areas of the audit. Professionals with specialized skill and knowledge were used to assist in evaluating the appropriateness of the valuation methods and evaluating significant assumptions, including the discount rate.



/s/ PricewaterhouseCoopers LLP

Salt Lake City, Utah
December 20, 2019, except with respect to our opinion on the consolidated financial statements insofar as it relates to the matters that raise substantial doubt about the Company’s ability to continue as a going concern discussed in Note 1, as to which the date is September 22, 2020.

We have served as the Company’s auditor since 2016.



F-4

VAREX IMAGING CORPORATION
CONSOLIDATED STATEMENTS OF EARNINGS


 
Fiscal Years
(In millions, except per share amounts)
2019
 
2018
 
2017
Revenues, net
$
780.6

 
$
773.4

 
$
698.1

Cost of revenues
523.9

 
519.5

 
444.6

Gross margin
256.7

 
253.9

 
253.5

Operating expenses:
 
 
 
 
 
Research and development
78.1

 
83.0

 
67.3

Selling, general and administrative
128.1

 
123.4

 
102.5

Impairment of intangible assets
4.8

 
3.0

 
—

Total operating expenses
211.0

 
209.4

 
169.8

Operating earnings
45.7

 
44.5

 
83.7

Interest income
0.1

 
0.2

 
0.2

Interest expense
(21.1
)
 
(21.7
)
 
(12.3
)
Other (expense) income, net
(3.2
)
 
2.7

 
3.2

Interest and other expenses, net
(24.2
)
 
(18.8
)
 
(8.9
)
Earnings before taxes
21.5

 
25.7

 
74.8

Taxes (benefit) on earnings
5.7

 
(2.6
)
 
22.8

Net earnings
15.8

 
28.3

 
52.0

Less: Net earnings attributable to noncontrolling interests
0.3

 
0.8

 
0.4

Net earnings attributable to Varex
$
15.5

 
$
27.5

 
$
51.6

Net earnings per common share attributable to Varex
 
 
 
 
 
Basic
$
0.41

 
$
0.73

 
$
1.37

Diluted
$
0.40

 
$
0.72

 
$
1.36

Weighted average common shares outstanding
 
 
 
 
 
Basic
38.2

 
37.9

 
37.6

Diluted
38.6

 
38.4

 
38.0


See accompanying notes to the consolidated financial statements.


F-5

VAREX IMAGING CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS


 
Fiscal Years
(In millions)
2019
 
2018
 
2017
Net earnings
$
15.8

 
$
28.3

 
$
52.0

Other comprehensive (loss) earnings, net of tax:
 
 
 
 
 
Unrealized (loss) gain on interest rate swap contracts
(6.2
)
 
5.2

 
0.6

Unrealized (loss) gain on defined benefit obligations
(1.3
)
 
(0.2
)
 
0.2

Other comprehensive (loss) earnings, net of tax
(7.5
)
 
5.0

 
0.8

Comprehensive earnings
8.3

 
33.3

 
52.8

Less: Comprehensive earnings attributable to noncontrolling interests
0.3

 
0.8

 
0.4

Comprehensive earnings attributable to Varex
$
8.0

 
$
32.5

 
$
52.4




See accompanying notes to the consolidated financial statements.


F-6

VAREX IMAGING CORPORATION
CONSOLIDATED BALANCE SHEETS

(In millions, except share amounts)
September 27, 2019
 
September 28, 2018
Assets
 
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
29.9

 
$
51.9

Accounts receivable, net of allowance for doubtful accounts of $1.0 and $0.6 at September 27, 2019 and September 28, 2018, respectively
141.0

 
154.0

Inventories
248.2

 
235.1

Prepaid expenses and other current assets
19.3

 
17.1

Total current assets
$
438.4

 
$
458.1

Property, plant and equipment, net
142.3

 
144.9

Goodwill
290.8

 
243.6

Intangibles assets, net
86.3

 
73.8

Investments in privately-held companies
53.6

 
51.0

Other assets
27.5

 
16.5

Total assets
$
1,038.9

 
$
987.9

Liabilities, redeemable noncontrolling interests and stockholders' equity
 
 
 
Current liabilities:
 
 
 
Accounts payable
$
58.2

 
$
66.3

Accrued liabilities
75.7

 
47.5

Current maturities of long-term debt
30.7

 
25.0

Deferred revenues
10.5

 
13.2

Total current liabilities
$
175.1

 
$
152.0

Long-term debt, net
364.4

 
364.8

Deferred tax liabilities
8.2

 
23.2

Other long-term liabilities
32.5

 
8.5

Total liabilities
$
580.2

 
$
548.5

Commitments and contingencies (Note 11)

 

Redeemable noncontrolling interests
10.5

 
11.1

Equity:
 
 
 
Preferred stock, $.01 par value: 20,000,000 shares authorized, none issued
—

 
—

Common stock, $.01 par value: 150,000,000 shares authorized
 
 
 
Shares issued and outstanding: 38,371,305 and 38,026,597 at September 27, 2019 and September 28, 2018, respectively
0.4

 
0.4

Additional paid-in capital
371.8

 
357.6

Accumulated other comprehensive (loss) income
(1.7
)
 
5.8

Retained earnings
74.4

 
62.4

Total Varex stockholders' equity
$
444.9

 
$
426.2

Noncontrolling interests
3.3

 
2.1

Total stockholders' equity
$
448.2

 
$
428.3

Total liabilities, redeemable noncontrolling interests and stockholders' equity
$
1,038.9

 
$
987.9

See accompanying notes to the consolidated financial statements.

F-7

VAREX IMAGING CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
Fiscal Years
(In millions)
2019
 
2018
 
2017
Cash flows from operating activities:
 
 
 
 
 
Net earnings
$
15.8

 
$
28.3

 
$
52.0

Adjustments to reconcile net earnings to net cash provided by operating activities:
 
 
 
 
 
Share-based compensation expense
11.7

 
10.0

 
8.4

Depreciation
23.5

 
26.0

 
16.9

Amortization of intangible assets
15.7

 
16.2

 
10.5

Impairment of intangible assets
4.8

 
3.0

 
—

Other assets impairment charges
—

 
1.3

 
—

Inventory write-down
3.1

 
3.1

 
—

Deferred taxes
(12.9
)
 
(7.7
)
 
(8.9
)
Amortization of deferred loan costs
2.4

 
2.3

 
1.8

Loss (gain) from equity method investments, net of dividends received
2.3

 
(3.9
)
 
(1.3
)
Other, net
0.8

 
0.7

 
1.8

Changes in assets and liabilities, net of effects of acquisitions:
 
 
 
 
 
Accounts receivable
14.8

 
9.0

 
(23.1
)
Inventories
(11.1
)
 
(2.4
)
 
(4.2
)
Prepaid expenses and other assets
4.3

 
2.0

 
(10.1
)
Accounts payable
(9.0
)
 
5.2

 
4.9

Accrued operating liabilities and other long-term operating liabilities
10.9

 
(10.2
)
 
28.1

Deferred revenues
(5.2
)
 
2.4

 
(1.6
)
Net cash provided by operating activities
71.9

 
85.3

 
75.2

Cash flows from investing activities:
 
 
 
 
 
Purchases of property, plant and equipment
(19.8
)
 
(20.4
)
 
(20.2
)
Acquisitions of businesses, net of cash acquired
(69.5
)
 
(4.8
)
 
(271.8
)
Investments in privately-held companies
(3.9
)
 
—

 
—

Net cash used in investing activities
(93.2
)
 
(25.2
)
 
(292.0
)
Cash flows from financing activities:
 
 
 
 
 
Net transfers from parent
—

 
—

 
5.0

Distributions to Varian Medical Systems, Inc.
—

 
—

 
(227.1
)
Taxes related to net share settlement of equity awards
(2.1
)
 
(2.3
)
 
(1.9
)
Borrowings under credit agreements
85.4

 
10.0

 
749.0

Repayments of borrowing under credit agreements
(87.0
)
 
(106.0
)
 
(255.0
)
Proceeds from exercise of stock options
0.8

 
3.8

 
2.8

Proceeds from shares issued under employee stock purchase plan
3.8

 
3.3

 
—

Excess tax benefits from share-based compensation
—

 
—

 
2.4

Payment of debt issuance costs
(0.5
)
 
(0.4
)
 
(11.9
)
Contributions from noncontrolling partner
—

 
1.8

 
—

Dividends paid to redeemable noncontrolling interest
(0.5
)
 
(0.6
)
 
—

Net cash (used in) provided by financing activities
(0.1
)
 
(90.4
)
 
263.3

Effects of exchange rate changes on cash and cash equivalents and restricted cash
(0.7
)
 
(0.5
)
 
0.9

Net (decrease) increase in cash and cash equivalents and restricted cash
(22.1
)
 
(30.8
)
 
47.4

Cash and cash equivalents and restricted cash at beginning of period
53.4

 
84.2

 
36.8

Cash and cash equivalents and restricted cash at end of period
$
31.3

 
$
53.4

 
$
84.2

Supplemental cash flow information:
 
 
 
 
 
Cash paid for interest
$
19.9

 
$
19.3

 
$
9.8

Cash paid for income tax
8.2

 
13.8

 
6.0

Supplemental non-cash activities:
 
 
 
 
 
Purchases of property, plant and equipment financed through accounts payable
$
1.8

 
$
2.0

 
$
4.0

Transfers of property, plant and equipment from Varian Medical Systems, Inc.
—

 
—

 
15.0

Other non-cash transfers to Varian Medical Systems, Inc.
—

 
—

 
1.6

See accompanying notes to the consolidated financial statements.

F-8

VAREX IMAGING CORPORATION
CONSOLIDATED STATEMENTS OF EQUITY

 
 
Common Stock
 
Additional Paid-in Capital
 
Net Parent Investment
 
Accumulated Other Comprehensive Income (Loss)
 
Retained Earnings
 
Total Varex Equity
 
Noncontrolling Interests
 
Total Stockholders' Equity
(In millions)
 
Shares
 
Amount
 
 
 
 
 
 
 
September 30, 2016
 
—

 
—

 
—

 
526.0

 
—

 
—

 
526.0

 
—

 
526.0

Net earnings
 
—

 
—

 
—

 
16.5

 
—

 
35.1

 
51.6

 
—

 
51.6

Net transfers from parent
 
—

 
—

 
—

 
18.4

 
—

 
—

 
18.4

 
—

 
18.4

Distribution to Varian Medical Systems
 
—

 
—

 
—

 
(227.1
)
 
—

 
—

 
(227.1
)
 
—

 
(227.1
)
Conversion of net parent investment into common stock
 
37.4

 
0.4

 
333.4

 
(333.8
)
 
—

 
—

 
—

 
—

 
—

Exercise of stock options
 
0.1

 
—

 
2.8

 
—

 
—

 
—

 
2.8

 
—

 
2.8

Common stock issued upon vesting of restricted shares
 
0.2

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

Shares withheld on vesting of restricted stock
 
(0.1
)
 
—

 
(1.9
)
 
—

 
—

 
—

 
(1.9
)
 
—

 
(1.9
)
Share-based compensation
 
—

 
—

 
6.2

 
—

 
—

 
—

 
6.2

 
—

 
6.2

Unrealized gain on interest rate swap contracts, net of tax
 
—

 
—

 
—

 
—

 
0.6

 
—

 
0.6

 
—

 
0.6

Unrealized gain on defined benefit obligations, net of tax
 
—

 
—

 
—

 
—

 
0.2

 
—

 
0.2

 
—

 
0.2

Tax impacts to APIC related to share-based award activity
 
—

 
—

 
2.4

 
—

 
—

 
—

 
2.4

 
—

 
2.4

Other
 
—

 
—

 
(0.2
)
 
—

 
—

 
—

 
(0.2
)
 
—

 
(0.2
)
September 29, 2017
 
37.6

 
0.4

 
342.7

 
—

 
0.8

 
35.1

 
379.0

 
—

 
379.0

Net earnings
 
—

 
—

 
—

 
—

 
—

 
27.5

 
27.5

 
0.3

 
27.8

Exercise of stock options
 
0.2

 
—

 
3.8

 
—

 
—

 
—

 
3.8

 
—

 
3.8

Common stock issued upon vesting of restricted shares
 
0.2

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

Shares withheld on vesting of restricted stock
 
(0.1
)
 
—

 
(2.2
)
 
—

 
—

 
—

 
(2.2
)
 
—

 
(2.2
)
Common stock issued under employee stock purchase plan
 
0.1

 
 
 
3.3

 
—

 
—

 
—

 
3.3

 
—

 
3.3

Share-based compensation
 
—

 
—

 
10.0

 
—

 
—

 
—

 
10.0

 
—

 
10.0

Unrealized gain on interest rate swap contracts, net of tax
 
—

 
—

 
—

 
—

 
5.2

 
—

 
5.2

 
—

 
5.2

Unrealized loss on defined benefit obligations, net of tax
 
—

 
—

 
—

 
—

 
(0.2
)
 
—

 
(0.2
)
 
—

 
(0.2
)
Capital contribution by noncontrolling interest
 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
1.8

 
1.8

Other
 
—

 
—

 
—

 
—

 
—

 
(0.2
)
 
(0.2
)
 
—

 
(0.2
)
September 28, 2018
 
38.0

 
$
0.4

 
$
357.6

 
$
—

 
$
5.8

 
$
62.4

 
$
426.2

 
$
2.1

 
$
428.3

Effect of adoption of ASC 606
 
—

 
—

 
—

 
—

 
—

 
(3.5
)
 
(3.5
)
 
—

 
(3.5
)
Net earnings
 
—

 
—

 
—

 
—

 
—

 
15.5

 
15.5

 
(0.2
)
 
15.3

Exercise of stock options
 
—

 
—

 
0.8

 
—

 
—

 
—

 
0.8

 
—

 
0.8

Common stock issued upon vesting of restricted shares
 
0.2

 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
—

Shares withheld on vesting of restricted stock
 
—

 
—

 
(2.1
)
 
—

 
—

 
—

 
(2.1
)
 
—

 
(2.1
)
Common stock issued under employee stock purchase plan
 
0.2

 
—

 
3.8

 
—

 
—

 
—

 
3.8

 
—

 
3.8

Share-based compensation
 
—

 
—

 
11.7

 
—

 
—

 
—

 
11.7

 
—

 
11.7

Unrealized loss on interest rate swap contracts, net of tax
 
—

 
—

 
—

 
—

 
(6.2
)
 
—

 
(6.2
)
 
—

 
(6.2
)
Unrealized loss on defined benefit obligations, net of tax
 
—

 
—

 
—

 
—

 
(1.3
)
 
—

 
(1.3
)
 
—

 
(1.3
)
Noncontrolling interest acquired/consolidated
 
—

 
—

 
—

 
—

 
—

 
—

 
—

 
1.4

 
1.4

September 27, 2019
 
38.4

 
$
0.4

 
$
371.8

 
$
—

 
$
(1.7
)
 
$
74.4

 
$
444.9

 
$
3.3

 
$
448.2


See accompanying notes to the consolidated financial statements.


F-9

VAREX IMAGING CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Description of Business
Varex Imaging Corporation (the “Company,” “Varex” or “Varex Imaging”) designs, manufactures, sells and services a broad range of Medical products, which include X-ray imaging components, including X-ray tubes, digital detectors and accessories, high voltage connectors, image processing software and workstations, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, ionization chambers and buckys, for use in a range of applications, including radiographic or fluoroscopic imaging, mammography, computed tomography, oncology and computer-aided detection. The Company sells its products to imaging system original equipment manufacturer (“OEM”) customers for incorporation into new medical diagnostic, radiation therapy, dental, and veterinary, to independent service companies, distributors and directly to end-users for replacement purposes.
The Company also designs, manufacturers, sells and services industrial products, which include Linatron® X-ray accelerators, imaging processing software and image detection products for security and inspection purposes, such as cargo screening at ports and borders and nondestructive examination in a variety of applications. The Company generally sells security and inspection products to OEM customers who incorporate Varex’s products into their inspection systems. The Company conducts an active research and development program to focus on new technology and applications in both the medical and industrial X-ray imaging markets.
Varex Imaging Corporation was incorporated in Delaware on July 18, 2016 for the purpose of holding the assets and liabilities associated with the Company's business and separated from Varian Medical Systems, Inc. (“Varian”) on January 28, 2017, upon which Varian completed the distribution of 100% of the outstanding common stock of Varex to Varian stockholders. Following the separation and distribution, Varex became an independent publicly-traded company and is listed on the NASDAQ Global Select Market under the ticker “VREX.”
Basis of Presentation and Principle of Consolidation
The accompanying consolidated financial statements are audited and have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). Prior to January 28 2017, the date of separation and distribution, the financial statements were prepared on a stand-alone basis and were derived from Varian’s consolidated financial statements and records as it operated as part of Varian prior to the distribution, in conformity with GAAP. Prior to the separation and distribution, the consolidated financial statements included allocations of certain Varian corporate expenses these costs were allocated to the Company on the basis of direct usage when identifiable or other systematic measures that reflect utilization of services provided to or benefits received by the Company.
All transactions between the Company and Varian prior to the separation have been included in the accompanying consolidated financial statements. All intercompany transactions while the Company operated as part of Varian were considered to be effectively settled for cash and are reflected as a component of financing activities as net transfers from (to) Varian in the consolidated statements of cash flows at the time the transactions were recorded.
Prior to the separation, the Company was dependent upon Varian for its working capital and financing requirements, as Varian uses a centralized approach to cash management and financing of its operations. Financial transactions relating to the Company were accounted for through the net parent investment account. Cash and cash equivalents held by Varian were not allocated to the Company.
Net parent investment in the consolidated statements of equity represents Varian’s historical investment in the Company, the net effect of transactions with and allocations from Varian and the Company’s accumulated earnings.
Impact of COVID-19
The coronavirus (“COVID-19”) pandemic and the mitigation efforts by governments to attempt to control its spread created uncertainties and disruptions in the economic and financial markets. The extent to which COVID-19 will continue to impact the Company’s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it will impact worldwide macroeconomic conditions including interest rates and employment rates, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. During the quarter ended July 3, 2020, as a result of the economic downturn resulting from COVID-19, the Company experienced reduced demand in the

F-10

Company’s industrial segment and for certain higher end medical products that negatively impacted revenues and gross margin. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the currently estimated future impacts of COVID-19 through the date of reissuance of these consolidated financial statements. The Company’s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material negative impacts to the Company’s consolidated financial statements in future reporting periods. These future developments are highly uncertain, and the outcomes cannot be estimated with certainty. Actual results may differ from those estimates, and such differences may be material to the consolidated financial statements.

The Company’s Credit Agreement, as defined in Note 8, Borrowings, contains financial covenants, including certain leverage ratio covenants. The adverse effects of the COVID-19 pandemic on the Company’s financial condition and results of operations are expected to be more persistent and have been more severe than previously estimated. The Company now believes that reduced demand in the Company’s industrial segment and for certain higher end medical products will continue to negatively impact revenues, gross margin, and the other items used to calculate the Company’s financial covenants contained in its Credit Agreement. Based on the Company’s current forecasts, it is probable that the Company will be in violation of certain leverage ratio covenants contained in its Credit Agreement within the twelve-month period following the reissuance of these consolidated financial statements, including as early as the end of the Company's fiscal year end 2020. Failure to comply with the covenants, if not amended or waived, would result in an event of default under the Credit Agreement and the acceleration of the outstanding balance of the loans thereunder. If an event of default under the Credit Agreement occurs, then pursuant to cross default and/or cross acceleration clauses, substantially all of the Company’s other outstanding debt and derivative contract payables would become due, and all debt and derivative contracts could be terminated, which would have a material adverse impact to the Company’s operations and liquidity as the Company currently does not have the financial resources to satisfy such obligations if they were to become due and payable. These events and conditions raise substantial doubt about the Company’s ability to continue as a going concern within the twelve-month period following the reissuance of these consolidated financial statements.

The Company is actively pursuing various options to prevent an event of default from occurring under the Credit Agreement. The Company is implementing actions to improve its financial results and other items used to calculate the financial covenants, such as accelerating the closure of its Santa Clara facility, the previously announced reduction in force, austerity programs related to outside services, and other appropriate actions. The Company is also taking actions to improve cash flow such as working capital reductions and reduced spending for property, plant and equipment, as well as pursuing potential additional fundraising to modify, supplement, or replace its Credit Agreement. While the Company has and continues to take actions to mitigate the risk of an event of default under the Credit Agreement, there is no assurance that it will be successful in doing so. The Company’s consolidated financial statements have been prepared on a going concern basis and do not reflect any adjustments that might result if the Company is unable to continue as a going concern.
Reclassification
The Company has reclassified $3.0 million from selling, general and administrative expense to impairment of intangible assets for the year ended September 28, 2018, to conform to the current year's presentation. Such reclassifications had no impact on net earnings as previously reported.
Segment Reporting
The Company has two reportable operating segments; (i) Medical and (ii) Industrial, which aligns with how its CEO, who is the Company's Chief Operating Decision Maker (“CODM”), reviews the Company’s performance. See Note 15. Segment Information, included in this report, for further information on the Company’s segments.
Fiscal Year
The fiscal years of the Company as reported are the 52 or 53-week period ending on the Friday nearest September 30. Fiscal year 2019 was the 52-week period that ended on September 27, 2019. Fiscal year 2018 was the 52-week period that ended on September 28, 2018. Fiscal year 2017 was the 52-week period that ended on September 29, 2017.
Variable Interest Entities
For entities in which the Company has variable interests, the Company focuses on identifying which entity has the power to direct the activities that most significantly impact the variable interest entity’s economic performance and which enterprise has the obligation to absorb losses or the right to receive benefits from the variable interest entity. If the Company is the primary beneficiary of a variable interest entity, the assets, liabilities and results of operations of the variable interest entity will be included in the

F-11

Company’s consolidated financial statements. As of September 27, 2019, the Company had two variable interest entities neither of which were consolidated.
 Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Such estimates include the valuation of inventories, goodwill and intangible assets, impairment on investments, and taxes on earnings. Actual results could differ from these estimates.
Cash and Cash Equivalents
The Company considers currency on hand, demand deposits, time deposits and all highly-liquid investments with an original maturity of three months or less at the date of purchase to be cash and cash equivalents.
Restricted Cash
Restricted cash primarily consists of cash collateral related to certain leases and inventory arrangements. Restricted cash is
included in other assets on the consolidated balance sheet. Cash and cash equivalents and restricted cash as reported within
the consolidated statements of cash flows consisted of the following:
 
Twelve Months Ended September 27, 2019
 
Twelve Months Ended September 28, 2018
 
Beginning of Period
 
End of Period
 
Beginning of Period
 
End of Period
Cash and cash equivalents
$
51.9

 
$
29.9

 
$
83.3

 
$
51.9

Restricted cash
1.5

 
1.4

 
0.9

 
1.5

Cash and cash equivalents and restricted cash as reported per statement of cash flows
$
53.4

 
$
31.3

 
$
84.2

 
$
53.4


Fair Value
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. There is a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:
Level 1—Quoted prices in active markets for identical assets or liabilities.
Level 2—Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or, other inputs that are observable or can be corroborated by observable market data.
Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
Derivative instruments and hedging activities
The Company records all derivatives on the balance sheet at fair value. Derivatives designated as a hedge are recorded on the Consolidated Balance Sheets at fair value as of the reporting date. For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative is reported as a component of other comprehensive income or loss and reclassified from accumulated other comprehensive loss into earnings when the hedged transaction affects earnings.  For derivatives that are designated and qualify as net investment hedges, the gain or loss on the derivative is reported as a component of other comprehensive income or loss. Time value is excluded and the cash payments are recognized as an adjustment to interest expense. A qualitative assessment of hedge effectiveness is performed on a quarterly basis, unless facts and circumstances indicate the hedge may no longer be highly effective.

F-12

Concentration of Risk
Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash, cash equivalents and trade accounts receivable. Cash held with financial institutions may exceed the Federal Deposit Insurance Corporation insurance limits or similar limits in foreign jurisdictions. The Company has not experienced any losses on its deposits of cash and cash equivalents. The Company performs ongoing credit evaluations of its customers and, except for government tenders, group purchases and orders with a letter of credit, its industrial customers often provide a down payment. The Company maintains an allowance for doubtful accounts based upon the expected collectability of all accounts receivable. The Company obtains some of the components in its products from a limited group of suppliers or from a single-source supplier. The Company has neither experienced nor expects any significant disruptions to its operations due to supplier concentration.
Credit is extended to customers based on an evaluation of the customer’s financial condition, and collateral is not required. During the periods presented, one of the Company's Medical segment customers accounted for a significant portion of revenues, which is as follows:
 
Fiscal Year
 
2019
 
2018
 
2017
Canon Medical Systems Corporation
17.3
%
 
18.1
%
 
19.3
%

Canon Medical Systems Corporation accounted for 10.1% and 9.8% of the Company’s accounts receivable as of September 27, 2019 and September 28, 2018, respectively.
Inventories
Inventories are valued at the lower of cost or net realizable value. Costs include materials, labor and manufacturing overhead
and is computed using standard cost (which approximates actual cost) on a first-in-first-out basis. The Company evaluates the carrying
value of its inventories taking into consideration such factors as historical and anticipated future sales compared to quantities on hand
and the prices the Company expects to obtain for products in its various markets. The Company adjust excess and obsolete
inventories to net realizable value and write-downs of excess and obsolete inventories are recorded as a component of cost of revenues.
The following table summarizes the Company’s inventories, net:
(In millions)
September 27, 2019
 
September 28, 2018
Raw materials and parts
$
160.1

 
$
149.9

Work-in-process
27.9

 
25.4

Finished goods
60.2

 
59.8

Total inventories
$
248.2

 
$
235.1


Property, Plant and Equipment, net
Property, plant and equipment are stated at cost, net of accumulated depreciation. Major improvements are capitalized, while repairs and maintenance are expensed as incurred. Depreciation are computed using the straight-line method over the estimated useful lives of the assets. Land is not subject to depreciation, but land improvements are depreciated over fifteen years. Land leasehold rights and leasehold improvements are depreciated over the lesser of their estimated useful lives or remaining lease terms. Buildings are depreciated over twenty years. Machinery and equipment are depreciated over their estimated useful lives, which range from three years to seven years. Assets subject to lease are depreciated over the lesser of their estimated useful lives or remaining lease terms. Estimated useful lives are periodically reviewed and, when appropriate, changes are made prospectively. When certain events or changes in operating conditions occur, asset lives may be adjusted, and an impairment assessment may be performed on the recoverability of the carrying amounts. When assets are retired or otherwise disposed of, the assets and related accumulated depreciation are removed from the accounts.

F-13

The following table summarizes the Company’s property, plant and equipment, net:
(In millions)
September 27, 2019
 
September 28, 2018
Land
$
8.3

 
$
8.3

Buildings and leasehold improvements
134.4

 
138.1

Machinery
170.7

 
166.1

Construction in progress
28.5

 
23.1

 
$
341.9

 
$
335.6

Accumulated depreciation and amortization
(199.6
)
 
(190.7
)
Property, plant, and equipment, net
$
142.3

 
$
144.9


The Company recorded depreciation expense of $23.5 million, $26.0 million and $16.9 million, in fiscal years 2019, 2018 and 2017, respectively. During fiscal year 2019 the company recorded accelerated depreciation of $4.5 million on the machinery and equipment used in the fabrication of amorphous silicon glass at its facility in Santa Clara, CA. See Note 4. Restructuring, included in this report, for further information. During fiscal year 2018 the company recorded accelerated depreciation of $4.2 million on the machinery and equipment used in the fabrication of amorphous silicon glass at its facility in Santa Clara, CA. See Note 4. Restructuring, included in this report, for further information.
Investments
The Company accounts for its equity investments in privately-held companies under the equity method of accounting if the Company has the ability to exercise significant influence in these investments. Distributions received from an equity method investment are classified using the cumulative earnings approach. Under the cumulative earnings approach, distributions up to the amount of cumulative equity in earnings recognized will be treated as returns on investment as operating cash flows and those in excess of that amount will be treated as returns of investment as investing cash flows. The Company monitors these equity investments for impairment and makes appropriate reductions in carrying values if the Company determines that impairment charges are required based primarily on the financial condition and near-term prospects of these companies.
Goodwill and Intangible Assets
Goodwill is recorded when the purchase price of an acquisition exceeds the fair value of the net identified tangible and intangible assets acquired. Purchased intangible assets are carried at cost, net of accumulated amortization, and are included in intangible assets in the Company's consolidated balance sheets. Intangible assets with finite lives are amortized over their estimated useful lives of primarily two years to seven years using the straight-line method.
Impairment of Long-lived Assets, Intangible Assets and Goodwill
The Company reviews long-lived assets and identifiable intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. The Company assesses these assets for impairment based on their estimated undiscounted future cash flows. If the carrying value of the assets exceeds the estimated future undiscounted cash flows, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets.
The Company evaluates goodwill and indefinite lived intangible assets for impairment at least annually at the beginning of the fourth quarter of each fiscal year or whenever an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The Company performs a step one analysis, which consists of a comparison of the fair value of a reporting unit against its carrying amount, including the goodwill allocated to each reporting unit. The Company determines the fair value of its reporting units based on a combination of income and market approaches. The income approach is based on the present value of estimated future cash flows of the reporting units, and the market approach is based on a market multiple calculated for each reporting unit based on market data of other companies engaged in similar business. If the carrying amount of the reporting unit is in excess of its fair value, step two requires the comparison of the implied fair value of the reporting unit’s goodwill against the carrying amount of the reporting unit’s goodwill. Any excess of the carrying value of the reporting unit’s goodwill over the implied fair value of the reporting unit’s goodwill is recorded as an impairment loss. The impairment test for intangible assets with indefinite useful lives, if any, consists of a comparison of fair value to carrying value, with any excess of carrying value over fair value being recorded as an impairment loss.

F-14

During the fiscal year ended September 27, 2019 and 2018, the Company recognized $4.8 million and $3.0 million of impairments of intangible assets related to the restructuring activities see Note 4. Restructuring, included in this report. No goodwill impairment charges were recognized for any of the prior periods presented. No impairment charges were recognized in fiscal year 2017.
Loss Contingencies
From time to time, the Company is a party to or otherwise involved in legal proceedings, claims and government inspections or investigations, customs and duties audits and other loss contingency matters, both inside and outside the United States, arising in the ordinary course of its business or otherwise. The Company accrues amounts, to the extent an unfavorable outcome is determined to be probable and the losses can be reasonably estimated, that it believes are adequate to address any liabilities related to legal proceedings and other loss contingencies that it believes will result in a probable loss.
Product Warranty
The Company warrants most of its products for a specific period of time, usually 12 to 24 months from delivery or acceptance, against material defects. The Company provides for the estimated future costs of warranty obligations in cost of revenues when the related revenues are recognized. The accrued warranty costs represent the best estimate at the time of sale of the total costs that the Company will incur to repair or replace product parts that fail while still under warranty.
The amount of the accrued estimated warranty costs obligation for established products is primarily based on historical experience as to product failures adjusted for current information on repair costs. For new products, estimates include the historical experience of similar products, as well as a reasonable allowance for warranty expenses associated with new products. On a quarterly basis, the Company reviews the accrued warranty costs and updates the historical warranty cost trends, if required.
The following table reflects the changes in the Company’s accrued product warranty:
 
Fiscal Years
(In millions)
2019
 
2018
Accrued product warranty, at beginning of period
$
7.3

 
$
7.0

Charged to cost of revenues
12.9

 
11.6

Actual product warranty expenditures
(12.1
)
 
(11.3
)
Accrued product warranty, at end of period
$
8.1

 
$
7.3


Revenue Recognition
Effective September 29, 2018, the Company adopted the requirements of Accounting Standards Update (“ASU”) 2014-09 and related amendments, Revenue from Contracts with Customers (“ASC 606”), which superseded all prior revenue recognition methods and industry-specific guidance. See “Recently Adopted Accounting Pronouncements” below.
The Company’s revenues are derived primarily from the sale of hardware and services. The Company recognizes its revenues net of any value-added or sales tax and net of sales discounts.
The Company sells a high proportion of its X-ray products to a limited number of OEM customers. X-ray tubes, digital detectors and image-processing tools and security and inspection products are generally sold on a stand-alone basis. However, the Company occasionally sells its digital detectors, X-ray tubes and imaging processing tools as a package that is optimized for digital X ray imaging and sells its Linatron ® X-ray accelerators together with its imaging processing software and image detection products to OEM customers that incorporate them into their inspection systems. Service contracts are often sold with certain security and inspection products and computer-aided detection products.
The Company determines revenue recognition through the following steps:
•
Identification of the contract, or contracts, with a customer
•
Identification of the performance obligations in the contract
•
Determination of the transaction price
•
Allocation of the transaction price to the performance obligations in the contract
•
Recognition of revenue when, or as, a performance obligation is satisfied

F-15

Deferred Revenues
Deferred revenue primarily represents (i) the amount received applicable to non-software products for which parts
and services under the warranty contracts have not been delivered, and (ii) the amount received for service contracts for
which the services have not been rendered.
Allowance for Doubtful Accounts
The Company evaluates the creditworthiness of customers prior to authorizing shipment for all major sale transactions. On a quarterly basis, the Company evaluates aged items in the accounts receivable aging report and provide an allowance in an amount deemed adequate for doubtful accounts. If the evaluation of customers’ financial conditions does not reflect a future ability to collect outstanding receivables, additional provisions may be needed. We had an allowance for doubtful accounts of $1.0 million and $0.6 million as of September 27, 2019 and September 28, 2018, respectively.
Share-Based Compensation Expense
The Company has an equity-based incentive plan that provides for the grant of nonqualified stock options and restricted stock units to directors, officers and other employees. The Company also permits employees to purchase shares under the Varex employee stock purchase plan. Prior to the separation, the Company’s employees historically participated in Varian’s equity-based incentive plans. Share-based compensation expense through the date of separation included allocations to the Company based on the awards and terms previously granted to its employees as well as an allocation of Varian’s corporate and shared functional employee expenses.
The Company values stock options granted and the option component of the shares of common stock purchased under the equity-based incentive plans and stock purchased under the employee stock purchase plan using the Black-Scholes option-pricing model. Share-based compensation expense for restricted stock units is measured using the fair value of the Company’s stock on the date of grant and is amortized over the award’s respective service period. The Black-Scholes option-pricing model requires the input of certain assumptions, and changes in the assumptions can materially affect the fair value estimates of share-based payment awards.
The Company measures and recognizes expense for all share-based payment awards based on their fair values. Share-based compensation expense recognized in the consolidated statements of earnings includes compensation expense for the share-based payment awards based on the grant date fair value estimated in accordance with the guidance on share-based compensation. Share-based compensation expense recognized is based on the value of the portion of share-based payment awards that is ultimately expected to vest. The Company attributes the value of share-based compensation to expense using the straight-line method. The Company considers only the direct tax impacts of share-based compensation awards when calculating the amount of tax windfalls or shortfalls. For additional information, see Note 13. Employee Stock Plans, included in this report.
Shipping and Handling Costs
Shipping and handling costs are included as a component of cost of revenues.
Research and Development
Research and development costs have been expensed as incurred. These costs primarily include employees’ compensation, consulting fees and material costs.
Software Development Costs
Costs for the development of new software products and substantial enhancements to existing software products are expensed as incurred until technological feasibility has been established, at which time any additional costs would be capitalized. No costs associated with the development of software have been capitalized, as the Company believes its current software development process is essentially completed concurrent with the establishment of technological feasibility.
Taxes on Earnings
Current income tax expense is the amount of income taxes expected to be payable for the current year. Deferred income tax liabilities or assets are established for the expected future tax consequences resulting from the differences in financial reporting and tax bases of assets and liabilities. A valuation allowance is provided if it is more likely than not that some or all of the deferred tax assets will not be realized. In addition, we provide reserves for uncertain tax positions when such tax positions do not meet the recognition thresholds or measurement standards prescribed by the authoritative guidance for accounting for income taxes. Amounts

F-16

for uncertain tax positions are adjusted in periods when new information becomes available or when positions are effectively settled. Interest and penalties related to uncertain tax positions are recognized as a component of income tax expense.
On December 22, 2017, the U.S. Government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act of 2017 (“U. S. Tax Reform”). U.S. Tax Reform significantly revised the U.S. corporate income tax structure including a lower corporate statutory rate and changes to the way foreign earnings are taxed. U.S. GAAP requires that the impact of tax legislation be recognized in the period in which the law is enacted. In accordance with these rules, we are including the impact of certain provisions of U.S. Tax Reform to the extent they are effective during the current reporting period.
Foreign Currency Translation
The Company uses the U.S. Dollar predominately as the functional currency of its foreign operations. Gains and losses from remeasurement of foreign currency balances into U.S. Dollars are included in the consolidated statements of earnings. For the foreign subsidiary where the local currency is the functional currency, translation adjustments of foreign currency financial statements into U.S. dollars are recorded to a separate component of accumulated other comprehensive (loss) earnings.
Accounting Standards Recently Adopted
In November 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (“ASU 2016-18”), which requires that the statement of cash flows explain the change in the total amount of restricted cash during the period and other additional disclosures. The Company adopted ASU 2016-18 in the first quarter of 2019 using the retrospective transition method and the Company's consolidated statements of cash flows have been retrospectively adjusted to reflect restricted cash balances. Net cash flows for fiscal years 2019, 2018 and 2017 did not change as a result of adopting ASU 2016-18.
The Company adopted ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”), which was issued to reduce the diversity in practice in how certain transactions are classified in the statement of cash flows. The Company adopted ASU 2016-15 in the first quarter of 2019 retrospectively. Net cash flows for fiscal years 2019, 2018 and 2017 did not change as a result of adopting ASU 2016-15.

The Company adopted ASC 606 as of September 29, 2018, using the modified retrospective transition method applied to those contracts which were not completed as of that date. The Company recorded a net reduction to retained earnings of $4.1 million, net of tax, as of September 29, 2018 due to the impact of adopting ASC 606. During the second quarter of 2019 the Company recorded an increase to retained earnings of $0.6 million, net of tax, to correct an error that was not quantitatively or qualitatively material to the current period, related to the adoption of ASC 606. The net cumulative impact of adopting ASC 606 was $3.5 million, net of tax. Refer to Note 18. Revenue Recognition, included in this report report for the detailed impact of adopting ASC 606.

In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities, which amends the application of hedge accounting and improves financial reporting of hedging relationships to more accurately present the economic effects of risk management activities in the financial statements. The ASU is effective for public companies for annual reporting periods beginning after December 15, 2018, with early adoption permitted. The Company early adopted the provisions of ASU 2017-12 during the quarter ended September 27, 2019, using the modified retrospective method. The adoption did not have an impact on the consolidated financial statements.
Recent Accounting Standards Updates Not Yet Effective
In February 2018, the FASB issued ASU 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from U.S. federal tax legislation commonly referred to as the Tax Cuts and Jobs Act, which was enacted in December 2017 (the “2017 Tax Act”). ASU 2018-02 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect that the adoption of this guidance will have a material impact on its consolidated financial statements.
In January 2017, the FASB issued ASU 2017-04 which clarified its guidance to simplify the measurement of goodwill by eliminating the Step 2 impairment test. The new guidance requires companies to perform the goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2021. The amendment is required to be adopted prospectively. The Company is evaluating the impact of adopting this amendment to its consolidated financial statements.

F-17

In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Instruments." This ASU replaces the incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. In addition, the ASU requires new disclosures. This standard will be effective for the Company's interim and annual periods beginning with the first quarter of fiscal 2021, and must be applied on a modified retrospective basis. The Company is currently evaluating the potential impact of this standard.
In February 2016, the FASB issued ASU 2016-02 on accounting for leases. The new standard is intended to provide enhanced transparency and comparability by requiring lessees to record right-of-use assets and corresponding lease liabilities on the balance sheet. The new standard will continue to classify leases as either finance or operating, with classification affecting the pattern of expense recognition in the statement of earnings. The new standard is required to be adopted using a modified retrospective method to each prior reporting period presented with various optional practical expedients. The new standard will be effective for the Company beginning in its first quarter of fiscal year 2020 with early adoption permitted. The Company has not completed its assessment of the new standard, but anticipate that the most substantial change to its consolidated financial statements will be a gross-up of its total assets and liabilities. The adoption is not expected to materially impact our results of operations in the upcoming fiscal years and interim periods. The Company will continue to monitor the overall impact of adoption and update our disclosures as appropriate.
2. BUSINESS COMBINATIONS
Acquisition of Direct Conversion AB (publ)
On April 29, 2019, Varex completed the acquisition of 98.2% of the outstanding shares of common stock of Direct Conversion AB (publ) (“Direct Conversion”) for $69.5 million in cash, net of cash acquired, the assumption of Direct Conversion's debt of $4.5 million and deferred consideration equal to $9.9 million or 0.3 million shares of the Company’s common stock (subject to reduction to settle indemnity claims) to be paid on the first anniversary of the closing with a mixture of cash and shares of Varex common stock. The acquisition of Direct Conversion expands our detector product portfolio to include photon counting technology.  This technology will allow Varex to expand its range of imaging applications and offer new solutions to both Medical and Industrial customers.
The following table summarizes the preliminary purchase price allocation:
(In millions)
Fair Value
Allocation of the purchase consideration:
 
Accounts receivable
$
2.4

Inventories
5.7

Prepaid expenses and other current assets
0.7

Property, plant, and equipment
0.9

Goodwill
47.2

Intangible assets
32.9

Total assets acquired
89.8

Accounts payable
(1.0
)
Accrued liabilities
(1.5
)
Current maturities of long-term debt
(1.0
)
Deferred revenues
(0.9
)
Long-term debt
(3.5
)
Other long-term liabilities
(1.1
)
Total liabilities assumed
(9.0
)
Noncontrolling interest
(1.4
)
Net assets acquired, less noncontrolling interest
$
79.4

Net cash paid
$
69.5

Deferred consideration
9.9

Total consideration
$
79.4



F-18


The Company recorded the assets acquired and liabilities assumed at their preliminary estimated fair values. Intangibles were valued primarily using a discounted cash flow, which included estimated revenue growth and discount rate. Due to the complexity of this transaction as of September 27, 2019, the Company had not finalized the determination of the fair values allocated to various assets and liabilities, including, but not limited to, inventory; deferred tax assets and liabilities; intangible assets and the residual amount allocated to goodwill. The fair value assigned to goodwill is primarily attributable to expected synergies. The goodwill related to the Direct Conversion acquisition is not tax deductible.
The following amounts represent the determination of the fair value and estimated weighted average useful lives of identifiable intangible assets for the Direct Conversion, which are amortized straight-line:
(In millions)
Fair Value
 
Estimated Weighted Average
Useful Life
(In Years)
Backlog
$
0.2

 
1
Trade names
2.5

 
5
Developed technology
18.4

 
10
In-process research and development
2.8

 
indefinite
Customer relationships
9.0

 
10
Total intangible assets acquired
$
32.9

 
 

The following amounts represent revenues by reporting segment from Direct Conversion from the acquisition date of April 29, 2019, through September 27, 2019:
(In millions)
Direct Conversion Revenue
Medical
$
4.5

Industrial
1.8

Total Direct Conversion revenues
$
6.3



The acquisition of Direct Conversion did not have a significant impact on our consolidated results of operations on a pro forma basis for the current or prior years.
Acquisition of Virtual Media Integration
On August 31, 2018, the Company completed the acquisition of Virtual Media Integration, Ltd. (“VMI”) from MISTRAS Group, Inc for $4.8 million. VMI is a provider of computed and digital radiography and X-ray film digitizer systems for industrial non-destructive testing. The acquired assets and liabilities of the VMI business were allocated to the Industrial reporting segment. The acquisition related costs were included in the consolidated statements of earnings under selling, general and administrative expenses.
The following table summarizes the purchase price allocation:
(In millions)
Fair Value
Allocation of the purchase consideration:
 
Accounts Receivable
$
0.2

Inventories
1.0

Other assets
0.2

Intangibles
1.6

Goodwill
1.5

Other liabilities
(0.2
)
Net assets acquired
4.3

Post-closing adjustments
0.5

Total cash consideration
$
4.8



F-19

Acquisition of PerkinElmer’s Medical Imaging Business
On May 1, 2017, the Company completed the acquisition of the medical imaging business (“Acquired Detector Business”) of PerkinElmer, Inc. (“PKI”) for $277.4 million, or $273.2 million after post-closing working capital adjustments. The acquisition consisted of PerkinElmer Medical Holdings, Inc. and Dexela Limited, together with certain assets of PKI and its direct and indirect subsidiaries relating to digital flat panel X-ray detectors that serve as components for industrial, medical, dental and veterinary X-ray imaging systems. The Acquired Detector Business included about 280 employees, with operations in Santa Clara, California as well as operations in Germany, the Netherlands, China and the United Kingdom. The acquisition of the Acquired Detector Business was pursuant to the Master Purchase and Sale Agreement, dated December 21, 2016 (the “Purchase Agreement”), by and between PKI and Varian and the subsequent Assignment and Assumption Agreement, dated January 27, 2017, by and between Varian and Varex, pursuant to which Varian assigned and conveyed all of its rights, obligations, title and interest in the Purchase Agreement to Varex.
The following amounts represent the determination of the fair value of identifiable assets acquired and liabilities for the Acquired Detector Business:
(In millions)
Fair Value
Total cash consideration
$
273.2

Allocation of the purchase consideration:
 
Cash
1.4

Accounts Receivable
18.7

Inventory
34.7

Prepaids and other current assets
0.6

Property, plant, and equipment
21.4

Other assets, non-current
2.0

Intangibles
81.1

Goodwill
167.3

Total assets acquired
$
327.2


 
 
Current liabilities
$
(17.2
)
Other liabilities, non-current
(36.8
)
Total liabilities assumed
(54.0
)
Net assets acquired
$
273.2


The fair value assigned to goodwill is attributable to expected cost synergy opportunities. Included in the goodwill recorded for the Acquired Detector Business is approximately $35 million that will be deductible for income tax purposes in Germany, China and the Netherlands. The remaining goodwill related to the stock acquisition in the United States is not tax deductible. Also, as a result of the acquisition, non-current deferred income tax liability increased by approximately $31 million related to basis differences for both tangible and intangible assets acquired as part of the stock purchases in the United States and the United Kingdom, and asset purchases in Germany, the Netherlands and China.
The following amounts represent the determination of the fair value of identifiable intangible assets for the Acquired Detector Business, which are amortized straight-line:
(In millions)
Fair Value
 
Estimated
Useful Life
(In Years)
Favorable leasehold interests
$
3.8

 
16
Backlog
1.2

 
1
Trade names
1.4

 
5
Developed technology
37.7

 
7
In-process research and development
4.0

 
indefinite
Customer relationships
33.0

 
7
Total intangible assets acquired
$
81.1

 
 


F-20

The following amounts represent revenues by reporting segment from the Acquired Detector Business from the acquisition date of May 1, 2017 through September 29, 2017:
(In millions)
May 1, 2017 through September 29, 2017
Acquired Detector Business
 
Medical
$
41.1

Industrial
20.2

Total Acquired Detector Business revenues
$
61.3


Unaudited Pro Forma Information
The unaudited pro-forma amounts presented below for the fiscal year 2017 are presented for informational purposes only. In addition to the Company's results for the periods presented, the amounts below also include effects of the Acquired Detector Business as if it had been consummated on October 1, 2016. These unaudited pro-forma results include effects that are directly attributable to the acquisition which include the amortization of intangible assets, interest expense, and other adjustments, including estimated tax effects. The unaudited pro-forma results do not reflect any operating efficiencies or potential cost savings which may result from the consolidation of the Acquired Detector Business and are not necessarily indicative of what the actual results of operations of the combined company would have been if the acquisition had occurred at the beginning of the period presented nor are they indicative of future results of operations or results that might have been achieved had the acquisition been consummated as of October 3, 2015.
 
Fiscal Year
(In millions)
2017
Revenue
$
777.8

Operating earnings
$
84.7

Net earnings
$
43.1

Net earnings per share, basic
$
1.15

Net earnings per share, diluted
$
1.13


3. RELATED-PARTY TRANSACTIONS
Investment in Privately-Held Companies
The Company has a 40% ownership interest in dpiX Holding LLC (“dpiX Holding”), a four-member consortium that has a 100% ownership interest in dpiX LLC (“dpiX”), a supplier of amorphous silicon based thin film transistor arrays for digital flat panel image detectors. In accordance with the dpiX Holding Agreement, net profits or losses are allocated to the members, in accordance with their ownership interests.
The equity investment in dpiX Holding is accounted for under the equity method of accounting. When the Company recognizes its share of net profits or losses of dpiX Holding, profits or losses in inventory purchased from dpiX are eliminated until realized by the Company. In fiscal years 2019, 2018 and 2017, the Company recorded (loss) and income on the equity investment in dpiX Holding of $(1.1) million, $3.4 million and $0.8 million, respectively. Income and loss on the equity investment in dpiX Holding is included in other (expense) income, net in the consolidated statements of earnings. The carrying value of the equity investment in dpiX Holding, which was included in investments in privately-held companies on the consolidated balance sheets, was $48.1 million and $48.9 million at September 27, 2019 and September 28, 2018, respectively.
In fiscal years 2019, 2018 and 2017, the Company purchased glass transistor arrays from dpiX totaling $23.5 million, $19.3 million and $24.7 million, respectively. These purchases of glass transistor arrays are included as a component of inventories on the consolidated balance sheets or cost of revenues in the consolidated statements of earnings for these fiscal years.
As of September 27, 2019 and September 28, 2018, the Company had accounts payable to dpiX totaling $3.6 million and $3.7 million, respectively.
In October 2013, the Company entered into an amended agreement with dpiX and other parties that, among other things, provides the Company with the right to 50% of dpiX’s total manufacturing capacity produced after January 1, 2014. The amended agreement requires the Company to pay for 50% of the fixed costs (as defined in the amended agreement), as determined at the

F-21

beginning of each calendar year. As of September 27, 2019, the Company estimated it has fixed cost commitments of $3.7 million related to this amended agreement through the remainder of calendar year 2019. The fixed cost commitment for future periods will be determined and approved by the dpiX board of directors at the beginning of each calendar year. The amended agreement will continue unless the ownership structure of dpiX changes (as defined in the amended agreement).
The Company has determined that dpiX is a variable interest entity because at-risk equity holders, as a group, lack the characteristics of a controlling financial interest. Majority votes are required to direct the manufacturing activities, legal operations and other activities that most significantly affect dpiX’s economic performance. The Company does not have majority voting rights and no power to direct the activities of dpiX and therefore is not the primary beneficiary of dpiX. The Company’s exposure to loss as a result of its involvement with dpiX is limited to the carrying value of the Company’s investment of $48.1 million and fixed cost commitments of $3.7 million.
In November 2018, the Company and CETTEEN GmbH (“CETTEEN”), formed a German limited liability company that governs the affairs and conduct of the business of VEC Imaging Verwaltungsgesellschaft GmbH (“VEC”), a joint venture formed to develop technology to be used in X-ray imaging components. In accordance with the VEC agreement, net profits or losses are allocated to the members, in accordance with their ownership interest. The Company's investment in VEC is accounted for under the equity method. The Company has made contributions totaling $2.9 million, and has committed to contribute an additional $2.2 million, as milestones are achieved, and to provide certain full time employees to support prototyping and manufacturing activities in exchange for a 50% interest in VEC. CETTEEN made contributions of certain assets including intellectual property in exchange for a 50% interest in VEC. The Company's investment in VEC was $2.0 million as of September 27, 2019.
4. RESTRUCTURING
Following the acquisition of the medical imaging business from PKI in May of 2017, management began a multiyear program to consolidate the acquired operations, reduce costs, improve productivity and realize synergies.
In March 2018, the Company made the decision to transfer the complementary metal oxide semiconductor (“CMOS”) research and development capability from the U.K. to the U.S. and to permanently close the operation of the acquired detector business in London. The company will continue to develop the CMOS technology in the U.S. due to its competitive advantages, product differentiation and future economic benefit. In connection with this initiative, we recorded $1.7 million in restructuring charges during fiscal year 2018.
In July 2018, the Company committed to a plan to relocate the production of amorphous silicon glass for digital detectors, from its Santa Clara facility, to the jointly owned dpiX fabrication facility in Colorado. In July 2019, the Company committed to close its Santa Clara facility and to relocate the remaining production to its other existing facilities. The Company expects operations at the Santa Clara facility to cease by the end of December 2020 and all activities related to the closure of the facility to be complete by the end of March 2021. In connection with the relocation of the glass production and site closure the Company recorded $16.1 million and $14.2 million of restructuring and impairment charges during fiscal year 2019 and 2018, respectively. Fiscal year 2019 intangible asset impairment charges consisted of in-process research and development related to certain projects that were discontinued as a result of the Santa Clara facility closure. Fiscal year 2018 intangible asset impairment charges were related to a favorable leasehold interest that was impaired as a result of the amorphous silicon glass relocation. The Company expects to incur an additional $8.1 million to $12.1 million of restructuring charges through March 2021.
The Company also incurred approximately $2.8 million and $0.8 million of other unrelated restructuring expenses during fiscal years 2019 and 2018, respectively.
Cash outflows associated with these restructuring charges are limited to employee termination expenses, facility closure and equipment sales and disposals. Below is a detail of restructuring charges incurred during the 2019 and 2018 fiscal years, which predominately relate to the Company's Medical segment:

F-22


(In millions)
Location of Restructuring Charges in Consolidated Statements of Earnings
 
September 27, 2019
 
September 28, 2018
Other assets impairment charges
Selling, general and administrative
 
$
—

 
$
1.3

Inventory write downs
Cost of revenues
 
3.1

 
3.1

Intangible assets impairment
Impairment of intangible assets
 
4.8

 
3.0

Accelerated depreciation
Cost of revenues
 
4.5

 
4.2

Severance costs
Selling, general and administrative
 
6.2

 
4.3

Facility closure costs
Selling, general and administrative
 
0.3

 
0.8

Total restructuring charges
 
 
$
18.9

 
$
16.7


5. OTHER FINANCIAL INFORMATION
     The following table summarizes the Company’s accrued liabilities:
(In millions)
September 27, 2019
 
September 28, 2018
Accrued compensation and benefits
$
32.1

 
$
27.0

Product warranty
8.1

 
7.3

Income taxes payable
10.7

 
1.4

Payable to Varian Medical Systems
—

 
2.3

Right of return liability
6.9

 
—

Deferred consideration
8.9

 
—

Other
9.0

 
9.5

Total accrued liabilities
$
75.7

 
$
47.5


The following table summarizes the Company’s other long-term liabilities:
(In millions)
September 27, 2019
 
September 28, 2018
Long-term income tax payable
$
3.9

 
$
3.5

Environment liabilities
0.9

 
1.3

Defined benefit obligation liability
5.5

 
3.3

Long-term right of return liability
19.5

 
—

Long-term other
2.7

 
0.4

Total other long-term liabilities
$
32.5

 
$
8.5

The following table summarizes the Company’s other income (expense), net:
 
Fiscal Years
(In millions)
2019
 
2018
 
2017
Income (loss) from equity method investments
$
(2.3
)
 
$
3.9

 
$
1.3

Change in fair value of deferred consideration
1.0

 
—

 
—

Realized income (loss) on foreign currencies
(1.9
)
 
(1.2
)
 
1.9

Total other income (expense), net
$
(3.2
)
 
$
2.7

 
$
3.2


6. NET EARNINGS PER SHARE
Basic net earnings per common share is computed by dividing the net earnings for the period by the weighted average number of shares of common stock outstanding during the reporting period. Diluted net earnings per common share reflects the effects of potentially dilutive securities, which is computed by dividing net earnings by the sum of the weighted average number of common shares outstanding and dilutive common shares, which consists of stock options and unvested restricted stock.

F-23


A reconciliation of the numerator and denominator used in the calculation of basic and diluted net income per common share is as follows:
 
Fiscal Year
(In millions, except per share amounts)
2019
 
2018
 
2017
Net earnings attributable to Varex
$
15.5

 
$
27.5

 
$
51.6

Weighted average shares outstanding - basic
38.2

 
37.9

 
37.6

Dilutive effect of potential common shares
0.4

 
0.5

 
0.4

Weighted average shares outstanding - diluted
38.6

 
38.4

 
38

Net earnings per share attributable to Varex - basic
$
0.41

 
$
0.73

 
$
1.37

Net earnings per share attributable to Varex - diluted
$
0.40

 
$
0.72

 
$
1.36

Anti-dilutive employee shared based awards, excluded
1.9

 
1.2

 
1.0


The Company excludes potentially dilutive common shares (consisting of shares underlying stock options and the employee stock purchase plan) from the computation of diluted weighted average shares outstanding if the inclusion of the shares underlying these stock awards would be anti-dilutive to earnings per share.
7. FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES
As part of the Company’s overall risk management practices, the Company enters into financial derivatives to manage its financial exposures to foreign currency exchange rates and interest rates.
The Company records all derivatives on the consolidated balance sheets at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting, and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. A qualitative assessment of hedge effectiveness is performed on a quarterly basis, unless facts and circumstances indicate the hedge may no longer be highly effective.    The changes in fair value for all trades that are not designated for hedge accounting are recognized in current period earnings. The Company does not offset fair value amounts recognized for derivative instruments in its consolidated balance sheets for presentation purposes.
Credit risk related to derivative transactions reflects the risk that a party to the transaction could fail to meet its obligation under the derivative contracts. Therefore, the Company’s exposure to the counterparty’s credit risk is generally limited to the amounts, if any, by which the counterparty’s obligations to the Company exceed the Company’s obligations to the counterparty. The Company’s policy is to enter into contracts only with financial institutions which meet certain minimum credit ratings to help mitigate counterparty credit risk.
Derivatives Designated as Hedging Instruments - Cash Flow Hedges
The Company uses interest rate swap contracts as cash flow hedges to manage its exposure to fluctuations in LIBOR interest rates. Interest rate swap contracts hedging variable rate debt effectively fix the LIBOR component of its interest rate for a specific period of time.
As of September 27, 2019, the Company had the following outstanding derivatives designated as cash flow hedging instruments:
(In millions, except for number of instruments)
Number of Instruments
 
Notional Value
Interest Rate Swap Contracts
6
 
$
264.4


The following table summarizes the amount of pre-tax earnings recognized from derivative instruments for the periods indicated and the line items in the accompanying statements of operations where the results are recorded for cash flow hedges:

F-24

 
Amount of Gain or (Loss) Recognized in OCI on Derivative
Fiscal Year Ended
 
Location of Gain or (Loss) Reclassified from Accumulated OCI into Income
 
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income
Fiscal Year Ended
(In millions)
2019
 
2018
 
2017
 
 
2019
 
2018
 
2017
Interest Rate Swap Contracts
$
(6.3
)
 
$
6.9

 
$
0.6

 
Interest expense
 
$
1.9

 
$
0.1

 
$
(0.3
)
The Company expects that $0.1 million of the accumulated other comprehensive (loss) income related to cash flow hedges will be realized in pre-tax earnings over the next 12 months, but the amount will vary depending on interest rates.
These derivative instruments are subject to master netting agreements giving effect to rights of offset with each counterparty. None of the balances were eligible for netting. The following table summarizes the gross fair values of derivative instruments as of the periods indicated and the line items in the accompanying consolidated balance sheets where the instruments are recorded.
 
Derivative Assets
 
Derivative Liabilities
(In millions)
 
 
September 27, 2019
 
September 28, 2018
 
 
 
September 27, 2019
 
September 28, 2018
Derivatives designated as cash flow hedges
Balance sheet location
 
 
 
 
 
Balance sheet location
 
 
 
 
Interest rate swap contracts
Other current assets
 
$
—

 
$
2.2

 
Other current liabilities
 
$
—

 
$
—

Interest rate swap contracts
Other non-current assets
 
—

 
5.5

 
Other non-current liabilities
 
(0.5
)
 
—

 
 
 
$
—

 
$
7.7

 
 
 
$
(0.5
)
 
$
—


Derivatives Designated as Hedging Instruments - Net Investment Hedges
The Company uses cross currency swap contracts as net investment hedges to manage its risk of variability in foreign currency-denominated net investments in wholly-owned international operations. All changes in fair value of the derivatives designated as net investment hedges are reported in accumulated other comprehensive (loss) income along with the foreign currency translation adjustments on those investments. As of September 27, 2019, the Company had the following outstanding derivatives designated as net investment hedging instruments:
(In millions, except for number of instruments)
Number of Instruments
 
Notional Value
Cross Currency Swap Contracts
4
 
$
77.7


The following table summarizes the amount of pre-tax earnings recognized from derivative instruments for the periods indicated and the line items in the accompanying statements of operations where the results are recorded for net investment hedges:
 
Amount of Gain or (Loss) Recognized in OCI on Derivative
Fiscal Year Ended
 
Location of Gain or (Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)
 
Amount of Gain or (Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)
(In millions)
2019
 
2018
 
2017
 
 
2019
 
2018
 
2017
Cross Currency Swap Contracts
$
(0.2
)
 
$
—

 
$
—

 
Interest expense
 
$
0.2

 
$
—

 
$
—

These derivative instruments are subject to master netting agreements giving effect to rights of offset with each counterparty. None of the balances were eligible for netting. The following table summarizes the gross fair values of derivative instruments as of the periods indicated and the line items in the accompanying consolidated balance sheets where the instruments are recorded:
 
Derivative Assets
 
Derivative Liabilities
(In millions)
 
 
September 27, 2019
 
September 28, 2018
 
 
 
September 27, 2019
 
September 28, 2018
Derivatives designated as net investment hedges
Balance sheet location
 
 
 
 
 
Balance sheet location
 
 
 
 
Cross currency swap contracts
Other current assets
 
—

 
—

 
Other current liabilities
 
(0.2
)
 
—

 
 
 
$
—

 
$
—

 
 
 
$
(0.2
)
 
$
—



F-25

Balance Sheet Hedges
The Company also enters into foreign currency forward contracts to hedge fluctuations associated with foreign currency denominated monetary assets and liabilities, primarily cash, third-party accounts receivable, accounts payable, and intercompany receivables and payables. These forward contracts expire within 30 days. These forward contracts are not designated for hedge accounting treatment, therefore, the change in fair value of these derivatives is recorded as a component of other income (expense) and offsets the change in fair value of the foreign currency denominated assets and liabilities, which are also recorded in other income (expense). The effect of derivative instruments not designated as hedges for fiscal year 2019 was a loss of $1.5 million, which was primarily related to the purchase price hedge established following the announcement of the Company's planned acquisition of Direct Conversion. The Company does not, and does not intend to use derivative financial instruments for speculative or trading purposes.
The following table shows the notional amounts of outstanding foreign currency contracts entered into under its balance sheet hedge program as of September 27, 2019:
 
Notional Value of Derivatives not Designated as Hedging Instruments:
In millions
Buy contracts
 
Sell contract
Japanese yen
$
0.9

 
$
—

Swiss franc
—

 
(1.0
)
Chinese renminbi
1.8

 
—

Euro
8.8

 
—

 
$
11.5

 
$
(1.0
)


8. BORROWINGS
The following table summarizes the Company's short-term and long-term debt:
 
September 27, 2019
 
September 28, 2018
(In millions, except for percentages)
Amount
 
Weighted-Average Interest Rate
 
Amount
 
Weighted-Average Interest Rate
Current maturities of long-term debt
 
 
 
 
 
 
 
Term facility
$
29.4

 
5.6
%
 
$
25.0

 
4.2
%
Other debt
1.3

 
 
 
—

 
 
Total current maturities of long-term debt
$
30.7

 
 
 
$
25.0

 
 
 
 
 
 
 
 
 
 
Non-current maturities of long-term debt:
 
 
 
 
 
 
 
Revolving credit facility
$
59.0

 
5.6
%
 
$
28.0

 
4.2
%
Term facility
308.6

 
5.6
%
 
345.0

 
4.2
%
Other debt
2.5

 
 
 
—

 
 
Debt issuance costs
(5.7
)
 
 
 
(8.2
)
 
 
Non-current maturities of long-term debt
364.4

 
 
 
364.8

 
 
Total long-term debt, net
$
395.1

 
 
 
$
389.8

 
 

Existing Credit Facility
On May 1, 2017 and in connection with the Acquired Detector Business, the Company entered into a new secured revolving credit facility (the “Revolving Credit Facility”) in an aggregate principal amount of up to $200.0 million with a five-year term, and a secured term facility (the “Term Facility” and together with the Revolving Credit Facility, the “Credit Agreement”) in an aggregate principal amount of $400.0 million. The Term Facility will be repaid over five years, with 5.0% payable in quarterly installments

F-26

during each of the first two years of the term thereof, 7.5% payable in quarterly installments during the third and fourth years of the term thereof, and 10% payable in quarterly installments in the fifth year of the term thereof, with the remaining amount due at maturity. Varex used the net proceeds from the Term Facility, and the net proceeds from approximately $97.0 million drawn on the Revolving Credit Facility, to pay the purchase price for the Acquired Detector Business, plus related credit facility fees, and to repay all of Varex’s obligations under the Previous Credit Agreement. Both the Term Facility and Revolving Credit Facility expire on May 1, 2022.
The Credit Agreement contains various customary restrictive covenants that limits, among other things, the incurrence of indebtedness by Varex and its subsidiaries, the grant or incurrence of liens by Varex and its subsidiaries, the entry into sale and leaseback transactions by Varex and its subsidiaries, and the entry into certain fundamental change transactions by Varex and its subsidiaries. It also contains customary events of default and certain financial covenants. The Company agreed to maintain financial covenants, which include maximum consolidated total leverage ratio, maximum senior secured leverage ratio, maximum capital expenditures and a minimum consolidated fixed charge coverage ratio. The Company was in compliance with all financial covenants under the Credit Agreement as of September 27, 2019.
The Credit Agreement is secured by the stock and assets of Varex’s material subsidiaries. The Credit Agreement has several borrowing and interest rate options including the following indices: (a) LIBOR rate, or (b) the base rate (equal to the greater of the prime rate, the federal funds rate plus 0.50% or the LIBOR rate for a one-month period plus 1.00%). Loans under the Credit Agreement bear interest at a rate per annum using the applicable indices plus a varying interest rate margin of between 1.75% and 2.75% (for LIBOR rate loans) and 0.75%-1.75% (for base rate loans). The Credit Agreement also provides for fees applicable to amounts available to be drawn under outstanding letters of credit of 0.125%, and a fee on unused commitments which ranges from 0.25% to 0.40%.
On October 3, 2018, the Company, in accordance with the terms of the Credit Agreement, provided notice to the administrative agent that effective as of October 10, 2018, the Company had permanently reducing the revolving credit commitment under the Credit Agreement by $50.0 million to $150.0 million. The reduction in the revolving credit commitment reduced the fees paid by the Company in connection with such commitment.
Subsequent to fiscal year 2019, the Company, in accordance with the terms of the Credit Agreement, provided notice to the administrative agent that effective as of October 8, 2019, the Company was permanently reducing the revolving credit commitment under the Credit Agreement by $25.0 million to $125.0 million.
Subsequent to fiscal year 2019, the Company did not comply with the covenant under the Credit Agreement to timely deliver the Company's fiscal year 2019 annual financial statements. However, upon the filing of this Annual Report with the SEC, the Company will be able to deliver the fiscal year 2019 annual financial statements within the 30-day cure period set forth in the Credit Agreement and consequently no event of default will occur.
At September 27, 2019, the Company had $364.4 million in non-current maturities of long-term debt outstanding, net of deferred debt issuance costs of $5.7 million, and $30.7 million of current maturities of long-term debt outstanding.
Future principal payments of the long-term debt outstanding as of September 27, 2019 are as follows:
(In millions)
 
Fiscal years:
 
2020
$
30.7

2021
34.3

2022
335.8

Total debt outstanding
400.8

Less: current maturities of long-term debt
(30.7
)
Non-current portion of long -term debt
$
370.1



F-27

9. FAIR VALUE
Assets/Liabilities Measured at Fair Value on a Recurring Basis
In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.
(In millions)
Fair Value Measurements at September 27, 2019
 
Quoted Prices in Active Markets for Identical Assets and Liabilities
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
 
Total
Assets:
 
 
 
 
 
 
 
Cash equivalents - money market funds
$
—

 
$
8.8

 
$
—

 
$
8.8

Total assets measured at fair value
$
—

 
$
8.8

 
$
—

 
$
8.8

Liabilities:
 
 
 
 
 
 
 
Derivative liabilities
$
—

 
$
0.7

 
$
—

 
$
0.7

Deferred consideration
8.9

 
—

 
—

 
8.9

Total liabilities measured at fair value
$
8.9

 
$
0.7

 
$
—

 
$
9.6


As of September 27, 2019, the total outstanding borrowings under the Company's credit agreement were $395.1 million, net of deferred loan costs, which approximated its fair value because it is carried at a market observable interest rate that resets periodically and is categorized as Level 2 in the fair value hierarchy. The fair values of certain of the Company’s financial instruments, including bank deposits included in cash and cash equivalents, accounts receivable and accounts payable, also approximate their fair values due to their short maturities.
There were no financial assets or liabilities measured on a recurring basis using significant unobservable inputs (Level 3) and there were no transfers in or out of Level 1, 2 or 3 during fiscal year 2018.
At September 28, 2018, the Company determined the following levels of inputs for the following assets or liabilities:
(In millions)
Fair Value Measurements at September 28, 2018
 
Quoted Prices in Active Markets for Identical Assets and Liabilities
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
 
Total
Assets:
 
 
 
 
 
 
 
Cash equivalents - Money market funds
$
—

 
$
18.4

 
$
—

 
$
18.4

Derivative assets
—

 
7.7

 
—

 
7.7

Total assets measured at fair value
$
—

 
$
26.1

 
$
—

 
$
26.1

Liabilities:
 
 
 
 
 
 
 
Derivative liabilities
$
—

 
$
—

 
$
—

 
$
—



F-28

10. GOODWILL AND INTANGIBLE ASSETS
The following table reflects goodwill by reportable operating segment:
(In millions)
Medical
 
Industrial
 
Total
Balance at September 28, 2018
$
147.0

 
$
96.6

 
$
243.6

Business combination
26.0

 
21.2

 
47.2

Balance at September 27, 2019
$
173.0

 
$
117.8

 
$
290.8


The following table reflects the gross carrying amount and accumulated amortization of the Company’s finite-lived intangible assets included in other assets in the consolidated balance sheets:
 
September 27, 2019
 
September 28, 2018
(In millions)
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
Acquired existing technology
$
74.1

 
$
(28.4
)
 
$
45.7

 
$
57.9

 
$
(21.8
)
 
$
36.1

Patents, licenses and other
12.7

 
(8.4
)
 
4.3

 
9.9

 
(7.4
)
 
2.5

Customer contracts and supplier relationship
50.7

 
(17.2
)
 
33.5

 
42.6

 
(11.4
)
 
31.2

Total intangible assets with finite lives
137.5

 
(54.0
)
 
83.5

 
110.4

 
(40.6
)
 
69.8

In-process R&D with indefinite lives
2.8

 
0.0

 
2.8

 
4.0

 
0.0

 
4.0

Total intangible assets
$
140.3

 
$
(54.0
)
 
$
86.3

 
$
114.4

 
$
(40.6
)
 
$
73.8

 
 
 
 
 
 
 
 
 
 
 
 

Amortization expense for intangible assets was $15.7 million, $16.2 million and $10.5 million in fiscal years 2019, 2018 and 2017, respectively. The Company recognized an impairment loss of $4.8 million and $3.0 million in fiscal years 2019 and 2018, respectively. These impairment costs were included in the consolidated statements of earnings under impairment of intangible assets.
As of September 27, 2019, the estimated future amortization expense of intangible assets with finite lives is as follows:
(In millions)
 
Fiscal years:
 
2020
$
17.2

2021
16.3

2022
14.7

2023
13.7

2024
9.1

Thereafter
12.5

Total
$
83.5


11. COMMITMENTS AND CONTINGENCIES
Lease Commitments
At September 27, 2019, the Company was committed to minimum rentals under non-cancelable operating leases (including rent escalation clauses) for fiscal years 2020 through 2024 and thereafter, as follows: $7.5 million, $5.4 million, $4.7 million, $1.8 million, $0.9 million, and $0.2 million, respectively. Rental expenses were $5.1 million, $5.3 million, and $4.0 million for fiscal years 2019, 2018 and 2017, respectively.
Other Commitments
See Note 3. Related Party Transactions, included in this report, for additional information about the Company’s commitments to dpiX.

F-29


See Note 12. Redeemable Noncontrolling Interests & Noncontrolling Interests, included in this report, for additional information about the Company’s commitment to the noncontrolling shareholders of MeVis.
The Company has an environmental liability of approximately $0.9 million as of September 27, 2019.
 Contingencies
From time to time, the Company is a party to or otherwise involved in legal proceedings, claims and government inspections or investigations, customs and duty audits, other contingency matters, both inside and outside the United States, arising in the ordinary course of its business or otherwise. The Company accrues amounts for probable losses, to the extent they can be reasonably estimated, that it believes are adequate to address any liabilities related to legal proceedings and other loss contingencies that the Company believes will result in a probable loss (including, among other things, probable settlement value). A loss or a range of loss is disclosed when it is reasonably possible that a material loss will be incurred and can be estimated or when it is reasonably possible that the amount of a loss, when material, will exceed the recorded provision. The Company did not have any contingent liabilities as of September 27, 2019 and September 28, 2018. Legal expenses are expensed as incurred.
12. REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS
In April 2019, a subsidiary of Varex completed the acquisition of 98.2% of the outstanding shares of common stock of Direct Conversion. As the Company has majority voting rights it has consolidated Direct Conversion's operations in its consolidated financial statements and recorded the noncontrolling interest. The noncontrolling interest related to Direct Conversion is included in noncontrolling interest in the equity section of the Company's consolidated balance sheet. Earnings representing the noncontrolling interest's portion of Direct Conversion's income from operations is included in the Company's consolidated statements of earnings.
In September 2018, the Company entered into a partnership in Saudi Arabia. The Company has majority voting rights with an approximate 75% interest. Accordingly, the Company has consolidated the operations of the Saudi Arabia partnership in our consolidated financial statements and recorded the noncontrolling interests. The noncontrolling interest related to the partner’s 25% interest in the joint venture is included in noncontrolling interest in the equity section of the Company’s consolidated balance sheet. Earnings representing the noncontrolling partner's share of income from operations is included in the Company's consolidated statements of earnings.
In April 2015, the Company completed the acquisition of 73.5% of the then outstanding shares of MeVis Medical Solutions AG (“MeVis”), a public company based in Bremen, Germany that provides image processing software and services for cancer screening. In August 2015, the Company, through one of its German subsidiaries, entered into a domination and profit and loss transfer agreement (the “DPLTA”) with MeVis. In October 2015, the DPLTA became effective upon its registration at the local court of Bremen, Germany. Under the DPLTA, MeVis subordinates its management to the Company and undertakes to transfer all of its annual profits and losses to the Company. In return, the DPLTA grants the noncontrolling shareholders of MeVis: (1) an annual recurring net compensation of €0.95 per MeVis share starting from January 1, 2015 and (2) a put right for their MeVis shares at €19.77 per MeVis share. Upon effectiveness of the DPLTA, the noncontrolling interests in MeVis became redeemable as a result of the put right and were reclassified to temporary equity. As of September 27, 2019, the redemption value of redeemable noncontrolling interests in MeVis was $10.5 million.
During fiscal year 2018, an immaterial number of MeVis’ shares were purchased under the put right. As of September 27, 2019, noncontrolling shareholders together held approximately 0.5 million shares of MeVis, representing 26.3% of the outstanding shares.

F-30

Changes in redeemable noncontrolling interests and noncontrolling interests were as follows: 
 
Fiscal Years
 
2019
 
2018
(In millions)
Redeemable
Noncontrolling
Interests
 
Noncontrolling
Interests
 
Redeemable
Noncontrolling
Interests
 
Noncontrolling Interest
Balance at beginning of period
$
11.1

 
$
2.1

 
$
11.2

 
$
—

Net earnings attributable to noncontrolling interests
0.5

 
(0.2
)
 
0.5

 
0.3

Contributions from noncontrolling interests
—

 
1.4

 
—

 
1.8

Dividend distributions
(0.5
)
 
—

 
(0.6
)
 
—

Other
(0.6
)
 
—

 
—

 
—

Balance at end of period
$
10.5

 
$
3.3

 
$
11.1

 
$
2.1


13. EMPLOYEE STOCK PLANS
Employee Stock Plans
The Company's employees participate in Varex Imaging Corporation 2017 Omnibus Stock Plan (the “2017 Stock Plan”) and Varex Imaging Corporation 2017 Employee Stock Purchase Plan (the “2017 ESPP”) which allows the grants of stock options, restricted stock units and performance shares among other types of awards.
In January 2017, Varex stockholders approved the 2017 ESPP, which provides eligible employees with an opportunity to purchase shares of Varex common stock at 85% of the lower of its fair market value at the start and end of a six months purchase period. The 2017 ESPP provides for the purchase of up to one million shares of Varex common stock.
Share-Based Compensation Expense
Share-based compensation expense recognized in the consolidated statements of earnings is based on awards ultimately expected to vest. Share-based compensation expense includes expenses related to the Company’s direct employees. Prior to the separation, Varian also charged the Company for the allocated share-based compensation costs of certain employees of Varian who provided selling, general and administrative services on the Company’s behalf.
The table below summarizes the effect of recording share-based compensation expense and for the option component of the employee stock purchase plan shares:
 
Fiscal Year
(In millions)
2019
 
2018
 
2017
Cost of revenues
$
1.2

 
$
1.3

 
$
0.9

Research and development
2.2

 
1.8

 
1.5

Selling, general and administrative (1)
8.3

 
6.9

 
6.0

Total share-based compensation expense
$
11.7

 
$
10.0

 
$
8.4

(1) Includes allocated share-based compensation of $0.8 million for fiscal year 2017 and represents charges by Varian to the Company for certain Varian employees who provided general and administrative services on the Company’s behalf.
The unrecognized share-based compensation cost as of September 27, 2019 was $23.1 million, and is expected to be recognized in the next 3 to 4 fiscal years. As of September 27, 2019, there were approximately 1.2 million and 0.7 million shares of common stock available for future issuances under the 2017 Stock Plan and the 2017 ESPP, respectively.

F-31

The Company utilized the Black-Scholes valuation model for estimating the fair value of stock options granted and the option component of ESPP grants. The Company calculated the fair value of option grants and option component of ESPP grants on the respective dates of grant using the following weighted average assumptions:
 
Employee Stock Option Plan
 
Employee Stock Purchase Plans
 
Fiscal Year
 
Fiscal Year
 
2019
 
2018
 
2017
 
2019
 
2018
 
2017
Expected term (in years)
4.6

 
4.8

 
4.2

 
0.5

 
0.5

 
0.5

Risk-free interest rate
2.5
%
 
2.6
%
 
1.6
%
 
2.5
%
 
2.0
%
 
1.0
%
Expected volatility
33.9
%
 
31.8
%
 
23.6
%
 
43.9
%
 
34.1
%
 
28.0
%
Expected dividend
0.0
%
 
0.0
%
 
0.0
%
 
0.0
%
 
0.0
%
 
0.0
%
Weighted average fair value at grant date
$10.19
 
$11.57
 
$8.08
 
$7.81
 
$8.92
 
$7.81

Option valuation methods, including Black-Scholes, require the input of subjective assumptions, which are discussed below.
Risk-Free Interest Rate
The interest rates used are based on the implied yield currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term equal to the expected life of the award.
Expected Term
Options granted generally vest over a period of 36 to 48 months and expire 7 to 10 years from date of grant. Employee stock purchase plan offering periods are 6 months and provides eligible employees with an opportunity to purchase shares of Varex common stock at 85% of the lower of its fair market value at the start and end of a six-month purchase period.
Expected Dividend Yield
The dividend rate used is zero as the Company has never paid any cash dividends on its common stock and does not anticipate doing so in the foreseeable future. The Company is also restricted from paying dividends on common stock under its credit facility.
Expected Volatility
Authoritative accounting guidance on stock-based compensation indicates that companies should consider volatility over a period generally commensurate with the expected or contractual term of the stock option. Adequate Company-specific data does not exist for this time period as the Company began trading in January 2017. The volatility variable used is a blended approach by using the Company's historic data for the years it has been publicly traded and a benchmark of other comparable companies’ volatility rates for the prior years.

F-32

Stock Option Activity
The following table summarizes the activity for stock options under Varex’s employee incentive plans for the Company’s employees:
(In thousands, except per share amounts and the remaining term)
Options
 
Price range
 
Weighted Average
Exercise Price
 
Weighted Average Remaining Term (in years)
 
Aggregate Intrinsic Value (1)
Outstanding at September 28, 2018
2,011
 
$22.63 — $37.60
 
$
30.35

 
 
 
 
Granted
297
 
$31.42 — $31.42
 
31.42

 
 
 
 
Canceled, expired or forfeited
(4)
 
$31.08 — $31.08
 
31.08

 
 
 
 
Exercised
(35)
 
$22.84 — $27.77
 
23.38

 
 
 
 
Outstanding at September 27, 2019
2,269
 
$22.63 — $37.60
 
$
30.60

 
4.1
 
$
1,220.3

Exercisable at September 27, 2019
1,477
 
$22.63 — $37.60
 
$
29.67

 
3.4
 
$
1,220.3

(1) The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of Varex common stock of $28.28 as of September 27, 2019, the last trading date of the Company's respective fiscal years, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date.
The weighted-average grant-date fair value of options granted during fiscal years 2019, 2018 and 2017 was $3.0 million, $3.1 million and $9.2 million respectively. The total intrinsic value of the options exercised during the years ended September 27, 2019, September 28, 2018 and September 29, 2017 was $0.2 million, $1.7 million and $1.4 million respectively
Restricted Stock Units, Restricted Stock Awards and Deferred Stock Units
The following table summarizes the activity for restricted stock units, restricted stock awards and deferred stock units under Varex’s employee incentive plans for the Company’s employees:
(In thousands, except per share amounts)
Number of Shares
 
Weighted Average
Grant-Date Fair
Value
Balance at September 28, 2018
641
 
$
33.60

Granted
288
 
31.29

Vested
(201)
 
31.56

Canceled or expired
(50)
 
34.13

Balance at September 27, 2019
678
 
$
33.18

The total grant-date fair value of shares granted in fiscal year was $9.0 million, $10.1 million and $11.4 million for fiscal years 2019, 2018 and 2017, respectively. Shares outstanding at September 27, 2019, September 28, 2018 and September 29, 2017 had an estimated market value of $19.2 million, $18.4 million and $17.8 million, respectively.
14. TAXES ON EARNINGS
Income tax expense is based on reported income or loss before income taxes. Deferred income taxes reflect the effect of temporary differences between asset and liability amounts that are recognized for financial reporting purposes and the amounts that are recognized for income tax purposes. These deferred taxes are measured by applying currently enacted tax laws. Valuation allowances are recognized to reduce deferred tax assets to the amount that is more likely than not to be realized.

F-33

Taxes on earnings were as follows:
 
Fiscal Years
(In millions)
2019
 
2018
 
2017
Current provision:
 
 
 
 
 
Federal
$
9.2

 
$
(2.1
)
 
$
24.8

State and local
1.3

 
(0.3
)
 
1.6

Foreign
6.8

 
7.5

 
5.3

Total current
17.3

 
5.1

 
31.7

Deferred provision (benefit):
 
 
 
 
 
Federal
(10.0
)
 
(7.0
)
 
(7.0
)
State and local
(1.6
)
 
0.7

 
(1.0
)
Foreign
—

 
(1.4
)
 
(0.9
)
Total deferred
(11.6
)
 
(7.7
)
 
(8.9
)
Taxes on earnings
$
5.7

 
$
(2.6
)
 
$
22.8


Earnings before taxes are generated from the following geographic areas:
 
Fiscal Years
(In millions)
2019
 
2018
 
2017
United States
$
5.9

 
$
3.7

 
$
55.5

Foreign
15.6

 
22.0

 
19.3

Earnings before taxes
$
21.5

 
$
25.7

 
$
74.8


The effective tax rate differs from the U.S. federal statutory tax rate as a result of the following:
 
Fiscal Years
 
2019
 
2018
 
2017
Federal statutory income tax rate
21.0
 %
 
24.5
 %
 
35.0
 %
State and local taxes, net of federal tax benefit
(0.9
)%
 
1.1
 %
 
1.3
 %
Revaluation of deferred tax liabilities for US statutory change
—
 %
 
(41.8
)%
 
—
 %
Mandatory repatriation tax on foreign earnings
1.9
 %
 
13.0
 %
 
—
 %
Domestic production activities deduction
—
 %
 
(0.8
)%
 
(2.4
)%
Research and development credit
(10.2
)%
 
(11.1
)%
 
(2.6
)%
Prior year deferred tax adjustments
4.7
 %
 
1.9
 %
 
(4.0
)%
Foreign Rate Difference
6
 %
 
0.8
 %
 
—
 %
Change in valuation allowance
11.2
 %
 
(1.9
)%
 
3.8
 %
US Tax Reform - International Provisions
(4.7
)%
 
—
 %
 
—
 %
Other
(2.5
)%
 
4.2
 %
 
(0.6
)%
Effective tax rate
26.5
 %
 
(10.1
)%
 
30.5
 %

On December 22, 2017, the Tax Cuts and Jobs Act of 2017 (U.S. Tax Reform) was enacted in the U.S. which significantly revised the U.S. corporate income tax structure. Among the revisions impacting our effective tax rate are a lower U.S. corporate statutory rate going from 35% to 21% effective January 1, 2018 and changes to the way foreign earnings are taxed. As a September fiscal year filer, the lower corporate income tax rate is phased in from a U.S. statutory federal rate of 24.5% in fiscal year ending September 28, 2018 to a rate of 21% for the fiscal year ending September 27, 2019.
During fiscal year 2019, the Company’s effective tax rate varied from the U.S. federal statutory rate of 21% primarily because of the favorable impact of changes to the U.S. corporate tax structure resulting from U.S. Tax Reform, and U.S. research and development tax credits. These favorable U.S. tax items are offset by losses in certain foreign jurisdictions for which no benefit is recognized and earnings in other foreign jurisdictions that are taxed at higher rates.

F-34

During fiscal year 2018, the Company’s effective tax rate varied from the U.S. federal statutory rate primarily because the favorable impact of changes to the U.S. corporate tax structure resulting from U.S. Tax Reform. During fiscal years 2018 and 2017, the effective tax rate also differs from the U.S. federal statutory rate due to increases resulting from U.S. state income tax expense, losses in certain foreign jurisdictions for which no benefit is recognized, earnings in other foreign jurisdictions that are taxed at higher rates, and limitations on the deductibility of officers' compensation. These are offset by decreases due to U.S. research and development credits, tax windfalls for share-based compensation, and the release of a valuation allowance against loss carryforwards in certain foreign jurisdictions.
The SEC issued guidance under Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (“SAB 118”) that allows for reasonable estimated amounts to be recorded and a measurement period of up to one year from the date of enactment to revise these provisional amounts as new information is obtained and additional guidance is issued. During the three months ended December 28, 2018, the Company completed its analysis of U.S. Tax Reform, and the accounting for the income tax effects has been finalized for the measurement period under SAB 118, with no significant adjustments from the provisional amounts. During fiscal year 2019, additional U.S. Tax Reform provisions, including GILTI (global intangible low-taxed income), BEAT (base-erosion anti-abuse tax), FDII (foreign-derived intangible income), limitations on interest expense deductions (if certain conditions apply), and other components became effective for the Company and, if applicable, have been included in the calculation of the fiscal year 2019 tax provision. The determination of the tax effects of U.S. Tax Reform may change following future legislation or further interpretation of U.S. Tax Reform from U.S. Federal and state tax authorities.
The guidance for accounting for U.S. Tax Reform requires taxpayers to make an election regarding the accounting for GILTI. This policy election is to either: (1) treat GILTI as a period cost if and when incurred, or (2) recognize deferred taxes for basis differences that are expected to reverse as GILTI in future years. During the first quarter of fiscal year 2019, the Company has made the accounting policy election to account for GILTI under the period cost method.
Significant components of deferred tax assets and liabilities are as follows:
(In millions)
September 27, 2019
 
September 28, 2018
Deferred Tax Assets:
 
 
 
Inventory adjustments
$
5.6

 
$
4.2

Share-based compensation
3.1

 
0.8

Product warranty
1.6

 
1.4

Deferred compensation
1.1

 
0.9

Net operating loss carryforwards
24.3

 
3.3

Accrued vacation
1.0

 
1.3

Credit carryforwards
1.9

 
1.8

Other
7.5

 
4.7

 
46.1

 
18.4

Valuation allowance
(18.8
)
 
(4.0
)
Total deferred tax assets
27.3

 
14.4

Deferred Tax Liabilities:
 
 
 
Acquired intangibles
(19.3
)
 
(15.2
)
Property, plant and equipment
(10.6
)
 
(14.3
)
Investments in privately held companies
(3.3
)
 
(4.1
)
Other
(2.3
)
 
(4.0
)
Total deferred tax liabilities
(35.5
)
 
(37.6
)
Net deferred tax liabilities
$
(8.2
)
 
$
(23.2
)
Reported As:
 
 
 
Deferred tax assets
$
27.3

 
$
14.4

Deferred tax liabilities
(35.5
)
 
(37.6
)
Net deferred tax liabilities
$
(8.2
)
 
$
(23.2
)

As a result of the changes to the U.S. taxation of foreign earnings included in U.S. Tax Reform, the Company reevaluated its previous indefinite reinvestment assertion with respect to these earnings during fiscal year 2018, which resulted in the Company revoking its assertion for current and future earnings for all countries, while maintaining the assertion that historic earnings are

F-35

indefinitely reinvested outside the U.S. The Company has modified this prior assertion for the year ended September 27, 2019 with respect to the acquisition of Direct Conversion. The modification was to assert that all earnings for Direct Conversion, located primarily in Sweden and Finland, are indefinitely reinvested in those countries. Due to the level of earnings available for repatriation, the treaty benefits applicable to jurisdictions in which those earnings are located, and the now favorable U.S. tax treatment of repatriated foreign earnings, the amount of deferred tax liability recorded related to the potential repatriation is approximately $0.1 million. This estimated liability is for U.S. State income taxes and foreign withholding taxes that would apply if the foreign earnings were actually repatriated in the form of a dividend.
As of September 27, 2019, the Company has net operating loss carryforwards of approximately $24.3 million with $4.4 million expiring between 2020 and 2030 and $19.9 million carried forward indefinitely.
The valuation allowance relates primarily to net operating losses in certain foreign jurisdictions where, based on the weight of available evidence, it is more likely than not that the tax benefit of the net operating losses will not be realized. The valuation allowance increased by $14.8 million during fiscal year 2019 and decreased by $0.3 million during fiscal year 2018. The increase during the current year was primarily related to the acquisition of Direct Conversion that included deferred tax assets subject to a valuation allowance as of acquisition. Changes in the Company's valuation allowance for deferred tax assets were as follows:
 
Fiscal Years
(In millions)
2019
 
2018
 
2017
Valuation allowance balance–beginning of fiscal year
$
4.0

 
$
4.3

 
$
2.5

Increases resulting from business combinations
12.0

 
—

 
—

Other increases
2.8

 
2.2

 
2.5

Other decreases
—

 
(2.5
)
 
(0.7
)
Valuation allowance balance—end of fiscal year
$
18.8

 
$
4.0

 
$
4.3


During fiscal year 2019, the Company paid U.S and foreign taxes of approximately $8.2 million. In fiscal year 2018, the Company paid U.S. and foreign taxes of approximately $13.8 million.
The Company accounts for uncertainty in income taxes following a two-step approach for recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining whether the weight of available evidence indicates that it is more likely than not that, based on the technical merits, the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.
Changes in the Company’s unrecognized tax benefits were as follows:
 
Fiscal Years
(In millions)
2019
 
2018
Unrecognized tax benefits balance–beginning of fiscal year
$
0.6

 
$
0.5

Subtractions based on tax positions related to a prior year
(0.2
)
 
—

Additions based on tax positions related to the current year
0.2

 
0.1

Unrecognized tax benefits balance—end of fiscal year
$
0.6

 
$
0.6


As of September 27, 2019 and September 28, 2018, the total amount of gross unrecognized tax benefits was $0.6 million and $0.6 million, respectively, all of which would affect the effective tax rate if recognized.
The Company includes interest and penalties related to income taxes within taxes on earnings on the Combined Statements of Earnings. For the year ended September 27, 2019, $0.1 million interest and penalties have been included for this period. For the year ended September 28, 2018 any interest or penalties related to unrecognized tax benefits are minimal and have been included in the balance for that period.
The Company files U.S. Federal and state income tax returns and non-U.S. income tax returns in various jurisdictions. All of these returns are subject to examination by their respective taxing jurisdictions from the date of filing through each applicable statute of limitation period. The Company’s significant operations up to the date of separation have historically been included in Varian’s U.S. federal and state income tax returns and non-U.S. jurisdiction tax returns. Material liabilities arising related to the pre-spin operations

F-36

would be the responsibility of Varian. Other periods for entities acquired are still open and subject to examination. Generally, periods prior to 2009 are no longer subject to examination.
15. SEGMENT INFORMATION
The Company has two reportable operating segments Medical and Industrial. The segments align the Company’s products and service offerings with customer use in medical and industrial markets and are consistent with how the Company’s Chief Executive Officer, who is also its CODM, evaluates the business for the allocation of resources. The CODM allocates resources to and evaluates the financial performance of each operating segment primarily based on revenues and gross margin. The operating and reportable segment structure provides alignment between business strategies and operating results.
Description of Segments
The Medical segment designs, manufactures, sells and services X-ray imaging components for use in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy and computer-aided detection. The Company provides a broad range of X-ray imaging components for Medical customers including X-ray tubes, digital flat panel detectors, generators, high voltage connectors, image-processing software and workstations, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, ionization chambers and buckys. The Company’s X-ray imaging components are primarily sold to imaging system OEM customers that incorporate them into their medical diagnostic, radiation therapy, dental, veterinary and industrial imaging systems. The Company also sells its X-ray imaging components to independent service companies, distributors and directly to end-users for replacement purposes.
The Industrial segment designs, manufactures, sells and services products for use in the security and industrial inspection applications, such as airport security, cargo screening at ports and borders and nondestructive examination in a variety of applications. The products include Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high voltage connectors and image processing software that we generally sell to OEM customers that incorporate these products into their inspection systems.
Accordingly, the following information is provided for purposes of achieving an understanding of operations, but it may not be indicative of the financial results of the reported segments were they independent organizations. In addition, comparisons of the Company’s operations to similar operations of other companies may not be meaningful.
Information related to the Company’s segments is as follows:
 
Fiscal Year
(In millions)
2019
 
2018
 
2017
Revenues
 
 
 
 
 
Medical
$
596.8

 
$
602.0

 
$
556.9

Industrial
183.8

 
171.4

 
141.2

Total revenues
780.6

 
773.4

 
698.1

Gross margin
 
 
 
 
 
Medical
188.9

 
190.5

 
193.6

Industrial
67.8

 
63.4

 
59.9

Total gross margin
256.7

 
253.9

 
253.5

Total operating expenses
211.0

 
209.4

 
169.8

Interest and other expenses, net
(24.2
)
 
(18.8
)
 
(8.9
)
Earnings before taxes
21.5

 
25.7

 
74.8

Taxes (benefit) on earnings
5.7

 
(2.6
)
 
22.8

Net earnings
15.8

 
28.3

 
52.0

Less: Net earnings attributable to noncontrolling interests
0.3

 
0.8

 
0.4

Net earnings attributable to Varex
$
15.5

 
$
27.5

 
$
51.6



F-37

The following table summarizes the Company’s total assets by its reportable segments:
(In millions)
September 27, 2019
 
September 28, 2018
Identifiable assets:
 
 
 
Medical
$
794.3

 
$
770.6

Industrial
244.6

 
217.3

Total reportable segments
$
1,038.9

 
$
987.9


Geographic Information
 
Revenues
 
Property, plant and equipment, net
 
Fiscal Years
 
Fiscal Years
(In millions)
2019
 
2018
 
2017
 
2019
 
2018
United States
$
275.3

 
$
268.8

 
$
231.9

 
$
122.6

 
$
127.9

Latin America
7.3

 
7.0

 
7.9

 
—

 
—

EMEA
269.0

 
254.5

 
219.5

 
11.4

 
8.7

APAC
229.0

 
243.1

 
238.8

 
8.3

 
8.3

Total company
$
780.6

 
$
773.4

 
$
698.1

 
$
142.3

 
$
144.9


The Company operates various manufacturing and marketing operations outside the United States. Latin America includes Brazil and Mexico. EMEA includes Europe, Russia, the Middle East, India and Africa. APAC includes Asia and Australia. Revenues by region are based on the known final destination of products sold.
16. EMPLOYEE BENEFIT PLANS
Varex’s 401(k) plan became effective on January 1, 2017. Varex’s 401(k) plan is intended to be qualified under Section 401(a) of the Code with the 401(k) plan’s related trust intended to be tax exempt under Section 501(a) of the Code and intended for all full-time employees in the United States. This plan allows employees to contribute a portion of their pretax salary up to the maximum dollar limitation prescribed by the Internal Revenue Service. Prior to Varex's 401(k) plan becoming effective, Company employees participated in Varian's 401(k) plan. The Company made matching contributions to the plan totaling $6.7 million, $6.5 million and $4.3 million in fiscal years 2019, 2018 and 2017, respectively.
The Company also maintains defined benefit plans for employees located outside the US. The net pension liability is included in non-current liability on the Company's consolidated balance sheets and totaled $5.5 million and $3.3 million as of September 27, 2019 and September 28, 2018, respectively. The Company’s net periodic benefit costs for the Company’s defined benefit plans was not material for fiscal years 2019, 2018 and 2017.
17. OTHER COMPREHENSIVE INCOME
The following table presents the changes in the accumulated balances for each component of other comprehensive income (loss):
(In millions)
Unrealized Gain (Loss) on Derivative Financial Instruments
 
Unrealized Gain on Defined Benefit Obligations
 
Accumulated Other Comprehensive Income
Balance at September 28, 2018
$
5.8

 
$
—

 
$
5.8

Other comprehensive loss before reclassifications
(8.3
)
 
(1.9
)
 
(10.2
)
Income tax benefit
2.1

 
0.6

 
2.7

Balance at September 27, 2019
$
(0.4
)
 
$
(1.3
)
 
$
(1.7
)
 
 
 
 
 
 

No amounts were reclassified out of accumulated other comprehensive income during fiscal years 2019 and 2018.


F-38

18. REVENUE RECOGNITION
The Company adopted ASC 606 on September 29, 2018, using the modified retrospective method for all contracts not completed as of the date of adoption. The reported results for fiscal year 2019 reflect the application of ASC 606 guidance while the reported results for fiscal year 2018 were prepared under the guidance of ASC 605, “Revenue Recognition.” The primary impacts of the adoption include: (1) recording a separate contract liability and contract asset related to the sale of X-ray tubes that were sold with an option for the customer to require the Company to repurchase specific parts of the X‑ray tube at a specific price; and (2) recording a liability related to the deferral of revenue for service type warranties that are provided to certain customers who purchase Linatron® X-ray accelerators.
The Company has made the following accounting policy elections and elected to use certain practical expedients, as permitted by the FASB, in applying ASC 606: (1) the Company accounts for amounts collected from customers for sales and other taxes, net of related amounts remitted to tax authorities; (2) the Company does not adjust the promised amount of consideration for the effects of a significant financing component, if, at contract inception, the Company expects the period between the time when the Company transfers a promised good or service to the customer and the time when the customer pays for that good or service will be one year or less; (3) the Company expenses costs to obtain a contract as they are incurred if the expected period of benefit, and therefore the amortization period, is one year or less; (4) the Company accounts for shipping and handling activities that occur after control transfers to the customer as a fulfillment cost rather than an additional promised service and these fulfillment costs are included as a component of cost of revenues; and (5) the Company does not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.
Transaction price and allocation to performance obligations
Transaction prices of products or services are typically based on contracted rates. To the extent that the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing the expected value method when there is a large number of transactions with similar characteristics or the most likely amount method when there are two possible outcomes, depending on the circumstances of the transaction, to which the Company expects to be entitled. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of the Company’s anticipated performance and all information (historical, current and forecasted) that is reasonably available.
The Company allows customers to return specific parts of purchased X-ray tubes for a partial refund credit, which is identified as variable consideration. ASC 606-10-55-23 requires that for sales with a right of return, revenue is reduced for expected returns, a liability is recorded for expected returns, and an asset is recorded for the right to recover products from customers on settling the liability. The Company recognizes a reduction to revenue and cost of sales at the time of sale and a corresponding contract liability and contract asset. The Company records this estimate based on the historical volume of product returns and adjusts the estimate on a quarterly basis based on the current quarter sales and current quarter returns.
If a contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products or services underlying each performance obligation. The Company determines standalone selling prices based on the price at which the performance obligation is sold separately.
The beginning net cumulative-effect adjustment to the balance sheet for the adoption of ASC 606 is as follows:
 
Balance at
 
Adjustment Due to
 
Balance at
(In millions)
September 28, 2018
 
ASC 606
 
September 29, 2018
Assets:
 
 
 
 
 
Prepaid expenses and other current assets
$
17.1

 
$
6.4

 
$
23.5

Other assets
16.5

 
18.0

 
34.5

Liabilities and Equity:
 
 
 
 
 
Deferred revenues
13.2

 
0.3

 
13.5

Accrued liabilities
47.5

 
7.1

 
54.6

Deferred tax liabilities
23.2

 
(0.8
)
 
22.4

Other long-term liabilities
8.5

 
21.3

 
29.8

Retained earnings
62.4

 
(3.5
)
 
58.9


F-39


The following tables compare the reported consolidated balance sheet and statement of operations for fiscal year ended September 27, 2019, to the amounts that would have been reported if ASC 605 had been in effect:
 
September 27, 2019
(In millions)
Balance without Adoption
 
As Reported
Assets:
 
 
 
Prepaid expenses and other current assets
$
13.1

 
$
19.3

Other assets
$
10.0

 
$
27.5

Liabilities and equity:
 
 
 
Deferred revenues
$
9.9

 
$
10.5

Accrued liabilities
$
68.8

 
$
75.7

Deferred tax liabilities
$
9.1

 
$
8.2

Other long-term liabilities
$
12.1

 
$
32.5

Retained earnings
$
77.7

 
$
74.4


 
Twelve Months Ended September 27, 2019
(In millions)
Balance without Adoption
 
As Reported
Revenues
781.2

 
780.6

Cost of revenues
524.7

 
523.9

Taxes on earnings
5.7

 
5.7

Net earnings attributable to Varex
15.3

 
15.5


Contracts and performance obligations
The Company accounts for a contract with a customer when there is an approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. The Company's performance obligations consist mainly of transferring control of products and services identified in the contracts or purchase orders. For each contract, the Company considers the obligation to transfer products and services to the customer, which are distinct, to be performance obligations.
Revenue recognition
Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the promised products or services is transferred to customers. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or services to a customer.
Product revenue is recognized when the customer obtains control of the Company’s product, which occurs at a point in time, and may be upon shipment or upon delivery based on the contractual shipping terms of a contract.
Service revenue is recognized over time as the services are rendered to the customer based on the extent of progress towards completion of the performance obligation. The Company recognizes service revenue over the term of the service contract. Services are expected to be transferred to the customer throughout the term of the contract and the Company believes recognizing revenue ratably over the term of the contract best depicts the transfer of value to the customer.
Disaggregation of Revenue
Revenue is disaggregated from contracts between geography and by reportable operating segment, which the Company believes best depicts how the nature, amount, timing, and uncertainty of revenues and cash flows are affected by economic factors. Refer to Note 15. Segment Information, included in this report, for the disaggregation of the Company’s revenue based on reportable operating segments and disaggregated by geographic region.    

F-40

Contract Balances
Contract assets are included within the prepaid expenses and other current assets, and other assets balances. Contract liabilities, which also includes refund obligations are included within the accrued liabilities, deferred revenues, and other long-term liabilities balances. The following table summarizes the changes in the contract assets and refund liabilities for the twelve months ended September 27, 2019:
(In millions)
Contact Assets
Balance at September 29, 2018
$
24.4

Costs recovered from product returns during the period
(6.4
)
Contract asset from shipments of products, subject to return during the period
5.7

Balance at September 27, 2019
$
23.7

(In millions)
Refund Liabilities
Balance at September 29, 2018
$
27.1

Recognition of revenue included in beginning of year refund liability
(7.0
)
Additions to refund liabilities
6.3

Balance at September 27, 2019
$
26.4


Remaining Performance Obligations
Remaining performance obligations represent the transaction price of firm orders for which revenue has not yet been recognized. As of September 27, 2019, total remaining performance obligations amounted to $265.2 million. The Company expects to recognize a majority of the remaining performance obligations over the next 12 months.
Costs to Obtain or Fulfill a Customer Contract
The Company has certain costs to obtain and fulfill a customer contract, such as commissions and shipping costs. The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. Incremental costs of obtaining contracts that would be recognized over greater than one year are not material. The Company accounts for shipping and handling activities related to contracts with customers as costs to fulfill the promise to transfer the associated products. These costs are included as a component of cost of revenues.
19. SUBSEQUENT EVENTS
On October 1, 2019, the Company, in accordance with the terms of the Credit Agreement, provided notice to the administrative agent that effective as of October 8, 2019, the Company was permanently reducing the revolving credit commitment under the Credit Agreement by $25.0 million to $125.0 million. The reduction in the revolving credit commitment will also reduce the fees paid by the Company in connection with such commitment.

Events Subsequent to Original Issuance of Consolidated Financial Statements (Unaudited) 
Existing Credit Facility
In connection with the issuance of the Convertible Notes (defined below), on June 6, 2020, the Company amended the Credit Agreement (“Amendment No. 6”) to revise certain covenants, including covenants that restricted the incurrence of debt and restricted the Company’s ability to enter into the Call Spread Transactions (defined below) and issue the Convertible Notes (defined below). In connection with Amendment No. 6, the Company permanently reduced the total amount available under the Revolving Credit Facility to $100 million.
Convertible Notes
On June 9, 2020, the Company issued $200.0 million in aggregate principal amount of 4.00% unsecured convertible senior notes due 2025 (“Convertible Notes”). The net proceeds from the issuance of the Convertible Notes, after deducting transaction fees and offering expense payable by us, were approximately $193.1 million. The Convertible Notes bear interest at the annual rate of

F-41


4.00%, payable semiannually on June 15 and December 15 of each year, beginning on December 15, 2020, and will mature on June 15, 2025, unless earlier converted or repurchased by us.

The Convertible Notes will be convertible into cash, shares of our common stock or a combination thereof, at our election, at an initial conversion rate of 48.05 shares of common stock per $1,000 principal amount of Convertible Notes, which is equivalent to an initial conversion price of approximately $20.81 per share, subject to adjustment pursuant to the terms of the Indenture governing the Convertible Notes (the "Indenture"). The Convertible Notes may be converted at any time after, and including, December 15, 2024 until the close of business on the second scheduled trading day immediately before the maturity date.

The conversion rate of the Convertible Notes may be adjusted in certain circumstances, including in connection with a conversion of the Convertible Notes made following certain fundamental changes and under other circumstances set forth in the Indenture. It is our current intent and policy to settle any conversions of notes through a combination of cash and shares.

Prior to the close of business on the business day immediately preceding December 15, 2024, the Convertible Notes at the option of the holder can be convertible only under the following circumstances:

1.
during any calendar quarter commencing after the calendar quarter ending on September 30, 2020, if the last reported sale price per share of our common stock exceeds 130% of the conversion price for each of at least 20 trading days during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter;
2.
during the five consecutive business days immediately after any five consecutive trading day period (such five consecutive trading day period, the “measurement period”) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day;
3.
upon the occurrence of certain corporate events or distributions on our common stock, as described in the Indenture; or
4.
if we call any notes for redemption (under the conditions specified below).

The Convertible Notes will be redeemable, in whole or in part, at the Company’s option at any time, and from time to time, on or after June 1, 2023 and on or before the 60th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Convertible Notes to be redeemed, plus accrued and unpaid interest, if any, but only if the last reported sale price per share of the Company’s common stock exceeds 130% of the conversion price on (i) each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice; and (ii) the trading day immediately before the date the Company sends such notice. In addition, calling any Convertible Note for redemption will constitute a make-whole fundamental change with respect to that Convertible Note, in which case the conversion rate applicable to the conversion of that Convertible Note will be increased in certain circumstances if it is converted after it is called for redemption. No sinking fund is provided for the Convertible Notes.

Call Spread

On June 4, 2020 and June 5, 2020, in connection with the offering of the Convertible Notes, the Company entered into privately negotiated convertible note hedge transactions (collectively, the “Hedge Transactions”). The Hedge Transactions cover, subject to customary anti-dilution adjustments, the number of shares of our common stock that initially underlie the Convertible Notes. The Hedge Transactions are expected generally to reduce the potential dilution and/or offset any cash payments the Company is required to make in excess of the principal amount due upon conversion of the Convertible Notes in the event that the market price of our common stock is greater than the strike price of the Hedge Transactions, which was initially $20.81 per share (subject to adjustment under the terms of the Hedge Transactions). The strike price of $20.81 corresponds to the initial conversion price of the Convertible Notes. The number of shares underlying the Hedge Transactions is 9.6 million.

On June 4, 2020 and June 5, 2020, the Company also entered into privately negotiated warrant transactions (collectively, the “Warrant Transactions” and, together with the Hedge Transactions, the “Call Spread Transactions”), whereby we sold warrants at a higher strike price relating to the same number of shares of our common stock that initially underlie the Convertible Notes, subject to customary anti-dilution adjustments. The initial strike price of the warrants is $24.975 per share (subject to adjustment under the terms of the Warrant Transactions), which is 50% above the last reported sale price of our common stock on June 4, 2020. The Warrant Transactions could have a dilutive effect to our stockholders to the extent that the market price per share of our common stock, as measured under the terms of the Warrant Transactions, exceeds the applicable strike price of the warrants. The number of shares underlying the Warrant Transactions is 9.6 million.


F-42


The Company used $11.2 million of the net proceeds from the issuance of the Convertible Notes and $49.8 million from the Warrant Transactions to pay the cost of the Hedge Transactions, which totaled $61.0 million.

The Hedge Transactions and the Warrant Transactions are separate transactions, in each case, and are not part of the terms of the Convertible Notes and will not affect any holder’s rights under the Convertible Notes. Holders of the Convertible Notes will not have any rights with respect to the Call Spread Transactions.

Accounting Treatment of the Convertible Notes and Related Hedge Transactions and Warrant Transactions

As the Call Spread Transactions meet certain accounting criteria, the Call Spread Transactions will be classified as equity and are not accounted for as derivatives. The proceeds from the offering of the Convertible Notes were separated into liability and equity components. On the date of issuance, the liability and equity components of the Convertible Notes were calculated to be approximately $152.3 million and $47.7 million, respectively. The initial $152.3 million liability component was determined based on the fair value of similar debt instruments excluding the conversion feature assuming a hypothetical interest rate of 10.45%. The initial $47.7 million equity component represents the difference between the fair value of the initial $152.3 million in debt and the $200.0 million of gross proceeds. The equity component will be included in additional paid-in capital in the consolidated balance sheet and will not be subsequently remeasured as long as it continues to meet the conditions for equity classification. The related initial debt discount of $47.7 million will be amortized over the life of the Convertible Notes as non-cash interest expense using the effective interest method at an interest rate of 10.9%.

In connection with the above-noted transactions, we incurred approximately $6.9 million of offering-related costs. These offering fees were allocated to the liability and equity components in proportion to the allocation of proceeds and will be accounted for as debt and equity issuance costs, respectively. We allocated $5.3 million of debt issuance costs to the liability component, which will be capitalized as deferred financing costs within long-term debt. These costs will be amortized as interest expense over the term of the debt using the effective interest method. The remaining $1.6 million of transaction costs allocated to the equity component will be recorded as a reduction of the equity component.



F-43
 EX-101.SCH 4 vrex-20200922.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2108100 - Disclosure - BORROWINGS link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - BORROWINGS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - BORROWINGS - Schedule of Debt Maturities (Details) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - BORROWINGS - Schedule of Short-Term and Long-Term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - BORROWINGS (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - BUSINESS COMBINATIONS link:presentationLink link:calculationLink link:definitionLink 2402402 - Disclosure - BUSINESS COMBINATIONS - Direct Conversion Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2402403 - Disclosure - BUSINESS COMBINATIONS - Fair Value of Identifiable Assets Acquired and Liabilities Assumed (Details) link:presentationLink link:calculationLink link:definitionLink 2402404 - Disclosure - BUSINESS COMBINATIONS - Intangibles Acquired (Details) link:presentationLink link:calculationLink link:definitionLink 2402407 - Disclosure - BUSINESS COMBINATIONS - PerkinElmer's Medical Imaging Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2402408 - Disclosure - BUSINESS COMBINATIONS - Pro Forma (Details) link:presentationLink link:calculationLink link:definitionLink 2402405 - Disclosure - BUSINESS COMBINATIONS - Revenues by Segment (Details) link:presentationLink link:calculationLink link:definitionLink 2302301 - Disclosure - BUSINESS COMBINATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 2402406 - Disclosure - BUSINESS COMBINATIONS - Virtual Media Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 2411401 - Disclosure - COMMITMENTS AND CONTINGENCIES - (Details) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 1003501 - Statement - CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - CONSOLIDATED STATEMENTS OF EARNINGS link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - CONSOLIDATED STATEMENTS OF EQUITY link:presentationLink link:calculationLink link:definitionLink 0004000 - Document - Cover Cover link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - EMPLOYEE BENEFIT PLANS link:presentationLink link:calculationLink link:definitionLink 2416401 - Disclosure - EMPLOYEE BENEFIT PLANS - (Details) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - EMPLOYEE STOCK PLANS link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - EMPLOYEE STOCK PLANS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2413406 - Disclosure - EMPLOYEE STOCK PLANS - Restricted Stock and Performance Stock (Details) link:presentationLink link:calculationLink link:definitionLink 2413403 - Disclosure - EMPLOYEE STOCK PLANS - Share-based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2413405 - Disclosure - EMPLOYEE STOCK PLANS - Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - EMPLOYEE STOCK PLANS (Tables) link:presentationLink link:calculationLink link:definitionLink 2413404 - Disclosure - EMPLOYEE STOCK PLANS - Valuation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - FAIR VALUE link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - FAIR VALUE - (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - FAIR VALUE (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivative Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 2407405 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivatives at Fair Value (Details) link:presentationLink link:calculationLink link:definitionLink 2407406 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Foreign Currency Contracts (Details) link:presentationLink link:calculationLink link:definitionLink 2407404 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Income Recognized From Derivative Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - GOODWILL AND INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 2410404 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Amortization Schedule (Details) link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Summary of Goowill (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - NET EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - NET EARNINGS PER SHARE - (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - NET EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - OTHER COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - OTHER COMPREHENSIVE INCOME - (Details) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - OTHER COMPREHENSIVE INCOME (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - OTHER FINANCIAL INFORMATION link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - OTHER FINANCIAL INFORMATION - (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - OTHER FINANCIAL INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2412403 - Disclosure - REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS - Summary of Changes in Redeemable Noncontrolling Interests & Noncontrolling INterets (Details) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS (Tables) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - RELATED-PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 2403401 - Disclosure - RELATED-PARTY TRANSACTIONS - Investment in Privately Held Companies (Details) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - RESTRUCTURING link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - RESTRUCTURING - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - RESTRUCTURING - Restructuring Charges Incurred (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - RESTRUCTURING (Tables) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - REVENUE RECOGNITION link:presentationLink link:calculationLink link:definitionLink 2418405 - Disclosure - REVENUE RECOGNITION - Remaining Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 2418403 - Disclosure - REVENUE RECOGNITION - Schedule of ASC 606 Adoption Impact On Income Statement (Details) link:presentationLink link:calculationLink link:definitionLink 2418402 - Disclosure - REVENUE RECOGNITION - Schedule of Balance Sheet Adjustment for ASC 606 Adoption (Details) link:presentationLink link:calculationLink link:definitionLink 2418404 - Disclosure - REVENUE RECOGNITION - Schedule of Changes in Contract Balances (Details) link:presentationLink link:calculationLink link:definitionLink 2318301 - Disclosure - REVENUE RECOGNITION (Tables) link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - SEGMENT INFORMATION link:presentationLink link:calculationLink link:definitionLink 2415404 - Disclosure - SEGMENT INFORMATION - Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2415405 - Disclosure - SEGMENT INFORMATION - Geographic (Details) link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - SEGMENT INFORMATION - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2415403 - Disclosure - SEGMENT INFORMATION - Summary of Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink 2315301 - Disclosure - SEGMENT INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 2419401 - Disclosure - SUBSEQUENT EVENTS - (Details) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 2401415 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounting Standards Recently Adopted (Details) link:presentationLink link:calculationLink link:definitionLink 2401414 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Allowance for Doubtful Accounts (Details) link:presentationLink link:calculationLink link:definitionLink 2401408 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration of Risk (Details) link:presentationLink link:calculationLink link:definitionLink 2401403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Description of Business (Details) link:presentationLink link:calculationLink link:definitionLink 2401411 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2401412 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Impairment of Long-Lived Assets, Intangible Assets and Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 2401409 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 2401413 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Product Warranty (Details) link:presentationLink link:calculationLink link:definitionLink 2401410 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property Plant and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2401404 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reclassification (Details) link:presentationLink link:calculationLink link:definitionLink 2401407 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 2401405 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Segment Reporting (Details) link:presentationLink link:calculationLink link:definitionLink 2301302 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 2401406 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Variable Interest Entities (Details) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - TAXES ON EARNINGS link:presentationLink link:calculationLink link:definitionLink 2414405 - Disclosure - TAXES ON EARNINGS - Deferred Tax Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2414407 - Disclosure - TAXES ON EARNINGS - Income Tax Contingency (Details) link:presentationLink link:calculationLink link:definitionLink 2414403 - Disclosure - TAXES ON EARNINGS - Income Tax Rate Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 2414404 - Disclosure - TAXES ON EARNINGS - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - TAXES ON EARNINGS - Summary of Taxes by Jurisdiction and Classification (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - TAXES ON EARNINGS (Tables) link:presentationLink link:calculationLink link:definitionLink 2414406 - Disclosure - TAXES ON EARNINGS - Valuation Allowance (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 5 vrex-20200922_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 6 vrex-20200922_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 7 vrex-20200922_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Share-based Payment Arrangement [Abstract] Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Restricted Stock Units and Performance Stock Units, nonvested, beginning balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Restricted Stock Units and Performance Stock Units, grants in period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Restricted Stock Units and Performance Stock Units, vested in period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Restricted Stock Units and Performance Stock Units, forfeited in period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Restricted Stock Units and Performance Stock Units, nonvested, ending balance (in shares) Weighted Average Grant-Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Restricted Stock Units and Performance Stock Units, nonvested, beginning of period, weighted average grant date fair value (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Restricted Stock Units and Performance Stock Units, grants in period, weighted average grant date fair value (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Restricted Stock Units and Performance Stock Units, vested in period, weighted average grant date fair value (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Restricted Stock Units and Performance Stock Units, forfeitures, weighted average grant date fair value (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Restricted Stock Units and Performance Stock Units, nonvested, end of period, weighted average grant date fair value (in USD per share) Equity [Abstract] Schedule of Changes in Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Segment Reporting [Abstract] Number of operating segments Number of Operating Segments Income Tax Disclosure [Abstract] Deferred Tax Assets Valuation Allowance [Roll Forward] Deferred Tax Assets Valuation Allowance [Roll Forward] Deferred Tax Assets Valuation Allowance [Roll Forward] Valuation allowance balance–beginning of fiscal year Deferred Tax Assets, Valuation Allowance Increases resulting from business combinations Valuation Allowance, Deferred Tax Asset, Increase From Business Combination, Amount Valuation Allowance, Deferred Tax Asset, Increase From Business Combination, Amount Other increases Valuation Allowance, Deferred Tax Asset, Increase, Amount Valuation Allowance, Deferred Tax Asset, Increase, Amount Other decreases Valuation Allowance, Deferred Tax Asset, Decrease, Amount Valuation Allowance, Deferred Tax Asset, Decrease, Amount Valuation allowance balance—end of fiscal year Subsequent Events [Abstract] SUBSEQUENT EVENTS Subsequent Events [Text Block] Restructuring and Related Activities [Abstract] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Statistical Measurement [Axis] Statistical Measurement [Axis] Statistical Measurement [Domain] Statistical Measurement [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Restructuring Plan [Axis] Restructuring Plan [Axis] Restructuring Plan [Domain] Restructuring Plan [Domain] London Facility Closing London Facility Closing [Member] London Facility Closing [Member] Santa Clara Facility Relocation Santa Clara Facility Relocation [Member] Santa Clara Facility Relocation [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Restructuring charges Restructuring Charges Restructuring and impairment charges Restructuring Costs and Asset Impairment Charges Expected additional costs to be incurred Restructuring and Related Cost, Expected Cost Remaining Other unrelated restructuring costs Other Restructuring Costs Accounting Policies [Abstract] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Land Improvements Land Improvements [Member] Building Building [Member] Land Land [Member] Buildings and leasehold improvements Buildings and Leasehold Improvements [Member] Buildings and Leasehold Improvements [Member] Machinery Machinery and Equipment [Member] Construction in progress Construction in Progress [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Property, plant and equipment, useful lives Property, Plant and Equipment, Useful Life Property, plant and equipment, gross Property, Plant and Equipment, Gross Accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property, plant, and equipment, net Property, Plant and Equipment, Net Depreciation Depreciation Accelerated depreciation Restructuring and Related Cost, Accelerated Depreciation Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] United States UNITED STATES Latin America Latin America [Member] EMEA EMEA [Member] APAC Asia Pacific [Member] Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] Revenues, net Revenues Property, plant and equipment, net Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Consolidation Consolidation, Policy [Policy Text Block] Reclassification Reclassification, Policy [Policy Text Block] Segment Reporting Segment Reporting, Policy [Policy Text Block] Fiscal Year Fiscal Period, Policy [Policy Text Block] Variable Interest Entities Consolidation, Variable Interest Entity, Policy [Policy Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Cash and Cash Equivalents and Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Fair Value Fair Value Measurement, Policy [Policy Text Block] Derivative instruments and hedging activities Derivatives, Policy [Policy Text Block] Concentration of Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Inventories Inventory, Policy [Policy Text Block] Property, Plant and Equipment, net Property, Plant and Equipment, Policy [Policy Text Block] Investments Investment, Policy [Policy Text Block] Goodwill and Intangible Assets Goodwill and Intangible Assets, Policy [Policy Text Block] Impairment of Long-lived Assets, Intangible Assets and Goodwill Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] Loss Contingencies Commitments and Contingencies, Policy [Policy Text Block] Product Warranty Standard Product Warranty, Policy [Policy Text Block] Allowance for Doubtful Accounts Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block] Share-Based Compensation Expense Share-based Payment Arrangement [Policy Text Block] Research and Development Research and Development Expense, Policy [Policy Text Block] Software Development Costs Research, Development, and Computer Software, Policy [Policy Text Block] Taxes on Earnings Income Tax, Policy [Policy Text Block] Foreign Currency Translation Foreign Currency Transactions and Translations Policy [Policy Text Block] Accounting Standards Recently Adopted, Recent Accounting Standards Updates Not Yet Effective New Accounting Pronouncements, Policy [Policy Text Block] Revenue from Contract with Customer Revenue from Contract with Customer [Policy Text Block] Debt Disclosure [Abstract] Schedule of Short-Term and Long-Term Debt Schedule of Debt [Table Text Block] Schedule of Maturities of Long-term Debt Schedule of Maturities of Long-term Debt [Table Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Medical Medical [Member] Medical [Member] Industrial Industrial [Member] Industrial [Member] Goodwill [Line Items] Goodwill [Line Items] Goodwill [Roll Forward] Goodwill [Roll Forward] Balance at September 28, 2018 Goodwill Business combination Goodwill, Acquired During Period Balance at September 27, 2019 Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Unrealized Gain (Loss) on Derivative Financial Instruments Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member] Unrealized Gain on Defined Benefit Obligations Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member] Accumulated Other Comprehensive Income AOCI Including Portion Attributable to Noncontrolling Interest [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Changes In Accumulated Other Comprehensive Income (Loss) [Roll Forward] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] Balance at beginning of period Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Other comprehensive loss before reclassifications Other Comprehensive Income (Loss), before Reclassifications, before Tax Income tax benefit Other Comprehensive Income (Loss), Tax Ending balance Amount reclassified out of accumulated other comprehensive income Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Current provision: Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Federal Current Federal Tax Expense (Benefit) State and local Current State and Local Tax Expense (Benefit) Foreign Current Foreign Tax Expense (Benefit) Total current Current Income Tax Expense (Benefit) Deferred provision (benefit): Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Federal Deferred Federal Income Tax Expense (Benefit) State and local Deferred State and Local Income Tax Expense (Benefit) Foreign Deferred Foreign Income Tax Expense (Benefit) Total deferred Deferred Income Tax Expense (Benefit) Taxes on earnings Income Tax Expense (Benefit) United States Income (Loss) from Continuing Operations before Income Taxes, Domestic Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Earnings before taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Schedule of Goodwill Schedule of Goodwill [Table Text Block] Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule of Indefinite-Lived Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Other Noncurrent Liabilities Other Noncurrent Liabilities [Table Text Block] Schedule of Other Nonoperating Income (Expense) Schedule of Other Nonoperating Income (Expense) [Table Text Block] Revenue from Contract with Customer [Abstract] Revenue, remaining performance obligation, amount Revenue, Remaining Performance Obligation, Amount Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, remaining performance obligation, expected timing of satisfaction, period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Gross margin Gross Profit Total operating expenses Operating Expenses Interest and other expenses, net Nonoperating Income (Expense) Taxes (benefit) on earnings Net earnings Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Less: Net earnings attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Net earnings attributable to Varex Net Income (Loss) Attributable to Parent Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative [Table] Derivative [Table] Hedging Relationship [Axis] Hedging Relationship [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] Derivatives designated as cash flow hedges Cash Flow Hedging [Member] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Designated as Hedging Instrument Designated as Hedging Instrument [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Interest Rate Swap Contracts Interest Rate Swap [Member] Cross Currency Swap Contracts Cross Currency Interest Rate Contract [Member] Derivative [Line Items] Derivative [Line Items] Number of Instruments Derivative, Number of Instruments Held Notional Value Derivative, Notional Amount Business Combinations [Abstract] Schedule of Recognized Identified Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Schedule of Intangible Assets Acquired Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Business Acquisition, Pro Forma Information Business Acquisition, Pro Forma Information [Table Text Block] Federal statutory income tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Deferred tax liabilities of undistributed foreign earnings Deferred Tax Liabilities, Undistributed Foreign Earnings Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Operating loss carryforwards, that expire Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration Operating loss carryforwards, that do not expire Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration Operating loss carryforwards, valuation allowance increase (decrease) Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Cash paid for income tax Income Taxes Paid Unrecognized tax benefits Unrecognized Tax Benefits Income tax penalties and interest expense Income Tax Examination, Penalties and Interest Expense Unrecognized tax benefits, income tax penalties and interest accrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Statement of Financial Position [Abstract] Assets Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Accounts receivable, net of allowance for doubtful accounts of $1.0 and $0.6 at September 27, 2019 and September 28, 2018, respectively Accounts Receivable, after Allowance for Credit Loss, Current Inventories Inventory, Net Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Total current assets Assets, Current Goodwill Intangibles assets, net Intangible Assets, Net (Excluding Goodwill) Investments in privately-held companies Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Other assets Other Assets, Noncurrent Total assets Assets Liabilities, redeemable noncontrolling interests and stockholders' equity Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Accounts payable Accounts Payable, Current Accrued liabilities Accrued Liabilities, Current Current maturities of long-term debt Long-term Debt, Current Maturities Deferred revenues Contract with Customer, Liability, Current Total current liabilities Liabilities, Current Long-term debt, net Long-term Debt, Excluding Current Maturities Deferred tax liabilities Deferred Income Tax Liabilities, Net Other long-term liabilities Other Liabilities, Noncurrent Total liabilities Liabilities Commitments and contingencies (Note 11) Commitments and Contingencies Redeemable noncontrolling interests Redeemable Noncontrolling Interest, Equity, Carrying Amount Equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred stock, $.01 par value: 20,000,000 shares authorized, none issued Preferred Stock, Value, Issued Common stock, $.01 par value: 150,000,000 shares authorized, shares issued and outstanding: 38,371,305 and 38,026,597 at September 27, 2019 and September 28, 2018, respectively Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Accumulated other comprehensive (loss) income Accumulated Other Comprehensive Income (Loss), Net of Tax Retained earnings Retained Earnings (Accumulated Deficit) Total Varex stockholders' equity Stockholders' Equity Attributable to Parent Noncontrolling interests Stockholders' Equity Attributable to Noncontrolling Interest Total stockholders' equity Total liabilities, redeemable noncontrolling interests and stockholders' equity Liabilities and Equity Schedule of Derivative Instruments Schedule of Derivative Instruments [Table Text Block] Schedule of Interest Rate Derivative Instruments Schedule of Interest Rate Derivatives [Table Text Block] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Position [Axis] Position [Axis] Position [Domain] Position [Domain] Buy contracts Long [Member] Sell contract Short [Member] Currency [Axis] Currency [Axis] All Currencies [Domain] All Currencies [Domain] Japanese yen Japan, Yen Swiss franc Switzerland, Francs Chinese renminbi China, Yuan Renminbi Euro Euro Member Countries, Euro Foreign Exchange Contract Foreign Exchange Contract [Member] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Finite-lived intangible asset, useful life Finite-Lived Intangible Asset, Useful Life Concentration Risk [Table] Concentration Risk [Table] Customer [Axis] Customer [Axis] Customer [Domain] Customer [Domain] Canon Medical Systems Corporation Canon Medical Systems Corporation (Formerly Toshiba Medical Systems) [Member] Canon Medical Systems Corporation (Formerly Toshiba Medical Systems) [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Sales Revenue, Net Revenue Benchmark [Member] Accounts Receivable Accounts Receivable [Member] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Customer Concentration Risk Customer Concentration Risk [Member] Concentration Risk [Line Items] Concentration Risk [Line Items] Concentration risk, percentage Concentration Risk, Percentage Fair Value Disclosures [Abstract] FAIR VALUE Fair Value Disclosures [Text Block] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Measurement Frequency [Axis] Measurement Frequency [Axis] Measurement Frequency [Domain] Measurement Frequency [Domain] Fair Value, Measurements, Recurring Fair Value, Recurring [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) Fair Value, Inputs, Level 1 [Member] Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets: Assets, Fair Value Disclosure [Abstract] Cash equivalents - money market funds Cash and Cash Equivalents, Fair Value Disclosure Derivative assets Derivative Asset Total assets measured at fair value Assets, Fair Value Disclosure Liabilities: Liabilities, Fair Value Disclosure [Abstract] Derivative liabilities Derivative Liability Deferred consideration Business Combination, Contingent Consideration, Liability Total liabilities measured at fair value Financial and Nonfinancial Liabilities, Fair Value Disclosure Long-term debt, fair value Long-term Debt, Fair Value Statement of Comprehensive Income [Abstract] Net earnings Other comprehensive (loss) earnings, net of tax: Other Comprehensive Income (Loss), Net of Tax [Abstract] Unrealized (loss) gain on interest rate swap contracts Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax Unrealized (loss) gain on defined benefit obligations Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Other comprehensive (loss) earnings, net of tax Other Comprehensive Income (Loss), Net of Tax Comprehensive earnings Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Less: Comprehensive earnings attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive earnings attributable to Varex Comprehensive Income (Loss), Net of Tax, Attributable to Parent SEGMENT INFORMATION Segment Reporting Disclosure [Text Block] Commitments and Contingencies Disclosure [Abstract] Future minimum payments due, next twelve months Operating Leases, Future Minimum Payments Due, Next Twelve Months Future minimum payments, due in two years Operating Leases, Future Minimum Payments, Due in Two Years Future minimum payments, due in three years Operating Leases, Future Minimum Payments, Due in Three Years Future minimum payments, due in four years Operating Leases, Future Minimum Payments, Due in Four Years Future minimum payments, due in five years Operating Leases, Future Minimum Payments, Due in Five Years Future minimum payments, due thereafter Operating Leases, Future Minimum Payments, Due Thereafter Operating leases, rent expense Operating Leases, Rent Expense Environment liabilities Accrued Environmental Loss Contingencies, Noncurrent REVENUE RECOGNITION Revenue from Contract with Customer [Text Block] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Impairment of intangible assets Impairment of Intangible Assets (Excluding Goodwill) Goodwill, impairment loss Goodwill, Impairment Loss Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Operating Segments Operating Segments [Member] Assets Restrictions on Cash and Cash Equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Schedules of Concentration of Risk, by Risk Factor Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Schedule of Inventory, Current Schedule of Inventory, Current [Table Text Block] Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Schedule of Product Warranty Liability Schedule of Product Warranty Liability [Table Text Block] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Income Tax Authority [Axis] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] Foreign Tax Authority Foreign Tax Authority [Member] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] PerkinElmer, Inc. PerkinElmer, Inc. [Member] PerkinElmer, Inc. [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Net cash paid Payments to Acquire Businesses, Gross Total cash consideration Business Combination, Consideration Transferred Business combination, number of employees Business Combination, Number of Employees Business Combination, Number of Employees Goodwill expected tax deductible amount Business Acquisition, Goodwill, Expected Tax Deductible Amount Deferred tax liabilities noncurrent Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncontrolling Interest [Abstract] Noncontrolling Interest [Table] Noncontrolling Interest [Table] Noncontrolling Interests Noncontrolling Interest [Member] Noncontrolling Interest [Line Items] Noncontrolling Interest [Line Items] Balance at beginning of period Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests Net earnings attributable to noncontrolling interests Temporary Equity, Net Income Dividends paid to redeemable noncontrolling interest Payments of Ordinary Dividends, Noncontrolling Interest Other Temporary Equity, Other Changes Balance at end of period Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward] Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward] Net earnings attributable to noncontrolling interests Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest Contributions from noncontrolling interests Noncontrolling Interest, Increase from Sale of Parent Equity Interest Contributions from noncontrolling interests Noncontrolling Interest, Increase From Capital Contribution Noncontrolling Interest, Increase From Capital Contribution Balance at end of period Subsequent Event [Table] Subsequent Event [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Convertible Debt Convertible Debt [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Revolving Credit Facility Revolving Credit Facility May 2017 [Member] Revolving Credit Facility May 2017 [Member] Convertible Notes Convertible Notes [Member] Convertible Notes [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Revolving Credit Facility Revolving Credit Facility [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event Subsequent Event [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Permanent reduction in the revolving credit commitment Line of Credit Facility, Increase (Decrease), Net Revolving credit commitment Line of Credit Facility, Maximum Borrowing Capacity Debt instrument, face amount Debt Instrument, Face Amount Debt instrument, interest rate, stated percentage Debt Instrument, Interest Rate, Stated Percentage Proceeds from convertible debt Proceeds from Convertible Debt Debt instrument, convertible, conversion ratio Debt Instrument, Convertible, Conversion Ratio Debt instrument, convertible, conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Debt instrument, convertible, threshold percentage of stock price trigger Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger Debt instrument, convertible, threshold trading days Debt Instrument, Convertible, Threshold Trading Days Debt instrument, convertible, threshold consecutive trading days Debt Instrument, Convertible, Threshold Consecutive Trading Days Debt instrument, convertible, consecutive business days Debt Instrument, Convertible, Consecutive Business Days Debt Instrument, Convertible, Consecutive Business Days Debt instrument, convertible, consecutive trading day measurement period Debt Instrument, Convertible, Consecutive Trading Day Measurement Period Debt Instrument, Convertible, Consecutive Trading Day Measurement Period Debt instrument, convertible, threshold for measurement period Debt Instrument, Convertible, Threshold For Measurement Period Debt Instrument, Convertible, Threshold For Measurement Period Debt instrument, convertible, number of equity instruments (in shares) Debt Instrument, Convertible, Number of Equity Instruments Exercise price of warrants (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Percent increase of strike price over sale price Class Of Warrant Or Right, Percent Increase Of Strike Price Over Sale Price Class Of Warrant Or Right, Percent Increase Of Strike Price Over Sale Price Payment of hedge transactions from proceeds of convertible debt Payment Of Hedge Transactions From Proceeds Of Convertible Debt Payment Of Hedge Transactions From Proceeds Of Convertible Debt Payment of hedge transactions from proceeds of warrant transactions Payment Of Hedge Transactions From Proceeds Of Warrant Transactions Payment Of Hedge Transactions From Proceeds Of Warrant Transactions Payments for hedge, financing activities Payments for Hedge, Financing Activities Convertible debt Convertible Debt Debt instrument, convertible, carrying amount of equity component Debt Instrument, Convertible, Carrying Amount of Equity Component Debt instrument, convertible, hypothetical interest rate Debt Instrument, Convertible, Hypothetical Interest Rate Debt Instrument, Convertible, Hypothetical Interest Rate Debt instrument, interest rate, effective percentage Debt Instrument, Interest Rate, Effective Percentage Payment of financing and stock issuance costs Payment of Financing and Stock Issuance Costs Payments of debt issuance costs Payments of Debt Issuance Costs Payments of stock issuance costs Payments of Stock Issuance Costs Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Developed technology Developed Technology Rights [Member] Patents, licenses and other Intellectual Property [Member] Customer contracts and supplier relationship Customer Contracts and Supplier Relationships [Member] Customer Contracts and Supplier Relationships [Member] Gross Carrying Amount Finite-Lived Intangible Assets, Gross Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Net Carrying Amount Finite-Lived Intangible Assets, Net In-process R&D with indefinite lives Indefinite-lived Intangible Assets (Excluding Goodwill) Total intangible assets, gross Intangible Assets, Gross (Excluding Goodwill) Total intangible assets, net Amortization of intangible assets Amortization of Intangible Assets Schedule of Restructuring Charges Restructuring and Related Costs [Table Text Block] Earnings Per Share [Abstract] Net earnings attributable to Varex Weighted average shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Dilutive effect of potential common shares (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Weighted average shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Net earnings per share attributable to Varex - basic (in USD per share) Earnings Per Share, Basic Net earnings per share attributable to Varex - diluted (in USD per share) Earnings Per Share, Diluted Anti-dilutive employee shared based awards, excluded (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Related Party Transactions [Abstract] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Scenario [Axis] Scenario [Axis] Scenario [Domain] Scenario [Domain] Forecast Forecast [Member] Counterparty Name [Axis] Counterparty Name [Axis] Counterparty Name [Domain] Counterparty Name [Domain] CETTEEN GmbH CETTEEN GmbH [Member] CETTEEN GmbH [Member] Related Party Transaction [Axis] Related Party Transaction [Axis] Related Party Transaction [Domain] Related Party Transaction [Domain] Fixed Cost Commitments Fixed Cost Commitments [Member] Fixed Cost Commitments [Member] Investment, Name [Axis] Investment, Name [Axis] Investment, Name [Domain] Investment, Name [Domain] dpiX Holding dpiX Holding [Member] dpiX Holding [Member] dpiX LLC dpiX LLC [Member] dpiX LLC [Member] VEC Imaging VEC Imaging GmbH & Co. KG [Member] VEC Imaging GmbH & Co. KG [Member] Related Party [Axis] Related Party [Axis] Related Party [Domain] Related Party [Domain] Equity Method Investee Equity Method Investee [Member] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Equity method investment, ownership percentage Equity Method Investment, Ownership Percentage Number of consortium members Equity Method Investments, Number of Full Ownership Members Equity Method Investments, Number of Full Ownership Members Income (loss) from equity method investments Income (Loss) from Equity Method Investments Equity method investments Equity Method Investments Purchases from related party Related Party Transaction, Purchases from Related Party Accounts payable, related parties Accounts Payable, Related Parties Percentage of manufacturing capacity Percentage Of Manufacturing Capacity The percentage of manufacturing capacity that the entity has the guaranteed right to purchase up to. Percentage of fixed costs Percentage Of Fixed Costs The percentage of fixed costs as defined in the agreement and determined at the beginning of each calendar year that the entity is required to pay. Related party transaction, expected fixed cost Related Party Transaction, Expected Fixed Cost Related Party Transaction, Expected Fixed Cost Contributions to equity method investments Payments to Acquire Equity Method Investments Number of variable interest entities Number of Variable Interest Entities Number of Variable Interest Entities REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS Noncontrolling Interest Disclosure [Text Block] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Plan Name [Axis] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] 2017 ESPP 2017 ESPP [Member] 2017 ESPP [Member] 2017 Omnibus Stock Plan 2017 Omnibus Stock Plan [Member] 2017 Omnibus Stock Plan [Member] Award Type [Axis] Award Type [Axis] Award Type [Domain] Award Type [Domain] Employee Stock Employee Stock [Member] Employee Stock Option Share-based Payment Arrangement, Option [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Purchase price of common stock, percent Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent Stock plan offering period (in months) Share-based Compensation Arrangement By Share-based Payment Award, Stock Plan Offering Period Share-based Compensation Arrangement By Share-based Payment Award, Stock Plan Offering Period Number of shares authorized (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Compensation cost not yet recognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Compensation cost period for recognition (in years) Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Number of shares available for grant (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Award vesting period (in months) Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Award expiration period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Options exercised, intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Options, grants in period, grant date fair value Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Grant Date Fair Value Grant-date fair value of shares granted in the period Share-based Compensation Arrangement By Share-Based Payment Award, Other Than Options, Grants In Period, Grant Date Fair Value Share-based Compensation Arrangement By Share-Based Payment Award, Other Than Options, Grants In Period, Grant Date Fair Value Shares outstanding, market value Share-based Compensation by Share-based Payment Award, Equity Instruments Other than Options, Shares Outstanding, Market Value Share-based Compensation by Share- based Payment Award, Shares Outstanding, Market Value EMPLOYEE STOCK PLANS Share-based Payment Arrangement [Text Block] TAXES ON EARNINGS Income Tax Disclosure [Text Block] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Other current assets Other Current Assets [Member] Other non-current assets Other Noncurrent Assets [Member] Other current liabilities Other Current Liabilities [Member] Other non-current liabilities Other Noncurrent Liabilities [Member] Derivative Assets Derivative Asset, Fair Value, Gross Asset Derivative Liabilities Derivative Liability, Fair Value, Gross Liability Cover [Abstract] Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Central Index Key Entity Central Index Key Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Amount of Gain or (Loss) Recognized in OCI on Derivative Fiscal Year Ended Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income Fiscal Year Ended Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net GOODWILL AND INTANGIBLE ASSETS Goodwill and Intangible Assets Disclosure [Text Block] Change in Contract with Customer, Asset [Abstract] Change in Contract with Customer, Asset [Abstract] Balance at September 29, 2018 Contract With Customer, Asset Contract With Customer, Asset Costs recovered from product returns during the period Increase (Decrease) In Contract with Customer, Asset, Costs Recovered From Product Returns Increase (Decrease) In Contract with Customer, Asset, Costs Recovered From Product Returns Contract asset from shipments of products, subject to return during the period Increase (Decrease) In Contract with Customer, Asset, Shipment Of Product Subject To Return Increase (Decrease) In Contract with Customer, Asset, Shipment Of Product Subject To Return Balance at September 27, 2019 Change in Contract with Customer, Liability [Abstract] Change in Contract with Customer, Liability [Abstract] Balance at September 29, 2018 Contract with Customer, Liability Recognition of revenue included in beginning of year refund liability Contract with Customer, Liability, Revenue Recognized Additions to refund liabilities Contract With Customer, Liability, Additions Contract With Customer, Liability, Additions Balance at September 27, 2019 Recorded component of accumulated other comprehensive income (loss) that will be reclassified in the statements of comprehensive earnings over the next 12 months Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months Loss on derivative instruments not designated as cash flow hedges Derivative Instruments Not Designated as Hedging Instruments, Loss OTHER FINANCIAL INFORMATION Additional Financial Information Disclosure [Text Block] Retirement Benefits [Abstract] EMPLOYEE BENEFIT PLANS Compensation and Employee Benefit Plans [Text Block] Other assets impairment charges Other Asset Impairment Charges Inventory write-down Inventory Write-down Intangible assets impairment Impairment of Intangible Assets, Finite-lived Severance costs Severance Costs Facility closure costs Business Exit Costs Total restructuring charges Cash and cash equivalents Restricted cash Restricted Cash Cash and cash equivalents and restricted cash as reported per statement of cash flows Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Varian Majority Shareholder [Member] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Cost of revenues Cost of Sales [Member] Research and development Research and Development Expense [Member] Selling, general and administrative Selling, General and Administrative Expenses [Member] General and administrative General and Administrative Expense [Member] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Allocated share-based compensation expense Share-based Payment Arrangement, Expense Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Deferred Tax Assets: Deferred Tax Assets, Net [Abstract] Inventory adjustments Deferred Tax Assets, Inventory Share-based compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Product warranty Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Warranty Reserves Deferred compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation Accrued vacation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Compensated Absences Credit carryforwards Deferred Tax Assets, Tax Credit Carryforwards, Foreign Other Deferred Tax Assets, Other Deferred tax assets, gross Deferred Tax Assets, Gross Valuation allowance Total deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Deferred Tax Liabilities: Deferred Tax Liabilities, Net [Abstract] Acquired intangibles Deferred Tax Liabilities, Intangible Assets Property, plant and equipment Deferred Tax Liabilities, Property, Plant and Equipment Investments in privately held companies Deferred Tax Liabilities, Investment in Noncontrolled Affiliates Other Deferred Tax Liabilities, Other Total deferred tax liabilities Deferred Tax Liabilities, Gross Net deferred tax liabilities Deferred Tax Liabilities, Net Deferred tax assets Deferred Tax Assets, Jurisdictional Amount, Gross Deferred Tax Assets, Jurisdictional Amount, Gross Deferred tax liabilities Deferred Tax Liability, Jurisdictional Amount, Gross Deferred Tax Liability, Jurisdictional Amount, Gross Net deferred tax liabilities 2020 Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months 2021 Long-term Debt, Maturities, Repayments of Principal in Year Two 2022 Long-term Debt, Maturities, Repayments of Principal in Year Three Total debt outstanding Long-term Debt, Gross Less: current maturities of long-term debt Non-current portion of long -term debt Long-term Debt Excluding Current Maturities, Gross Long-term Debt Excluding Current Maturities, Gross Direct Conversion AB Direct Conversion AB [Member] Direct Conversion AB [Member] MeVis Medical Solutions AG (MeVis) MeVis Medical Solutions AG (MeVis) [Member] MeVis Medical Solutions AG (MeVis) [Member] Ownership [Axis] Ownership [Axis] Ownership [Domain] Ownership [Domain] Joint Venture In Saudi Arabia Joint Venture In Saudi Arabia [Member] Joint Venture In Saudi Arabia [Member] Noncontrolling interest, ownership percentage by parent Noncontrolling Interest, Ownership Percentage by Parent Noncontrolling interest, ownership percentage by noncontrolling owners Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Percentage of voting interests acquired Business Acquisition, Percentage of Voting Interests Acquired Annual recurring compensation (in euros per share) Business Acquisition, Annual Recurring Compensation Business Acquisition, Annual Recurring Compensation Temporary equity, redemption price per share (in eur per share) Temporary Equity, Redemption Price Per Share Redeemable noncontrolling interest, equity, redemption value Temporary equity, shares outstanding (in shares) Temporary Equity, Shares Outstanding Schedule Of Short-Term And Long-Term Debt [Table] Schedule Of Short-Term And Long-Term Debt [Table] Schedule Of Short-Term And Long-Term Debt [Table] Secured Debt Secured Debt [Member] Other Debt Other Debt [Member] Other Debt [Member] Schedule Of Short-Term And Long-Term Debt [Line Items] Schedule Of Short-Term And Long-Term Debt [Line Items] [Line Items] for Schedule Of Short-Term And Long-Term Debt [Table] Current maturities of long-term debt Long-term Debt, Current Maturities [Abstract] Non-current maturities of long-term debt: Long-term Debt, Excluding Current Maturities [Abstract] Long-term debt excluding current maturities, gross Debt issuance costs Debt Issuance Costs, Net Long-term debt outstanding Long-term Debt Long-term Debt Weighted-average interest rate, short-term debt Short-term Debt, Weighted Average Interest Rate, over Time Weighted-average interest rate, long-term debt Long-term Debt, Weighted Average Interest Rate, over Time Accrued compensation and benefits Accrued Employee Benefits, Current Product warranty Standard Product Warranty Accrual, Current Income taxes payable Accrued Income Taxes, Current Payable to Varian Medical Systems Due to Related Parties, Current Right of return liability Contract with Customer, Refund Liability, Current Deferred consideration Business Combination, Contingent Consideration, Liability, Current Other Other Accrued Liabilities, Current Total accrued liabilities Long-term income tax payable Accrued Income Taxes, Noncurrent Defined benefit obligation liability Liability, Defined Benefit Plan, Noncurrent Long-term right of return liability Contract with Customer, Refund Liability, Noncurrent Long-term other Other Sundry Liabilities, Noncurrent Total other long-term liabilities Change in fair value of deferred consideration Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Realized income (loss) on foreign currencies Foreign Currency Transaction Gain (Loss), before Tax Total other income (expense), net Other Nonoperating Income (Expense) Intangible Assets Acquired as Part of Business Combination [Table] [Table] Intangible Assets Acquired as Part of Business Combination [Table] [Table] Intangible Assets Acquired as Part of Business Combination [Table] [Table] Favorable leasehold interests Lease Agreements [Member] Backlog Order or Production Backlog [Member] Trade names Trade Names [Member] Customer relationships Customer Relationships [Member] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] In-process research and development In Process Research and Development [Member] Intangible Assets Acquired as Part of Business Combination [Table] [Line Items] Intangible Assets Acquired as Part of Business Combination [Table] [Line Items] [Line Items] for Intangible Assets Acquired as Part of Business Combination [Table] [Table] Intangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Estimated useful life Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Schedule of Pro Rata Distribution [Table] Schedule of Pro Rata Distribution [Table] Schedule of Pro Rata Distribution [Table] Varian Medical Systems, Inc. Varian Medical Systems, Inc. [Member] Varian Medical Systems, Inc. [Member] Schedule of Pro Rata Distribution [Line Items] Schedule of Pro Rata Distribution [Line Items] [Line Items] for Schedule of Pro Rata Distribution [Table] Outstanding common stock, percentage distributed Outstanding Common Stock, Percentage Distributed Outstanding Common Stock, Percentage Distributed Income Statement [Abstract] Cost of revenues Cost of Revenue Gross margin Operating expenses: Operating Expenses [Abstract] Research and development Research and Development Expense Selling, general and administrative Selling, General and Administrative Expense Total operating expenses Operating earnings Operating Income (Loss) Interest income Investment Income, Interest Interest expense Interest Expense Other (expense) income, net Interest and other expenses, net Net earnings per common share attributable to Varex Basic (in USD per share) Diluted (in USD per share) Weighted average common shares outstanding Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic (in shares) Diluted (in shares) Changes in Redeemable Noncontrolling Interest Redeemable Noncontrolling Interest [Table Text Block] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Schedule of ASC 606 Adoption Impacts Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] Schedule of Changes in Contract With Customer Assets And Liabilities Contract with Customer, Asset and Liability [Table Text Block] Line of Credit Facility [Table] Line of Credit Facility [Table] Debt Repayment Period [Axis] Debt Repayment Period [Axis] Debt Repayment Period [Axis] Debt Repayment Period [Domain] Debt Repayment Period [Domain] [Domain] for Debt Repayment Period [Axis] Debt Instrument, Repayment, Period One Debt Instrument, Repayment, Period One [Member] Debt Instrument, Repayment, Period One [Member] Debt Instrument, Repayment, Period Two Debt Instrument, Repayment, Period Two [Member] Debt Instrument, Repayment, Period Two [Member] Debt Instrument, Repayment, Period Three Debt Instrument, Repayment, Period Three [Member] Debt Instrument, Repayment, Period Three [Member] Debt Instrument, Repayment, Period Four Debt Instrument, Repayment, Period Four [Member] Debt Instrument, Repayment, Period Four [Member] Debt Instrument, Repayment, Period Five Debt Instrument, Repayment, Period Five [Member] Debt Instrument, Repayment, Period Five [Member] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] Federal Funds Effective Swap Rate Fed Funds Effective Rate Overnight Index Swap Rate [Member] London Interbank Offered Rate (LIBOR) London Interbank Offered Rate (LIBOR) [Member] Base Rate Base Rate [Member] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Maximum borrowing capacity Debt instrument, term Debt Instrument, Term Repayment percentage Debt Instrument, Periodic Payment, Percentage Debt Instrument, Periodic Payment, Percentage Proceeds from lines of credit Proceeds from Lines of Credit Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Used capacity, commitment fee percentage Line of Credit Facility, Commitment Fee Percentage Unused capacity, commitment fee percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Debt issuance costs BUSINESS COMBINATIONS Business Combination Disclosure [Text Block] Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] 2020 Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months 2021 Finite-Lived Intangible Assets, Amortization Expense, Year Two 2022 Finite-Lived Intangible Assets, Amortization Expense, Year Three 2023 Finite-Lived Intangible Assets, Amortization Expense, Year Four 2024 Finite-Lived Intangible Assets, Amortization Expense, Year Five Thereafter Finite-Lived Intangible Assets, Amortization Expense, after Year Five Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss, Current Preferred stock, par value per share (usd per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Common stock, par value per share (usd per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized (in shares) Common Stock, Shares Authorized Common stock, shares, issued (in shares) Common Stock, Shares, Issued Common stock, shares, outstanding (in shares) Common Stock, Shares, Outstanding Employer discretionary contribution amount Defined Contribution Plan, Cost Defined benefit pension plan liability Liability, Defined Benefit Pension Plan, Noncurrent Expected term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected dividend Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Weighted average fair value at grant date (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Revenues Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Schedule of Share-based Compensation, Stock Options, Activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Schedule of Error Corrections and Prior Period Adjustment Restatement [Table] Schedule of Error Corrections and Prior Period Adjustment Restatement [Table] Restatement [Axis] Restatement [Axis] Restatement [Domain] Restatement [Domain] Restatement Adjustment Restatement Adjustment [Member] Error Corrections and Prior Period Adjustments Restatement [Line Items] Error Corrections and Prior Period Adjustments Restatement [Line Items] Reclassification of selling, general and administrative Summary of Valuation Allowance [Table Text Block] Summary of Valuation Allowance [Table Text Block] Schedule of Components of Income Tax Expense (Benefit) Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of Income before Income Tax, Domestic and Foreign Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Schedule of Effective Income Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of Unrecognized Tax Benefits Roll Forward Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] NET EARNINGS PER SHARE Earnings Per Share [Text Block] Virtual Media Integration, Ltd. Virtual Media Integration, Ltd. [Member] Virtual Media Integration, Ltd. [Member] BORROWINGS Debt Disclosure [Text Block] Revenue, Initial Application Period Cumulative Effect Transition [Table] Revenue, Initial Application Period Cumulative Effect Transition [Table] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] ASU 2014-09 Accounting Standards Update 2014-09 [Member] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Domain] Initial Application Period Cumulative Effect Transition [Domain] Adjustment Due to ASC 606 Difference between Revenue Guidance in Effect before and after Topic 606 [Member] Balance without Adoption Calculated under Revenue Guidance in Effect before Topic 606 [Member] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] OTHER COMPREHENSIVE INCOME Comprehensive Income (Loss) Note [Text Block] Revenue Business Acquisition, Pro Forma Revenue Operating earnings Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax Net earnings Business Acquisition, Pro Forma Net Income (Loss) Net earnings per share, basic (in USD per share) Business Acquisition, Pro Forma Earnings Per Share, Basic Net earnings per share, diluted (in USD per share) Business Acquisition, Pro Forma Earnings Per Share, Diluted RELATED-PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Common Stock Common Stock [Member] Additional Paid-in Capital Additional Paid-in Capital [Member] Net Parent Investment Net Parent Investment [Member] Net Parent Investment [Member] Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Retained Earnings Retained Earnings [Member] Total Varex Equity Parent [Member] Statement [Line Items] Statement [Line Items] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Shares outstanding, beginning of period (in shares) Effect of adoption of ASC 606 Cumulative Effect of New Accounting Principle in Period of Adoption Net earnings Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest Net transfers to parent Net Transfers From (To) Parent Net Transfers from Parent Other Stockholders' Equity, Other Distribution to Varian Medical Systems Distributions to Parent Distributions to Parent Conversion of net parent investment into common stock (in shares) Stock Issued During Period, Shares, Conversion of Units Conversion of net parent investment into common stock Stock Issued During Period, Value, Conversion of Units Exercise of stock options (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Common stock issued upon vesting of restricted shares (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Shares withheld on vesting of restricted stock (in shares) Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Shares withheld on vesting of restricted stock Share-based Payment Arrangement, Decrease for Tax Withholding Obligation Share-based compensation APIC, Share-based Payment Arrangement, Increase for Cost Recognition Unrealized gain on interest rate swap contracts, net of tax Unrealized gain (loss) on defined benefit obligations Tax impacts to APIC related to share-based award activity Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net Common stock issued under employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Common stock issued under employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Capital contribution by noncontrolling interest Noncontrolling interest acquired/consolidated Shares outstanding, end of period (in shares) Difference between Revenue Guidance in Effect before and after Topic 606 (Decrease) increase to retained earnings for adoption of new accounting guidance FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES Derivative Instruments and Hedging Activities Disclosure [Text Block] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Unrecognized tax benefits balance–beginning of fiscal year Subtractions based on tax positions related to a prior year Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Additions based on tax positions related to the current year Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Unrecognized tax benefits balance—end of fiscal year Product Warranty Liability [Table] Product Warranty Liability [Table] Product Warranty Liability [Line Items] Product Warranty Liability [Line Items] Warranty term (in months) Warranty Term Warranty Term Movement in Standard Product Warranty Accrual [Roll Forward] Movement in Standard Product Warranty Accrual [Roll Forward] Accrued product warranty, at beginning of period Standard Product Warranty Accrual Charged to cost of revenues Standard Product Warranty Accrual, Increase for Warranties Issued Actual product warranty expenditures Standard Product Warranty Accrual, Decrease for Payments Accrued product warranty, at end of period Raw materials and parts Inventory, Raw Materials and Supplies, Net of Reserves Work-in-process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Total inventories Options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Options, outstanding, beginning balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Options, grants in period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Options, forfeitures and expirations in period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Options, exercises in period, value (in shares) Options, outstanding, ending balance (in shares) Options, exercisable (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Price Range Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercise Price Range [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercise Price Range [Roll Forward] Options, outstanding, price, beginning (in USD per share) Share-based Compensation Arrangement By Share-based Payment Award, Options, Outstanding, Price Share-based Compensation Arrangement By Share-based Payment Award, Options, Outstanding, Price Options, grants in period, price (in USD per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Price Options, forfeitures and expirations in period, price (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Price Options, exercises in period, price (in USD per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Price Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Price Options, outstanding, price, ending (in USD per share) Options, exercisable, price (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Price Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Options, outstanding, weighted average exercise price, beginning (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Options, grants in period, weighted average exercise price (in USD per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Options, forfeitures and expirations in period, weighted average exercise price (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Options, exercises in period, weighted average exercise price (in USD per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Options, outstanding, weighted average exercise price, ending (in USD per share) Options, exercisable, weighted average exercise price (in USD per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Options, outstanding, weighted average remaining contractual term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Options, exercisable, weighted average remaining contractual term (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Options, outstanding, intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Options, exercisable, intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Share price (in usd per share) Share Price Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Reconciliation of Assets from Segment to Consolidated Reconciliation of Assets from Segment to Consolidated [Table Text Block] Revenue from External Customers by Geographic Areas Revenue from External Customers by Geographic Areas [Table Text Block] Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net earnings to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Share-based compensation expense Share-based Payment Arrangement, Noncash Expense Impairment of intangible assets Deferred taxes Deferred Income Tax Expense (Benefit) Excluding Portion to APIC Deferred Income Tax Expense (Benefit) Excluding Portion to APIC Amortization of deferred loan costs Amortization of Debt Issuance Costs Loss (gain) from equity method investments, net of dividends received Other, net Other Noncash Income (Expense) Changes in assets and liabilities, net of effects of acquisitions: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Accounts payable Increase (Decrease) in Accounts Payable Accrued operating liabilities and other long-term operating liabilities Increase (Decrease) in Accrued Liabilities Deferred revenues Increase (Decrease) in Deferred Revenue Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Purchases of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Acquisitions of businesses, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Investments in privately-held companies Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Net transfers from parent Proceeds from Contributions from Parent Distributions to Varian Medical Systems, Inc. Payments of Distributions to Affiliates Taxes related to net share settlement of equity awards Payment, Tax Withholding, Share-based Payment Arrangement Borrowings under credit agreements Proceeds from Long-term Lines of Credit Repayments of borrowing under credit agreements Repayments of Long-term Lines of Credit Proceeds from exercise of stock options Proceeds from Stock Options Exercised Proceeds from shares issued under employee stock purchase plan Proceeds from Stock Plans Excess tax benefits from share-based compensation Excess Tax Benefit from Share-based Compensation, Financing Activities Payment of debt issuance costs Contributions from noncontrolling partner Proceeds from Noncontrolling Interests Net cash (used in) provided by financing activities Net Cash Provided by (Used in) Financing Activities Effects of exchange rate changes on cash and cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Net (decrease) increase in cash and cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash and cash equivalents and restricted cash at beginning of period Cash and cash equivalents and restricted cash at end of period Supplemental cash flow information: Supplemental Cash Flow Information [Abstract] Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Supplemental non-cash activities: Noncash Investing and Financing Items [Abstract] Purchases of property, plant and equipment financed through accounts payable Capital Expenditures Incurred but Not yet Paid Transfers of property, plant and equipment from Varian Medical Systems, Inc. Receipt of Property Receipt of Property Other non-cash transfers to Varian Medical Systems, Inc. Noncash Transfers to Parent Noncash Transfers to Parent RESTRUCTURING Restructuring and Related Activities Disclosure [Text Block] State and local taxes, net of federal tax benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent Revaluation of deferred tax liabilities for US statutory change Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Mandatory repatriation tax on foreign earnings Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent Domestic production activities deduction Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent Research and development credit Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Prior year deferred tax adjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Foreign Rate Difference Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent US Tax Reform - International Provisions Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Transition Tax on Accumulated Foreign Earnings, Percent Other Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent Effective tax rate Effective Income Tax Rate Reconciliation, Percent Debt assumed Noncash or Part Noncash Acquisition, Debt Assumed Deferred payment, value assigned Business Acquisition, Equity Interest Issued Or Issuable, Contingent Consideration, Value Assigned Business Acquisition, Equity Interest Issued Or Issuable, Contingent Consideration, Value Assigned Deferred payment (in shares) Business Acquisition, Equity Interest Issued or Issuable, Contingent Consideration Business Acquisition, Equity Interest Issued or Issuable, Contingent Consideration Allocation of the purchase consideration: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract] Cash Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Accounts Receivable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Other assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Prepaids and other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Property, plant, and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Other assets, non-current Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets and Goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets and Goodwill Accounts payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Accrued liabilities Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accrued Liabilities Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accrued Liabilities Current maturities of long-term debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt Deferred revenues Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Revenue From Contract With Customer, Liability Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Revenue From Contract With Customer, Liability Current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Other liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Long-term debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt Other liabilities, non-current Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Total liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Noncontrolling interest Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value Net assets acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Net assets acquired, less noncontrolling interest Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest Deferred consideration Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Post-closing adjustments Goodwill, Purchase Accounting Adjustments Total cash consideration EX-101.PRE 8 vrex-20200922_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 9 form8-kcoverxreissued2_htm.xml IDEA: XBRL DOCUMENT 0001681622 2018-09-29 2019-09-27 0001681622 2020-09-22 2020-09-22 0001681622 2017-09-30 2018-09-28 0001681622 2016-10-01 2017-09-29 0001681622 2018-09-28 0001681622 2019-09-27 0001681622 2017-09-29 0001681622 2016-09-30 0001681622 us-gaap:CommonStockMember 2018-09-29 2019-09-27 0001681622 us-gaap:CommonStockMember 2017-09-30 2018-09-28 0001681622 us-gaap:CommonStockMember 2017-09-29 0001681622 us-gaap:AdditionalPaidInCapitalMember 2018-09-29 2019-09-27 0001681622 us-gaap:NoncontrollingInterestMember 2017-09-30 2018-09-28 0001681622 us-gaap:ParentMember 2017-09-30 2018-09-28 0001681622 us-gaap:RetainedEarningsMember 2017-09-29 0001681622 us-gaap:AdditionalPaidInCapitalMember 2019-09-27 0001681622 us-gaap:NoncontrollingInterestMember 2017-09-29 0001681622 us-gaap:CommonStockMember 2016-10-01 2017-09-29 0001681622 us-gaap:NoncontrollingInterestMember 2018-09-29 2019-09-27 0001681622 us-gaap:ParentMember 2016-10-01 2017-09-29 0001681622 vrex:NetParentInvestmentMember 2016-09-30 0001681622 us-gaap:RetainedEarningsMember 2016-10-01 2017-09-29 0001681622 us-gaap:AdditionalPaidInCapitalMember 2017-09-30 2018-09-28 0001681622 us-gaap:CommonStockMember 2016-09-30 0001681622 us-gaap:RetainedEarningsMember 2017-09-30 2018-09-28 0001681622 vrex:NetParentInvestmentMember 2016-10-01 2017-09-29 0001681622 vrex:NetParentInvestmentMember 2018-09-28 0001681622 us-gaap:RetainedEarningsMember 2018-09-29 2019-09-27 0001681622 us-gaap:AdditionalPaidInCapitalMember 2017-09-29 0001681622 vrex:NetParentInvestmentMember 2019-09-27 0001681622 us-gaap:NoncontrollingInterestMember 2019-09-27 0001681622 us-gaap:ParentMember 2016-09-30 0001681622 us-gaap:RetainedEarningsMember 2019-09-27 0001681622 us-gaap:CommonStockMember 2018-09-28 0001681622 us-gaap:ParentMember 2018-09-29 2019-09-27 0001681622 us-gaap:ParentMember 2018-09-28 0001681622 us-gaap:ParentMember 2019-09-27 0001681622 us-gaap:RetainedEarningsMember 2016-09-30 0001681622 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-09-30 2018-09-28 0001681622 us-gaap:AdditionalPaidInCapitalMember 2016-10-01 2017-09-29 0001681622 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-10-01 2017-09-29 0001681622 us-gaap:RetainedEarningsMember 2018-09-28 0001681622 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-29 2019-09-27 0001681622 us-gaap:AdditionalPaidInCapitalMember 2016-09-30 0001681622 us-gaap:AdditionalPaidInCapitalMember 2018-09-28 0001681622 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-27 0001681622 us-gaap:NoncontrollingInterestMember 2018-09-28 0001681622 us-gaap:CommonStockMember 2019-09-27 0001681622 vrex:NetParentInvestmentMember 2017-09-29 0001681622 us-gaap:NoncontrollingInterestMember 2016-09-30 0001681622 us-gaap:ParentMember 2017-09-29 0001681622 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-28 0001681622 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-09-29 0001681622 us-gaap:MachineryAndEquipmentMember 2019-09-27 0001681622 us-gaap:MachineryAndEquipmentMember 2018-09-28 0001681622 vrex:BuildingsandLeaseholdImprovementsMember 2019-09-27 0001681622 us-gaap:ConstructionInProgressMember 2019-09-27 0001681622 us-gaap:LandMember 2019-09-27 0001681622 vrex:BuildingsandLeaseholdImprovementsMember 2018-09-28 0001681622 us-gaap:LandMember 2018-09-28 0001681622 us-gaap:ConstructionInProgressMember 2018-09-28 0001681622 vrex:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2017-09-30 2018-09-28 0001681622 vrex:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-09-29 2019-09-27 0001681622 vrex:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2016-10-01 2017-09-29 0001681622 srt:RestatementAdjustmentMember 2017-09-30 2018-09-28 0001681622 srt:MinimumMember 2018-09-29 2019-09-27 0001681622 vrex:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2018-09-29 2019-09-27 0001681622 srt:MaximumMember 2018-09-29 2019-09-27 0001681622 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2019-09-27 0001681622 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2019-03-29 0001681622 us-gaap:BuildingMember 2018-09-29 2019-09-27 0001681622 vrex:VarianMedicalSystemsInc.Member 2017-01-28 0001681622 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2018-09-29 2019-09-27 0001681622 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-12-28 0001681622 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2018-09-29 2019-09-27 0001681622 us-gaap:LandImprovementsMember 2018-09-29 2019-09-27 0001681622 vrex:CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2017-09-30 2018-09-28 0001681622 vrex:DirectConversionABMember us-gaap:DevelopedTechnologyRightsMember 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:CustomerRelationshipsMember 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:CustomerRelationshipsMember 2019-04-29 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:DevelopedTechnologyRightsMember 2019-04-29 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:TradeNamesMember 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:OrderOrProductionBacklogMember 2019-04-29 0001681622 vrex:DirectConversionABMember 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:OrderOrProductionBacklogMember 2019-04-29 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:TradeNamesMember 2019-04-29 2019-04-29 0001681622 vrex:DirectConversionABMember us-gaap:InProcessResearchAndDevelopmentMember 2019-04-29 0001681622 vrex:PerkinElmerInc.Member vrex:IndustrialMember 2017-05-01 2017-09-29 0001681622 vrex:PerkinElmerInc.Member 2017-05-01 2017-09-29 0001681622 vrex:PerkinElmerInc.Member vrex:MedicalMember 2017-05-01 2017-09-29 0001681622 vrex:DirectConversionABMember 2019-04-30 2019-09-27 0001681622 vrex:DirectConversionABMember vrex:IndustrialMember 2019-04-30 2019-09-27 0001681622 vrex:DirectConversionABMember vrex:MedicalMember 2019-04-30 2019-09-27 0001681622 vrex:PerkinElmerInc.Member 2017-05-01 0001681622 vrex:PerkinElmerInc.Member 2017-05-01 2017-05-01 0001681622 vrex:PerkinElmerInc.Member 2016-10-01 2017-09-29 0001681622 vrex:DirectConversionABMember 2019-04-29 2019-04-29 0001681622 vrex:VirtualMediaIntegrationLtd.Member 2018-08-31 2018-08-31 0001681622 vrex:PerkinElmerInc.Member us-gaap:ForeignCountryMember 2017-05-01 0001681622 vrex:DirectConversionABMember 2019-04-30 0001681622 vrex:VirtualMediaIntegrationLtd.Member 2018-08-31 0001681622 vrex:PerkinElmerInc.Member us-gaap:LeaseAgreementsMember 2017-05-01 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:OrderOrProductionBacklogMember 2017-05-01 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:LeaseAgreementsMember 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:TradeNamesMember 2017-05-01 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:OrderOrProductionBacklogMember 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:CustomerRelationshipsMember 2017-05-01 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:DevelopedTechnologyRightsMember 2017-05-01 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:DevelopedTechnologyRightsMember 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:TradeNamesMember 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:CustomerRelationshipsMember 2017-05-01 0001681622 vrex:PerkinElmerInc.Member us-gaap:InProcessResearchAndDevelopmentMember 2017-05-01 0001681622 vrex:VECImagingGmbHCo.KGMember 2018-11-01 2019-09-27 0001681622 vrex:DpiXHoldingMember us-gaap:EquityMethodInvesteeMember 2019-09-27 0001681622 vrex:VECImagingGmbHCo.KGMember srt:ScenarioForecastMember 2019-12-17 2019-12-17 0001681622 vrex:DpiXHoldingMember us-gaap:EquityMethodInvesteeMember 2018-09-29 2019-09-27 0001681622 vrex:DpiXHoldingMember us-gaap:EquityMethodInvesteeMember 2013-10-01 2013-10-31 0001681622 vrex:DpiXHoldingMember 2019-09-27 0001681622 vrex:DpiXHoldingMember 2018-09-29 2019-09-27 0001681622 vrex:DpiXLLCMember 2019-09-27 0001681622 vrex:CETTEENGmbHMember vrex:VECImagingGmbHCo.KGMember 2019-09-27 0001681622 vrex:DpiXHoldingMember us-gaap:EquityMethodInvesteeMember 2018-09-28 0001681622 vrex:DpiXHoldingMember 2016-10-01 2017-09-29 0001681622 vrex:DpiXHoldingMember 2017-09-30 2018-09-28 0001681622 vrex:DpiXHoldingMember us-gaap:EquityMethodInvesteeMember 2016-10-01 2017-09-29 0001681622 vrex:VECImagingGmbHCo.KGMember 2019-09-27 0001681622 vrex:DpiXHoldingMember vrex:FixedCostCommitmentsMember 2018-09-29 2019-09-27 0001681622 vrex:DpiXHoldingMember 2018-09-28 0001681622 vrex:DpiXHoldingMember us-gaap:EquityMethodInvesteeMember 2017-09-30 2018-09-28 0001681622 vrex:LondonFacilityClosingMember 2017-09-30 2018-09-28 0001681622 vrex:SantaClaraFacilityRelocationMember 2017-09-30 2018-09-28 0001681622 vrex:SantaClaraFacilityRelocationMember 2018-09-29 2019-09-27 0001681622 srt:MinimumMember vrex:SantaClaraFacilityRelocationMember 2019-09-27 0001681622 srt:MaximumMember vrex:SantaClaraFacilityRelocationMember 2019-09-27 0001681622 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:OtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:OtherCurrentAssetsMember us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-28 0001681622 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-27 0001681622 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember 2018-09-29 2019-09-27 0001681622 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-10-01 2017-09-29 0001681622 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-09-30 2018-09-28 0001681622 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-29 2019-09-27 0001681622 currency:CHF us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-09-27 0001681622 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-09-27 0001681622 currency:JPY us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-09-27 0001681622 currency:EUR us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-09-27 0001681622 currency:CNY us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-09-27 0001681622 currency:CHF us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-09-27 0001681622 currency:EUR us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-09-27 0001681622 currency:CNY us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:ShortMember 2019-09-27 0001681622 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-09-27 0001681622 currency:JPY us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:LongMember 2019-09-27 0001681622 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-09-29 2019-09-27 0001681622 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-09-30 2018-09-28 0001681622 us-gaap:CrossCurrencyInterestRateContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-10-01 2017-09-29 0001681622 us-gaap:SecuredDebtMember 2019-09-27 0001681622 vrex:OtherDebtMember 2019-09-27 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2018-09-29 2019-09-27 0001681622 us-gaap:SecuredDebtMember 2018-09-29 2019-09-27 0001681622 us-gaap:SecuredDebtMember 2018-09-28 0001681622 us-gaap:SecuredDebtMember 2017-09-30 2018-09-28 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2017-09-30 2018-09-28 0001681622 vrex:OtherDebtMember 2018-09-28 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2019-09-27 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2018-09-28 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2018-10-10 0001681622 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:LondonInterbankOfferedRateLIBORMember 2017-05-01 2017-05-01 0001681622 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:BaseRateMember 2017-05-01 2017-05-01 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member vrex:DebtInstrumentRepaymentPeriodOneMember 2017-05-01 2017-05-01 0001681622 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:BaseRateMember 2017-05-01 2017-05-01 0001681622 vrex:RevolvingCreditFacilityMay2017Member 2017-05-01 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member 2017-05-01 2017-05-01 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member vrex:DebtInstrumentRepaymentPeriodThreeMember 2017-05-01 2017-05-01 0001681622 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2017-05-01 2017-05-01 0001681622 vrex:RevolvingCreditFacilityMay2017Member us-gaap:SubsequentEventMember 2019-10-08 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member vrex:DebtInstrumentRepaymentPeriodFiveMember 2017-05-01 2017-05-01 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:LondonInterbankOfferedRateLIBORMember 2017-05-01 2017-05-01 0001681622 vrex:RevolvingCreditFacilityMay2017Member us-gaap:SubsequentEventMember 2019-10-08 2019-10-08 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2018-10-10 2018-10-10 0001681622 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:LondonInterbankOfferedRateLIBORMember 2017-05-01 2017-05-01 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2017-05-01 0001681622 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2017-05-01 2017-05-01 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:FederalFundsEffectiveSwapRateMember 2017-05-01 2017-05-01 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member 2017-05-01 2017-05-01 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member vrex:DebtInstrumentRepaymentPeriodTwoMember 2017-05-01 2017-05-01 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member vrex:DebtInstrumentRepaymentPeriodFourMember 2017-05-01 2017-05-01 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member vrex:DebtInstrumentRepaymentPeriodFourMember 2017-01-25 2017-01-25 0001681622 us-gaap:SecuredDebtMember vrex:RevolvingCreditFacilityMay2017Member vrex:DebtInstrumentRepaymentPeriodTwoMember 2017-01-25 2017-01-25 0001681622 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-27 0001681622 us-gaap:FairValueMeasurementsRecurringMember 2019-09-27 0001681622 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-27 0001681622 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-09-27 0001681622 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-09-28 0001681622 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2018-09-28 0001681622 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-09-28 0001681622 us-gaap:FairValueMeasurementsRecurringMember 2018-09-28 0001681622 us-gaap:IntellectualPropertyMember 2018-09-28 0001681622 vrex:CustomerContractsandSupplierRelationshipsMember 2019-09-27 0001681622 us-gaap:DevelopedTechnologyRightsMember 2018-09-28 0001681622 us-gaap:IntellectualPropertyMember 2019-09-27 0001681622 us-gaap:DevelopedTechnologyRightsMember 2019-09-27 0001681622 vrex:CustomerContractsandSupplierRelationshipsMember 2018-09-28 0001681622 vrex:MedicalMember 2018-09-29 2019-09-27 0001681622 vrex:IndustrialMember 2018-09-29 2019-09-27 0001681622 vrex:IndustrialMember 2019-09-27 0001681622 vrex:MedicalMember 2018-09-28 0001681622 vrex:IndustrialMember 2018-09-28 0001681622 vrex:MedicalMember 2019-09-27 0001681622 vrex:JointVentureInSaudiArabiaMember 2018-09-28 0001681622 vrex:MeVisMedicalSolutionsAGMeVisMember 2015-04-30 0001681622 vrex:MeVisMedicalSolutionsAGMeVisMember 2019-09-27 0001681622 vrex:MeVisMedicalSolutionsAGMeVisMember vrex:MeVisMedicalSolutionsAGMeVisMember 2019-09-27 0001681622 vrex:MeVisMedicalSolutionsAGMeVisMember 2015-10-31 0001681622 vrex:MeVisMedicalSolutionsAGMeVisMember 2015-10-01 2015-10-31 0001681622 us-gaap:EmployeeStockMember vrex:A2017ESPPMember 2017-01-01 2017-01-31 0001681622 us-gaap:EmployeeStockOptionMember vrex:A2017ESPPMember 2019-09-27 0001681622 us-gaap:EmployeeStockOptionMember vrex:A2017OmnibusStockPlanMember 2019-09-27 0001681622 us-gaap:EmployeeStockOptionMember 2019-09-27 0001681622 us-gaap:EmployeeStockMember vrex:A2017ESPPMember 2018-09-29 2019-09-27 0001681622 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2018-09-29 2019-09-27 0001681622 us-gaap:EmployeeStockMember vrex:A2017ESPPMember 2017-01-31 0001681622 us-gaap:GeneralAndAdministrativeExpenseMember us-gaap:MajorityShareholderMember 2016-10-01 2017-09-29 0001681622 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2018-09-29 2019-09-27 0001681622 us-gaap:EmployeeStockMember 2018-09-29 2018-12-28 0001681622 us-gaap:EmployeeStockMember 2018-09-29 2019-09-27 0001681622 us-gaap:EmployeeStockOptionMember 2018-09-29 2019-09-27 0001681622 us-gaap:EmployeeStockOptionMember 2017-09-30 2017-12-29 0001681622 us-gaap:EmployeeStockOptionMember 2018-09-29 2018-12-28 0001681622 us-gaap:EmployeeStockMember 2017-09-30 2017-12-29 0001681622 us-gaap:CostOfSalesMember 2016-10-01 2017-09-29 0001681622 us-gaap:ResearchAndDevelopmentExpenseMember 2017-09-30 2018-09-28 0001681622 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-09-29 2019-09-27 0001681622 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-10-01 2017-09-29 0001681622 us-gaap:CostOfSalesMember 2018-09-29 2019-09-27 0001681622 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-09-30 2018-09-28 0001681622 us-gaap:ResearchAndDevelopmentExpenseMember 2016-10-01 2017-09-29 0001681622 us-gaap:CostOfSalesMember 2017-09-30 2018-09-28 0001681622 us-gaap:ResearchAndDevelopmentExpenseMember 2018-09-29 2019-09-27 0001681622 srt:MaximumMember 2019-09-27 0001681622 srt:MinimumMember 2019-09-27 0001681622 srt:MaximumMember 2018-09-28 0001681622 srt:MinimumMember 2018-09-28 0001681622 us-gaap:OperatingSegmentsMember 2019-09-27 0001681622 us-gaap:OperatingSegmentsMember vrex:MedicalMember 2019-09-27 0001681622 us-gaap:OperatingSegmentsMember vrex:MedicalMember 2018-09-28 0001681622 us-gaap:OperatingSegmentsMember vrex:IndustrialMember 2019-09-27 0001681622 us-gaap:OperatingSegmentsMember vrex:IndustrialMember 2018-09-28 0001681622 us-gaap:OperatingSegmentsMember 2018-09-28 0001681622 srt:LatinAmericaMember 2018-09-29 2019-09-27 0001681622 us-gaap:EMEAMember 2018-09-29 2019-09-27 0001681622 us-gaap:EMEAMember 2018-09-28 0001681622 srt:LatinAmericaMember 2017-09-30 2018-09-28 0001681622 srt:AsiaPacificMember 2018-09-29 2019-09-27 0001681622 srt:AsiaPacificMember 2016-10-01 2017-09-29 0001681622 srt:AsiaPacificMember 2019-09-27 0001681622 country:US 2019-09-27 0001681622 us-gaap:EMEAMember 2019-09-27 0001681622 country:US 2018-09-29 2019-09-27 0001681622 srt:LatinAmericaMember 2018-09-28 0001681622 country:US 2016-10-01 2017-09-29 0001681622 srt:LatinAmericaMember 2016-10-01 2017-09-29 0001681622 srt:LatinAmericaMember 2019-09-27 0001681622 us-gaap:EMEAMember 2016-10-01 2017-09-29 0001681622 country:US 2018-09-28 0001681622 country:US 2017-09-30 2018-09-28 0001681622 srt:AsiaPacificMember 2018-09-28 0001681622 us-gaap:EMEAMember 2017-09-30 2018-09-28 0001681622 srt:AsiaPacificMember 2017-09-30 2018-09-28 0001681622 vrex:IndustrialMember 2017-09-30 2018-09-28 0001681622 vrex:MedicalMember 2017-09-30 2018-09-28 0001681622 vrex:IndustrialMember 2016-10-01 2017-09-29 0001681622 vrex:MedicalMember 2016-10-01 2017-09-29 0001681622 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2019-09-27 0001681622 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-09-29 2019-09-27 0001681622 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2018-09-28 0001681622 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2019-09-27 0001681622 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-09-29 2019-09-27 0001681622 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-09-28 0001681622 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-09-27 0001681622 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-09-28 0001681622 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-09-29 2019-09-27 0001681622 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-09-28 0001681622 2018-09-29 0001681622 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-09-29 0001681622 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2019-09-27 0001681622 2019-09-28 2019-09-27 0001681622 vrex:ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2020-06-09 0001681622 vrex:ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2020-06-09 2020-06-09 0001681622 vrex:ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2020-06-04 0001681622 vrex:ConvertibleNotesMember us-gaap:ConvertibleDebtMember us-gaap:SubsequentEventMember 2020-06-04 2020-06-05 0001681622 us-gaap:SubsequentEventMember 2020-06-04 2020-06-05 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:SubsequentEventMember 2020-06-06 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:SubsequentEventMember 2019-10-08 2019-10-08 0001681622 us-gaap:RevolvingCreditFacilityMember vrex:RevolvingCreditFacilityMay2017Member us-gaap:SubsequentEventMember 2019-10-08 iso4217:USD iso4217:USD shares pure vrex:member shares vrex:entity vrex:employee vrex:segment vrex:derivative iso4217:EUR shares vrex:day utreg:Rate false FY 2019 0001681622 0.01 0.01 150000000 150000000 38026597 38371305 38026597 38371305 0.04805 P5Y 0 0 3000000 0 0.01 0.01 20000000 20000000 0 0 0 P12M 0 100000 5 5 0.1 0.075 0.075 0.05 37.60 22.63 37.60 22.63 37.60 22.63 31.08 31.08 27.77 22.84 31.42 31.42 8-K 2020-09-22 VAREX IMAGING CORPORATION DE 001-37860 81-3434516 1678 S. Pioneer Road, Salt Lake City, UT 84104 801 972-5000 false false false false Common Stock VREX NASDAQ false 780600000 773400000 698100000 523900000 519500000 444600000 256700000 253900000 253500000 78100000 83000000.0 67300000 128100000 123400000 102500000 4800000 3000000.0 0 211000000.0 209400000 169800000 45700000 44500000 83700000 100000 200000 200000 21100000 21700000 12300000 -3200000 2700000 3200000 -24200000 -18800000 -8900000 21500000 25700000 74800000 5700000 -2600000 22800000 15800000 28300000 52000000.0 300000 800000 400000 15500000 27500000 51600000 0.41 0.73 1.37 0.40 0.72 1.36 38200000 37900000 37600000 38600000 38400000 38000000.0 15800000 28300000 52000000.0 -6200000 5200000 600000 1300000 200000 -200000 -7500000 5000000.0 800000 8300000 33300000 52800000 300000 800000 400000 8000000.0 32500000 52400000 29900000 51900000 141000000.0 154000000.0 248200000 235100000 19300000 17100000 438400000 458100000 142300000 144900000 290800000 243600000 86300000 73800000 53600000 51000000.0 27500000 16500000 1038900000 987900000 58200000 66300000 75700000 47500000 30700000 25000000.0 10500000 13200000 175100000 152000000.0 364400000 364800000 8200000 23200000 32500000 8500000 580200000 548500000 10500000 11100000 0 0 400000 400000 371800000 357600000 -1700000 5800000 74400000 62400000 444900000 426200000 3300000 2100000 448200000 428300000 1038900000 987900000 15800000 28300000 52000000.0 11700000 10000000.0 8400000 23500000 26000000.0 16900000 15700000 16200000 10500000 4800000 3000000.0 0 0 1300000 0 3100000 3100000 0 -12900000 -7700000 -8900000 2400000 2300000 1800000 -2300000 3900000 1300000 -800000 -700000 -1800000 -14800000 -9000000.0 23100000 11100000 2400000 4200000 -4300000 -2000000.0 10100000 -9000000.0 5200000 4900000 10900000 -10200000 28100000 -5200000 2400000 -1600000 71900000 85300000 75200000 19800000 20400000 20200000 69500000 4800000 271800000 3900000 0 0 -93200000 -25200000 -292000000.0 0 0 5000000.0 0 0 227100000 2100000 2300000 1900000 85400000 10000000.0 749000000.0 87000000.0 106000000.0 255000000.0 800000 3800000 2800000 3800000 3300000 0 0 0 2400000 500000 400000 11900000 0 1800000 0 500000 600000 0 -100000 -90400000 263300000 -700000 -500000 900000 -22100000 -30800000 47400000 53400000 84200000 36800000 31300000 53400000 84200000 19900000 19300000 9800000 8200000 13800000 6000000.0 1800000 2000000.0 4000000.0 0 0 15000000.0 0 0 1600000 0 0 0 526000000.0 0 0 526000000.0 0 526000000.0 16500000 35100000 51600000 51600000 18400000 18400000 18400000 227100000 227100000 227100000 37400000 400000 333400000 -333800000 0 100000 2800000 2800000 2800000 200000 100000 1900000 1900000 1900000 6200000 6200000 6200000 600000 600000 600000 -200000 -200000 -200000 2400000 2400000 2400000 200000 200000 200000 37600000 400000 342700000 0 800000 35100000 379000000.0 0 379000000.0 27500000 27500000 300000 27800000 200000 3800000 3800000 3800000 200000 100000 2200000 2200000 2200000 100000 3300000 3300000 3300000 10000000.0 10000000.0 10000000.0 5200000 5200000 5200000 200000 200000 200000 1800000 1800000 200000 200000 200000 38000000.0 400000 357600000 0 5800000 62400000 426200000 2100000 428300000 -3500000 -3500000 -3500000 15500000 15500000 -200000 15300000 0 800000 800000 800000 200000 0 2100000 2100000 2100000 200000 3800000 3800000 3800000 11700000 11700000 11700000 -6200000 -6200000 -6200000 1300000 1300000 1300000 1400000 1400000 38400000 400000 371800000 0 -1700000 74400000 444900000 3300000 448200000 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Description of Business</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Varex Imaging Corporation (the “Company,” “Varex” or “Varex Imaging”) designs, manufactures, sells and services a broad range of Medical products, which include X-ray imaging components, including X-ray tubes, digital detectors and accessories, high voltage connectors, image processing software and workstations, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, ionization chambers and buckys, for use in a range of applications, including radiographic or fluoroscopic imaging, mammography, computed tomography, oncology and computer-aided detection. The Company sells its products to imaging system original equipment manufacturer (“OEM”) customers for incorporation into new medical diagnostic, radiation therapy, dental, and veterinary, to independent service companies, distributors and directly to end-users for replacement purposes.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company also designs, manufacturers, sells and services industrial products, which include Linatron</span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">®</sup></span><span style="font-family:inherit;font-size:10pt;"> X-ray accelerators, imaging processing software and image detection products for security and inspection purposes, such as cargo screening at ports and borders and nondestructive examination in a variety of applications. The Company generally sells security and inspection products to OEM customers who incorporate Varex’s products into their inspection systems. The Company conducts an active research and development program to focus on new technology and applications in both the medical and industrial X-ray imaging markets.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Varex Imaging Corporation was incorporated in Delaware on July 18, 2016 for the purpose of holding the assets and liabilities associated with the Company's business and separated from Varian Medical Systems, Inc. (“Varian”) on January 28, 2017, upon which Varian completed the distribution of </span><span style="font-family:inherit;font-size:10pt;"><span>100%</span></span><span style="font-family:inherit;font-size:10pt;"> of the outstanding common stock of Varex to Varian stockholders. Following the separation and distribution, Varex became an independent publicly-traded company and is listed on the NASDAQ Global Select Market under the ticker “VREX.”</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Basis of Presentation and Principle of Consolidation</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The accompanying consolidated financial statements are audited and have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). Prior to January 28 2017, the date of separation and distribution, the financial statements were prepared on a stand-alone basis and were derived from Varian’s consolidated financial statements and records as it operated as part of Varian prior to the distribution, in conformity with GAAP. Prior to the separation and distribution, the consolidated financial statements included allocations of certain Varian corporate expenses these costs were allocated to the Company on the basis of direct usage when identifiable or other systematic measures that reflect utilization of services provided to or benefits received by the Company.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">All transactions between the Company and Varian prior to the separation have been included in the accompanying consolidated financial statements. All intercompany transactions while the Company operated as part of Varian were considered to be effectively settled for cash and are reflected as a component of financing activities as net transfers from (to) Varian in the consolidated statements of cash flows at the time the transactions were recorded.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior to the separation, the Company was dependent upon Varian for its working capital and financing requirements, as Varian uses a centralized approach to cash management and financing of its operations. Financial transactions relating to the Company were accounted for through the net parent investment account. Cash and cash equivalents held by Varian were not allocated to the Company.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net parent investment in the consolidated statements of equity represents Varian’s historical investment in the Company, the net effect of transactions with and allocations from Varian and the Company’s accumulated earnings.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Impact of COVID-19</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The coronavirus (“COVID-19”) pandemic and the mitigation efforts by governments to attempt to control its spread created uncertainties and disruptions in the economic and financial markets. The extent to which COVID-19 will continue to impact the Company’s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it will impact worldwide macroeconomic conditions including interest rates and employment rates, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. During the quarter ended July 3, 2020, as a result of the economic downturn resulting from COVID-19, the Company experienced reduced demand in the </span></div><div style="line-height:120%;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Company’s industrial segment and for certain higher end medical products that negatively impacted revenues and gross margin. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the currently estimated future impacts of COVID-19 through the date of reissuance of these consolidated financial statements. The Company’s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material negative impacts to the Company’s consolidated financial statements in future reporting periods. These future developments are highly uncertain, and the outcomes cannot be estimated with certainty. Actual results may differ from those estimates, and such differences may be material to the consolidated financial statements.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company’s Credit Agreement, as defined in Note 8, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Borrowings</span><span style="font-family:inherit;font-size:10pt;">, contains financial covenants, including certain leverage ratio covenants. The adverse effects of the COVID-19 pandemic on the Company’s financial condition and results of operations are expected to be more persistent and have been more severe than previously estimated. The Company now believes that reduced demand in the Company’s industrial segment and for certain higher end medical products will continue to negatively impact revenues, gross margin, and the other items used to calculate the Company’s financial covenants contained in its Credit Agreement. Based on the Company’s current forecasts, it is probable that the Company will be in violation of certain leverage ratio covenants contained in its Credit Agreement within the twelve-month period following the reissuance of these consolidated financial statements, including as early as the end of the Company's fiscal year end 2020. Failure to comply with the covenants, if not amended or waived, would result in an event of default under the Credit Agreement and the acceleration of the outstanding balance of the loans thereunder. If an event of default under the Credit Agreement occurs, then pursuant to cross default and/or cross acceleration clauses, substantially all of the Company’s other outstanding debt and derivative contract payables would become due, and all debt and derivative contracts could be terminated, which would have a material adverse impact to the Company’s operations and liquidity as the Company currently does not have the financial resources to satisfy such obligations if they were to become due and payable. These events and conditions raise substantial doubt about the Company’s ability to continue as a going concern within the twelve-month period following the reissuance of these consolidated financial statements.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company is actively pursuing various options to prevent an event of default from occurring under the Credit Agreement. The Company is implementing actions to improve its financial results and other items used to calculate the financial covenants, such as accelerating the closure of its Santa Clara facility, the previously announced reduction in force, austerity programs related to outside services, and other appropriate actions. The Company is also taking actions to improve cash flow such as working capital reductions and reduced spending for property, plant and equipment, as well as pursuing potential additional fundraising to modify, supplement, or replace its Credit Agreement. While the Company has and continues to take actions to mitigate the risk of an event of default under the Credit Agreement, there is no assurance that it will be successful in doing so. The Company’s consolidated financial statements have been prepared on a going concern basis and do not reflect any adjustments that might result if the Company is unable to continue as a going concern.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassification</span></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has reclassified </span><span style="font-family:inherit;font-size:10pt;"><span>$3.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> from selling, general and administrative expense to impairment of intangible assets for the year ended September 28, 2018, to conform to the current year's presentation. Such reclassifications had no impact on net earnings as previously reported.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Segment Reporting</span></div><div style="line-height:120%;padding-top:9px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> reportable operating segments; (i) Medical and (ii) Industrial, which aligns with how its CEO, who is the Company's Chief Operating Decision Maker (“CODM”), reviews the Company’s performance. See Note </span><span style="font-family:inherit;font-size:10pt;">15</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Segment Information, </span><span style="font-family:inherit;font-size:10pt;">included in this report, for further information on the Company’s segments.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fiscal Year</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The fiscal years of the Company as reported are the 52 or 53-week period ending on the Friday nearest September 30. Fiscal year 2019 was the 52-week period that ended on September 27, 2019. Fiscal year 2018 was the 52-week period that ended on September 28, 2018. Fiscal year 2017 was the 52-week period that ended on September 29, 2017. </span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Variable Interest Entities</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For entities in which the Company has variable interests, the Company focuses on identifying which entity has the power to direct the activities that most significantly impact the variable interest entity’s economic performance and which enterprise has the obligation to absorb losses or the right to receive benefits from the variable interest entity. If the Company is the primary beneficiary of a variable interest entity, the assets, liabilities and results of operations of the variable interest entity will be included in the </span></div><div style="line-height:120%;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Company’s consolidated financial statements. As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, the Company had </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> variable interest entities neither of which were consolidated. </span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:8pt;"> </span><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Such estimates include the valuation of inventories, goodwill and intangible assets, impairment on investments, and taxes on earnings. Actual results could differ from these estimates.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cash and Cash Equivalents</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company considers currency on hand, demand deposits, time deposits and all highly-liquid investments with an original maturity of three months or less at the date of purchase to be cash and cash equivalents.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Restricted Cash</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;"/><span style="font-family:inherit;font-size:10pt;">Restricted cash primarily consists of cash collateral related to certain leases and inventory arrangements. Restricted cash is</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">included in other assets on the consolidated balance sheet. Cash and cash equivalents and restricted cash as reported within</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the consolidated statements of cash flows consisted of the following:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:720px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:382px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:6px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Twelve Months Ended September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Twelve Months Ended September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Beginning of Period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">End of Period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Beginning of Period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">End of Period</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>51.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>29.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>83.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>51.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Restricted cash</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Cash and cash equivalents and restricted cash as reported per statement of cash flows</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>53.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>31.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>84.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>53.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fair Value</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. There is a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:</span></div><div style="line-height:120%;padding-top:10px;text-align:left;padding-left:102px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level 1—Quoted prices in active markets for identical assets or liabilities.</span></div><div style="line-height:120%;text-align:left;padding-left:102px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level 2—Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or, other inputs that are observable or can be corroborated by observable market data.</span></div><div style="line-height:120%;text-align:left;padding-left:102px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Derivative instruments and hedging activities</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company records all derivatives on the balance sheet at fair value. Derivatives designated as a hedge are recorded on the Consolidated Balance Sheets at fair value as of the reporting date. For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative is reported as a component of other comprehensive income or loss and reclassified from accumulated other comprehensive loss into earnings when the hedged transaction affects earnings.  For derivatives that are designated and qualify as net investment hedges, the gain or loss on the derivative is reported as a component of other comprehensive income or loss. Time value is excluded and the cash payments are recognized as an adjustment to interest expense. A qualitative assessment of hedge effectiveness is performed on a quarterly basis, unless facts and circumstances indicate the hedge may no longer be highly effective.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Risk</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash, cash equivalents and trade accounts receivable. Cash held with financial institutions may exceed the Federal Deposit Insurance Corporation insurance limits or similar limits in foreign jurisdictions. The Company has not experienced any losses on its deposits of cash and cash equivalents. The Company performs ongoing credit evaluations of its customers and, except for government tenders, group purchases and orders with a letter of credit, its industrial customers often provide a down payment. The Company maintains an allowance for doubtful accounts based upon the expected collectability of all accounts receivable. The Company obtains some of the components in its products from a limited group of suppliers or from a single-source supplier. The Company has neither experienced nor expects any significant disruptions to its operations due to supplier concentration.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Credit is extended to customers based on an evaluation of the customer’s financial condition, and collateral is not required. During the periods presented, one of the Company's Medical segment customers accounted for a significant portion of revenues, which is as follows:</span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:62%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Year</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Canon Medical Systems Corporation</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Canon Medical Systems Corporation accounted for </span><span style="font-family:inherit;font-size:10pt;"><span>10.1%</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>9.8%</span></span><span style="font-family:inherit;font-size:10pt;"> of the Company’s accounts receivable as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Inventories</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories are valued at the lower of cost or net realizable value. Costs include materials, labor and manufacturing overhead</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">and is computed using standard cost (which approximates actual cost) on a first-in-first-out basis. The Company evaluates the carrying</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">value of its inventories taking into consideration such factors as historical and anticipated future sales compared to quantities on hand</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">and the prices the Company expects to obtain for products in its various markets. The Company adjust excess and obsolete</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">inventories to net realizable value and write-downs of excess and obsolete inventories are recorded as a component of cost of revenues.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The following table summarizes the Company’s inventories, net:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Raw materials and parts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>160.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>149.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Work-in-process</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finished goods</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>59.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total inventories</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>248.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>235.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Property, Plant and Equipment, net</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment are stated at cost, net of accumulated depreciation. Major improvements are capitalized, while repairs and maintenance are expensed as incurred. Depreciation are computed using the straight-line method over the estimated useful lives of the assets. Land is not subject to depreciation, but land improvements are depreciated over </span><span style="font-family:inherit;font-size:10pt;"><span>fifteen years</span></span><span style="font-family:inherit;font-size:10pt;">. Land leasehold rights and leasehold improvements are depreciated over the lesser of their estimated useful lives or remaining lease terms. Buildings are depreciated over </span><span style="font-family:inherit;font-size:10pt;"><span>twenty years</span></span><span style="font-family:inherit;font-size:10pt;">. Machinery and equipment are depreciated over their estimated useful lives, which range from </span><span style="font-family:inherit;font-size:10pt;"><span>three years</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>seven years</span></span><span style="font-family:inherit;font-size:10pt;">. Assets subject to lease are depreciated over the lesser of their estimated useful lives or remaining lease terms. Estimated useful lives are periodically reviewed and, when appropriate, changes are made prospectively. When certain events or changes in operating conditions occur, asset lives may be adjusted, and an impairment assessment may be performed on the recoverability of the carrying amounts. When assets are retired or otherwise disposed of, the assets and related accumulated depreciation are removed from the accounts.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The following table summarizes the Company’s property, plant and equipment, net:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Land</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Buildings and leasehold improvements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>134.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>138.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Machinery</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>170.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>166.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Construction in progress</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>28.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>23.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>341.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>335.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Accumulated depreciation and amortization</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(199.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(190.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Property, plant, and equipment, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>142.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>144.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company recorded depreciation expense of </span><span style="font-family:inherit;font-size:10pt;"><span>$23.5 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$26.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$16.9 million</span></span><span style="font-family:inherit;font-size:10pt;">, in fiscal years </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, respectively. During fiscal year 2019 the company recorded accelerated depreciation of </span><span style="font-family:inherit;font-size:10pt;"><span>$4.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> on the machinery and equipment used in the fabrication of amorphous silicon glass at its facility in Santa Clara, CA. See Note </span><span style="font-family:inherit;font-size:10pt;">4</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Restructuring, </span><span style="font-family:inherit;font-size:10pt;">included in this report, for further information. During fiscal year 2018 the company recorded accelerated depreciation of </span><span style="font-family:inherit;font-size:10pt;"><span>$4.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> on the machinery and equipment used in the fabrication of amorphous silicon glass at its facility in Santa Clara, CA. See Note </span><span style="font-family:inherit;font-size:10pt;">4</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Restructuring, </span><span style="font-family:inherit;font-size:10pt;">included in this report, for further information.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Investments</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company accounts for its equity investments in privately-held companies under the equity method of accounting if the Company has the ability to exercise significant influence in these investments. Distributions received from an equity method investment are classified using the cumulative earnings approach. Under the cumulative earnings approach, distributions up to the amount of cumulative equity in earnings recognized will be treated as returns on investment as operating cash flows and those in excess of that amount will be treated as returns of investment as investing cash flows. The Company monitors these equity investments for impairment and makes appropriate reductions in carrying values if the Company determines that impairment charges are required based primarily on the financial condition and near-term prospects of these companies.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill and Intangible Assets</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill is recorded when the purchase price of an acquisition exceeds the fair value of the net identified tangible and intangible assets acquired. Purchased intangible assets are carried at cost, net of accumulated amortization, and are included in intangible assets in the Company's consolidated balance sheets. Intangible assets with finite lives are amortized over their estimated useful lives of primarily </span><span style="font-family:inherit;font-size:10pt;"><span>two years</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>seven years</span></span><span style="font-family:inherit;font-size:10pt;"> using the straight-line method.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Impairment of Long-lived Assets, Intangible Assets and Goodwill</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company reviews long-lived assets and identifiable intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. The Company assesses these assets for impairment based on their estimated undiscounted future cash flows. If the carrying value of the assets exceeds the estimated future undiscounted cash flows, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company evaluates goodwill and indefinite lived intangible assets for impairment at least annually at the beginning of the fourth quarter of each fiscal year or whenever an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The Company performs a step one analysis, which consists of a comparison of the fair value of a reporting unit against its carrying amount, including the goodwill allocated to each reporting unit. The Company determines the fair value of its reporting units based on a combination of income and market approaches. The income approach is based on the present value of estimated future cash flows of the reporting units, and the market approach is based on a market multiple calculated for each reporting unit based on market data of other companies engaged in similar business. If the carrying amount of the reporting unit is in excess of its fair value, step two requires the comparison of the implied fair value of the reporting unit’s goodwill against the carrying amount of the reporting unit’s goodwill. Any excess of the carrying value of the reporting unit’s goodwill over the implied fair value of the reporting unit’s goodwill is recorded as an impairment loss. The impairment test for intangible assets with indefinite useful lives, if any, consists of a comparison of fair value to carrying value, with any excess of carrying value over fair value being recorded as an impairment loss.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During the fiscal year ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, the Company recognized </span><span style="font-family:inherit;font-size:10pt;"><span>$4.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$3.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> of impairments of intangible assets related to the restructuring activities see Note </span><span style="font-family:inherit;font-size:10pt;">4</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Restructuring</span><span style="font-family:inherit;font-size:10pt;">, included in this report. </span><span style="font-family:inherit;font-size:10pt;"><span>No</span></span><span style="font-family:inherit;font-size:10pt;"> goodwill impairment charges were recognized for any of the prior periods presented. No impairment charges were recognized in fiscal year </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Loss Contingencies</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">From time to time, the Company is a party to or otherwise involved in legal proceedings, claims and government inspections or investigations, customs and duties audits and other loss contingency matters, both inside and outside the United States, arising in the ordinary course of its business or otherwise. The Company accrues amounts, to the extent an unfavorable outcome is determined to be probable and the losses can be reasonably estimated, that it believes are adequate to address any liabilities related to legal proceedings and other loss contingencies that it believes will result in a probable loss.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Product Warranty</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company warrants most of its products for a specific period of time, usually </span><span style="font-family:inherit;font-size:10pt;"><span>12</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>24</span></span><span style="font-family:inherit;font-size:10pt;"> months from delivery or acceptance, against material defects. The Company provides for the estimated future costs of warranty obligations in cost of revenues when the related revenues are recognized. The accrued warranty costs represent the best estimate at the time of sale of the total costs that the Company will incur to repair or replace product parts that fail while still under warranty.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The amount of the accrued estimated warranty costs obligation for established products is primarily based on historical experience as to product failures adjusted for current information on repair costs. For new products, estimates include the historical experience of similar products, as well as a reasonable allowance for warranty expenses associated with new products. On a quarterly basis, the Company reviews the accrued warranty costs and updates the historical warranty cost trends, if required.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The following table reflects the changes in the Company’s accrued product warranty:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Years</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Accrued product warranty, at beginning of period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Charged to cost of revenues</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>12.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>11.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Actual product warranty expenditures</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(12.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(11.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Accrued product warranty, at end of period</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Effective September 29, 2018, the Company adopted the requirements of Accounting Standards Update (“ASU”) 2014-09 and related amendments, Revenue from Contracts with Customers (“ASC 606”), which superseded all prior revenue recognition methods and industry-specific guidance. See “Recently Adopted Accounting Pronouncements” below.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company’s revenues are derived primarily from the sale of hardware and services. The Company recognizes its revenues net of any value-added or sales tax and net of sales discounts. </span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company sells a high proportion of its X-ray products to a limited number of OEM customers. X-ray tubes, digital detectors and image-processing tools and security and inspection products are generally sold on a stand-alone basis. However, the Company occasionally sells its digital detectors, X-ray tubes and imaging processing tools as a package that is optimized for digital X ray imaging and sells its Linatron ® X-ray accelerators together with its imaging processing software and image detection products to OEM customers that incorporate them into their inspection systems. Service contracts are often sold with certain security and inspection products and computer-aided detection products.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company determines revenue recognition through the following steps:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Identification of the contract, or contracts, with a customer</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Identification of the performance obligations in the contract</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Determination of the transaction price</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Allocation of the transaction price to the performance obligations in the contract</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recognition of revenue when, or as, a performance obligation is satisfied</span></div></td></tr></table><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Deferred Revenues</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred revenue primarily represents (i) the amount received applicable to non-software products for which parts</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">and services under the warranty contracts have not been delivered, and (ii) the amount received for service contracts for</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">which the services have not been rendered.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Allowance for Doubtful Accounts</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company evaluates the creditworthiness of customers prior to authorizing shipment for all major sale transactions. On a quarterly basis, the Company evaluates aged items in the accounts receivable aging report and provide an allowance in an amount deemed adequate for doubtful accounts. If the evaluation of customers’ financial conditions does not reflect a future ability to collect outstanding receivables, additional provisions may be needed. We had an allowance for doubtful accounts of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$0.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Share-Based Compensation Expense</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has an equity-based incentive plan that provides for the grant of nonqualified stock options and restricted stock units to directors, officers and other employees. The Company also permits employees to purchase shares under the Varex employee stock purchase plan. Prior to the separation, the Company’s employees historically participated in Varian’s equity-based incentive plans. Share-based compensation expense through the date of separation included allocations to the Company based on the awards and terms previously granted to its employees as well as an allocation of Varian’s corporate and shared functional employee expenses.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company values stock options granted and the option component of the shares of common stock purchased under the equity-based incentive plans and stock purchased under the employee stock purchase plan using the Black-Scholes option-pricing model. Share-based compensation expense for restricted stock units is measured using the fair value of the Company’s stock on the date of grant and is amortized over the award’s respective service period. The Black-Scholes option-pricing model requires the input of certain assumptions, and changes in the assumptions can materially affect the fair value estimates of share-based payment awards.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company measures and recognizes expense for all share-based payment awards based on their fair values. Share-based compensation expense recognized in the consolidated statements of earnings includes compensation expense for the share-based payment awards based on the grant date fair value estimated in accordance with the guidance on share-based compensation. Share-based compensation expense recognized is based on the value of the portion of share-based payment awards that is ultimately expected to vest. The Company attributes the value of share-based compensation to expense using the straight-line method. The Company considers only the direct tax impacts of share-based compensation awards when calculating the amount of tax windfalls or shortfalls. For additional information, see Note </span><span style="font-family:inherit;font-size:10pt;">13</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Employee Stock Plans</span><span style="font-family:inherit;font-size:10pt;">, included in this report.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Shipping and Handling Costs</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Shipping and handling costs are included as a component of cost of revenues.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Research and Development</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Research and development costs have been expensed as incurred. These costs primarily include employees’ compensation, consulting fees and material costs. </span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Software Development Costs</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Costs for the development of new software products and substantial enhancements to existing software products are expensed as incurred until technological feasibility has been established, at which time any additional costs would be capitalized. No costs associated with the development of software have been capitalized, as the Company believes its current software development process is essentially completed concurrent with the establishment of technological feasibility.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Taxes on Earnings</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"/><span style="font-family:inherit;font-size:10pt;">Current income tax expense is the amount of income taxes expected to be payable for the current year. Deferred income tax liabilities or assets are established for the expected future tax consequences resulting from the differences in financial reporting and tax bases of assets and liabilities. A valuation allowance is provided if it is more likely than not that some or all of the deferred tax assets will not be realized. In addition, we provide reserves for uncertain tax positions when such tax positions do not meet the recognition thresholds or measurement standards prescribed by the authoritative guidance for accounting for income taxes. Amounts </span></div><div style="line-height:120%;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">for uncertain tax positions are adjusted in periods when new information becomes available or when positions are effectively settled. Interest and penalties related to uncertain tax positions are recognized as a component of income tax expense.</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On December 22, 2017, the U.S. Government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act of 2017 (“U. S. Tax Reform”). U.S. Tax Reform significantly revised the U.S. corporate income tax structure including a lower corporate statutory rate and changes to the way foreign earnings are taxed. U.S. GAAP requires that the impact of tax legislation be recognized in the period in which the law is enacted. In accordance with these rules, we are including the impact of certain provisions of U.S. Tax Reform to the extent they are effective during the current reporting period. </span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Foreign Currency Translation</span></div><div style="line-height:120%;padding-top:9px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company uses the U.S. Dollar predominately as the functional currency of its foreign operations. Gains and losses from remeasurement of foreign currency balances into U.S. Dollars are included in the consolidated statements of earnings. For the foreign subsidiary where the local currency is the functional currency, translation adjustments of foreign currency financial statements into U.S. dollars are recorded to a separate component of accumulated other comprehensive (loss) earnings. </span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Accounting Standards Recently Adopted</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"/><span style="font-family:inherit;font-size:10pt;">In November 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (“ASU 2016-18”), which requires that the statement of cash flows explain the change in the total amount of restricted cash during the period and other additional disclosures. The Company adopted ASU 2016-18 in the first quarter of 2019 using the retrospective transition method and the Company's consolidated statements of cash flows have been retrospectively adjusted to reflect restricted cash balances. Net cash flows for fiscal years 2019, 2018 and 2017 did not change as a result of adopting ASU 2016-18.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company adopted ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”), which was issued to reduce the diversity in practice in how certain transactions are classified in the statement of cash flows. The Company adopted ASU 2016-15 in the first quarter of 2019 retrospectively. Net cash flows for fiscal years 2019, 2018 and 2017 did not change as a result of adopting ASU 2016-15.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company adopted ASC 606 as of September 29, 2018, using the modified retrospective transition method applied to those contracts which were not completed as of that date. The Company recorded a net reduction to retained earnings of </span><span style="font-family:inherit;font-size:10pt;"><span>$4.1 million</span></span><span style="font-family:inherit;font-size:10pt;">, net of tax, as of September 29, 2018 due to the impact of adopting ASC 606. During the second quarter of 2019 the Company recorded an increase to retained earnings of </span><span style="font-family:inherit;font-size:10pt;"><span>$0.6 million</span></span><span style="font-family:inherit;font-size:10pt;">, net of tax, to correct an error that was not quantitatively or qualitatively material to the current period, related to the adoption of ASC 606. The net cumulative impact of adopting ASC 606 was </span><span style="font-family:inherit;font-size:10pt;"><span>$3.5 million</span></span><span style="font-family:inherit;font-size:10pt;">, net of tax. Refer to Note </span><span style="font-weight:normal;">18.</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition</span><span style="font-family:inherit;font-size:10pt;">, included in this report report for the detailed impact of adopting ASC 606.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities, which amends the application of hedge accounting and improves financial reporting of hedging relationships to more accurately present the economic effects of risk management activities in the financial statements. The ASU is effective for public companies for annual reporting periods beginning after December 15, 2018, with early adoption permitted. The Company early adopted the provisions of ASU 2017-12 during the quarter ended September 27, 2019, using the modified retrospective method. The adoption did not have an impact on the consolidated financial statements.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Standards Updates Not Yet Effective</span></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2018, the FASB issued ASU 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from U.S. federal tax legislation commonly referred to as the Tax Cuts and Jobs Act, which was enacted in December 2017 (the “2017 Tax Act”). ASU 2018-02 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect that the adoption of this guidance will have a material impact on its consolidated financial statements.</span></div><div style="line-height:120%;padding-top:9px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU 2017-04 which clarified its guidance to simplify the measurement of goodwill by eliminating the Step 2 impairment test. The new guidance requires companies to perform the goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2021. The amendment is required to be adopted prospectively. The Company is evaluating the impact of adopting this amendment to its consolidated financial statements.</span></div><div style="line-height:120%;padding-top:9px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Instruments." This ASU replaces the incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. In addition, the ASU requires new disclosures. This standard will be effective for the Company's interim and annual periods beginning with the first quarter of fiscal 2021, and must be applied on a modified retrospective basis. The Company is currently evaluating the potential impact of this standard.</span></div><div style="line-height:120%;padding-top:9px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02 on accounting for leases. The new standard is intended to provide enhanced transparency and comparability by requiring lessees to record right-of-use assets and corresponding lease liabilities on the balance sheet. The new standard will continue to classify leases as either finance or operating, with classification affecting the pattern of expense recognition in the statement of earnings. The new standard is required to be adopted using a modified retrospective method to each prior reporting period presented with various optional practical expedients. The new standard will be effective for the Company beginning in its first quarter of fiscal year 2020 with early adoption permitted. The Company has not completed its assessment of the new standard, but anticipate that the most substantial change to its consolidated financial statements will be a gross-up of its total assets and liabilities. The adoption is not expected to materially impact our results of operations in the upcoming fiscal years and interim periods. The Company will continue to monitor the overall impact of adoption and update our disclosures as appropriate.</span></div> 1 The accompanying consolidated financial statements are audited and have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). Prior to January 28 2017, the date of separation and distribution, the financial statements were prepared on a stand-alone basis and were derived from Varian’s consolidated financial statements and records as it operated as part of Varian prior to the distribution, in conformity with GAAP. <div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">All transactions between the Company and Varian prior to the separation have been included in the accompanying consolidated financial statements. All intercompany transactions while the Company operated as part of Varian were considered to be effectively settled for cash and are reflected as a component of financing activities as net transfers from (to) Varian in the consolidated statements of cash flows at the time the transactions were recorded.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior to the separation, the Company was dependent upon Varian for its working capital and financing requirements, as Varian uses a centralized approach to cash management and financing of its operations. Financial transactions relating to the Company were accounted for through the net parent investment account. Cash and cash equivalents held by Varian were not allocated to the Company.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net parent investment in the consolidated statements of equity represents Varian’s historical investment in the Company, the net effect of transactions with and allocations from Varian and the Company’s accumulated earnings.</span></div> <div style="line-height:120%;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Impact of COVID-19</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The coronavirus (“COVID-19”) pandemic and the mitigation efforts by governments to attempt to control its spread created uncertainties and disruptions in the economic and financial markets. The extent to which COVID-19 will continue to impact the Company’s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it will impact worldwide macroeconomic conditions including interest rates and employment rates, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. During the quarter ended July 3, 2020, as a result of the economic downturn resulting from COVID-19, the Company experienced reduced demand in the </span></div><div style="line-height:120%;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Company’s industrial segment and for certain higher end medical products that negatively impacted revenues and gross margin. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the currently estimated future impacts of COVID-19 through the date of reissuance of these consolidated financial statements. The Company’s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material negative impacts to the Company’s consolidated financial statements in future reporting periods. These future developments are highly uncertain, and the outcomes cannot be estimated with certainty. Actual results may differ from those estimates, and such differences may be material to the consolidated financial statements.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company’s Credit Agreement, as defined in Note 8, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Borrowings</span><span style="font-family:inherit;font-size:10pt;">, contains financial covenants, including certain leverage ratio covenants. The adverse effects of the COVID-19 pandemic on the Company’s financial condition and results of operations are expected to be more persistent and have been more severe than previously estimated. The Company now believes that reduced demand in the Company’s industrial segment and for certain higher end medical products will continue to negatively impact revenues, gross margin, and the other items used to calculate the Company’s financial covenants contained in its Credit Agreement. Based on the Company’s current forecasts, it is probable that the Company will be in violation of certain leverage ratio covenants contained in its Credit Agreement within the twelve-month period following the reissuance of these consolidated financial statements, including as early as the end of the Company's fiscal year end 2020. Failure to comply with the covenants, if not amended or waived, would result in an event of default under the Credit Agreement and the acceleration of the outstanding balance of the loans thereunder. If an event of default under the Credit Agreement occurs, then pursuant to cross default and/or cross acceleration clauses, substantially all of the Company’s other outstanding debt and derivative contract payables would become due, and all debt and derivative contracts could be terminated, which would have a material adverse impact to the Company’s operations and liquidity as the Company currently does not have the financial resources to satisfy such obligations if they were to become due and payable. These events and conditions raise substantial doubt about the Company’s ability to continue as a going concern within the twelve-month period following the reissuance of these consolidated financial statements.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company is actively pursuing various options to prevent an event of default from occurring under the Credit Agreement. The Company is implementing actions to improve its financial results and other items used to calculate the financial covenants, such as accelerating the closure of its Santa Clara facility, the previously announced reduction in force, austerity programs related to outside services, and other appropriate actions. The Company is also taking actions to improve cash flow such as working capital reductions and reduced spending for property, plant and equipment, as well as pursuing potential additional fundraising to modify, supplement, or replace its Credit Agreement. While the Company has and continues to take actions to mitigate the risk of an event of default under the Credit Agreement, there is no assurance that it will be successful in doing so. The Company’s consolidated financial statements have been prepared on a going concern basis and do not reflect any adjustments that might result if the Company is unable to continue as a going concern.</span></div><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</span><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Such estimates include the valuation of inventories, goodwill and intangible assets, impairment on investments, and taxes on earnings. Actual results could differ from these estimates.</span></div> <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassification</span></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has reclassified </span><span style="font-family:inherit;font-size:10pt;"><span>$3.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> from selling, general and administrative expense to impairment of intangible assets for the year ended September 28, 2018, to conform to the current year's presentation. Such reclassifications had no impact on net earnings as previously reported.</span></div> -3000000.0 <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Segment Reporting</span></div><span style="font-family:inherit;font-size:10pt;">The Company has </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span> reportable operating segments; (i) Medical and (ii) Industrial, which aligns with how its CEO, who is the Company's Chief Operating Decision Maker (“CODM”), reviews the Company’s performance. 2 <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fiscal Year</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The fiscal years of the Company as reported are the 52 or 53-week period ending on the Friday nearest September 30. Fiscal year 2019 was the 52-week period that ended on September 27, 2019. Fiscal year 2018 was the 52-week period that ended on September 28, 2018. Fiscal year 2017 was the 52-week period that ended on September 29, 2017. </span></div> <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Variable Interest Entities</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">For entities in which the Company has variable interests, the Company focuses on identifying which entity has the power to direct the activities that most significantly impact the variable interest entity’s economic performance and which enterprise has the obligation to absorb losses or the right to receive benefits from the variable interest entity. If the Company is the primary beneficiary of a variable interest entity, the assets, liabilities and results of operations of the variable interest entity will be included in the </span></div><span style="font-family:inherit;font-size:10pt;">Company’s consolidated financial statements. As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, the Company had </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span> variable interest entities neither of which were consolidated. 2 <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Cash and Cash Equivalents</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company considers currency on hand, demand deposits, time deposits and all highly-liquid investments with an original maturity of three months or less at the date of purchase to be cash and cash equivalents.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Restricted Cash</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;"/><span style="font-family:inherit;font-size:10pt;">Restricted cash primarily consists of cash collateral related to certain leases and inventory arrangements. Restricted cash is</span></div>included in other assets on the consolidated balance sheet. Cash and cash equivalents and restricted cash as reported within<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">the consolidated statements of cash flows consisted of the following:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:720px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:382px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:6px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:69px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Twelve Months Ended September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Twelve Months Ended September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Beginning of Period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">End of Period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Beginning of Period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">End of Period</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>51.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>29.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>83.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>51.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Restricted cash</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Cash and cash equivalents and restricted cash as reported per statement of cash flows</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>53.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>31.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>84.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>53.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 51900000 29900000 83300000 51900000 1500000 1400000 900000 1500000 53400000 31300000 84200000 53400000 <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fair Value</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. There is a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:</span></div><div style="line-height:120%;padding-top:10px;text-align:left;padding-left:102px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level 1—Quoted prices in active markets for identical assets or liabilities.</span></div><div style="line-height:120%;text-align:left;padding-left:102px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level 2—Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or, other inputs that are observable or can be corroborated by observable market data.</span></div><div style="line-height:120%;text-align:left;padding-left:102px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div> <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Derivative instruments and hedging activities</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company records all derivatives on the balance sheet at fair value. Derivatives designated as a hedge are recorded on the Consolidated Balance Sheets at fair value as of the reporting date. For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative is reported as a component of other comprehensive income or loss and reclassified from accumulated other comprehensive loss into earnings when the hedged transaction affects earnings.  For derivatives that are designated and qualify as net investment hedges, the gain or loss on the derivative is reported as a component of other comprehensive income or loss. Time value is excluded and the cash payments are recognized as an adjustment to interest expense. A qualitative assessment of hedge effectiveness is performed on a quarterly basis, unless facts and circumstances indicate the hedge may no longer be highly effective.</span></div> <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Risk</span></div>Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash, cash equivalents and trade accounts receivable. Cash held with financial institutions may exceed the Federal Deposit Insurance Corporation insurance limits or similar limits in foreign jurisdictions. The Company has not experienced any losses on its deposits of cash and cash equivalents. The Company performs ongoing credit evaluations of its customers and, except for government tenders, group purchases and orders with a letter of credit, its industrial customers often provide a down payment. The Company maintains an allowance for doubtful accounts based upon the expected collectability of all accounts receivable. The Company obtains some of the components in its products from a limited group of suppliers or from a single-source supplier. <div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Credit is extended to customers based on an evaluation of the customer’s financial condition, and collateral is not required. During the periods presented, one of the Company's Medical segment customers accounted for a significant portion of revenues, which is as follows:</span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:62%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Year</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Canon Medical Systems Corporation</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">%</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0.173 0.181 0.193 0.101 0.098 <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Inventories</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories are valued at the lower of cost or net realizable value. Costs include materials, labor and manufacturing overhead</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">and is computed using standard cost (which approximates actual cost) on a first-in-first-out basis. The Company evaluates the carrying</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">value of its inventories taking into consideration such factors as historical and anticipated future sales compared to quantities on hand</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">and the prices the Company expects to obtain for products in its various markets. The Company adjust excess and obsolete</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">inventories to net realizable value and write-downs of excess and obsolete inventories are recorded as a component of cost of revenues.</span></div> <div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The following table summarizes the Company’s inventories, net:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Raw materials and parts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>160.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>149.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Work-in-process</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Finished goods</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>59.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total inventories</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>248.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>235.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 160100000 149900000 27900000 25400000 60200000 59800000 248200000 235100000 <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Property, Plant and Equipment, net</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment are stated at cost, net of accumulated depreciation. Major improvements are capitalized, while repairs and maintenance are expensed as incurred. Depreciation are computed using the straight-line method over the estimated useful lives of the assets. Land is not subject to depreciation, but land improvements are depreciated over </span><span style="font-family:inherit;font-size:10pt;"><span>fifteen years</span></span><span style="font-family:inherit;font-size:10pt;">. Land leasehold rights and leasehold improvements are depreciated over the lesser of their estimated useful lives or remaining lease terms. Buildings are depreciated over </span><span style="font-family:inherit;font-size:10pt;"><span>twenty years</span></span><span style="font-family:inherit;font-size:10pt;">. Machinery and equipment are depreciated over their estimated useful lives, which range from </span><span style="font-family:inherit;font-size:10pt;"><span>three years</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>seven years</span></span><span style="font-family:inherit;font-size:10pt;">. Assets subject to lease are depreciated over the lesser of their estimated useful lives or remaining lease terms. Estimated useful lives are periodically reviewed and, when appropriate, changes are made prospectively. When certain events or changes in operating conditions occur, asset lives may be adjusted, and an impairment assessment may be performed on the recoverability of the carrying amounts. When assets are retired or otherwise disposed of, the assets and related accumulated depreciation are removed from the accounts.</span></div> P15Y P20Y P3Y P7Y <div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The following table summarizes the Company’s property, plant and equipment, net:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Land</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Buildings and leasehold improvements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>134.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>138.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Machinery</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>170.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>166.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Construction in progress</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>28.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>23.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>341.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>335.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Accumulated depreciation and amortization</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(199.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(190.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Property, plant, and equipment, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>142.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>144.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 8300000 8300000 134400000 138100000 170700000 166100000 28500000 23100000 341900000 335600000 199600000 190700000 142300000 144900000 23500000 26000000.0 16900000 4500000 4200000 <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Investments</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company accounts for its equity investments in privately-held companies under the equity method of accounting if the Company has the ability to exercise significant influence in these investments. Distributions received from an equity method investment are classified using the cumulative earnings approach. Under the cumulative earnings approach, distributions up to the amount of cumulative equity in earnings recognized will be treated as returns on investment as operating cash flows and those in excess of that amount will be treated as returns of investment as investing cash flows. The Company monitors these equity investments for impairment and makes appropriate reductions in carrying values if the Company determines that impairment charges are required based primarily on the financial condition and near-term prospects of these companies.</span></div> <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Goodwill and Intangible Assets</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill is recorded when the purchase price of an acquisition exceeds the fair value of the net identified tangible and intangible assets acquired. Purchased intangible assets are carried at cost, net of accumulated amortization, and are included in intangible assets in the Company's consolidated balance sheets. Intangible assets with finite lives are amortized over their estimated useful lives of primarily </span><span style="font-family:inherit;font-size:10pt;"><span>two years</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>seven years</span></span><span style="font-family:inherit;font-size:10pt;"> using the straight-line method.</span></div> P2Y P7Y <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Impairment of Long-lived Assets, Intangible Assets and Goodwill</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company reviews long-lived assets and identifiable intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. The Company assesses these assets for impairment based on their estimated undiscounted future cash flows. If the carrying value of the assets exceeds the estimated future undiscounted cash flows, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company evaluates goodwill and indefinite lived intangible assets for impairment at least annually at the beginning of the fourth quarter of each fiscal year or whenever an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The Company performs a step one analysis, which consists of a comparison of the fair value of a reporting unit against its carrying amount, including the goodwill allocated to each reporting unit. The Company determines the fair value of its reporting units based on a combination of income and market approaches. The income approach is based on the present value of estimated future cash flows of the reporting units, and the market approach is based on a market multiple calculated for each reporting unit based on market data of other companies engaged in similar business. If the carrying amount of the reporting unit is in excess of its fair value, step two requires the comparison of the implied fair value of the reporting unit’s goodwill against the carrying amount of the reporting unit’s goodwill. Any excess of the carrying value of the reporting unit’s goodwill over the implied fair value of the reporting unit’s goodwill is recorded as an impairment loss. The impairment test for intangible assets with indefinite useful lives, if any, consists of a comparison of fair value to carrying value, with any excess of carrying value over fair value being recorded as an impairment loss.</span></div> 4800000 3000000.0 0 <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Loss Contingencies</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">From time to time, the Company is a party to or otherwise involved in legal proceedings, claims and government inspections or investigations, customs and duties audits and other loss contingency matters, both inside and outside the United States, arising in the ordinary course of its business or otherwise. The Company accrues amounts, to the extent an unfavorable outcome is determined to be probable and the losses can be reasonably estimated, that it believes are adequate to address any liabilities related to legal proceedings and other loss contingencies that it believes will result in a probable loss.</span></div> <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Product Warranty</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company warrants most of its products for a specific period of time, usually </span><span style="font-family:inherit;font-size:10pt;"><span>12</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>24</span></span><span style="font-family:inherit;font-size:10pt;"> months from delivery or acceptance, against material defects. The Company provides for the estimated future costs of warranty obligations in cost of revenues when the related revenues are recognized. The accrued warranty costs represent the best estimate at the time of sale of the total costs that the Company will incur to repair or replace product parts that fail while still under warranty.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The amount of the accrued estimated warranty costs obligation for established products is primarily based on historical experience as to product failures adjusted for current information on repair costs. For new products, estimates include the historical experience of similar products, as well as a reasonable allowance for warranty expenses associated with new products. On a quarterly basis, the Company reviews the accrued warranty costs and updates the historical warranty cost trends, if required.</span></div> P12M P24M <div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The following table reflects the changes in the Company’s accrued product warranty:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Years</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Accrued product warranty, at beginning of period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Charged to cost of revenues</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>12.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>11.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Actual product warranty expenditures</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(12.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(11.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Accrued product warranty, at end of period</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 7300000 7000000.0 12900000 11600000 12100000 11300000 8100000 7300000 <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Allowance for Doubtful Accounts</span></div>The Company evaluates the creditworthiness of customers prior to authorizing shipment for all major sale transactions. On a quarterly basis, the Company evaluates aged items in the accounts receivable aging report and provide an allowance in an amount deemed adequate for doubtful accounts. If the evaluation of customers’ financial conditions does not reflect a future ability to collect outstanding receivables, additional provisions may be needed. 1000000.0 600000 <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Share-Based Compensation Expense</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has an equity-based incentive plan that provides for the grant of nonqualified stock options and restricted stock units to directors, officers and other employees. The Company also permits employees to purchase shares under the Varex employee stock purchase plan. Prior to the separation, the Company’s employees historically participated in Varian’s equity-based incentive plans. Share-based compensation expense through the date of separation included allocations to the Company based on the awards and terms previously granted to its employees as well as an allocation of Varian’s corporate and shared functional employee expenses.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company values stock options granted and the option component of the shares of common stock purchased under the equity-based incentive plans and stock purchased under the employee stock purchase plan using the Black-Scholes option-pricing model. Share-based compensation expense for restricted stock units is measured using the fair value of the Company’s stock on the date of grant and is amortized over the award’s respective service period. The Black-Scholes option-pricing model requires the input of certain assumptions, and changes in the assumptions can materially affect the fair value estimates of share-based payment awards.</span></div>The Company measures and recognizes expense for all share-based payment awards based on their fair values. Share-based compensation expense recognized in the consolidated statements of earnings includes compensation expense for the share-based payment awards based on the grant date fair value estimated in accordance with the guidance on share-based compensation. Share-based compensation expense recognized is based on the value of the portion of share-based payment awards that is ultimately expected to vest. The Company attributes the value of share-based compensation to expense using the straight-line method. The Company considers only the direct tax impacts of share-based compensation awards when calculating the amount of tax windfalls or shortfalls. <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Shipping and Handling Costs</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Shipping and handling costs are included as a component of cost of revenues.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Effective September 29, 2018, the Company adopted the requirements of Accounting Standards Update (“ASU”) 2014-09 and related amendments, Revenue from Contracts with Customers (“ASC 606”), which superseded all prior revenue recognition methods and industry-specific guidance. See “Recently Adopted Accounting Pronouncements” below.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company’s revenues are derived primarily from the sale of hardware and services. The Company recognizes its revenues net of any value-added or sales tax and net of sales discounts. </span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company sells a high proportion of its X-ray products to a limited number of OEM customers. X-ray tubes, digital detectors and image-processing tools and security and inspection products are generally sold on a stand-alone basis. However, the Company occasionally sells its digital detectors, X-ray tubes and imaging processing tools as a package that is optimized for digital X ray imaging and sells its Linatron ® X-ray accelerators together with its imaging processing software and image detection products to OEM customers that incorporate them into their inspection systems. Service contracts are often sold with certain security and inspection products and computer-aided detection products.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company determines revenue recognition through the following steps:</span></div><table cellpadding="0" cellspacing="0" style="padding-top:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Identification of the contract, or contracts, with a customer</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Identification of the performance obligations in the contract</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Determination of the transaction price</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Allocation of the transaction price to the performance obligations in the contract</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:60px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Recognition of revenue when, or as, a performance obligation is satisfied</span></div></td></tr></table><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Deferred Revenues</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred revenue primarily represents (i) the amount received applicable to non-software products for which parts</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">and services under the warranty contracts have not been delivered, and (ii) the amount received for service contracts for</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">which the services have not been rendered.</span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company adopted ASC 606 on September 29, 2018, using the modified retrospective method for all contracts not completed as of the date of adoption. The reported results for fiscal year 2019 reflect the application of ASC 606 guidance while the reported results for fiscal year 2018 were prepared under the guidance of ASC 605, “Revenue Recognition.” The primary impacts of the adoption include: (1) recording a separate contract liability and contract asset related to the sale of X-ray tubes that were sold with an option for the customer to require the Company to repurchase specific parts of the X‑ray tube at a specific price; and (2) recording a liability related to the deferral of revenue for service type warranties that are provided to certain customers who purchase Linatron</span><span style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></span><span style="font-family:inherit;font-size:10pt;"> X-ray accelerators.</span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has made the following accounting policy elections and elected to use certain practical expedients, as permitted by the FASB, in applying ASC 606: (1) the Company accounts for amounts collected from customers for sales and other taxes, net of related amounts remitted to tax authorities; (2) the Company does not adjust the promised amount of consideration for the effects of a significant financing component, if, at contract inception, the Company expects the period between the time when the Company transfers a promised good or service to the customer and the time when the customer pays for that good or service will be one year or less; (3) the Company expenses costs to obtain a contract as they are incurred if the expected period of benefit, and therefore the amortization period, is one year or less; (4) the Company accounts for shipping and handling activities that occur after control transfers to the customer as a fulfillment cost rather than an additional promised service and these fulfillment costs are included as a component of cost of revenues; and (5) the Company does not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.</span></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Transaction price and allocation to performance obligations</span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Transaction prices of products or services are typically based on contracted rates. To the extent that the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing the expected value method when there is a large number of transactions with similar characteristics or the most likely amount method when there are two possible outcomes, depending on the circumstances of the transaction, to which the Company expects to be entitled. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of the Company’s anticipated performance and all information (historical, current and forecasted) that is reasonably available.</span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company allows customers to return specific parts of purchased X-ray tubes for a partial refund credit, which is identified as variable consideration. ASC 606-10-55-23 requires that for sales with a right of return, revenue is reduced for expected returns, a liability is recorded for expected returns, and an asset is recorded for the right to recover products from customers on settling the liability. The Company recognizes a reduction to revenue and cost of sales at the time of sale and a corresponding contract liability and contract asset. The Company records this estimate based on the historical volume of product returns and adjusts the estimate on a quarterly basis based on the current quarter sales and current quarter returns.</span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If a contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products or services underlying each performance obligation. The Company determines standalone selling prices based on the price at which the performance obligation is sold separately.</span></div> <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Research and Development</span></div>Research and development costs have been expensed as incurred. These costs primarily include employees’ compensation, consulting fees and material costs. <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Software Development Costs</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Costs for the development of new software products and substantial enhancements to existing software products are expensed as incurred until technological feasibility has been established, at which time any additional costs would be capitalized. No costs associated with the development of software have been capitalized, as the Company believes its current software development process is essentially completed concurrent with the establishment of technological feasibility.</span></div> <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Taxes on Earnings</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"/><span style="font-family:inherit;font-size:10pt;">Current income tax expense is the amount of income taxes expected to be payable for the current year. Deferred income tax liabilities or assets are established for the expected future tax consequences resulting from the differences in financial reporting and tax bases of assets and liabilities. A valuation allowance is provided if it is more likely than not that some or all of the deferred tax assets will not be realized. In addition, we provide reserves for uncertain tax positions when such tax positions do not meet the recognition thresholds or measurement standards prescribed by the authoritative guidance for accounting for income taxes. Amounts </span></div><div style="line-height:120%;padding-top:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">for uncertain tax positions are adjusted in periods when new information becomes available or when positions are effectively settled. Interest and penalties related to uncertain tax positions are recognized as a component of income tax expense.</span><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On December 22, 2017, the U.S. Government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act of 2017 (“U. S. Tax Reform”). U.S. Tax Reform significantly revised the U.S. corporate income tax structure including a lower corporate statutory rate and changes to the way foreign earnings are taxed. U.S. GAAP requires that the impact of tax legislation be recognized in the period in which the law is enacted. In accordance with these rules, we are including the impact of certain provisions of U.S. Tax Reform to the extent they are effective during the current reporting period. </span></div> <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Foreign Currency Translation</span></div>The Company uses the U.S. Dollar predominately as the functional currency of its foreign operations. Gains and losses from remeasurement of foreign currency balances into U.S. Dollars are included in the consolidated statements of earnings. For the foreign subsidiary where the local currency is the functional currency, translation adjustments of foreign currency financial statements into U.S. dollars are recorded to a separate component of accumulated other comprehensive (loss) earnings. <div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Accounting Standards Recently Adopted</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"/><span style="font-family:inherit;font-size:10pt;">In November 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (“ASU 2016-18”), which requires that the statement of cash flows explain the change in the total amount of restricted cash during the period and other additional disclosures. The Company adopted ASU 2016-18 in the first quarter of 2019 using the retrospective transition method and the Company's consolidated statements of cash flows have been retrospectively adjusted to reflect restricted cash balances. Net cash flows for fiscal years 2019, 2018 and 2017 did not change as a result of adopting ASU 2016-18.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company adopted ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”), which was issued to reduce the diversity in practice in how certain transactions are classified in the statement of cash flows. The Company adopted ASU 2016-15 in the first quarter of 2019 retrospectively. Net cash flows for fiscal years 2019, 2018 and 2017 did not change as a result of adopting ASU 2016-15.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company adopted ASC 606 as of September 29, 2018, using the modified retrospective transition method applied to those contracts which were not completed as of that date. The Company recorded a net reduction to retained earnings of </span><span style="font-family:inherit;font-size:10pt;"><span>$4.1 million</span></span><span style="font-family:inherit;font-size:10pt;">, net of tax, as of September 29, 2018 due to the impact of adopting ASC 606. During the second quarter of 2019 the Company recorded an increase to retained earnings of </span><span style="font-family:inherit;font-size:10pt;"><span>$0.6 million</span></span><span style="font-family:inherit;font-size:10pt;">, net of tax, to correct an error that was not quantitatively or qualitatively material to the current period, related to the adoption of ASC 606. The net cumulative impact of adopting ASC 606 was </span><span style="font-family:inherit;font-size:10pt;"><span>$3.5 million</span></span><span style="font-family:inherit;font-size:10pt;">, net of tax. Refer to Note </span><span style="font-weight:normal;">18.</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue Recognition</span><span style="font-family:inherit;font-size:10pt;">, included in this report report for the detailed impact of adopting ASC 606.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities, which amends the application of hedge accounting and improves financial reporting of hedging relationships to more accurately present the economic effects of risk management activities in the financial statements. The ASU is effective for public companies for annual reporting periods beginning after December 15, 2018, with early adoption permitted. The Company early adopted the provisions of ASU 2017-12 during the quarter ended September 27, 2019, using the modified retrospective method. The adoption did not have an impact on the consolidated financial statements.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Recent Accounting Standards Updates Not Yet Effective</span></div><div style="line-height:120%;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2018, the FASB issued ASU 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from U.S. federal tax legislation commonly referred to as the Tax Cuts and Jobs Act, which was enacted in December 2017 (the “2017 Tax Act”). ASU 2018-02 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect that the adoption of this guidance will have a material impact on its consolidated financial statements.</span></div><div style="line-height:120%;padding-top:9px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU 2017-04 which clarified its guidance to simplify the measurement of goodwill by eliminating the Step 2 impairment test. The new guidance requires companies to perform the goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2021. The amendment is required to be adopted prospectively. The Company is evaluating the impact of adopting this amendment to its consolidated financial statements.</span></div><div style="line-height:120%;padding-top:9px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Instruments." This ASU replaces the incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. In addition, the ASU requires new disclosures. This standard will be effective for the Company's interim and annual periods beginning with the first quarter of fiscal 2021, and must be applied on a modified retrospective basis. The Company is currently evaluating the potential impact of this standard.</span></div><div style="line-height:120%;padding-top:9px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02 on accounting for leases. The new standard is intended to provide enhanced transparency and comparability by requiring lessees to record right-of-use assets and corresponding lease liabilities on the balance sheet. The new standard will continue to classify leases as either finance or operating, with classification affecting the pattern of expense recognition in the statement of earnings. The new standard is required to be adopted using a modified retrospective method to each prior reporting period presented with various optional practical expedients. The new standard will be effective for the Company beginning in its first quarter of fiscal year 2020 with early adoption permitted. The Company has not completed its assessment of the new standard, but anticipate that the most substantial change to its consolidated financial statements will be a gross-up of its total assets and liabilities. The adoption is not expected to materially impact our results of operations in the upcoming fiscal years and interim periods. The Company will continue to monitor the overall impact of adoption and update our disclosures as appropriate.</span></div> -4100000 600000 -3500000 BUSINESS COMBINATIONS<div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Acquisition of Direct Conversion AB (publ)</span></div><div style="line-height:120%;padding-top:10px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On </span><span style="font-family:inherit;font-size:10pt;">April 29, 2019</span><span style="font-family:inherit;font-size:10pt;">, Varex completed the acquisition of </span><span style="font-family:inherit;font-size:10pt;"><span>98.2%</span></span><span style="font-family:inherit;font-size:10pt;"> of the outstanding shares of common stock of Direct Conversion AB (publ) (“Direct Conversion”) for $</span><span style="font-family:inherit;font-size:10pt;"><span>69.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> in cash, net of cash acquired, the assumption of Direct Conversion's debt of </span><span style="font-family:inherit;font-size:10pt;"><span>$4.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> and deferred consideration equal to </span><span style="font-family:inherit;font-size:10pt;"><span>$9.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> or </span><span style="font-family:inherit;font-size:10pt;"><span>0.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares of the Company’s common stock (subject to reduction to settle indemnity claims) to be paid on the first anniversary of the closing with a mixture of cash and shares of Varex common stock. The acquisition of Direct Conversion expands our detector product portfolio to include photon counting technology.  This technology will allow Varex to expand its range of imaging applications and offer new solutions to both Medical and Industrial customers.</span></div><div style="line-height:120%;padding-top:10px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the preliminary purchase price allocation:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:79%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Allocation of the purchase consideration:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts receivable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant, and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>47.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total assets acquired</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>89.8</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts payable</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current maturities of long-term debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred revenues</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other long-term liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total liabilities assumed</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(9.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Noncontrolling interest</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(1.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net assets acquired, less noncontrolling interest</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>79.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash paid</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>69.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred consideration</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total consideration</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>79.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company recorded the assets acquired and liabilities assumed at their preliminary estimated fair values. Intangibles were valued primarily using a discounted cash flow, which included estimated revenue growth and discount rate. Due to the complexity of this transaction as of September 27, 2019, the Company had not finalized the determination of the fair values allocated to various assets and liabilities, including, but not limited to, inventory; deferred tax assets and liabilities; intangible assets and the residual amount allocated to goodwill. The fair value assigned to goodwill is primarily attributable to expected synergies. The goodwill related to the Direct Conversion acquisition is not tax deductible.</span></div><div style="line-height:120%;padding-bottom:9px;padding-top:9px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following amounts represent the determination of the fair value and estimated weighted average useful lives of identifiable intangible assets for the Direct Conversion, which are amortized straight-line:</span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:69%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Estimated Weighted Average <br/>Useful Life<br/>(In Years)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Backlog</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Trade names</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Developed technology</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>18.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>10</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">In-process research and development</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">indefinite</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>9.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>10</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total intangible assets acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>32.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:9px;padding-top:13px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following amounts represent revenues by reporting segment from Direct Conversion from the acquisition date of </span><span style="font-family:inherit;font-size:10pt;">April 29, 2019</span><span style="font-family:inherit;font-size:10pt;">, through September 27, 2019:</span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:79%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Direct Conversion Revenue</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Medical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Industrial</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total Direct Conversion revenues</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>6.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The acquisition of Direct Conversion did not have a significant impact on our consolidated results of operations on a pro forma basis for the current or prior years.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Acquisition of Virtual Media Integration </span></div><div style="line-height:120%;padding-top:10px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On August 31, 2018, the Company completed the acquisition of Virtual Media Integration, Ltd. (“VMI”) from MISTRAS Group, Inc for </span><span style="font-family:inherit;font-size:10pt;"><span>$4.8 million</span></span><span style="font-family:inherit;font-size:10pt;">. VMI is a provider of computed and digital radiography and X-ray film digitizer systems for industrial non-destructive testing. The acquired assets and liabilities of the VMI business were allocated to the Industrial reporting segment. The acquisition related costs were included in the consolidated statements of earnings under selling, general and administrative expenses.</span></div><div style="line-height:120%;padding-top:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the purchase price allocation:</span></div><div style="line-height:120%;padding-top:10px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:79%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Allocation of the purchase consideration:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Accounts Receivable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Inventories</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net assets acquired</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Post-closing adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total cash consideration</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Acquisition of PerkinElmer’s Medical Imaging Business</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On May 1, 2017, the Company completed the acquisition of the medical imaging business (“Acquired Detector Business”) of PerkinElmer, Inc. (“PKI”) for </span><span style="font-family:inherit;font-size:10pt;"><span>$277.4 million</span></span><span style="font-family:inherit;font-size:10pt;">, or </span><span style="font-family:inherit;font-size:10pt;"><span>$273.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> after post-closing working capital adjustments. The acquisition consisted of PerkinElmer Medical Holdings, Inc. and Dexela Limited, together with certain assets of PKI and its direct and indirect subsidiaries relating to digital flat panel X-ray detectors that serve as components for industrial, medical, dental and veterinary X-ray imaging systems. The Acquired Detector Business included about </span><span style="font-family:inherit;font-size:10pt;"><span>280</span></span><span style="font-family:inherit;font-size:10pt;"> employees, with operations in Santa Clara, California as well as operations in Germany, the Netherlands, China and the United Kingdom. The acquisition of the Acquired Detector Business was pursuant to the Master Purchase and Sale Agreement, dated December 21, 2016 (the “Purchase Agreement”), by and between PKI and Varian and the subsequent Assignment and Assumption Agreement, dated January 27, 2017, by and between Varian and Varex, pursuant to which Varian assigned and conveyed all of its rights, obligations, title and interest in the Purchase Agreement to Varex.</span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following amounts represent the determination of the fair value of identifiable assets acquired and liabilities for the Acquired Detector Business:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:79%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total cash consideration</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>273.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Allocation of the purchase consideration:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Cash</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Accounts Receivable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>18.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Inventory</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>34.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Prepaids and other current assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Property, plant, and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>21.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other assets, non-current</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>81.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>167.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total assets acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>327.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:79%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Current liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(17.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other liabilities, non-current</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(36.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total liabilities assumed</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(54.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net assets acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>273.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:13px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The fair value assigned to goodwill is attributable to expected cost synergy opportunities. Included in the goodwill recorded for the Acquired Detector Business is approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$35 million</span></span><span style="font-family:inherit;font-size:10pt;"> that will be deductible for income tax purposes in Germany, China and the Netherlands. The remaining goodwill related to the stock acquisition in the United States is not tax deductible. Also, as a result of the acquisition, non-current deferred income tax liability increased by approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$31 million</span></span><span style="font-family:inherit;font-size:10pt;"> related to basis differences for both tangible and intangible assets acquired as part of the stock purchases in the United States and the United Kingdom, and asset purchases in Germany, the Netherlands and China.</span></div><div style="line-height:120%;padding-bottom:9px;padding-top:9px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following amounts represent the determination of the fair value of identifiable intangible assets for the Acquired Detector Business, which are amortized straight-line:</span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:69%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Estimated <br/>Useful Life<br/>(In Years)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Favorable leasehold interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>16</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Backlog</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Trade names</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Developed technology</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>37.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">In-process research and development</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">indefinite</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>33.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total intangible assets acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>81.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:9px;padding-top:13px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following amounts represent revenues by reporting segment from the Acquired Detector Business from the acquisition date of May 1, 2017 through September 29, 2017:</span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:81%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">May 1, 2017 through September 29, 2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Acquired Detector Business</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Medical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>41.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Industrial</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>20.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total Acquired Detector Business revenues</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>61.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Unaudited Pro Forma Information </span></div><div style="line-height:120%;padding-top:9px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The unaudited pro-forma amounts presented below for the fiscal year 2017 are presented for informational purposes only. In addition to the Company's results for the periods presented, the amounts below also include effects of the Acquired Detector Business as if it had been consummated on October 1, 2016. These unaudited pro-forma results include effects that are directly attributable to the acquisition which include the amortization of intangible assets, interest expense, and other adjustments, including estimated tax effects. The unaudited pro-forma results do not reflect any operating efficiencies or potential cost savings which may result from the consolidation of the Acquired Detector Business and are not necessarily indicative of what the actual results of operations of the combined company would have been if the acquisition had occurred at the beginning of the period presented nor are they indicative of future results of operations or results that might have been achieved had the acquisition been consummated as of October 3, 2015.</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:81%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Year</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>777.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Operating earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>84.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>43.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net earnings per share, basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.15</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net earnings per share, diluted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.13</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0.982 69500000 4500000 9900000 300000 2400000 5700000 700000 900000 47200000 32900000 89800000 1000000.0 1500000 1000000.0 900000 3500000 1100000 9000000.0 1400000 79400000 69500000 9900000 79400000 200000 P1Y 2500000 P5Y 18400000 P10Y 2800000 9000000.0 P10Y 32900000 <div style="line-height:120%;padding-bottom:9px;padding-top:13px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following amounts represent revenues by reporting segment from Direct Conversion from the acquisition date of </span><span style="font-family:inherit;font-size:10pt;">April 29, 2019</span><span style="font-family:inherit;font-size:10pt;">, through September 27, 2019:</span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:79%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Direct Conversion Revenue</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Medical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Industrial</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total Direct Conversion revenues</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>6.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:9px;padding-top:13px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following amounts represent revenues by reporting segment from the Acquired Detector Business from the acquisition date of May 1, 2017 through September 29, 2017:</span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:81%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">May 1, 2017 through September 29, 2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Acquired Detector Business</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Medical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>41.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Industrial</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>20.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total Acquired Detector Business revenues</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>61.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:9px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Information related to the Company’s segments is as follows:</span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:47%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Year</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Revenues</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Medical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>596.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>602.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>556.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Industrial</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>183.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>171.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>141.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total revenues</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>780.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>773.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>698.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Gross margin</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>188.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>190.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>193.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Industrial</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>67.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>63.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>59.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total gross margin</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>256.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>253.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>253.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total operating expenses</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>211.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>209.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>169.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Interest and other expenses, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(24.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(8.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Earnings before taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>21.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>25.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>74.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Taxes (benefit) on earnings</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(2.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>22.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net earnings</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>15.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>28.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>52.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Less: Net earnings attributable to noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net earnings attributable to Varex</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>15.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>27.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>51.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 4500000 1800000 6300000 4800000 <div style="line-height:120%;padding-top:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the purchase price allocation:</span></div><div style="line-height:120%;padding-top:10px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:79%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Allocation of the purchase consideration:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Accounts Receivable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Inventories</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net assets acquired</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Post-closing adjustments</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total cash consideration</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:10px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the preliminary purchase price allocation:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:79%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Allocation of the purchase consideration:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts receivable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Inventories</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant, and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>47.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>32.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total assets acquired</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>89.8</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accounts payable</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accrued liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current maturities of long-term debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred revenues</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(0.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Long-term debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other long-term liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total liabilities assumed</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(9.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Noncontrolling interest</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(1.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net assets acquired, less noncontrolling interest</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>79.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net cash paid</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>69.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred consideration</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total consideration</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>79.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following amounts represent the determination of the fair value of identifiable assets acquired and liabilities for the Acquired Detector Business:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:79%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total cash consideration</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>273.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Allocation of the purchase consideration:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Cash</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Accounts Receivable</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>18.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Inventory</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>34.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Prepaids and other current assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Property, plant, and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>21.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other assets, non-current</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>81.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>167.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total assets acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>327.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:79%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Current liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(17.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:20px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other liabilities, non-current</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(36.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total liabilities assumed</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(54.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net assets acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>273.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 200000 1000000.0 200000 1600000 1500000 200000 4300000 500000 4800000 277400000 273200000 280 273200000 1400000 18700000 34700000 600000 21400000 2000000.0 81100000 167300000 327200000 17200000 36800000 54000000.0 273200000 35000000 31000000 <div style="line-height:120%;padding-bottom:9px;padding-top:9px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following amounts represent the determination of the fair value of identifiable intangible assets for the Acquired Detector Business, which are amortized straight-line:</span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:69%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Estimated <br/>Useful Life<br/>(In Years)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Favorable leasehold interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>16</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Backlog</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Trade names</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Developed technology</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>37.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">In-process research and development</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">indefinite</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>33.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total intangible assets acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>81.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:9px;padding-top:9px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following amounts represent the determination of the fair value and estimated weighted average useful lives of identifiable intangible assets for the Direct Conversion, which are amortized straight-line:</span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:69%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Estimated Weighted Average <br/>Useful Life<br/>(In Years)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Backlog</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Trade names</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Developed technology</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>18.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>10</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">In-process research and development</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">indefinite</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>9.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>10</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total intangible assets acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>32.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 3800000 P16Y 1200000 P1Y 1400000 P5Y 37700000 P7Y 4000000.0 33000000.0 P7Y 81100000 41100000 20200000 61300000 The unaudited pro-forma results do not reflect any operating efficiencies or potential cost savings which may result from the consolidation of the Acquired Detector Business and are not necessarily indicative of what the actual results of operations of the combined company would have been if the acquisition had occurred at the beginning of the period presented nor are they indicative of future results of operations or results that might have been achieved had the acquisition been consummated as of October 3, 2015.<div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:81%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Year</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Revenue</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>777.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Operating earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>84.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>43.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net earnings per share, basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.15</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net earnings per share, diluted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.13</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span> 777800000 84700000 43100000 1.15 1.13 RELATED-PARTY TRANSACTIONS<div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Investment in Privately-Held Companies </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has a </span><span style="font-family:inherit;font-size:10pt;"><span>40%</span></span><span style="font-family:inherit;font-size:10pt;"> ownership interest in dpiX Holding LLC (“dpiX Holding”), a </span><span style="font-family:inherit;font-size:10pt;"><span>four</span></span><span style="font-family:inherit;font-size:10pt;">-member consortium that has a </span><span style="font-family:inherit;font-size:10pt;"><span>100%</span></span><span style="font-family:inherit;font-size:10pt;"> ownership interest in dpiX LLC (“dpiX”), a supplier of amorphous silicon based thin film transistor arrays for digital flat panel image detectors. In accordance with the dpiX Holding Agreement, net profits or losses are allocated to the members, in accordance with their ownership interests.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The equity investment in dpiX Holding is accounted for under the equity method of accounting. When the Company recognizes its share of net profits or losses of dpiX Holding, profits or losses in inventory purchased from dpiX are eliminated until realized by the Company. In fiscal years </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, the Company recorded (loss) and income on the equity investment in dpiX Holding of </span><span style="font-family:inherit;font-size:10pt;"><span>$(1.1) million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$3.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$0.8 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. Income and loss on the equity investment in dpiX Holding is included in other (expense) income, net in the consolidated statements of earnings. The carrying value of the equity investment in dpiX Holding, which was included in investments in privately-held companies on the consolidated balance sheets, was </span><span style="font-family:inherit;font-size:10pt;"><span>$48.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$48.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> at </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In fiscal years </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, the Company purchased glass transistor arrays from dpiX totaling </span><span style="font-family:inherit;font-size:10pt;"><span>$23.5 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$19.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$24.7 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. These purchases of glass transistor arrays are included as a component of inventories on the consolidated balance sheets or cost of revenues in the consolidated statements of earnings for these fiscal years.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;">, the Company had accounts payable to dpiX totaling </span><span style="font-family:inherit;font-size:10pt;"><span>$3.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$3.7 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In October 2013, the Company entered into an amended agreement with dpiX and other parties that, among other things, provides the Company with the right to </span><span style="font-family:inherit;font-size:10pt;"><span>50%</span></span><span style="font-family:inherit;font-size:10pt;"> of dpiX’s total manufacturing capacity produced after January 1, 2014. The amended agreement requires the Company to pay for </span><span style="font-family:inherit;font-size:10pt;"><span>50%</span></span><span style="font-family:inherit;font-size:10pt;"> of the fixed costs (as defined in the amended agreement), as determined at the </span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">beginning of each calendar year. As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, the Company estimated it has fixed cost commitments of </span><span style="font-family:inherit;font-size:10pt;"><span>$3.7 million</span></span><span style="font-family:inherit;font-size:10pt;"> related to this amended agreement through the remainder of calendar year </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">. The fixed cost commitment for future periods will be determined and approved by the dpiX board of directors at the beginning of each calendar year. The amended agreement will continue unless the ownership structure of dpiX changes (as defined in the amended agreement).</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has determined that dpiX is a variable interest entity because at-risk equity holders, as a group, lack the characteristics of a controlling financial interest. Majority votes are required to direct the manufacturing activities, legal operations and other activities that most significantly affect dpiX’s economic performance. The Company does not have majority voting rights and no power to direct the activities of dpiX and therefore is not the primary beneficiary of dpiX. The Company’s exposure to loss as a result of its involvement with dpiX is limited to the carrying value of the Company’s investment of </span><span style="font-family:inherit;font-size:10pt;"><span>$48.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> and fixed cost commitments of </span><span style="font-family:inherit;font-size:10pt;"><span>$3.7 million</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In November 2018, the Company and CETTEEN GmbH (“CETTEEN”), formed a German limited liability company that governs the affairs and conduct of the business of VEC Imaging Verwaltungsgesellschaft GmbH (“VEC”), a joint venture formed to develop technology to be used in X-ray imaging components. In accordance with the VEC agreement, net profits or losses are allocated to the members, in accordance with their ownership interest. The Company's investment in VEC is accounted for under the equity method. The Company has made contributions totaling </span><span style="font-family:inherit;font-size:10pt;"><span>$2.9 million</span></span><span style="font-family:inherit;font-size:10pt;">, and has committed to contribute an additional </span><span style="font-family:inherit;font-size:10pt;"><span>$2.2 million</span></span><span style="font-family:inherit;font-size:10pt;">, as milestones are achieved, and to provide certain full time employees to support prototyping and manufacturing activities in exchange for a </span><span style="font-family:inherit;font-size:10pt;"><span>50%</span></span><span style="font-family:inherit;font-size:10pt;"> interest in VEC. CETTEEN made contributions of certain assets including intellectual property in exchange for a </span><span style="font-family:inherit;font-size:10pt;"><span>50%</span></span><span style="font-family:inherit;font-size:10pt;"> interest in VEC. The Company's investment in VEC was </span><span style="font-family:inherit;font-size:10pt;"><span>$2.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">.</span></div> 0.40 4 1 -1100000 3400000 800000 48100000 48900000 23500000 19300000 24700000 3600000 3700000 0.50 0.50 3700000 48100000 3700000 2900000 2200000 0.50 0.50 2000000.0 RESTRUCTURING<div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:Arial;font-size:10pt;"/><span style="font-family:inherit;font-size:10pt;">Following the acquisition of the medical imaging business from PKI in May of 2017, management began a multiyear program to consolidate the acquired operations, reduce costs, improve productivity and realize synergies.</span></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In March 2018, the Company made the decision to transfer the complementary metal oxide semiconductor (“CMOS”) research and development capability from the U.K. to the U.S. and to permanently close the operation of the acquired detector business in London. The company will continue to develop the CMOS technology in the U.S. due to its competitive advantages, product differentiation and future economic benefit. In connection with this initiative, we recorded </span><span style="font-family:inherit;font-size:10pt;"><span>$1.7 million</span></span><span style="font-family:inherit;font-size:10pt;"> in restructuring charges during fiscal year 2018.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;"/><span style="font-family:inherit;font-size:10pt;">In July 2018, the Company committed to a plan to relocate the production of amorphous silicon glass for digital detectors, from its Santa Clara facility, to the jointly owned dpiX fabrication facility in Colorado. In July 2019, the Company committed to close its Santa Clara facility and to relocate the remaining production to its other existing facilities. The Company expects operations at the Santa Clara facility to cease by the end of December 2020 and all activities related to the closure of the facility to be complete by the end of March 2021. In connection with the relocation of the glass production and site closure the Company recorded </span><span style="font-family:inherit;font-size:10pt;"><span>$16.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$14.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> of restructuring and impairment charges during fiscal year 2019 and 2018, respectively. Fiscal year 2019 intangible asset impairment charges consisted of in-process research and development related to certain projects that were discontinued as a result of the Santa Clara facility closure. Fiscal year 2018 intangible asset impairment charges were related to a favorable leasehold interest that was impaired as a result of the amorphous silicon glass relocation. The Company expects to incur an additional </span><span style="font-family:inherit;font-size:10pt;"><span>$8.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>$12.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> of restructuring charges through March 2021.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company also incurred approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$2.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$0.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> of other unrelated restructuring expenses during fiscal years 2019 and 2018, respectively.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash outflows associated with these restructuring charges are limited to employee termination expenses, facility closure and equipment sales and disposals. Below is a detail of restructuring charges incurred during the 2019 and 2018 fiscal years, which predominately relate to the Company's Medical segment:</span></div><div style="line-height:120%;padding-top:9px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:720px;border-collapse:collapse;text-align:left;"><tr><td colspan="10"/></tr><tr><td style="width:214px;"/><td style="width:273px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:99px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:99px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Location of Restructuring Charges in Consolidated Statements of Earnings</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other assets impairment charges</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Selling, general and administrative</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Inventory write downs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Cost of revenues</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Intangible assets impairment</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:38px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Impairment of intangible assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Accelerated depreciation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Cost of revenues</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Severance costs</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Selling, general and administrative</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>6.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Facility closure costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Selling, general and administrative</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total restructuring charges</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>18.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>16.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 1700000 16100000 14200000 8100000 12100000 2800000 800000 Below is a detail of restructuring charges incurred during the 2019 and 2018 fiscal years, which predominately relate to the Company's Medical segment:<div style="line-height:120%;padding-top:9px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:720px;border-collapse:collapse;text-align:left;"><tr><td colspan="10"/></tr><tr><td style="width:214px;"/><td style="width:273px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:99px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:99px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Location of Restructuring Charges in Consolidated Statements of Earnings</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other assets impairment charges</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Selling, general and administrative</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Inventory write downs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Cost of revenues</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Intangible assets impairment</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:38px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Impairment of intangible assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Accelerated depreciation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Cost of revenues</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Severance costs</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Selling, general and administrative</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>6.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Facility closure costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Selling, general and administrative</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total restructuring charges</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>18.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>16.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0 1300000 3100000 3100000 4800000 3000000.0 4500000 4200000 6200000 4300000 300000 800000 18900000 16700000 OTHER FINANCIAL INFORMATION<div style="line-height:120%;padding-top:12px;text-align:left;font-size:12pt;"><span style="font-family:inherit;font-size:12pt;background-color:#ffffff;">     </span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The following table summarizes the Company’s accrued liabilities:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:69%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Accrued compensation and benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>32.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>27.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Product warranty</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Income taxes payable</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>10.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Payable to Varian Medical Systems</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Right of return liability</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>6.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Deferred consideration</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>9.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>9.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total accrued liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>75.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>47.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The following table summarizes the Company’s other long-term liabilities:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:69%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Long-term income tax payable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Environment liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Defined benefit obligation liability</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Long-term right of return liability</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>19.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Long-term other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total other long-term liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>32.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The following table summarizes the Company’s other income (expense), net:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:53%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Years</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Income (loss) from equity method investments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(2.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Change in fair value of deferred consideration</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Realized income (loss) on foreign currencies</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total other income (expense), net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(3.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The following table summarizes the Company’s accrued liabilities:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:69%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Accrued compensation and benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>32.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>27.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Product warranty</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Income taxes payable</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>10.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Payable to Varian Medical Systems</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Right of return liability</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>6.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Deferred consideration</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>9.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>9.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total accrued liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>75.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>47.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span> 32100000 27000000.0 8100000 7300000 10700000 1400000 0 2300000 6900000 0 8900000 0 9000000.0 9500000 75700000 47500000 <div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The following table summarizes the Company’s other long-term liabilities:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:69%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Long-term income tax payable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Environment liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Defined benefit obligation liability</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Long-term right of return liability</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>19.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Long-term other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total other long-term liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>32.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div> 3900000 3500000 900000 1300000 5500000 3300000 19500000 0 2700000 400000 32500000 8500000 <div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The following table summarizes the Company’s other income (expense), net:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:53%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Years</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Income (loss) from equity method investments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(2.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Change in fair value of deferred consideration</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Realized income (loss) on foreign currencies</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total other income (expense), net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(3.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> -2300000 3900000 1300000 -1000000.0 0 0 -1900000 -1200000 1900000 -3200000 2700000 3200000 NET EARNINGS PER SHARE<div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic net earnings per common share is computed by dividing the net earnings for the period by the weighted average number of shares of common stock outstanding during the reporting period. Diluted net earnings per common share reflects the effects of potentially dilutive securities, which is computed by dividing net earnings by the sum of the weighted average number of common shares outstanding and dilutive common shares, which consists of stock options and unvested restricted stock.</span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A reconciliation of the numerator and denominator used in the calculation of basic and diluted net income per common share is as follows:</span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Year</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-bottom:2px;padding-left:1px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions, except per share amounts)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;padding-top:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;padding-top:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;padding-top:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net earnings attributable to Varex</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>15.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>27.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>51.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-bottom:2px;padding-left:1px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Weighted average shares outstanding - basic</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>38.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>37.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>37.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-bottom:2px;padding-left:22px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Dilutive effect of potential common shares</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-bottom:2px;padding-left:1px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Weighted average shares outstanding - diluted</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>38.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>38.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-bottom:2px;padding-left:1px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net earnings per share attributable to Varex - basic</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.41</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.73</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.37</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-bottom:2px;padding-left:1px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net earnings per share attributable to Varex - diluted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.40</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.72</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.36</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-bottom:2px;padding-left:1px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Anti-dilutive employee shared based awards, excluded</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="padding-bottom:2px;text-align:right;padding-left:1px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="padding-bottom:2px;text-align:right;padding-left:1px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="padding-bottom:2px;text-align:right;padding-left:1px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company excludes potentially dilutive common shares (consisting of shares underlying stock options and the employee stock purchase plan) from the computation of diluted weighted average shares outstanding if the inclusion of the shares underlying these stock awards would be anti-dilutive to earnings per share.</span></div> <div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">A reconciliation of the numerator and denominator used in the calculation of basic and diluted net income per common share is as follows:</span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Year</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-bottom:2px;padding-left:1px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions, except per share amounts)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;padding-top:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;padding-top:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;padding-top:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net earnings attributable to Varex</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>15.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>27.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>51.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-bottom:2px;padding-left:1px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Weighted average shares outstanding - basic</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>38.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>37.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>37.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-bottom:2px;padding-left:22px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Dilutive effect of potential common shares</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-bottom:2px;padding-left:1px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Weighted average shares outstanding - diluted</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>38.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>38.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-bottom:2px;padding-left:1px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net earnings per share attributable to Varex - basic</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.41</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.73</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.37</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-bottom:2px;padding-left:1px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net earnings per share attributable to Varex - diluted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.40</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.72</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.36</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:1px;"><div style="padding-bottom:2px;padding-left:1px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Anti-dilutive employee shared based awards, excluded</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="padding-bottom:2px;text-align:right;padding-left:1px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="padding-bottom:2px;text-align:right;padding-left:1px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="padding-bottom:2px;text-align:right;padding-left:1px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 15500000 27500000 51600000 38200000 37900000 37600000 400000 500000 400000 38600000 38400000 38000000 0.41 0.73 1.37 0.40 0.72 1.36 1900000 1200000 1000000.0 FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES<div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As part of the Company’s overall risk management practices, the Company enters into financial derivatives to manage its financial exposures to foreign currency exchange rates and interest rates.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company records all derivatives on the consolidated balance sheets at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting, and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. A qualitative assessment of hedge effectiveness is performed on a quarterly basis, unless facts and circumstances indicate the hedge may no longer be highly effective.    The changes in fair value for all trades that are not designated for hedge accounting are recognized in current period earnings. The Company does not offset fair value amounts recognized for derivative instruments in its consolidated balance sheets for presentation purposes.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Credit risk related to derivative transactions reflects the risk that a party to the transaction could fail to meet its obligation under the derivative contracts. Therefore, the Company’s exposure to the counterparty’s credit risk is generally limited to the amounts, if any, by which the counterparty’s obligations to the Company exceed the Company’s obligations to the counterparty. The Company’s policy is to enter into contracts only with financial institutions which meet certain minimum credit ratings to help mitigate counterparty credit risk.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives Designated as Hedging Instruments - Cash Flow Hedges</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company uses interest rate swap contracts as cash flow hedges to manage its exposure to fluctuations in LIBOR interest rates. Interest rate swap contracts hedging variable rate debt effectively fix the LIBOR component of its interest rate for a specific period of time.</span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, the Company had the following outstanding derivatives designated as cash flow hedging instruments:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:71%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions, except for number of instruments)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of Instruments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Notional Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Interest Rate Swap Contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>264.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the amount of pre-tax earnings recognized from derivative instruments for the periods indicated and the line items in the accompanying statements of operations where the results are recorded for cash flow hedges:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="26"/></tr><tr><td style="width:16%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of Gain or (Loss) Recognized in OCI on Derivative<br/>Fiscal Year Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Location of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income<br/>Fiscal Year Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Interest Rate Swap Contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(6.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>6.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Interest expense</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company expects that </span><span style="font-family:inherit;font-size:10pt;"><span>$0.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> of the accumulated other comprehensive (loss) income related to cash flow hedges will be realized in pre-tax earnings over the next 12 months, but the amount will vary depending on interest rates.</span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">These derivative instruments are subject to master netting agreements giving effect to rights of offset with each counterparty. None of the balances were eligible for netting. The following table summarizes the gross fair values of derivative instruments as of the periods indicated and the line items in the accompanying consolidated balance sheets where the instruments are recorded. </span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:20%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivative Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivative Liabilities</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;background-color:#cceeff;font-weight:bold;text-decoration:underline;">Derivatives designated as cash flow hedges</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;background-color:#cceeff;font-weight:bold;text-decoration:underline;">Balance sheet location</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;background-color:#cceeff;font-weight:bold;text-decoration:underline;">Balance sheet location</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Interest rate swap contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Other current liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;background-color:#cceeff;">Interest rate swap contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;background-color:#cceeff;">Other non-current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>5.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Other non-current liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>7.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Derivatives Designated as Hedging Instruments - Net Investment Hedges</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company uses cross currency swap contracts as net investment hedges to manage its risk of variability in foreign currency-denominated net investments in wholly-owned international operations. All changes in fair value of the derivatives designated as net investment hedges are reported in accumulated other comprehensive (loss) income along with the foreign currency translation adjustments on those investments. As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, the Company had the following outstanding derivatives designated as net investment hedging instruments:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:71%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions, except for number of instruments)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of Instruments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Notional Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Cross Currency Swap Contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>77.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the amount of pre-tax earnings recognized from derivative instruments for the periods indicated and the line items in the accompanying statements of operations where the results are recorded for net investment hedges:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="26"/></tr><tr><td style="width:16%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of Gain or (Loss) Recognized in OCI on Derivative<br/>Fiscal Year Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Location of Gain or (Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of Gain or (Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Cross Currency Swap Contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Interest expense</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">These derivative instruments are subject to master netting agreements giving effect to rights of offset with each counterparty. None of the balances were eligible for netting. The following table summarizes the gross fair values of derivative instruments as of the periods indicated and the line items in the accompanying consolidated balance sheets where the instruments are recorded:</span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:20%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivative Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivative Liabilities</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;background-color:#cceeff;font-weight:bold;text-decoration:underline;">Derivatives designated as net investment hedges</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;background-color:#cceeff;font-weight:bold;text-decoration:underline;">Balance sheet location</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;background-color:#cceeff;font-weight:bold;text-decoration:underline;">Balance sheet location</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Cross currency swap contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Other current liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Balance Sheet Hedges</span></div><div style="line-height:120%;padding-top:12px;padding-left:4px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company also enters into foreign currency forward contracts to hedge fluctuations associated with foreign currency denominated monetary assets and liabilities, primarily cash, third-party accounts receivable, accounts payable, and intercompany receivables and payables. These forward contracts expire within 30 days. These forward contracts are not designated for hedge accounting treatment, therefore, the change in fair value of these derivatives is recorded as a component of other income (expense) and offsets the change in fair value of the foreign currency denominated assets and liabilities, which are also recorded in other income (expense). The effect of derivative instruments not designated as hedges for fiscal year 2019 was a loss of </span><span style="font-family:inherit;font-size:10pt;"><span>$1.5 million</span></span><span style="font-family:inherit;font-size:10pt;">, which was primarily related to the purchase price hedge established following the announcement of the Company's planned acquisition of Direct Conversion. The Company does not, and does not intend to use derivative financial instruments for speculative or trading purposes.</span></div><div style="line-height:120%;padding-bottom:9px;padding-top:9px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table shows the notional amounts of outstanding foreign currency contracts entered into under its balance sheet hedge program as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;text-align:center;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Notional Value of Derivatives not Designated as Hedging Instruments:</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">In millions</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Buy contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Sell contract</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Japanese yen</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Swiss franc</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Chinese renminbi</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Euro</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>11.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 6 264400000 <div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the amount of pre-tax earnings recognized from derivative instruments for the periods indicated and the line items in the accompanying statements of operations where the results are recorded for cash flow hedges:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="26"/></tr><tr><td style="width:16%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of Gain or (Loss) Recognized in OCI on Derivative<br/>Fiscal Year Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Location of Gain or (Loss) Reclassified from Accumulated OCI into Income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income<br/>Fiscal Year Ended</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Interest Rate Swap Contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(6.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>6.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Interest expense</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company expects that </span><span style="font-family:inherit;font-size:10pt;"><span>$0.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> of the accumulated other comprehensive (loss) income related to cash flow hedges will be realized in pre-tax earnings over the next 12 months, but the amount will vary depending on interest rates.</span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">These derivative instruments are subject to master netting agreements giving effect to rights of offset with each counterparty. None of the balances were eligible for netting. The following table summarizes the gross fair values of derivative instruments as of the periods indicated and the line items in the accompanying consolidated balance sheets where the instruments are recorded. </span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:20%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivative Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivative Liabilities</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;background-color:#cceeff;font-weight:bold;text-decoration:underline;">Derivatives designated as cash flow hedges</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;background-color:#cceeff;font-weight:bold;text-decoration:underline;">Balance sheet location</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;background-color:#cceeff;font-weight:bold;text-decoration:underline;">Balance sheet location</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Interest rate swap contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Other current liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;background-color:#cceeff;">Interest rate swap contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;background-color:#cceeff;">Other non-current assets</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>5.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Other non-current liabilities</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>7.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the amount of pre-tax earnings recognized from derivative instruments for the periods indicated and the line items in the accompanying statements of operations where the results are recorded for net investment hedges:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="26"/></tr><tr><td style="width:16%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:8%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of Gain or (Loss) Recognized in OCI on Derivative<br/>Fiscal Year Ended</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td rowspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Location of Gain or (Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of Gain or (Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Cross Currency Swap Contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Interest expense</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">These derivative instruments are subject to master netting agreements giving effect to rights of offset with each counterparty. None of the balances were eligible for netting. The following table summarizes the gross fair values of derivative instruments as of the periods indicated and the line items in the accompanying consolidated balance sheets where the instruments are recorded:</span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:20%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivative Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Derivative Liabilities</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;background-color:#cceeff;font-weight:bold;text-decoration:underline;">Derivatives designated as net investment hedges</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;background-color:#cceeff;font-weight:bold;text-decoration:underline;">Balance sheet location</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;background-color:#cceeff;font-weight:bold;text-decoration:underline;">Balance sheet location</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Cross currency swap contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">Other current liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> -6300000 6900000 600000 1900000 100000 -300000 100000 0 2200000 0 0 0 5500000 500000 0 0 7700000 500000 0 4 77700000 -200000 0 0 200000 0 0 0 0 200000 0 0 0 200000 0 1500000 <div style="line-height:120%;padding-bottom:9px;padding-top:9px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table shows the notional amounts of outstanding foreign currency contracts entered into under its balance sheet hedge program as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">:</span></div><div style="line-height:120%;text-align:center;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:73%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Notional Value of Derivatives not Designated as Hedging Instruments:</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">In millions</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Buy contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Sell contract</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Japanese yen</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Swiss franc</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Chinese renminbi</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Euro</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>11.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, the Company had the following outstanding derivatives designated as cash flow hedging instruments:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:71%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions, except for number of instruments)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of Instruments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Notional Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Interest Rate Swap Contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>264.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> As of <span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, the Company had the following outstanding derivatives designated as net investment hedging instruments:</span><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:71%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions, except for number of instruments)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Number of Instruments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Notional Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Cross Currency Swap Contracts</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>77.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 900000 0 0 -1000000.0 1800000 0 8800000 0 11500000 -1000000.0 BORROWINGS<div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the Company's short-term and long-term debt:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:49%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions, except for percentages)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted-Average Interest Rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted-Average Interest Rate</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Current maturities of long-term debt</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Term facility</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>29.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>25.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total current maturities of long-term debt</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>30.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>25.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Non-current maturities of long-term debt:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Revolving credit facility</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>59.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>28.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Term facility</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>308.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>345.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(5.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(8.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Non-current maturities of long-term debt</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>364.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>364.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total long-term debt, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>395.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>389.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:10px;padding-top:16px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Existing Credit Facility</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On May 1, 2017 and in connection with the Acquired Detector Business, the Company entered into a new secured revolving credit facility (the “Revolving Credit Facility”) in an aggregate principal amount of up to </span><span style="font-family:inherit;font-size:10pt;"><span>$200.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> with a </span><span style="font-family:inherit;font-size:10pt;">five</span><span style="font-family:inherit;font-size:10pt;">-year term, and a secured term facility (the “Term Facility” and together with the Revolving Credit Facility, the “Credit Agreement”) in an aggregate principal amount of </span><span style="font-family:inherit;font-size:10pt;"><span>$400.0 million</span></span><span style="font-family:inherit;font-size:10pt;">. The Term Facility will be repaid over </span><span style="font-family:inherit;font-size:10pt;"><span>five years</span></span><span style="font-family:inherit;font-size:10pt;">, with </span><span style="font-family:inherit;font-size:10pt;"><span>5.0%</span></span><span style="font-family:inherit;font-size:10pt;"> payable in quarterly installments </span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">during each of the first two years of the term thereof, </span><span style="font-family:inherit;font-size:10pt;"><span>7.5%</span></span><span style="font-family:inherit;font-size:10pt;"> payable in quarterly installments during the third and fourth years of the term thereof, and </span><span style="font-family:inherit;font-size:10pt;"><span>10%</span></span><span style="font-family:inherit;font-size:10pt;"> payable in quarterly installments in the fifth year of the term thereof, with the remaining amount due at maturity. Varex used the net proceeds from the Term Facility, and the net proceeds from approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$97.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> drawn on the Revolving Credit Facility, to pay the purchase price for the Acquired Detector Business, plus related credit facility fees, and to repay all of Varex’s obligations under the Previous Credit Agreement. Both the Term Facility and Revolving Credit Facility expire on May 1, 2022.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Credit Agreement contains various customary restrictive covenants that limits, among other things, the incurrence of indebtedness by Varex and its subsidiaries, the grant or incurrence of liens by Varex and its subsidiaries, the entry into sale and leaseback transactions by Varex and its subsidiaries, and the entry into certain fundamental change transactions by Varex and its subsidiaries. It also contains customary events of default and certain financial covenants. The Company agreed to maintain financial covenants, which include maximum consolidated total leverage ratio, maximum senior secured leverage ratio, maximum capital expenditures and a minimum consolidated fixed charge coverage ratio. The Company was in compliance with all financial covenants under the Credit Agreement as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Credit Agreement is secured by the stock and assets of Varex’s material subsidiaries. The Credit Agreement has several borrowing and interest rate options including the following indices: (a) LIBOR rate, or (b) the base rate (equal to the greater of the prime rate, the federal funds rate plus </span><span style="font-family:inherit;font-size:10pt;"><span>0.50%</span></span><span style="font-family:inherit;font-size:10pt;"> or the LIBOR rate for a one-month period plus </span><span style="font-family:inherit;font-size:10pt;"><span>1.00%</span></span><span style="font-family:inherit;font-size:10pt;">). Loans under the Credit Agreement bear interest at a rate per annum using the applicable indices plus a varying interest rate margin of between </span><span style="font-family:inherit;font-size:10pt;"><span>1.75%</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>2.75%</span></span><span style="font-family:inherit;font-size:10pt;"> (for LIBOR rate loans) and </span><span style="font-family:inherit;font-size:10pt;"><span>0.75%</span></span><span style="font-family:inherit;font-size:10pt;">-</span><span style="font-family:inherit;font-size:10pt;"><span>1.75%</span></span><span style="font-family:inherit;font-size:10pt;"> (for base rate loans). The Credit Agreement also provides for fees applicable to amounts available to be drawn under outstanding letters of credit of </span><span style="font-family:inherit;font-size:10pt;"><span>0.125%</span></span><span style="font-family:inherit;font-size:10pt;">, and a fee on unused commitments which ranges from </span><span style="font-family:inherit;font-size:10pt;"><span>0.25%</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>0.40%</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On October 3, 2018, the Company, in accordance with the terms of the Credit Agreement, provided notice to the administrative agent that effective as of October 10, 2018, the Company had permanently reducing the revolving credit commitment under the Credit Agreement by </span><span style="font-family:inherit;font-size:10pt;"><span>$50.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>$150.0 million</span></span><span style="font-family:inherit;font-size:10pt;">. The reduction in the revolving credit commitment reduced the fees paid by the Company in connection with such commitment.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Subsequent to fiscal year 2019, the Company, in accordance with the terms of the Credit Agreement, provided notice to the administrative agent that effective as of </span><span style="font-family:inherit;font-size:10pt;">October 8, 2019</span><span style="font-family:inherit;font-size:10pt;">, the Company was permanently reducing the revolving credit commitment under the Credit Agreement by </span><span style="font-family:inherit;font-size:10pt;"><span>$25.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>$125.0 million</span></span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Subsequent to fiscal year 2019, the Company did not comply with the covenant under the Credit Agreement to timely deliver the Company's fiscal year 2019 annual financial statements. However, upon the filing of this Annual Report with the SEC, the Company will be able to deliver the fiscal year 2019 annual financial statements within the 30-day cure period set forth in the Credit Agreement and consequently no event of default will occur. </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, the Company had </span><span style="font-family:inherit;font-size:10pt;"><span>$364.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> in non-current maturities of long-term debt outstanding, net of deferred debt issuance costs of </span><span style="font-family:inherit;font-size:10pt;"><span>$5.7 million</span></span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;"><span>$30.7 million</span></span><span style="font-family:inherit;font-size:10pt;"> of current maturities of long-term debt outstanding.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Future principal payments of the long-term debt outstanding as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> are as follows:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:87%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal years:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>30.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>34.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>335.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total debt outstanding</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>400.8</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Less: current maturities of long-term debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(30.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Non-current portion of long -term debt</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>370.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the Company's short-term and long-term debt:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:49%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions, except for percentages)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted-Average Interest Rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted-Average Interest Rate</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Current maturities of long-term debt</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Term facility</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>29.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>25.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total current maturities of long-term debt</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>30.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>25.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Non-current maturities of long-term debt:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Revolving credit facility</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>59.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>28.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Term facility</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>308.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>345.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Debt issuance costs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(5.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(8.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Non-current maturities of long-term debt</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>364.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>364.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total long-term debt, net</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>395.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>389.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 29400000 0.056 25000000.0 0.042 1300000 0 30700000 25000000.0 59000000.0 0.056 28000000.0 0.042 308600000 0.056 345000000.0 0.042 2500000 0 5700000 8200000 364400000 364800000 395100000 389800000 200000000.0 400000000.0 P5Y 0.050 0.075 0.10 97000000.0 0.0050 0.0100 0.0175 0.0275 0.0075 0.0175 0.00125 0.0025 0.0040 50000000.0 150000000.0 25000000.0 125000000.0 364400000 5700000 30700000 <div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Future principal payments of the long-term debt outstanding as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> are as follows:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:87%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal years:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>30.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>34.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>335.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total debt outstanding</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>400.8</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Less: current maturities of long-term debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(30.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Non-current portion of long -term debt</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>370.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 30700000 34300000 335800000 400800000 30700000 370100000 FAIR VALUE<div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Assets/Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements at September 27, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Quoted Prices in Active Markets for Identical Assets and Liabilities<br/>(Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Significant Unobservable Inputs<br/>(Level 3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash equivalents - money market funds</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Derivative liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred consideration</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total liabilities measured at fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, the total outstanding borrowings under the Company's credit agreement were </span><span style="font-family:inherit;font-size:10pt;"><span>$395.1 million</span></span><span style="font-family:inherit;font-size:10pt;">, net of deferred loan costs, which approximated its fair value because it is carried at a market observable interest rate that resets periodically and is categorized as Level 2 in the fair value hierarchy. The fair values of certain of the Company’s financial instruments, including bank deposits included in cash and cash equivalents, accounts receivable and accounts payable, also approximate their fair values due to their short maturities.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">There were no financial assets or liabilities measured on a recurring basis using significant unobservable inputs (Level 3) and there were no transfers in or out of Level 1, 2 or 3 during fiscal year 2018. </span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;">, the Company determined the following levels of inputs for the following assets or liabilities:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:714px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:298px;"/><td style="width:9px;"/><td style="width:87px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:9px;"/><td style="width:87px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:9px;"/><td style="width:87px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:9px;"/><td style="width:87px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements at September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Quoted Prices in Active Markets for Identical Assets and Liabilities <br/>(Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Significant Other<br/>Observable Inputs <br/>(Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Significant Unobservable Inputs <br/>(Level 3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash equivalents - Money market funds</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Derivative assets</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26.1</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26.1</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Derivative liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0 8800000 0 8800000 0 8800000 0 8800000 0 700000 0 700000 8900000 0 0 8900000 8900000 700000 0 9600000 395100000 <div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">At </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;">, the Company determined the following levels of inputs for the following assets or liabilities:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:714px;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:298px;"/><td style="width:9px;"/><td style="width:87px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:9px;"/><td style="width:87px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:9px;"/><td style="width:87px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:9px;"/><td style="width:87px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</span></div></td><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements at September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Quoted Prices in Active Markets for Identical Assets and Liabilities <br/>(Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Significant Other<br/>Observable Inputs <br/>(Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Significant Unobservable Inputs <br/>(Level 3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash equivalents - Money market funds</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Derivative assets</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26.1</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>26.1</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Derivative liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements at September 27, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Quoted Prices in Active Markets for Identical Assets and Liabilities<br/>(Level 1)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Significant Other<br/>Observable Inputs<br/>(Level 2)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Significant Unobservable Inputs<br/>(Level 3)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Cash equivalents - money market funds</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Derivative liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Deferred consideration</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Total liabilities measured at fair value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0 18400000 0 18400000 0 7700000 0 7700000 0 26100000 0 26100000 0 0 0 0 GOODWILL AND INTANGIBLE ASSETS<div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table reflects goodwill by reportable operating segment: </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Medical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Industrial</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance at September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>147.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>96.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>243.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:38px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Business combination</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>26.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>21.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>47.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance at September 27, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>173.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>117.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>290.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table reflects the gross carrying amount and accumulated amortization of the Company’s finite-lived intangible assets included in other assets in the consolidated balance sheets: </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:29%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Carrying Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Carrying Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Carrying Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Carrying Amount</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Acquired existing technology</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>74.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(28.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>45.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>57.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(21.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>36.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Patents, licenses and other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>12.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(8.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>9.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(7.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Customer contracts and supplier relationship</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>50.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(17.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>33.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>42.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(11.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>31.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total intangible assets with finite lives</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>137.5</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(54.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>83.5</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>110.4</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(40.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>69.8</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">In-process R&amp;D with indefinite lives</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">0.0</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">0.0</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>140.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(54.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>86.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>114.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(40.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>73.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amortization expense for intangible assets was </span><span style="font-family:inherit;font-size:10pt;"><span>$15.7 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$16.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$10.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> in fiscal years </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, respectively. The Company recognized an impairment loss of </span><span style="font-family:inherit;font-size:10pt;"><span>$4.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$3.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> in fiscal years </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;">, respectively. These impairment costs were included in the consolidated statements of earnings under impairment of intangible assets.</span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">As of </span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, the estimated future amortization expense of intangible assets with finite lives is as follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:83%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal years:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>17.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>16.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>14.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>13.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>9.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>12.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:80px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>83.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table reflects goodwill by reportable operating segment: </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Medical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Industrial</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance at September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>147.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>96.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>243.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:38px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Business combination</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>26.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>21.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>47.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance at September 27, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>173.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>117.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>290.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 147000000.0 96600000 243600000 26000000.0 21200000 47200000 173000000.0 117800000 290800000 <div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table reflects the gross carrying amount and accumulated amortization of the Company’s finite-lived intangible assets included in other assets in the consolidated balance sheets: </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:29%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Carrying Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Carrying Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Carrying Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Carrying Amount</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Acquired existing technology</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>74.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(28.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>45.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>57.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(21.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>36.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Patents, licenses and other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>12.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(8.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>9.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(7.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Customer contracts and supplier relationship</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>50.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(17.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>33.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>42.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(11.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>31.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total intangible assets with finite lives</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>137.5</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(54.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>83.5</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>110.4</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(40.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>69.8</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">In-process R&amp;D with indefinite lives</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">0.0</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">0.0</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>140.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(54.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>86.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>114.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(40.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>73.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table reflects the gross carrying amount and accumulated amortization of the Company’s finite-lived intangible assets included in other assets in the consolidated balance sheets: </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:29%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Carrying Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Carrying Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Carrying Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Amortization</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Carrying Amount</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Acquired existing technology</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>74.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(28.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>45.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>57.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(21.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>36.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Patents, licenses and other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>12.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(8.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>9.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(7.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Customer contracts and supplier relationship</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>50.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(17.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>33.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>42.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(11.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>31.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total intangible assets with finite lives</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>137.5</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(54.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>83.5</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>110.4</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(40.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>69.8</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">In-process R&amp;D with indefinite lives</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">0.0</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">0.0</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>140.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(54.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>86.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>114.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(40.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>73.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 74100000 28400000 45700000 57900000 21800000 36100000 12700000 8400000 4300000 9900000 7400000 2500000 50700000 17200000 33500000 42600000 11400000 31200000 137500000 54000000.0 83500000 110400000 40600000 69800000 2800000 2800000 4000000.0 4000000.0 140300000 54000000.0 86300000 114400000 40600000 73800000 15700000 16200000 10500000 4800000 3000000.0 <div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">As of </span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, the estimated future amortization expense of intangible assets with finite lives is as follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:83%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal years:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>17.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">2021</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>16.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">2022</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>14.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">2023</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>13.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">2024</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>9.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Thereafter</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>12.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:80px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>83.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 17200000 16300000 14700000 13700000 9100000 12500000 83500000 COMMITMENTS AND CONTINGENCIES<div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;font-weight:bold;">Lease Commitments</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">At </span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, the Company was committed to minimum rentals under non-cancelable operating leases (including rent escalation clauses) for fiscal years 2020 through 2024 and therea</span><span style="font-family:inherit;font-size:10pt;">fter, as follows: </span><span style="font-family:inherit;font-size:10pt;"><span>$7.5 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$5.4 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$4.7 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$1.8 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$0.9 million</span></span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;"><span>$0.2 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. Ren</span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">tal expenses were</span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </span><span style="font-family:inherit;font-size:10pt;"><span>$5.1 million</span></span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">,</span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;"><span>$5.3 million</span></span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, and</span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;"><span>$4.0 million</span></span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">for fiscal years</span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, respectively</span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-style:italic;font-weight:bold;">Other Commitments</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">See Note 3. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Related Party Transactions, </span><span style="font-family:inherit;font-size:10pt;">included in this report, for additional information about the Company’s commitments to dpiX.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">See Note 12. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Redeemable Noncontrolling Interests &amp; Noncontrolling Interests, </span><span style="font-family:inherit;font-size:10pt;">included in this report, for additional information about the Company’s commitment to the noncontrolling shareholders of MeVis.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has an environmental liability of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$0.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:8pt;"> </span><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contingencies</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">From time to time, the Company is a party to or otherwise involved in legal proceedings, claims and government inspections or investigations, customs and duty audits, other contingency matters, both inside and outside the United States, arising in the ordinary course of its business or otherwise. The Company accrues amounts for probable losses, to the extent they can be reasonably estimated, that it believes are adequate to address any liabilities related to legal proceedings and other loss contingencies that the Company believes will result in a probable loss (including, among other things, probable settlement value). A loss or a range of loss is disclosed when it is reasonably possible that a material loss will be incurred and can be estimated or when it is reasonably possible that the amount of a loss, when material, will exceed the recorded provision. The Company did not have any contingent liabilities as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;">and </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;">. Legal expenses are expensed as incurred.</span></div> 7500000 5400000 4700000 1800000 900000 200000 5100000 5300000 4000000.0 900000 <span style="font-family:inherit;font-size:10pt;font-weight:bold;">REDEEMABLE NONCONTROLLING INTERESTS &amp; </span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">NONCONTROLLING INTERESTS</span><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">In </span><span style="font-family:inherit;font-size:10pt;">April 2019, a subsidiary of Varex completed the acquisition of </span><span style="font-family:inherit;font-size:10pt;"><span>98.2%</span></span><span style="font-family:inherit;font-size:10pt;"> of the outstanding shares of common stock of Direct Conversion. As the Company has majority voting rights it has consolidated Direct Conversion's operations in its consolidated financial statements and recorded the noncontrolling interest. The noncontrolling interest related to Direct Conversion is included in noncontrolling interest in the equity section of the Company's consolidated balance sheet. Earnings representing the noncontrolling interest's portion of Direct Conversion's income from operations is included in the Company's consolidated statements of earnings.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">In September 2018, the Company entered into a partnership in Saudi Arabia. </span><span style="font-family:inherit;font-size:10pt;">The Company has majority voting rights with an approximate </span><span style="font-family:inherit;font-size:10pt;"><span>75%</span></span><span style="font-family:inherit;font-size:10pt;"> interest. Accordingly, the Company has consolidated the operations of the Saudi Arabia partnership in our consolidated financial statements and recorded the noncontrolling interests. The noncontrolling interest related to the partner’s </span><span style="font-family:inherit;font-size:10pt;"><span>25%</span></span><span style="font-family:inherit;font-size:10pt;"> interest in the joint venture is included in noncontrolling interest in the equity section of the Company’s consolidated balance sheet. Earnings representing the noncontrolling partner's share of income from operations is included in the Company's consolidated statements of earnings.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">In April 2015, the Company completed the acquisition of </span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;"><span>73.5%</span></span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> of the then outstanding shares of MeVis Medical Solutions AG (“MeVis”), a public company based in Bremen, Germany that provides image processing software and services for cancer screening. In August 2015, the Company, through one of its German subsidiaries, entered into a domination and profit and loss transfer agreement (the “DPLTA”) with MeVis. In October 2015, the DPLTA became effective upon its registration at the local court of Bremen, Germany. Under the DPLTA, MeVis subordinates its management to the Company and undertakes to transfer all of its annual profits and losses to the Company. In return, the DPLTA grants the noncontrolling shareholders of MeVis: (1) an annual recurring net compensation of </span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;"><span>€0.95</span></span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> per MeVis share starting from January 1, 2015 and (2) a put right for their MeVis shares at </span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;"><span>€19.77</span></span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> per MeVis share. Upon effectiveness of the DPLTA, the noncontrolling interests in MeVis became redeemable as a result of the put right and were reclassified to temporary equity. As of </span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, the redemption value of redeemable noncontrolling interests in MeVis was </span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;"><span>$10.5 million</span></span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">During fiscal year 2018, an immaterial number of MeVis’ shares were purchased under the put right. As of </span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">, noncontrolling shareholders together held approximately </span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;"><span>0.5 million</span></span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> shares of MeVis, representing </span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;"><span>26.3%</span></span><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;"> of the outstanding shares.</span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:left;text-indent:48px;font-size:12pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Changes in redeemable noncontrolling interests and noncontrolling interests were as follows:</span><span style="font-family:inherit;font-size:12pt;background-color:#ffffff;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.77777777777777%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:49%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Years</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Redeemable <br/>Noncontrolling <br/>Interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Noncontrolling <br/>Interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Redeemable <br/>Noncontrolling <br/>Interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Noncontrolling Interest</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance at beginning of period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>11.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>11.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net earnings attributable to noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Contributions from noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Dividend distributions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance at end of period</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>10.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>11.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0.982 0.75 0.25 0.735 0.95 19.77 10500000 500000 0.263 <div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:left;text-indent:48px;font-size:12pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Changes in redeemable noncontrolling interests and noncontrolling interests were as follows:</span><span style="font-family:inherit;font-size:12pt;background-color:#ffffff;"> </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.77777777777777%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:49%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fiscal Years</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Redeemable <br/>Noncontrolling <br/>Interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Noncontrolling <br/>Interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Redeemable <br/>Noncontrolling <br/>Interests</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Noncontrolling Interest</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance at beginning of period</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>11.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>11.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net earnings attributable to noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Contributions from noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Dividend distributions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">—</span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">—</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">—</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance at end of period</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>10.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>11.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 11100000 2100000 11200000 0 500000 -200000 500000 300000 1400000 1800000 500000 600000 -600000 0 10500000 3300000 11100000 2100000 EMPLOYEE STOCK PLANS<div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Employee Stock Plans</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company's employees participate in Varex Imaging Corporation 2017 Omnibus Stock Plan (the “2017 Stock Plan”) and Varex Imaging Corporation 2017 Employee Stock Purchase Plan (the “2017 ESPP”) which allows the grants of stock options, restricted stock units and performance shares among other types of awards. </span></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In January 2017, Varex stockholders approved the 2017 ESPP, which provides eligible employees with an opportunity to purchase shares of Varex common stock at </span><span style="font-family:inherit;font-size:10pt;"><span>85%</span></span><span style="font-family:inherit;font-size:10pt;"> of the lower of its fair market value at the start and end of a </span><span style="font-family:inherit;font-size:10pt;"><span>six months</span></span><span style="font-family:inherit;font-size:10pt;"> purchase period. The 2017 ESPP provides for the purchase of up to </span><span style="font-family:inherit;font-size:10pt;"><span>one million</span></span><span style="font-family:inherit;font-size:10pt;"> shares of Varex common stock.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Share-Based Compensation Expense</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Share-based compensation expense recognized in the consolidated statements of earnings is based on awards ultimately expected to vest. Share-based compensation expense includes expenses related to the Company’s direct employees. Prior to the separation, Varian also charged the Company for the allocated share-based compensation costs of certain employees of Varian who provided selling, general and administrative services on the Company’s behalf.</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The table below summarizes the effect of recording share-based compensation expense and for the option component of the employee stock purchase plan shares:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:53%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Year</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;padding-top:2px;text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Cost of revenues</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Research and development</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-top:2px;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Selling, general and administrative</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> (1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>6.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>6.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:38px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total share-based compensation expense</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>11.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>10.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:9px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:7pt;">(1)</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:8pt;">Includes allocated share-based compensation of </span><span style="font-family:inherit;font-size:8pt;"><span>$0.8 million</span></span><span style="font-family:inherit;font-size:8pt;"> for fiscal year 2017 and represents charges by Varian to the Company for certain Varian employees who provided general and administrative services on the Company’s behalf.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The unrecognized share-based compensation cost as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$23.1 million</span></span><span style="font-family:inherit;font-size:10pt;">, and is expected to be recognized in the next </span><span style="font-family:inherit;font-size:10pt;"><span>3</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>4</span></span><span style="font-family:inherit;font-size:10pt;"> fiscal years. As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, there were approximately </span><span style="font-family:inherit;font-size:10pt;"><span>1.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>0.7 million</span></span><span style="font-family:inherit;font-size:10pt;"> shares of common stock available for future issuances under the 2017 Stock Plan and the 2017 ESPP, respectively. </span></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company utilized the Black-Scholes valuation model for estimating the fair value of stock options granted and the option component of ESPP grants. The Company calculated the fair value of option grants and option component of ESPP grants on the respective dates of grant using the following weighted average assumptions:</span></div><div style="line-height:120%;padding-top:9px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"/></tr><tr><td style="width:29%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Employee Stock Option Plan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Employee Stock Purchase Plans</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="8" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="8" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Year</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;padding-top:2px;text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;padding-top:2px;text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Expected term (in years)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Risk-free interest rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-top:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Expected volatility</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>33.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>31.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>23.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>43.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>34.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>28.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Expected dividend</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Weighted average fair value at grant date</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>$10.19</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>$11.57</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>$8.08</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>$7.81</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>$8.92</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>$7.81</span></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Option valuation methods, including Black-Scholes, require the input of subjective assumptions, which are discussed below.</span></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Risk-Free Interest Rate</span></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The interest rates used are based on the implied yield currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term equal to the expected life of the award.</span></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Expected Term</span></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Options granted generally vest over a period of </span><span style="font-family:inherit;font-size:10pt;"><span>36</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>48</span></span><span style="font-family:inherit;font-size:10pt;"> months and expire </span><span style="font-family:inherit;font-size:10pt;"><span>7</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>10</span></span><span style="font-family:inherit;font-size:10pt;"> years from date of grant. Employee stock purchase plan offering periods are </span><span style="font-family:inherit;font-size:10pt;"><span>6 months</span></span><span style="font-family:inherit;font-size:10pt;"> and provides eligible employees with an opportunity to purchase shares of Varex common stock at </span><span style="font-family:inherit;font-size:10pt;"><span>85%</span></span><span style="font-family:inherit;font-size:10pt;"> of the lower of its fair market value at the start and end of a six-month purchase period.</span></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Expected Dividend Yield</span></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The dividend rate used is zero as the Company has never paid any cash dividends on its common stock and does not anticipate doing so in the foreseeable future. The Company is also restricted from paying dividends on common stock under its credit facility.</span></div><div style="line-height:120%;padding-top:16px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Expected Volatility</span></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Authoritative accounting guidance on stock-based compensation indicates that companies should consider volatility over a period generally commensurate with the expected or contractual term of the stock option. Adequate Company-specific data does not exist for this time period as the Company began trading in January 2017. The volatility variable used is a blended approach by using the Company's historic data for the years it has been publicly traded and a benchmark of other comparable companies’ volatility rates for the prior years.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Stock Option Activity</span></div><div style="line-height:120%;padding-bottom:9px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the activity for stock options under Varex’s employee incentive plans for the Company’s employees:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:40%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In thousands, except per share amounts and the remaining term)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Price range</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted Average <br/>Exercise Price</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted Average Remaining Term (in years)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Aggregate Intrinsic Value (1)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-top:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Outstanding at September 28, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2,011</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$22.63 — $37.60</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>30.35</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:38px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>297</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$31.42 — $31.42</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>31.42</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:38px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Canceled, expired or forfeited</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(4)</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$31.08 — $31.08</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>31.08</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:38px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Exercised</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(35)</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$22.84 — $27.77</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>23.38</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Outstanding at September 27, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2,269</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$22.63 — $37.60</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>30.60</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1,220.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Exercisable at September 27, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1,477</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$22.63 — $37.60</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>29.67</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1,220.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">(1) The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of Varex common stock of </span><span style="font-family:inherit;font-size:8pt;"><span>$28.28</span></span><span style="font-family:inherit;font-size:8pt;"> as of </span><span style="font-family:inherit;font-size:8pt;">September 27, 2019</span><span style="font-family:inherit;font-size:8pt;">, the last trading date of the Company's respective fiscal years, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date.</span></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The weighted-average grant-date fair value of options granted during fiscal years </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$3.0 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$3.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$9.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> respectively. The total intrinsic value of the options exercised during the years ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">September 29, 2017</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$0.2 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$1.7 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$1.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> respectively</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Restricted Stock Units, Restricted Stock Awards and Deferred Stock Units</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the activity for restricted stock units, restricted stock awards and deferred stock units under Varex’s employee incentive plans for the Company’s employees:</span></div><div style="line-height:120%;padding-top:10px;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:63%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In thousands, except per share amounts)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Number of Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted Average <br/>Grant-Date Fair<br/>Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-top:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance at September 28, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>641</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>33.60</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:38px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>288</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>31.29</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:38px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(201)</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>31.56</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:38px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Canceled or expired</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(50)</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>34.13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance at September 27, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>678</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>33.18</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:9px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The total grant-date fair value of shares granted in fiscal year was </span><span style="font-family:inherit;font-size:10pt;"><span>$9.0 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$10.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$11.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> for fiscal years </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, respectively. Shares outstanding at </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">September 29, 2017</span><span style="font-family:inherit;font-size:10pt;"> had an estimated market value of </span><span style="font-family:inherit;font-size:10pt;"><span>$19.2 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$18.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$17.8 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div> 0.85 P6M 1000000000000 <div style="line-height:120%;padding-bottom:8px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The table below summarizes the effect of recording share-based compensation expense and for the option component of the employee stock purchase plan shares:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:53%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Year</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;padding-top:2px;text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Cost of revenues</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Research and development</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-top:2px;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Selling, general and administrative</span><span style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt"> (1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>6.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>6.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:38px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total share-based compensation expense</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>11.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>10.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:9px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:7pt;">(1)</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:8pt;">Includes allocated share-based compensation of </span><span style="font-family:inherit;font-size:8pt;"><span>$0.8 million</span></span><span style="font-family:inherit;font-size:8pt;"> for fiscal year 2017 and represents charges by Varian to the Company for certain Varian employees who provided general and administrative services on the Company’s behalf.</span></div> 1200000 1300000 900000 2200000 1800000 1500000 8300000 6900000 6000000.0 11700000 10000000.0 8400000 800000 23100000 P3Y P4Y 1200000 700000 <div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company utilized the Black-Scholes valuation model for estimating the fair value of stock options granted and the option component of ESPP grants. The Company calculated the fair value of option grants and option component of ESPP grants on the respective dates of grant using the following weighted average assumptions:</span></div><div style="line-height:120%;padding-top:9px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"/></tr><tr><td style="width:29%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Employee Stock Option Plan</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Employee Stock Purchase Plans</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="8" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="8" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Year</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;padding-top:2px;text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;padding-top:2px;text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Expected term (in years)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Risk-free interest rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-top:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Expected volatility</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>33.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>31.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>23.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>43.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>34.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>28.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Expected dividend</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Weighted average fair value at grant date</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>$10.19</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>$11.57</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>$8.08</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>$7.81</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>$8.92</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>$7.81</span></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> P4Y7M6D P4Y9M18D P4Y2M12D P0Y6M P0Y6M P0Y6M 0.025 0.026 0.016 0.025 0.020 0.010 0.339 0.318 0.236 0.439 0.341 0.280 0.000 0.000 0.000 0.000 0.000 0.000 10.19 11.57 8.08 7.81 8.92 7.81 P36M P48M P7Y P10Y P6M 0.85 <div style="line-height:120%;padding-bottom:9px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the activity for stock options under Varex’s employee incentive plans for the Company’s employees:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:40%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In thousands, except per share amounts and the remaining term)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Options</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Price range</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted Average <br/>Exercise Price</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted Average Remaining Term (in years)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Aggregate Intrinsic Value (1)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-top:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Outstanding at September 28, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2,011</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$22.63 — $37.60</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>30.35</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:38px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>297</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$31.42 — $31.42</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>31.42</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:38px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Canceled, expired or forfeited</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(4)</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$31.08 — $31.08</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>31.08</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:38px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Exercised</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(35)</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$22.84 — $27.77</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>23.38</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Outstanding at September 27, 2019</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2,269</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$22.63 — $37.60</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>30.60</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1,220.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Exercisable at September 27, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1,477</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$22.63 — $37.60</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>29.67</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1,220.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;">(1) The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of Varex common stock of </span><span style="font-family:inherit;font-size:8pt;"><span>$28.28</span></span><span style="font-family:inherit;font-size:8pt;"> as of </span><span style="font-family:inherit;font-size:8pt;">September 27, 2019</span><span style="font-family:inherit;font-size:8pt;">, the last trading date of the Company's respective fiscal years, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date.</span></div> 2011000 30.35 297000 31.42 4000 31.08 35000 23.38 2269000 30.60 P4Y1M6D 1220300 1477000 29.67 P3Y4M24D 1220300 28.28 3000000.0 3100000 9200000 200000 1700000 1400000 <div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the activity for restricted stock units, restricted stock awards and deferred stock units under Varex’s employee incentive plans for the Company’s employees:</span></div><div style="line-height:120%;padding-top:10px;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:63%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In thousands, except per share amounts)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Number of Shares</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Weighted Average <br/>Grant-Date Fair<br/>Value</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-top:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance at September 28, 2018</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>641</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>33.60</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:38px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Granted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>288</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>31.29</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:38px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Vested</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(201)</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>31.56</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:38px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Canceled or expired</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(50)</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>34.13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance at September 27, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>678</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>33.18</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div> 641000 33.60 288000 31.29 201000 31.56 50000 34.13 678000 33.18 9000000.0 10100000 11400000 19200000 18400000 17800000 TAXES ON EARNINGS<div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Income tax expense is based on reported income or loss before income taxes. Deferred income taxes reflect the effect of temporary differences between asset and liability amounts that are recognized for financial reporting purposes and the amounts that are recognized for income tax purposes. These deferred taxes are measured by applying currently enacted tax laws. Valuation allowances are recognized to reduce deferred tax assets to the amount that is more likely than not to be realized.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Taxes on earnings were as follows:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Years</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Current provision:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Federal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>9.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(2.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>24.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">State and local</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Foreign</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>6.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:80px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total current</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>17.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>31.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Deferred provision (benefit):</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Federal</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(10.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(7.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(7.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">State and local</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Foreign</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:80px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total deferred</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(11.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(7.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(8.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Taxes on earnings</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(2.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>22.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Earnings before taxes are generated from the following geographic areas:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Years</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>55.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Foreign</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>15.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>22.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>19.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Earnings before taxes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>21.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>25.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>74.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The effective tax rate differs from the U.S. federal statutory tax rate as a result of the following:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:56%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Years</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Federal statutory income tax rate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>21.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>24.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>35.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">State and local taxes, net of federal tax benefit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Revaluation of deferred tax liabilities for US statutory change</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(41.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Mandatory repatriation tax on foreign earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>13.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Domestic production activities deduction</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(2.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Research and development credit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(10.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(11.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(2.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Prior year deferred tax adjustments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(4.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Foreign Rate Difference</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Change in valuation allowance</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>11.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">US Tax Reform - International Provisions</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(4.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(2.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Effective tax rate</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>26.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(10.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>30.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On December 22, 2017, the Tax Cuts and Jobs Act of 2017 (U.S. Tax Reform) was enacted in the U.S. which significantly revised the U.S. corporate income tax structure. Among the revisions impacting our effective tax rate are a lower U.S. corporate statutory rate going from </span><span style="font-family:inherit;font-size:10pt;">35%</span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;">21%</span><span style="font-family:inherit;font-size:10pt;"> effective January 1, 2018 and changes to the way foreign earnings are taxed. As a September fiscal year filer, the lower corporate income tax rate is phased in from a U.S. statutory federal rate of </span><span style="font-family:inherit;font-size:10pt;"><span>24.5%</span></span><span style="font-family:inherit;font-size:10pt;"> in fiscal year ending September 28, 2018 to a rate of </span><span style="font-family:inherit;font-size:10pt;">21%</span><span style="font-family:inherit;font-size:10pt;"> for the fiscal year ending September 27, 2019. </span></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During fiscal year 2019, the Company’s effective tax rate varied from the U.S. federal statutory rate of </span><span style="font-family:inherit;font-size:10pt;">21%</span><span style="font-family:inherit;font-size:10pt;"> primarily because of the favorable impact of changes to the U.S. corporate tax structure resulting from U.S. Tax Reform, and U.S. research and development tax credits. These favorable U.S. tax items are offset by losses in certain foreign jurisdictions for which no benefit is recognized and earnings in other foreign jurisdictions that are taxed at higher rates.</span></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During fiscal year 2018, the Company’s effective tax rate varied from the U.S. federal statutory rate primarily because the favorable impact of changes to the U.S. corporate tax structure resulting from U.S. Tax Reform. During fiscal years 2018 and 2017, the effective tax rate also differs from the U.S. federal statutory rate due to increases resulting from U.S. state income tax expense, losses in certain foreign jurisdictions for which no benefit is recognized, earnings in other foreign jurisdictions that are taxed at higher rates, and limitations on the deductibility of officers' compensation. These are offset by decreases due to U.S. research and development credits, tax windfalls for share-based compensation, and the release of a valuation allowance against loss carryforwards in certain foreign jurisdictions.</span></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> The SEC issued guidance under Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (“SAB 118”) that allows for reasonable estimated amounts to be recorded and a measurement period of up to one year from the date of enactment to revise these provisional amounts as new information is obtained and additional guidance is issued. During the three months ended December 28, 2018, the Company completed its analysis of U.S. Tax Reform, and the accounting for the income tax effects has been finalized for the measurement period under SAB 118, with no significant adjustments from the provisional amounts. During fiscal year 2019, additional U.S. Tax Reform provisions, including GILTI (global intangible low-taxed income), BEAT (base-erosion anti-abuse tax), FDII (foreign-derived intangible income), limitations on interest expense deductions (if certain conditions apply), and other components became effective for the Company and, if applicable, have been included in the calculation of the fiscal year 2019 tax provision. The determination of the tax effects of U.S. Tax Reform may change following future legislation or further interpretation of U.S. Tax Reform from U.S. Federal and state tax authorities.</span></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The guidance for accounting for U.S. Tax Reform requires taxpayers to make an election regarding the accounting for GILTI. This policy election is to either: (1) treat GILTI as a period cost if and when incurred, or (2) recognize deferred taxes for basis differences that are expected to reverse as GILTI in future years. During the first quarter of fiscal year 2019, the Company has made the accounting policy election to account for GILTI under the period cost method.</span></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Significant components of deferred tax assets and liabilities are as follows:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:65%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Deferred Tax Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Inventory adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Product warranty</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Deferred compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net operating loss carryforwards</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>24.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Accrued vacation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Credit carryforwards</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>46.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>18.4</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Valuation allowance</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(4.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:80px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Total deferred tax assets</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>27.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>14.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Deferred Tax Liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Acquired intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(19.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(15.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Property, plant and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(10.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(14.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Investments in privately held companies</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(3.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(4.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(2.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(4.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:80px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Total deferred tax liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(35.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(37.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:80px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Net deferred tax liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(8.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(23.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Reported As:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Deferred tax assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>27.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>14.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Deferred tax liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(35.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(37.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:68px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Net deferred tax liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(8.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(23.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As a result of the changes to the U.S. taxation of foreign earnings included in U.S. Tax Reform, the Company reevaluated its previous indefinite reinvestment assertion with respect to these earnings during fiscal year 2018, which resulted in the Company revoking its assertion for current and future earnings for all countries, while maintaining the assertion that historic earnings are </span></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">indefinitely reinvested outside the U.S. The Company has modified this prior assertion for the year ended September 27, 2019 with respect to the acquisition of Direct Conversion. The modification was to assert that all earnings for Direct Conversion, located primarily in Sweden and Finland, are indefinitely reinvested in those countries. Due to the level of earnings available for repatriation, the treaty benefits applicable to jurisdictions in which those earnings are located, and the now favorable U.S. tax treatment of repatriated foreign earnings, the amount of deferred tax liability recorded related to the potential repatriation is approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$0.1 million</span></span><span style="font-family:inherit;font-size:10pt;">. This estimated liability is for U.S. State income taxes and foreign withholding taxes that would apply if the foreign earnings were actually repatriated in the form of a dividend.</span></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of September 27, 2019, the Company has net operating loss carryforwards of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$24.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> with </span><span style="font-family:inherit;font-size:10pt;"><span>$4.4 million</span></span><span style="font-family:inherit;font-size:10pt;"> expiring between 2020 and 2030 and </span><span style="font-family:inherit;font-size:10pt;"><span>$19.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> carried forward indefinitely. </span></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The valuation allowance relates primarily to net operating losses in certain foreign jurisdictions where, based on the weight of available evidence, it is more likely than not that the tax benefit of the net operating losses will not be realized. The valuation allowance increased by </span><span style="font-family:inherit;font-size:10pt;"><span>$14.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> during fiscal year 2019 and decreased by </span><span style="font-family:inherit;font-size:10pt;"><span>$0.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> during fiscal year 2018. The increase during the current year was primarily related to the acquisition of Direct Conversion that included deferred tax assets subject to a valuation allowance as of acquisition. Changes in the Company's valuation allowance for deferred tax assets were as follows:</span></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Years</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Valuation allowance balance–beginning of fiscal year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Increases resulting from business combinations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>12.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other increases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other decreases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(2.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Valuation allowance balance—end of fiscal year</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">During fiscal year 2019, the Company paid U.S and foreign taxes of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$8.2 million</span></span><span style="font-family:inherit;font-size:10pt;">. In fiscal year 2018, the Company paid U.S. and foreign taxes of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$13.8 million</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company accounts for uncertainty in income taxes following a two-step approach for recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining whether the weight of available evidence indicates that it is more likely than not that, based on the technical merits, the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Changes in the Company’s unrecognized tax benefits were as follows:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Years</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Unrecognized tax benefits balance–beginning of fiscal year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Subtractions based on tax positions related to a prior year</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Additions based on tax positions related to the current year</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Unrecognized tax benefits balance—end of fiscal year</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;">, the total amount of gross unrecognized tax benefits was </span><span style="font-family:inherit;font-size:10pt;"><span>$0.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$0.6 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively, all of which would affect the effective tax rate if recognized. </span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company includes interest and penalties related to income taxes within taxes on earnings on the Combined Statements of Earnings. For the year ended </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$0.1 million</span></span><span style="font-family:inherit;font-size:10pt;"> interest and penalties have been included for this period. For the year ended </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;"> any interest or penalties related to unrecognized tax benefits are minimal and have been included in the balance for that period.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;"/><span style="font-family:inherit;font-size:10pt;">The Company files U.S. Federal and state income tax returns and non-U.S. income tax returns in various jurisdictions. All of these returns are subject to examination by their respective taxing jurisdictions from the date of filing through each applicable statute of limitation period. The Company’s significant operations up to the date of separation have historically been included in Varian’s U.S. federal and state income tax returns and non-U.S. jurisdiction tax returns. Material liabilities arising related to the pre-spin operations </span></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">would be the responsibility of Varian. Other periods for entities acquired are still open and subject to examination. Generally, periods prior to 2009 are no longer subject to examination.</span></div> <div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Taxes on earnings were as follows:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Years</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Current provision:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Federal</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>9.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(2.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>24.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">State and local</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Foreign</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>6.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:80px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total current</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>17.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>31.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Deferred provision (benefit):</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Federal</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(10.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(7.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(7.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">State and local</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Foreign</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:80px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total deferred</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(11.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(7.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(8.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Taxes on earnings</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(2.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>22.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 9200000 -2100000 24800000 1300000 -300000 1600000 6800000 7500000 5300000 17300000 5100000 31700000 -10000000.0 -7000000.0 -7000000.0 -1600000 700000 -1000000.0 0 -1400000 -900000 -11600000 -7700000 -8900000 5700000 -2600000 22800000 <div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Earnings before taxes are generated from the following geographic areas:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Years</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>55.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Foreign</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>15.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>22.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>19.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Earnings before taxes</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>21.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>25.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>74.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 5900000 3700000 55500000 15600000 22000000.0 19300000 21500000 25700000 74800000 <div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">The effective tax rate differs from the U.S. federal statutory tax rate as a result of the following:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9"/></tr><tr><td style="width:56%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="8" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Years</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Federal statutory income tax rate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>21.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>24.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>35.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">State and local taxes, net of federal tax benefit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Revaluation of deferred tax liabilities for US statutory change</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(41.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Mandatory repatriation tax on foreign earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>13.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Domestic production activities deduction</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(2.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Research and development credit</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(10.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(11.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(2.6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;background-color:#cceeff;">Prior year deferred tax adjustments</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(4.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Foreign Rate Difference</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Change in valuation allowance</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>11.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">US Tax Reform - International Provisions</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(4.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(2.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Effective tax rate</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>26.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(10.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>30.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"> %</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0.210 0.245 0.350 -0.009 0.011 0.013 0 -0.418 0 0.019 0.130 0 0 0.008 0.024 0.102 0.111 0.026 0.047 0.019 -0.040 0.06 0.008 0 0.112 -0.019 0.038 -0.047 0 0 -0.025 0.042 -0.006 0.265 -0.101 0.305 0.245 <div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Significant components of deferred tax assets and liabilities are as follows:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:65%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Deferred Tax Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Inventory adjustments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Share-based compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Product warranty</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Deferred compensation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net operating loss carryforwards</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>24.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>3.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Accrued vacation</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Credit carryforwards</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>46.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>18.4</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Valuation allowance</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(4.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:80px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Total deferred tax assets</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>27.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>14.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Deferred Tax Liabilities:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Acquired intangibles</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(19.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(15.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:1px;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Property, plant and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(10.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(14.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Investments in privately held companies</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(3.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(4.1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(2.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(4.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:80px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Total deferred tax liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(35.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(37.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:80px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Net deferred tax liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(8.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(23.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Reported As:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Deferred tax assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>27.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>14.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Deferred tax liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(35.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(37.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:68px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Net deferred tax liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(8.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(23.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 5600000 4200000 3100000 800000 1600000 1400000 1100000 900000 24300000 3300000 1000000.0 1300000 1900000 1800000 7500000 4700000 46100000 18400000 18800000 4000000.0 27300000 14400000 19300000 15200000 10600000 14300000 3300000 4100000 2300000 4000000.0 35500000 37600000 8200000 23200000 27300000 14400000 35500000 37600000 8200000 23200000 100000 24300000 4400000 19900000 14800000 -300000 Changes in the Company's valuation allowance for deferred tax assets were as follows:<div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Years</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Valuation allowance balance–beginning of fiscal year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Increases resulting from business combinations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>12.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other increases</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other decreases</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(2.5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Valuation allowance balance—end of fiscal year</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>4.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 4000000.0 4300000 2500000 12000000.0 0 0 2800000 2200000 2500000 0 2500000 700000 18800000 4000000.0 4300000 8200000 13800000 <div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#ffffff;">Changes in the Company’s unrecognized tax benefits were as follows:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:71%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Years</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Unrecognized tax benefits balance–beginning of fiscal year</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Subtractions based on tax positions related to a prior year</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:48px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Additions based on tax positions related to the current year</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:16px;text-indent:-16px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Unrecognized tax benefits balance—end of fiscal year</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 600000 500000 200000 0 200000 100000 600000 600000 600000 600000 100000 SEGMENT INFORMATION<div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has </span><span style="font-family:inherit;font-size:10pt;"><span>two</span></span><span style="font-family:inherit;font-size:10pt;"> reportable operating segments Medical and Industrial. The segments align the Company’s products and service offerings with customer use in medical and industrial markets and are consistent with how the Company’s Chief Executive Officer, who is also its CODM, evaluates the business for the allocation of resources. The CODM allocates resources to and evaluates the financial performance of each operating segment primarily based on revenues and gross margin. The operating and reportable segment structure provides alignment between business strategies and operating results.</span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Description of Segments</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Medical segment designs, manufactures, sells and services X-ray imaging components for use in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy and computer-aided detection. The Company provides a broad range of X-ray imaging components for Medical customers including X-ray tubes, digital flat panel detectors, generators, high voltage connectors, image-processing software and workstations, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, ionization chambers and buckys. The Company’s X-ray imaging components are primarily sold to imaging system OEM customers that incorporate them into their medical diagnostic, radiation therapy, dental, veterinary and industrial imaging systems. The Company also sells its X-ray imaging components to independent service companies, distributors and directly to end-users for replacement purposes.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Industrial segment designs, manufactures, sells and services products for use in the security and industrial inspection applications, such as airport security, cargo screening at ports and borders and nondestructive examination in a variety of applications. The products include Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high voltage connectors and image processing software that we generally sell to OEM customers that incorporate these products into their inspection systems.</span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Accordingly, the following information is provided for purposes of achieving an understanding of operations, but it may not be indicative of the financial results of the reported segments were they independent organizations. In addition, comparisons of the Company’s operations to similar operations of other companies may not be meaningful.</span></div><div style="line-height:120%;padding-bottom:9px;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Information related to the Company’s segments is as follows:</span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:47%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Year</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Revenues</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Medical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>596.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>602.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>556.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Industrial</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>183.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>171.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>141.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total revenues</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>780.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>773.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>698.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Gross margin</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>188.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>190.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>193.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Industrial</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>67.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>63.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>59.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total gross margin</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>256.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>253.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>253.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total operating expenses</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>211.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>209.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>169.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Interest and other expenses, net</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(24.2</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(18.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(8.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Earnings before taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>21.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>25.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>74.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Taxes (benefit) on earnings</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(2.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>22.8</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net earnings</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>15.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>28.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>52.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Less: Net earnings attributable to noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net earnings attributable to Varex</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>15.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>27.5</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>51.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:9px;padding-top:9px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the Company’s total assets by its reportable segments: </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:65%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Identifiable assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Medical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>794.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>770.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Industrial</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>244.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>217.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total reportable segments</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1,038.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>987.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:9px;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Geographic Information</span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:21%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Property, plant and equipment, net</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Years</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Years</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>275.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>268.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>231.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>122.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>127.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Latin America</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">EMEA</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>269.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>254.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>219.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>11.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">APAC</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>229.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>243.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>238.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total company</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>780.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>773.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>698.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>142.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>144.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company operates various manufacturing and marketing operations outside the United States. Latin America includes Brazil and Mexico. EMEA includes Europe, Russia, the Middle East, India and Africa. APAC includes Asia and Australia. Revenues by region are based on the known final destination of products sold.</span></div> 2 596800000 602000000.0 556900000 183800000 171400000 141200000 780600000 773400000 698100000 188900000 190500000 193600000 67800000 63400000 59900000 256700000 253900000 253500000 211000000.0 209400000 169800000 -24200000 -18800000 -8900000 21500000 25700000 74800000 5700000 -2600000 22800000 15800000 28300000 52000000.0 300000 800000 400000 15500000 27500000 51600000 <div style="line-height:120%;padding-bottom:9px;padding-top:9px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table summarizes the Company’s total assets by its reportable segments: </span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:65%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 27, 2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 28, 2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Identifiable assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Medical</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>794.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>770.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Industrial</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>244.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>217.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total reportable segments</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>1,038.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>987.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 794300000 770600000 244600000 217300000 1038900000 987900000 <div style="line-height:120%;padding-bottom:9px;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Geographic Information</span></div><div style="line-height:120%;padding-left:4px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.44444444444444%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:21%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Revenues</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Property, plant and equipment, net</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Years</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Fiscal Years</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2019</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">2018</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">United States</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>275.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>268.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>231.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>122.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>127.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Latin America</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">EMEA</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>269.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>254.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>219.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>11.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">APAC</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>229.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>243.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>238.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Total company</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>780.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>773.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>698.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>142.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>144.9</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 275300000 268800000 231900000 122600000 127900000 7300000 7000000.0 7900000 0 0 269000000.0 254500000 219500000 11400000 8700000 229000000.0 243100000 238800000 8300000 8300000 780600000 773400000 698100000 142300000 144900000 EMPLOYEE BENEFIT PLANS<div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Varex’s 401(k) plan became effective on January 1, 2017. Varex’s 401(k) plan is intended to be qualified under Section 401(a) of the Code with the 401(k) plan’s related trust intended to be tax exempt under Section 501(a) of the Code and intended for all full-time employees in the United States. This plan allows employees to contribute a portion of their pretax salary up to the maximum dollar limitation prescribed by the Internal Revenue Service. Prior to Varex's 401(k) plan becoming effective, Company employees participated in Varian's 401(k) plan. The Company made matching contributions to the plan totaling </span><span style="font-family:inherit;font-size:10pt;"><span>$6.7 million</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$6.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$4.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> in fiscal years </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, respectively. </span></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company also maintains defined benefit plans for employees located outside the US. The net pension liability is included in non-current liability on the Company's consolidated balance sheets and totaled </span><span style="font-family:inherit;font-size:10pt;"><span>$5.5 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$3.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">September 27, 2019</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">September 28, 2018</span><span style="font-family:inherit;font-size:10pt;">, respectively. The Company’s net periodic benefit costs for the Company’s defined benefit plans was not material for fiscal years </span><span style="font-family:inherit;font-size:10pt;">2019</span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;">2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">.</span></div> 6700000 6500000 4300000 5500000 3300000 OTHER COMPREHENSIVE INCOME<div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the changes in the accumulated balances for each component of other comprehensive income (loss):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:721px;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:429px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized Gain (Loss) on Derivative Financial Instruments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized Gain on Defined Benefit Obligations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Other Comprehensive Income</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance at September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other comprehensive loss before reclassifications</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(8.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(10.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Income tax benefit </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance at September 27, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"/><span style="font-family:inherit;font-size:10pt;"><span>No</span></span><span style="font-family:inherit;font-size:10pt;"> amounts were reclassified out of accumulated other comprehensive income during fiscal years 2019 and 2018.</span></div> <div style="line-height:120%;padding-top:12px;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the changes in the accumulated balances for each component of other comprehensive income (loss):</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:721px;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:429px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/><td style="width:5px;"/><td style="width:6px;"/><td style="width:82px;"/><td style="width:4px;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized Gain (Loss) on Derivative Financial Instruments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Unrealized Gain on Defined Benefit Obligations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:center;padding-left:4px;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Other Comprehensive Income</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance at September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other comprehensive loss before reclassifications</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(8.3</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.9</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(10.2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Income tax benefit </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>2.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance at September 27, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(1.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="padding-bottom:2px;text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 5800000 0 5800000 -8300000 -1900000 -10200000 -2100000 -600000 -2700000 -400000 -1300000 -1700000 0 REVENUE RECOGNITION<div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company adopted ASC 606 on September 29, 2018, using the modified retrospective method for all contracts not completed as of the date of adoption. The reported results for fiscal year 2019 reflect the application of ASC 606 guidance while the reported results for fiscal year 2018 were prepared under the guidance of ASC 605, “Revenue Recognition.” The primary impacts of the adoption include: (1) recording a separate contract liability and contract asset related to the sale of X-ray tubes that were sold with an option for the customer to require the Company to repurchase specific parts of the X‑ray tube at a specific price; and (2) recording a liability related to the deferral of revenue for service type warranties that are provided to certain customers who purchase Linatron</span><span style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></span><span style="font-family:inherit;font-size:10pt;"> X-ray accelerators.</span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has made the following accounting policy elections and elected to use certain practical expedients, as permitted by the FASB, in applying ASC 606: (1) the Company accounts for amounts collected from customers for sales and other taxes, net of related amounts remitted to tax authorities; (2) the Company does not adjust the promised amount of consideration for the effects of a significant financing component, if, at contract inception, the Company expects the period between the time when the Company transfers a promised good or service to the customer and the time when the customer pays for that good or service will be one year or less; (3) the Company expenses costs to obtain a contract as they are incurred if the expected period of benefit, and therefore the amortization period, is one year or less; (4) the Company accounts for shipping and handling activities that occur after control transfers to the customer as a fulfillment cost rather than an additional promised service and these fulfillment costs are included as a component of cost of revenues; and (5) the Company does not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.</span></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Transaction price and allocation to performance obligations</span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Transaction prices of products or services are typically based on contracted rates. To the extent that the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing the expected value method when there is a large number of transactions with similar characteristics or the most likely amount method when there are two possible outcomes, depending on the circumstances of the transaction, to which the Company expects to be entitled. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of the Company’s anticipated performance and all information (historical, current and forecasted) that is reasonably available.</span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company allows customers to return specific parts of purchased X-ray tubes for a partial refund credit, which is identified as variable consideration. ASC 606-10-55-23 requires that for sales with a right of return, revenue is reduced for expected returns, a liability is recorded for expected returns, and an asset is recorded for the right to recover products from customers on settling the liability. The Company recognizes a reduction to revenue and cost of sales at the time of sale and a corresponding contract liability and contract asset. The Company records this estimate based on the historical volume of product returns and adjusts the estimate on a quarterly basis based on the current quarter sales and current quarter returns.</span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">If a contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products or services underlying each performance obligation. The Company determines standalone selling prices based on the price at which the performance obligation is sold separately.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The beginning net cumulative-effect adjustment to the balance sheet for the adoption of ASC 606 is as follows:</span></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:47%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance at</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Adjustment Due to</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance at</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">ASC 606</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 29, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>17.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>6.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>23.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>16.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>18.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>34.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Liabilities and Equity:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Deferred revenues</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>13.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>13.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Accrued liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>47.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>54.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Deferred tax liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>23.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>22.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other long-term liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>21.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>29.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Retained earnings</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>62.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(3.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>58.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following tables compare the reported consolidated balance sheet and statement of operations for fiscal year ended September 27, 2019, to the amounts that would have been reported if ASC 605 had been in effect:</span></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:65%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 27, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance without Adoption</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">As Reported</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>13.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>19.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>10.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>27.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Liabilities and equity:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Deferred revenues</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>9.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>10.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Accrued liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>68.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>75.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Deferred tax liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>9.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other long-term liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>12.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>32.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Retained earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>77.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>74.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:65%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Twelve Months Ended September 27, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance without Adoption</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">As Reported</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Revenues</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>781.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>780.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Cost of revenues</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>524.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>523.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Taxes on earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net earnings attributable to Varex</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>15.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>15.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contracts and performance obligations</span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company accounts for a contract with a customer when there is an approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. The Company's performance obligations consist mainly of transferring control of products and services identified in the contracts or purchase orders. For each contract, the Company considers the obligation to transfer products and services to the customer, which are distinct, to be performance obligations.</span></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue recognition</span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the promised products or services is transferred to customers. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or services to a customer.</span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Product revenue is recognized when the customer obtains control of the Company’s product, which occurs at a point in time, and may be upon shipment or upon delivery based on the contractual shipping terms of a contract.</span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Service revenue is recognized over time as the services are rendered to the customer based on the extent of progress towards completion of the performance obligation. The Company recognizes service revenue over the term of the service contract. Services are expected to be transferred to the customer throughout the term of the contract and the Company believes recognizing revenue ratably over the term of the contract best depicts the transfer of value to the customer.</span></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Disaggregation of Revenue</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Revenue is disaggregated from contracts between geography and by reportable operating segment, which the Company believes best depicts how the nature, amount, timing, and uncertainty of revenues and cash flows are affected by economic factors. Refer to Note </span><span style="font-family:inherit;font-size:10pt;">15</span><span style="font-family:inherit;font-size:10pt;">. </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Segment Information, </span><span style="font-family:inherit;font-size:10pt;">included in this report, for the disaggregation of the Company’s revenue based on reportable operating segments and disaggregated by geographic region.    </span></div><div style="line-height:120%;padding-top:16px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Contract Balances</span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Contract assets are included within the prepaid expenses and other current assets, and other assets balances. Contract liabilities, which also includes refund obligations are included within the accrued liabilities, deferred revenues, and other long-term liabilities balances. The following table summarizes the changes in the contract assets and refund liabilities for the twelve months ended September 27, 2019:</span></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:83%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Contact Assets</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance at September 29, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>24.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Costs recovered from product returns during the period</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(6.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Contract asset from shipments of products, subject to return during the period</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance at September 27, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>23.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:83%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Refund Liabilities</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance at September 29, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>27.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Recognition of revenue included in beginning of year refund liability</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(7.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Additions to refund liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>6.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance at September 27, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>26.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Remaining Performance Obligations</span></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Remaining performance obligations represent the transaction price of firm orders for which revenue has not yet been recognized. As of September 27, 2019, total remaining performance obligations amounted to </span><span style="font-family:inherit;font-size:10pt;"><span>$265.2 million</span></span><span style="font-family:inherit;font-size:10pt;">. The Company expects to recognize a majority of the remaining performance obligations over the next 12 months.</span></div><div style="line-height:120%;padding-top:10px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Costs to Obtain or Fulfill a Customer Contract</span></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has certain costs to obtain and fulfill a customer contract, such as commissions and shipping costs. The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. Incremental costs of obtaining contracts that would be recognized over greater than one year are not material. The Company accounts for shipping and handling activities related to contracts with customers as costs to fulfill the promise to transfer the associated products. These costs are included as a component of cost of revenues.</span></div> <div style="line-height:120%;padding-top:8px;text-align:justify;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The beginning net cumulative-effect adjustment to the balance sheet for the adoption of ASC 606 is as follows:</span></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12"/></tr><tr><td style="width:47%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance at</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Adjustment Due to</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance at</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 28, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">ASC 606</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 29, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>17.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>6.4</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>23.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>16.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>18.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>34.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Liabilities and Equity:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Deferred revenues</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>13.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>0.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>13.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Accrued liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>47.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>7.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>54.6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Deferred tax liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>23.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(0.8</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>22.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other long-term liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>21.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>29.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Retained earnings</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>62.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(3.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>58.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following tables compare the reported consolidated balance sheet and statement of operations for fiscal year ended September 27, 2019, to the amounts that would have been reported if ASC 605 had been in effect:</span></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:65%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">September 27, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance without Adoption</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">As Reported</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Assets:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Prepaid expenses and other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>13.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>19.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>10.0</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>27.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Liabilities and equity:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Deferred revenues</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>9.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>10.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Accrued liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>68.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>75.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Deferred tax liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>9.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>8.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Other long-term liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>12.1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>32.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Retained earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>77.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>74.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:65%;"/><td style="width:16%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:16%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Twelve Months Ended September 27, 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Balance without Adoption</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">As Reported</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Revenues</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>781.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>780.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Cost of revenues</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>524.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>523.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Taxes on earnings</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Net earnings attributable to Varex</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>15.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>15.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 17100000 6400000 23500000 16500000 18000000.0 34500000 13200000 300000 13500000 47500000 7100000 54600000 23200000 -800000 22400000 8500000 21300000 29800000 62400000 -3500000 58900000 13100000 19300000 10000000.0 27500000 9900000 10500000 68800000 75700000 9100000 8200000 12100000 32500000 77700000 74400000 781200000 780600000 524700000 523900000 5700000 5700000 15300000 15500000 The following table summarizes the changes in the contract assets and refund liabilities for the twelve months ended September 27, 2019:<div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:83%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Contact Assets</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance at September 29, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>24.4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Costs recovered from product returns during the period</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(6.4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Contract asset from shipments of products, subject to return during the period</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>5.7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance at September 27, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>23.7</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:83%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">(In millions)</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;font-weight:bold;">Refund Liabilities</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance at September 29, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>27.1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Recognition of revenue included in beginning of year refund liability</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>(7.0</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Additions to refund liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>6.3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">Balance at September 27, 2019</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:9pt;"><span style="font-family:inherit;font-size:9pt;"><span>26.4</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 24400000 -6400000 5700000 23700000 27100000 -7000000.0 6300000 26400000 265200000 SUBSEQUENT EVENTS<div style="line-height:120%;padding-top:9px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On October 1, 2019, the Company, in accordance with the terms of the Credit Agreement, provided notice to the administrative agent that effective as of October 8, 2019, the Company was permanently reducing the revolving credit commitment under the Credit Agreement by </span><span style="font-family:inherit;font-size:10pt;"><span>$25.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>$125.0 million</span></span><span style="font-family:inherit;font-size:10pt;">. The reduction in the revolving credit commitment will also reduce the fees paid by the Company in connection with such commitment.</span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Events Subsequent to Original Issuance of Consolidated Financial Statements (Unaudited) </span></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Existing Credit Facility</span></div><div style="line-height:120%;padding-top:9px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In connection with the issuance of the Convertible Notes (defined below), on June 6, 2020, the Company amended the Credit Agreement (“Amendment No. 6”) to revise certain covenants, including covenants that restricted the incurrence of debt and restricted the Company’s ability to enter into the Call Spread Transactions (defined below) and issue the Convertible Notes (defined below). In connection with Amendment No. 6, the Company permanently reduced the total amount available under the Revolving Credit Facility to </span><span style="font-family:inherit;font-size:10pt;"><span>$100 million</span></span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;padding-top:9px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Convertible Notes</span></div><div style="line-height:120%;padding-top:9px;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;"/><span style="font-family:inherit;font-size:10pt;">On June 9, 2020, the Company issued </span><span style="font-family:inherit;font-size:10pt;"><span>$200.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> in aggregate principal amount of </span><span style="font-family:inherit;font-size:10pt;"><span>4.00%</span></span><span style="font-family:inherit;font-size:10pt;"> unsecured convertible senior notes due 2025 (“Convertible Notes”). The net proceeds from the issuance of the Convertible Notes, after deducting transaction fees and offering expense payable by us, were approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$193.1 million</span></span><span style="font-family:inherit;font-size:10pt;">. The Convertible Notes bear interest at the annual rate of </span></div><div style="line-height:120%;padding-top:9px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4.00%</span></span><span style="font-family:inherit;font-size:10pt;">, payable semiannually on June 15 and December 15 of each year, beginning on December 15, 2020, and will mature on June 15, 2025, unless earlier converted or repurchased by us.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Convertible Notes will be convertible into cash, shares of our common stock or a combination thereof, at our election, at an initial conversion rate of </span><span style="font-family:inherit;font-size:10pt;">48.05</span><span style="font-family:inherit;font-size:10pt;"> shares of common stock per </span><span style="font-family:inherit;font-size:10pt;">$1,000</span><span style="font-family:inherit;font-size:10pt;"> principal amount of Convertible Notes, which is equivalent to an initial conversion price of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$20.81</span></span><span style="font-family:inherit;font-size:10pt;"> per share, subject to adjustment pursuant to the terms of the Indenture governing the Convertible Notes (the "Indenture"). The Convertible Notes may be converted at any time after, and including, December 15, 2024 until the close of business on the second scheduled trading day immediately before the maturity date.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The conversion rate of the Convertible Notes may be adjusted in certain circumstances, including in connection with a conversion of the Convertible Notes made following certain fundamental changes and under other circumstances set forth in the Indenture. It is our current intent and policy to settle any conversions of notes through a combination of cash and shares.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Prior to the close of business on the business day immediately preceding December 15, 2024, the Convertible Notes at the option of the holder can be convertible only under the following circumstances:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">1.</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">during any calendar quarter commencing after the calendar quarter ending on September 30, 2020, if the last reported sale price per share of our common stock exceeds </span><span style="font-family:inherit;font-size:10pt;"><span>130%</span></span><span style="font-family:inherit;font-size:10pt;"> of the conversion price for each of at least </span><span style="font-family:inherit;font-size:10pt;"><span>20</span></span><span style="font-family:inherit;font-size:10pt;"> trading days during the </span><span style="font-family:inherit;font-size:10pt;"><span>30</span></span><span style="font-family:inherit;font-size:10pt;"> consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">2.</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">during the five consecutive business days immediately after any five consecutive trading day period (such five consecutive trading day period, the “measurement period”) in which the trading price per </span><span style="font-family:inherit;font-size:10pt;">$1,000</span><span style="font-family:inherit;font-size:10pt;"> principal amount of notes for each trading day of the measurement period was less than </span><span style="font-family:inherit;font-size:10pt;"><span>98%</span></span><span style="font-family:inherit;font-size:10pt;"> of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day;</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">3.</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">upon the occurrence of certain corporate events or distributions on our common stock, as described in the Indenture; or</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><span style="font-family:inherit;font-size:10pt;">4.</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">if we call any notes for redemption (under the conditions specified below).</span></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Convertible Notes will be redeemable, in whole or in part, at the Company’s option at any time, and from time to time, on or after June 1, 2023 and on or before the 60th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Convertible Notes to be redeemed, plus accrued and unpaid interest, if any, but only if the last reported sale price per share of the Company’s common stock exceeds </span><span style="font-family:inherit;font-size:10pt;"><span>130%</span></span><span style="font-family:inherit;font-size:10pt;"> of the conversion price on (i) each of at least </span><span style="font-family:inherit;font-size:10pt;"><span>20</span></span><span style="font-family:inherit;font-size:10pt;"> trading days, whether or not consecutive, during the </span><span style="font-family:inherit;font-size:10pt;"><span>30</span></span><span style="font-family:inherit;font-size:10pt;"> consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice; and (ii) the trading day immediately before the date the Company sends such notice. In addition, calling any Convertible Note for redemption will constitute a make-whole fundamental change with respect to that Convertible Note, in which case the conversion rate applicable to the conversion of that Convertible Note will be increased in certain circumstances if it is converted after it is called for redemption. No sinking fund is provided for the Convertible Notes.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Call Spread </span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On June 4, 2020 and June 5, 2020, in connection with the offering of the Convertible Notes, the Company entered into privately negotiated convertible note hedge transactions (collectively, the “Hedge Transactions”). The Hedge Transactions cover, subject to customary anti-dilution adjustments, the number of shares of our common stock that initially underlie the Convertible Notes. The Hedge Transactions are expected generally to reduce the potential dilution and/or offset any cash payments the Company is required to make in excess of the principal amount due upon conversion of the Convertible Notes in the event that the market price of our common stock is greater than the strike price of the Hedge Transactions, which was initially </span><span style="font-family:inherit;font-size:10pt;"><span>$20.81</span></span><span style="font-family:inherit;font-size:10pt;"> per share (subject to adjustment under the terms of the Hedge Transactions). The strike price of </span><span style="font-family:inherit;font-size:10pt;"><span>$20.81</span></span><span style="font-family:inherit;font-size:10pt;"> corresponds to the initial conversion price of the Convertible Notes. The number of shares underlying the Hedge Transactions is </span><span style="font-family:inherit;font-size:10pt;"><span>9.6 million</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On June 4, 2020 and June 5, 2020, the Company also entered into privately negotiated warrant transactions (collectively, the “Warrant Transactions” and, together with the Hedge Transactions, the “Call Spread Transactions”), whereby we sold warrants at a higher strike price relating to the same number of shares of our common stock that initially underlie the Convertible Notes, subject to customary anti-dilution adjustments. The initial strike price of the warrants is </span><span style="font-family:inherit;font-size:10pt;"><span>$24.975</span></span><span style="font-family:inherit;font-size:10pt;"> per share (subject to adjustment under the terms of the Warrant Transactions), which is </span><span style="font-family:inherit;font-size:10pt;"><span>50%</span></span><span style="font-family:inherit;font-size:10pt;"> above the last reported sale price of our common stock on June 4, 2020. The Warrant Transactions could have a dilutive effect to our stockholders to the extent that the market price per share of our common stock, as measured under the terms of the Warrant Transactions, exceeds the applicable strike price of the warrants. The number of shares underlying the Warrant Transactions is </span><span style="font-family:inherit;font-size:10pt;"><span>9.6 million</span></span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company used </span><span style="font-family:inherit;font-size:10pt;"><span>$11.2 million</span></span><span style="font-family:inherit;font-size:10pt;"> of the net proceeds from the issuance of the Convertible Notes and </span><span style="font-family:inherit;font-size:10pt;"><span>$49.8 million</span></span><span style="font-family:inherit;font-size:10pt;"> from the Warrant Transactions to pay the cost of the Hedge Transactions, which totaled </span><span style="font-family:inherit;font-size:10pt;"><span>$61.0 million</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Hedge Transactions and the Warrant Transactions are separate transactions, in each case, and are not part of the terms of the Convertible Notes and will not affect any holder’s rights under the Convertible Notes. Holders of the Convertible Notes will not have any rights with respect to the Call Spread Transactions.</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Accounting Treatment of the Convertible Notes and Related Hedge Transactions and Warrant Transactions</span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As the Call Spread Transactions meet certain accounting criteria, the Call Spread Transactions will be classified as equity and are not accounted for as derivatives. The proceeds from the offering of the Convertible Notes were separated into liability and equity components. On the date of issuance, the liability and equity components of the Convertible Notes were calculated to be approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$152.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$47.7 million</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. The initial </span><span style="font-family:inherit;font-size:10pt;"><span>$152.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> liability component was determined based on the fair value of similar debt instruments excluding the conversion feature assuming a hypothetical interest rate of </span><span style="font-family:inherit;font-size:10pt;"><span>10.45%</span></span><span style="font-family:inherit;font-size:10pt;">. The initial </span><span style="font-family:inherit;font-size:10pt;"><span>$47.7 million</span></span><span style="font-family:inherit;font-size:10pt;"> equity component represents the difference between the fair value of the initial </span><span style="font-family:inherit;font-size:10pt;"><span>$152.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> in debt and the </span><span style="font-family:inherit;font-size:10pt;"><span>$200.0 million</span></span><span style="font-family:inherit;font-size:10pt;"> of gross proceeds. The equity component will be included in additional paid-in capital in the consolidated balance sheet and will not be subsequently remeasured as long as it continues to meet the conditions for equity classification. The related initial debt discount of </span><span style="font-family:inherit;font-size:10pt;"><span>$47.7 million</span></span><span style="font-family:inherit;font-size:10pt;"> will be amortized over the life of the Convertible Notes as non-cash interest expense using the effective interest method at an interest rate of </span><span style="font-family:inherit;font-size:10pt;"><span>10.9%</span></span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In connection with the above-noted transactions, we incurred approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$6.9 million</span></span><span style="font-family:inherit;font-size:10pt;"> of offering-related costs. These offering fees were allocated to the liability and equity components in proportion to the allocation of proceeds and will be accounted for as debt and equity issuance costs, respectively. We allocated </span><span style="font-family:inherit;font-size:10pt;"><span>$5.3 million</span></span><span style="font-family:inherit;font-size:10pt;"> of debt issuance costs to the liability component, which will be capitalized as deferred financing costs within long-term debt. These costs will be amortized as interest expense over the term of the debt using the effective interest method. The remaining </span><span style="font-family:inherit;font-size:10pt;"><span>$1.6 million</span></span><span style="font-family:inherit;font-size:10pt;"> of transaction costs allocated to the equity component will be recorded as a reduction of the equity component.</span></div> -25000000.0 125000000.0 100000000 200000000.0 0.0400 193100000 0.0400 20.81 1.30 20 30 0.98 1.30 20 30 20.81 20.81 9600000 24.975 0.50 9600000 11200000 49800000 61000000.0 152300000 47700000 152300000 0.1045 47700000 152300000 200000000.0 47700000 0.109 6900000 5300000 1600000 XML 10 R100.htm IDEA: XBRL DOCUMENT v3.20.2
REVENUE RECOGNITION - Schedule of Balance Sheet Adjustment for ASC 606 Adoption (Details) - USD ($)
$ in Millions
Sep. 27, 2019
Mar. 29, 2019
Dec. 28, 2018
Sep. 29, 2018
Sep. 28, 2018
Assets          
Prepaid expenses and other current assets $ 19.3     $ 23.5 $ 17.1
Other assets 27.5     34.5 16.5
Liabilities, redeemable noncontrolling interests and stockholders' equity          
Deferred revenues 10.5     13.5 13.2
Accrued liabilities 75.7     54.6 47.5
Deferred tax liabilities 8.2     22.4 23.2
Other long-term liabilities 32.5     29.8 8.5
Retained earnings 74.4     58.9 62.4
Balance without Adoption          
Assets          
Prepaid expenses and other current assets 13.1       17.1
Other assets 10.0       16.5
Liabilities, redeemable noncontrolling interests and stockholders' equity          
Deferred revenues 9.9       13.2
Accrued liabilities 68.8       47.5
Deferred tax liabilities 9.1       23.2
Other long-term liabilities 12.1       8.5
Retained earnings 77.7       $ 62.4
ASU 2014-09 | Adjustment Due to ASC 606          
Assets          
Prepaid expenses and other current assets       6.4  
Other assets       18.0  
Liabilities, redeemable noncontrolling interests and stockholders' equity          
Deferred revenues       0.3  
Accrued liabilities       7.1  
Deferred tax liabilities       (0.8)  
Other long-term liabilities       21.3  
Retained earnings $ (3.5) $ 0.6 $ (4.1) $ (3.5)  
XML 11 R101.htm IDEA: XBRL DOCUMENT v3.20.2
REVENUE RECOGNITION - Schedule of ASC 606 Adoption Impact On Income Statement (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Revenues, net $ 780.6 $ 773.4 $ 698.1
Cost of revenues 523.9 519.5 444.6
Taxes (benefit) on earnings 5.7 (2.6) 22.8
Net earnings attributable to Varex 15.5 $ 27.5 $ 51.6
Balance without Adoption      
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]      
Revenues, net 781.2    
Cost of revenues 524.7    
Taxes (benefit) on earnings 5.7    
Net earnings attributable to Varex $ 15.3    
XML 12 R102.htm IDEA: XBRL DOCUMENT v3.20.2
REVENUE RECOGNITION - Schedule of Changes in Contract Balances (Details)
$ in Millions
 12 Months Ended
Sep. 27, 2019
USD ($)
Change in Contract with Customer, Asset [Abstract]  
Balance at September 29, 2018 $ 24.4
Costs recovered from product returns during the period (6.4)
Contract asset from shipments of products, subject to return during the period 5.7
Balance at September 27, 2019 23.7
Change in Contract with Customer, Liability [Abstract]  
Balance at September 29, 2018 27.1
Recognition of revenue included in beginning of year refund liability (7.0)
Additions to refund liabilities 6.3
Balance at September 27, 2019 $ 26.4
XML 13 R103.htm IDEA: XBRL DOCUMENT v3.20.2
REVENUE RECOGNITION - Remaining Performance Obligations (Details)
$ in Millions
Sep. 27, 2019
USD ($)
Revenue from Contract with Customer [Abstract]  
Revenue, remaining performance obligation, amount $ 265.2
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-09-28  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Revenue, remaining performance obligation, expected timing of satisfaction, period 12 months
XML 14 R104.htm IDEA: XBRL DOCUMENT v3.20.2
SUBSEQUENT EVENTS - (Details)
 12 Months Ended
Jun. 09, 2020
USD ($)
day
$ / shares
Rate
Jun. 05, 2020
USD ($)
shares
Oct. 08, 2019
USD ($)
Oct. 10, 2018
USD ($)
Sep. 27, 2019
USD ($)
Sep. 28, 2018
USD ($)
Sep. 29, 2017
USD ($)
Jun. 06, 2020
USD ($)
Jun. 04, 2020
USD ($)
$ / shares
May 01, 2017
USD ($)
Subsequent Event [Line Items]                    
Payments of debt issuance costs         $ 500,000 $ 400,000 $ 11,900,000      
Subsequent Event                    
Subsequent Event [Line Items]                    
Payment of hedge transactions from proceeds of convertible debt   $ 11,200,000                
Payment of hedge transactions from proceeds of warrant transactions   49,800,000                
Payments for hedge, financing activities   $ 61,000,000.0                
Revolving Credit Facility                    
Subsequent Event [Line Items]                    
Revolving credit commitment                   $ 400,000,000.0
Revolving Credit Facility | Subsequent Event                    
Subsequent Event [Line Items]                    
Permanent reduction in the revolving credit commitment     $ (25,000,000.0)              
Revolving credit commitment     125,000,000.0              
Revolving Credit Facility | Revolving Credit Facility                    
Subsequent Event [Line Items]                    
Permanent reduction in the revolving credit commitment       $ (50,000,000.0)            
Revolving credit commitment       $ 150,000,000.0           $ 200,000,000.0
Revolving Credit Facility | Revolving Credit Facility | Subsequent Event                    
Subsequent Event [Line Items]                    
Permanent reduction in the revolving credit commitment     25,000,000.0              
Revolving credit commitment     $ 125,000,000.0         $ 100,000,000    
Convertible Debt | Convertible Notes | Subsequent Event                    
Subsequent Event [Line Items]                    
Debt instrument, face amount $ 200,000,000.0               $ 200,000,000.0  
Debt instrument, interest rate, stated percentage 4.00%                  
Proceeds from convertible debt $ 193,100,000                  
Debt instrument, convertible, conversion ratio | Rate 4.805%                  
Debt instrument, convertible, conversion price (in dollars per share) | $ / shares $ 20.81               $ 20.81  
Debt instrument, convertible, threshold percentage of stock price trigger 130.00%                  
Debt instrument, convertible, threshold trading days | day 20                  
Debt instrument, convertible, threshold consecutive trading days | day 30                  
Debt instrument, convertible, consecutive business days | day 5                  
Debt instrument, convertible, consecutive trading day measurement period | day 5                  
Debt instrument, convertible, threshold for measurement period 98.00%                  
Debt instrument, convertible, number of equity instruments (in shares) | shares   9,600,000                
Exercise price of warrants (in dollars per share) | $ / shares                 $ 24.975  
Percent increase of strike price over sale price                 50.00%  
Convertible debt                 $ 152,300,000  
Debt instrument, convertible, carrying amount of equity component                 $ 47,700,000  
Debt instrument, convertible, hypothetical interest rate                 10.45%  
Debt instrument, interest rate, effective percentage                 10.90%  
Payment of financing and stock issuance costs   $ 6,900,000                
Payments of debt issuance costs   5,300,000                
Payments of stock issuance costs   $ 1,600,000                
XML 15 R10.htm IDEA: XBRL DOCUMENT v3.20.2
RELATED-PARTY TRANSACTIONS
 12 Months Ended
Sep. 27, 2019
Related Party Transactions [Abstract]  
RELATED-PARTY TRANSACTIONS RELATED-PARTY TRANSACTIONS
Investment in Privately-Held Companies
The Company has a 40% ownership interest in dpiX Holding LLC (“dpiX Holding”), a four-member consortium that has a 100% ownership interest in dpiX LLC (“dpiX”), a supplier of amorphous silicon based thin film transistor arrays for digital flat panel image detectors. In accordance with the dpiX Holding Agreement, net profits or losses are allocated to the members, in accordance with their ownership interests.
The equity investment in dpiX Holding is accounted for under the equity method of accounting. When the Company recognizes its share of net profits or losses of dpiX Holding, profits or losses in inventory purchased from dpiX are eliminated until realized by the Company. In fiscal years 2019, 2018 and 2017, the Company recorded (loss) and income on the equity investment in dpiX Holding of $(1.1) million, $3.4 million and $0.8 million, respectively. Income and loss on the equity investment in dpiX Holding is included in other (expense) income, net in the consolidated statements of earnings. The carrying value of the equity investment in dpiX Holding, which was included in investments in privately-held companies on the consolidated balance sheets, was $48.1 million and $48.9 million at September 27, 2019 and September 28, 2018, respectively.
In fiscal years 2019, 2018 and 2017, the Company purchased glass transistor arrays from dpiX totaling $23.5 million, $19.3 million and $24.7 million, respectively. These purchases of glass transistor arrays are included as a component of inventories on the consolidated balance sheets or cost of revenues in the consolidated statements of earnings for these fiscal years.
As of September 27, 2019 and September 28, 2018, the Company had accounts payable to dpiX totaling $3.6 million and $3.7 million, respectively.
In October 2013, the Company entered into an amended agreement with dpiX and other parties that, among other things, provides the Company with the right to 50% of dpiX’s total manufacturing capacity produced after January 1, 2014. The amended agreement requires the Company to pay for 50% of the fixed costs (as defined in the amended agreement), as determined at the
beginning of each calendar year. As of September 27, 2019, the Company estimated it has fixed cost commitments of $3.7 million related to this amended agreement through the remainder of calendar year 2019. The fixed cost commitment for future periods will be determined and approved by the dpiX board of directors at the beginning of each calendar year. The amended agreement will continue unless the ownership structure of dpiX changes (as defined in the amended agreement).
The Company has determined that dpiX is a variable interest entity because at-risk equity holders, as a group, lack the characteristics of a controlling financial interest. Majority votes are required to direct the manufacturing activities, legal operations and other activities that most significantly affect dpiX’s economic performance. The Company does not have majority voting rights and no power to direct the activities of dpiX and therefore is not the primary beneficiary of dpiX. The Company’s exposure to loss as a result of its involvement with dpiX is limited to the carrying value of the Company’s investment of $48.1 million and fixed cost commitments of $3.7 million.
In November 2018, the Company and CETTEEN GmbH (“CETTEEN”), formed a German limited liability company that governs the affairs and conduct of the business of VEC Imaging Verwaltungsgesellschaft GmbH (“VEC”), a joint venture formed to develop technology to be used in X-ray imaging components. In accordance with the VEC agreement, net profits or losses are allocated to the members, in accordance with their ownership interest. The Company's investment in VEC is accounted for under the equity method. The Company has made contributions totaling $2.9 million, and has committed to contribute an additional $2.2 million, as milestones are achieved, and to provide certain full time employees to support prototyping and manufacturing activities in exchange for a 50% interest in VEC. CETTEEN made contributions of certain assets including intellectual property in exchange for a 50% interest in VEC. The Company's investment in VEC was $2.0 million as of September 27, 2019.
XML 16 R11.htm IDEA: XBRL DOCUMENT v3.20.2
RESTRUCTURING
 12 Months Ended
Sep. 27, 2019
Restructuring and Related Activities [Abstract]  
RESTRUCTURING RESTRUCTURING
Following the acquisition of the medical imaging business from PKI in May of 2017, management began a multiyear program to consolidate the acquired operations, reduce costs, improve productivity and realize synergies.
In March 2018, the Company made the decision to transfer the complementary metal oxide semiconductor (“CMOS”) research and development capability from the U.K. to the U.S. and to permanently close the operation of the acquired detector business in London. The company will continue to develop the CMOS technology in the U.S. due to its competitive advantages, product differentiation and future economic benefit. In connection with this initiative, we recorded $1.7 million in restructuring charges during fiscal year 2018.
In July 2018, the Company committed to a plan to relocate the production of amorphous silicon glass for digital detectors, from its Santa Clara facility, to the jointly owned dpiX fabrication facility in Colorado. In July 2019, the Company committed to close its Santa Clara facility and to relocate the remaining production to its other existing facilities. The Company expects operations at the Santa Clara facility to cease by the end of December 2020 and all activities related to the closure of the facility to be complete by the end of March 2021. In connection with the relocation of the glass production and site closure the Company recorded $16.1 million and $14.2 million of restructuring and impairment charges during fiscal year 2019 and 2018, respectively. Fiscal year 2019 intangible asset impairment charges consisted of in-process research and development related to certain projects that were discontinued as a result of the Santa Clara facility closure. Fiscal year 2018 intangible asset impairment charges were related to a favorable leasehold interest that was impaired as a result of the amorphous silicon glass relocation. The Company expects to incur an additional $8.1 million to $12.1 million of restructuring charges through March 2021.
The Company also incurred approximately $2.8 million and $0.8 million of other unrelated restructuring expenses during fiscal years 2019 and 2018, respectively.
Cash outflows associated with these restructuring charges are limited to employee termination expenses, facility closure and equipment sales and disposals. Below is a detail of restructuring charges incurred during the 2019 and 2018 fiscal years, which predominately relate to the Company's Medical segment:
(In millions)
Location of Restructuring Charges in Consolidated Statements of Earnings
 
September 27, 2019
 
September 28, 2018
Other assets impairment charges
Selling, general and administrative
 
$
—

 
$
1.3

Inventory write downs
Cost of revenues
 
3.1

 
3.1

Intangible assets impairment
Impairment of intangible assets
 
4.8

 
3.0

Accelerated depreciation
Cost of revenues
 
4.5

 
4.2

Severance costs
Selling, general and administrative
 
6.2

 
4.3

Facility closure costs
Selling, general and administrative
 
0.3

 
0.8

Total restructuring charges
 
 
$
18.9

 
$
16.7
XML 17 R12.htm IDEA: XBRL DOCUMENT v3.20.2
OTHER FINANCIAL INFORMATION
 12 Months Ended
Sep. 27, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
OTHER FINANCIAL INFORMATION OTHER FINANCIAL INFORMATION
     The following table summarizes the Company’s accrued liabilities:
(In millions)
September 27, 2019
 
September 28, 2018
Accrued compensation and benefits
$
32.1

 
$
27.0

Product warranty
8.1

 
7.3

Income taxes payable
10.7

 
1.4

Payable to Varian Medical Systems
—

 
2.3

Right of return liability
6.9

 
—

Deferred consideration
8.9

 
—

Other
9.0

 
9.5

Total accrued liabilities
$
75.7

 
$
47.5


The following table summarizes the Company’s other long-term liabilities:
(In millions)
September 27, 2019
 
September 28, 2018
Long-term income tax payable
$
3.9

 
$
3.5

Environment liabilities
0.9

 
1.3

Defined benefit obligation liability
5.5

 
3.3

Long-term right of return liability
19.5

 
—

Long-term other
2.7

 
0.4

Total other long-term liabilities
$
32.5

 
$
8.5

The following table summarizes the Company’s other income (expense), net:
 
Fiscal Years
(In millions)
2019
 
2018
 
2017
Income (loss) from equity method investments
$
(2.3
)
 
$
3.9

 
$
1.3

Change in fair value of deferred consideration
1.0

 
—

 
—

Realized income (loss) on foreign currencies
(1.9
)
 
(1.2
)
 
1.9

Total other income (expense), net
$
(3.2
)
 
$
2.7

 
$
3.2
XML 18 R13.htm IDEA: XBRL DOCUMENT v3.20.2
NET EARNINGS PER SHARE
 12 Months Ended
Sep. 27, 2019
Earnings Per Share [Abstract]  
NET EARNINGS PER SHARE NET EARNINGS PER SHARE
Basic net earnings per common share is computed by dividing the net earnings for the period by the weighted average number of shares of common stock outstanding during the reporting period. Diluted net earnings per common share reflects the effects of potentially dilutive securities, which is computed by dividing net earnings by the sum of the weighted average number of common shares outstanding and dilutive common shares, which consists of stock options and unvested restricted stock.
A reconciliation of the numerator and denominator used in the calculation of basic and diluted net income per common share is as follows:
 
Fiscal Year
(In millions, except per share amounts)
2019
 
2018
 
2017
Net earnings attributable to Varex
$
15.5

 
$
27.5

 
$
51.6

Weighted average shares outstanding - basic
38.2

 
37.9

 
37.6

Dilutive effect of potential common shares
0.4

 
0.5

 
0.4

Weighted average shares outstanding - diluted
38.6

 
38.4

 
38

Net earnings per share attributable to Varex - basic
$
0.41

 
$
0.73

 
$
1.37

Net earnings per share attributable to Varex - diluted
$
0.40

 
$
0.72

 
$
1.36

Anti-dilutive employee shared based awards, excluded
1.9

 
1.2

 
1.0


The Company excludes potentially dilutive common shares (consisting of shares underlying stock options and the employee stock purchase plan) from the computation of diluted weighted average shares outstanding if the inclusion of the shares underlying these stock awards would be anti-dilutive to earnings per share.
XML 19 R14.htm IDEA: XBRL DOCUMENT v3.20.2
FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES
 12 Months Ended
Sep. 27, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES
As part of the Company’s overall risk management practices, the Company enters into financial derivatives to manage its financial exposures to foreign currency exchange rates and interest rates.
The Company records all derivatives on the consolidated balance sheets at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting, and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. A qualitative assessment of hedge effectiveness is performed on a quarterly basis, unless facts and circumstances indicate the hedge may no longer be highly effective.    The changes in fair value for all trades that are not designated for hedge accounting are recognized in current period earnings. The Company does not offset fair value amounts recognized for derivative instruments in its consolidated balance sheets for presentation purposes.
Credit risk related to derivative transactions reflects the risk that a party to the transaction could fail to meet its obligation under the derivative contracts. Therefore, the Company’s exposure to the counterparty’s credit risk is generally limited to the amounts, if any, by which the counterparty’s obligations to the Company exceed the Company’s obligations to the counterparty. The Company’s policy is to enter into contracts only with financial institutions which meet certain minimum credit ratings to help mitigate counterparty credit risk.
Derivatives Designated as Hedging Instruments - Cash Flow Hedges
The Company uses interest rate swap contracts as cash flow hedges to manage its exposure to fluctuations in LIBOR interest rates. Interest rate swap contracts hedging variable rate debt effectively fix the LIBOR component of its interest rate for a specific period of time.
As of September 27, 2019, the Company had the following outstanding derivatives designated as cash flow hedging instruments:
(In millions, except for number of instruments)
Number of Instruments
 
Notional Value
Interest Rate Swap Contracts
6
 
$
264.4


The following table summarizes the amount of pre-tax earnings recognized from derivative instruments for the periods indicated and the line items in the accompanying statements of operations where the results are recorded for cash flow hedges:
 
Amount of Gain or (Loss) Recognized in OCI on Derivative
Fiscal Year Ended
 
Location of Gain or (Loss) Reclassified from Accumulated OCI into Income
 
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income
Fiscal Year Ended
(In millions)
2019
 
2018
 
2017
 
 
2019
 
2018
 
2017
Interest Rate Swap Contracts
$
(6.3
)
 
$
6.9

 
$
0.6

 
Interest expense
 
$
1.9

 
$
0.1

 
$
(0.3
)
The Company expects that $0.1 million of the accumulated other comprehensive (loss) income related to cash flow hedges will be realized in pre-tax earnings over the next 12 months, but the amount will vary depending on interest rates.
These derivative instruments are subject to master netting agreements giving effect to rights of offset with each counterparty. None of the balances were eligible for netting. The following table summarizes the gross fair values of derivative instruments as of the periods indicated and the line items in the accompanying consolidated balance sheets where the instruments are recorded.
 
Derivative Assets
 
Derivative Liabilities
(In millions)
 
 
September 27, 2019
 
September 28, 2018
 
 
 
September 27, 2019
 
September 28, 2018
Derivatives designated as cash flow hedges
Balance sheet location
 
 
 
 
 
Balance sheet location
 
 
 
 
Interest rate swap contracts
Other current assets
 
$
—

 
$
2.2

 
Other current liabilities
 
$
—

 
$
—

Interest rate swap contracts
Other non-current assets
 
—

 
5.5

 
Other non-current liabilities
 
(0.5
)
 
—

 
 
 
$
—

 
$
7.7

 
 
 
$
(0.5
)
 
$
—


Derivatives Designated as Hedging Instruments - Net Investment Hedges
The Company uses cross currency swap contracts as net investment hedges to manage its risk of variability in foreign currency-denominated net investments in wholly-owned international operations. All changes in fair value of the derivatives designated as net investment hedges are reported in accumulated other comprehensive (loss) income along with the foreign currency translation adjustments on those investments. As of September 27, 2019, the Company had the following outstanding derivatives designated as net investment hedging instruments:
(In millions, except for number of instruments)
Number of Instruments
 
Notional Value
Cross Currency Swap Contracts
4
 
$
77.7


The following table summarizes the amount of pre-tax earnings recognized from derivative instruments for the periods indicated and the line items in the accompanying statements of operations where the results are recorded for net investment hedges:
 
Amount of Gain or (Loss) Recognized in OCI on Derivative
Fiscal Year Ended
 
Location of Gain or (Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)
 
Amount of Gain or (Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)
(In millions)
2019
 
2018
 
2017
 
 
2019
 
2018
 
2017
Cross Currency Swap Contracts
$
(0.2
)
 
$
—

 
$
—

 
Interest expense
 
$
0.2

 
$
—

 
$
—

These derivative instruments are subject to master netting agreements giving effect to rights of offset with each counterparty. None of the balances were eligible for netting. The following table summarizes the gross fair values of derivative instruments as of the periods indicated and the line items in the accompanying consolidated balance sheets where the instruments are recorded:
 
Derivative Assets
 
Derivative Liabilities
(In millions)
 
 
September 27, 2019
 
September 28, 2018
 
 
 
September 27, 2019
 
September 28, 2018
Derivatives designated as net investment hedges
Balance sheet location
 
 
 
 
 
Balance sheet location
 
 
 
 
Cross currency swap contracts
Other current assets
 
—

 
—

 
Other current liabilities
 
(0.2
)
 
—

 
 
 
$
—

 
$
—

 
 
 
$
(0.2
)
 
$
—


Balance Sheet Hedges
The Company also enters into foreign currency forward contracts to hedge fluctuations associated with foreign currency denominated monetary assets and liabilities, primarily cash, third-party accounts receivable, accounts payable, and intercompany receivables and payables. These forward contracts expire within 30 days. These forward contracts are not designated for hedge accounting treatment, therefore, the change in fair value of these derivatives is recorded as a component of other income (expense) and offsets the change in fair value of the foreign currency denominated assets and liabilities, which are also recorded in other income (expense). The effect of derivative instruments not designated as hedges for fiscal year 2019 was a loss of $1.5 million, which was primarily related to the purchase price hedge established following the announcement of the Company's planned acquisition of Direct Conversion. The Company does not, and does not intend to use derivative financial instruments for speculative or trading purposes.
The following table shows the notional amounts of outstanding foreign currency contracts entered into under its balance sheet hedge program as of September 27, 2019:
 
Notional Value of Derivatives not Designated as Hedging Instruments:
In millions
Buy contracts
 
Sell contract
Japanese yen
$
0.9

 
$
—

Swiss franc
—

 
(1.0
)
Chinese renminbi
1.8

 
—

Euro
8.8

 
—

 
$
11.5

 
$
(1.0
)
XML 20 R15.htm IDEA: XBRL DOCUMENT v3.20.2
BORROWINGS
 12 Months Ended
Sep. 27, 2019
Debt Disclosure [Abstract]  
BORROWINGS BORROWINGS
The following table summarizes the Company's short-term and long-term debt:
 
September 27, 2019
 
September 28, 2018
(In millions, except for percentages)
Amount
 
Weighted-Average Interest Rate
 
Amount
 
Weighted-Average Interest Rate
Current maturities of long-term debt
 
 
 
 
 
 
 
Term facility
$
29.4

 
5.6
%
 
$
25.0

 
4.2
%
Other debt
1.3

 
 
 
—

 
 
Total current maturities of long-term debt
$
30.7

 
 
 
$
25.0

 
 
 
 
 
 
 
 
 
 
Non-current maturities of long-term debt:
 
 
 
 
 
 
 
Revolving credit facility
$
59.0

 
5.6
%
 
$
28.0

 
4.2
%
Term facility
308.6

 
5.6
%
 
345.0

 
4.2
%
Other debt
2.5

 
 
 
—

 
 
Debt issuance costs
(5.7
)
 
 
 
(8.2
)
 
 
Non-current maturities of long-term debt
364.4

 
 
 
364.8

 
 
Total long-term debt, net
$
395.1

 
 
 
$
389.8

 
 

Existing Credit Facility
On May 1, 2017 and in connection with the Acquired Detector Business, the Company entered into a new secured revolving credit facility (the “Revolving Credit Facility”) in an aggregate principal amount of up to $200.0 million with a five-year term, and a secured term facility (the “Term Facility” and together with the Revolving Credit Facility, the “Credit Agreement”) in an aggregate principal amount of $400.0 million. The Term Facility will be repaid over five years, with 5.0% payable in quarterly installments
during each of the first two years of the term thereof, 7.5% payable in quarterly installments during the third and fourth years of the term thereof, and 10% payable in quarterly installments in the fifth year of the term thereof, with the remaining amount due at maturity. Varex used the net proceeds from the Term Facility, and the net proceeds from approximately $97.0 million drawn on the Revolving Credit Facility, to pay the purchase price for the Acquired Detector Business, plus related credit facility fees, and to repay all of Varex’s obligations under the Previous Credit Agreement. Both the Term Facility and Revolving Credit Facility expire on May 1, 2022.
The Credit Agreement contains various customary restrictive covenants that limits, among other things, the incurrence of indebtedness by Varex and its subsidiaries, the grant or incurrence of liens by Varex and its subsidiaries, the entry into sale and leaseback transactions by Varex and its subsidiaries, and the entry into certain fundamental change transactions by Varex and its subsidiaries. It also contains customary events of default and certain financial covenants. The Company agreed to maintain financial covenants, which include maximum consolidated total leverage ratio, maximum senior secured leverage ratio, maximum capital expenditures and a minimum consolidated fixed charge coverage ratio. The Company was in compliance with all financial covenants under the Credit Agreement as of September 27, 2019.
The Credit Agreement is secured by the stock and assets of Varex’s material subsidiaries. The Credit Agreement has several borrowing and interest rate options including the following indices: (a) LIBOR rate, or (b) the base rate (equal to the greater of the prime rate, the federal funds rate plus 0.50% or the LIBOR rate for a one-month period plus 1.00%). Loans under the Credit Agreement bear interest at a rate per annum using the applicable indices plus a varying interest rate margin of between 1.75% and 2.75% (for LIBOR rate loans) and 0.75%-1.75% (for base rate loans). The Credit Agreement also provides for fees applicable to amounts available to be drawn under outstanding letters of credit of 0.125%, and a fee on unused commitments which ranges from 0.25% to 0.40%.
On October 3, 2018, the Company, in accordance with the terms of the Credit Agreement, provided notice to the administrative agent that effective as of October 10, 2018, the Company had permanently reducing the revolving credit commitment under the Credit Agreement by $50.0 million to $150.0 million. The reduction in the revolving credit commitment reduced the fees paid by the Company in connection with such commitment.
Subsequent to fiscal year 2019, the Company, in accordance with the terms of the Credit Agreement, provided notice to the administrative agent that effective as of October 8, 2019, the Company was permanently reducing the revolving credit commitment under the Credit Agreement by $25.0 million to $125.0 million.
Subsequent to fiscal year 2019, the Company did not comply with the covenant under the Credit Agreement to timely deliver the Company's fiscal year 2019 annual financial statements. However, upon the filing of this Annual Report with the SEC, the Company will be able to deliver the fiscal year 2019 annual financial statements within the 30-day cure period set forth in the Credit Agreement and consequently no event of default will occur.
At September 27, 2019, the Company had $364.4 million in non-current maturities of long-term debt outstanding, net of deferred debt issuance costs of $5.7 million, and $30.7 million of current maturities of long-term debt outstanding.
Future principal payments of the long-term debt outstanding as of September 27, 2019 are as follows:
(In millions)
 
Fiscal years:
 
2020
$
30.7

2021
34.3

2022
335.8

Total debt outstanding
400.8

Less: current maturities of long-term debt
(30.7
)
Non-current portion of long -term debt
$
370.1
XML 21 R16.htm IDEA: XBRL DOCUMENT v3.20.2
FAIR VALUE
 12 Months Ended
Sep. 27, 2019
Fair Value Disclosures [Abstract]  
FAIR VALUE FAIR VALUE
Assets/Liabilities Measured at Fair Value on a Recurring Basis
In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.
(In millions)
Fair Value Measurements at September 27, 2019
 
Quoted Prices in Active Markets for Identical Assets and Liabilities
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
 
Total
Assets:
 
 
 
 
 
 
 
Cash equivalents - money market funds
$
—

 
$
8.8

 
$
—

 
$
8.8

Total assets measured at fair value
$
—

 
$
8.8

 
$
—

 
$
8.8

Liabilities:
 
 
 
 
 
 
 
Derivative liabilities
$
—

 
$
0.7

 
$
—

 
$
0.7

Deferred consideration
8.9

 
—

 
—

 
8.9

Total liabilities measured at fair value
$
8.9

 
$
0.7

 
$
—

 
$
9.6


As of September 27, 2019, the total outstanding borrowings under the Company's credit agreement were $395.1 million, net of deferred loan costs, which approximated its fair value because it is carried at a market observable interest rate that resets periodically and is categorized as Level 2 in the fair value hierarchy. The fair values of certain of the Company’s financial instruments, including bank deposits included in cash and cash equivalents, accounts receivable and accounts payable, also approximate their fair values due to their short maturities.
There were no financial assets or liabilities measured on a recurring basis using significant unobservable inputs (Level 3) and there were no transfers in or out of Level 1, 2 or 3 during fiscal year 2018.
At September 28, 2018, the Company determined the following levels of inputs for the following assets or liabilities:
(In millions)
Fair Value Measurements at September 28, 2018
 
Quoted Prices in Active Markets for Identical Assets and Liabilities
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
 
Total
Assets:
 
 
 
 
 
 
 
Cash equivalents - Money market funds
$
—

 
$
18.4

 
$
—

 
$
18.4

Derivative assets
—

 
7.7

 
—

 
7.7

Total assets measured at fair value
$
—

 
$
26.1

 
$
—

 
$
26.1

Liabilities:
 
 
 
 
 
 
 
Derivative liabilities
$
—

 
$
—

 
$
—

 
$
—
XML 22 R17.htm IDEA: XBRL DOCUMENT v3.20.2
GOODWILL AND INTANGIBLE ASSETS
 12 Months Ended
Sep. 27, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
GOODWILL AND INTANGIBLE ASSETS GOODWILL AND INTANGIBLE ASSETS
The following table reflects goodwill by reportable operating segment:
(In millions)
Medical
 
Industrial
 
Total
Balance at September 28, 2018
$
147.0

 
$
96.6

 
$
243.6

Business combination
26.0

 
21.2

 
47.2

Balance at September 27, 2019
$
173.0

 
$
117.8

 
$
290.8


The following table reflects the gross carrying amount and accumulated amortization of the Company’s finite-lived intangible assets included in other assets in the consolidated balance sheets:
 
September 27, 2019
 
September 28, 2018
(In millions)
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
Acquired existing technology
$
74.1

 
$
(28.4
)
 
$
45.7

 
$
57.9

 
$
(21.8
)
 
$
36.1

Patents, licenses and other
12.7

 
(8.4
)
 
4.3

 
9.9

 
(7.4
)
 
2.5

Customer contracts and supplier relationship
50.7

 
(17.2
)
 
33.5

 
42.6

 
(11.4
)
 
31.2

Total intangible assets with finite lives
137.5

 
(54.0
)
 
83.5

 
110.4

 
(40.6
)
 
69.8

In-process R&D with indefinite lives
2.8

 
0.0

 
2.8

 
4.0

 
0.0

 
4.0

Total intangible assets
$
140.3

 
$
(54.0
)
 
$
86.3

 
$
114.4

 
$
(40.6
)
 
$
73.8

 
 
 
 
 
 
 
 
 
 
 
 

Amortization expense for intangible assets was $15.7 million, $16.2 million and $10.5 million in fiscal years 2019, 2018 and 2017, respectively. The Company recognized an impairment loss of $4.8 million and $3.0 million in fiscal years 2019 and 2018, respectively. These impairment costs were included in the consolidated statements of earnings under impairment of intangible assets.
As of September 27, 2019, the estimated future amortization expense of intangible assets with finite lives is as follows:
(In millions)
 
Fiscal years:
 
2020
$
17.2

2021
16.3

2022
14.7

2023
13.7

2024
9.1

Thereafter
12.5

Total
$
83.5
XML 23 R18.htm IDEA: XBRL DOCUMENT v3.20.2
COMMITMENTS AND CONTINGENCIES
 12 Months Ended
Sep. 27, 2019
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES
Lease Commitments
At September 27, 2019, the Company was committed to minimum rentals under non-cancelable operating leases (including rent escalation clauses) for fiscal years 2020 through 2024 and thereafter, as follows: $7.5 million, $5.4 million, $4.7 million, $1.8 million, $0.9 million, and $0.2 million, respectively. Rental expenses were $5.1 million, $5.3 million, and $4.0 million for fiscal years 2019, 2018 and 2017, respectively.
Other Commitments
See Note 3. Related Party Transactions, included in this report, for additional information about the Company’s commitments to dpiX.
See Note 12. Redeemable Noncontrolling Interests & Noncontrolling Interests, included in this report, for additional information about the Company’s commitment to the noncontrolling shareholders of MeVis.
The Company has an environmental liability of approximately $0.9 million as of September 27, 2019.
 Contingencies
From time to time, the Company is a party to or otherwise involved in legal proceedings, claims and government inspections or investigations, customs and duty audits, other contingency matters, both inside and outside the United States, arising in the ordinary course of its business or otherwise. The Company accrues amounts for probable losses, to the extent they can be reasonably estimated, that it believes are adequate to address any liabilities related to legal proceedings and other loss contingencies that the Company believes will result in a probable loss (including, among other things, probable settlement value). A loss or a range of loss is disclosed when it is reasonably possible that a material loss will be incurred and can be estimated or when it is reasonably possible that the amount of a loss, when material, will exceed the recorded provision. The Company did not have any contingent liabilities as of September 27, 2019 and September 28, 2018. Legal expenses are expensed as incurred.
XML 24 R19.htm IDEA: XBRL DOCUMENT v3.20.2
REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS
 12 Months Ended
Sep. 27, 2019
Noncontrolling Interest [Abstract]  
REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS
In April 2019, a subsidiary of Varex completed the acquisition of 98.2% of the outstanding shares of common stock of Direct Conversion. As the Company has majority voting rights it has consolidated Direct Conversion's operations in its consolidated financial statements and recorded the noncontrolling interest. The noncontrolling interest related to Direct Conversion is included in noncontrolling interest in the equity section of the Company's consolidated balance sheet. Earnings representing the noncontrolling interest's portion of Direct Conversion's income from operations is included in the Company's consolidated statements of earnings.
In September 2018, the Company entered into a partnership in Saudi Arabia. The Company has majority voting rights with an approximate 75% interest. Accordingly, the Company has consolidated the operations of the Saudi Arabia partnership in our consolidated financial statements and recorded the noncontrolling interests. The noncontrolling interest related to the partner’s 25% interest in the joint venture is included in noncontrolling interest in the equity section of the Company’s consolidated balance sheet. Earnings representing the noncontrolling partner's share of income from operations is included in the Company's consolidated statements of earnings.
In April 2015, the Company completed the acquisition of 73.5% of the then outstanding shares of MeVis Medical Solutions AG (“MeVis”), a public company based in Bremen, Germany that provides image processing software and services for cancer screening. In August 2015, the Company, through one of its German subsidiaries, entered into a domination and profit and loss transfer agreement (the “DPLTA”) with MeVis. In October 2015, the DPLTA became effective upon its registration at the local court of Bremen, Germany. Under the DPLTA, MeVis subordinates its management to the Company and undertakes to transfer all of its annual profits and losses to the Company. In return, the DPLTA grants the noncontrolling shareholders of MeVis: (1) an annual recurring net compensation of €0.95 per MeVis share starting from January 1, 2015 and (2) a put right for their MeVis shares at €19.77 per MeVis share. Upon effectiveness of the DPLTA, the noncontrolling interests in MeVis became redeemable as a result of the put right and were reclassified to temporary equity. As of September 27, 2019, the redemption value of redeemable noncontrolling interests in MeVis was $10.5 million.
During fiscal year 2018, an immaterial number of MeVis’ shares were purchased under the put right. As of September 27, 2019, noncontrolling shareholders together held approximately 0.5 million shares of MeVis, representing 26.3% of the outstanding shares.
Changes in redeemable noncontrolling interests and noncontrolling interests were as follows: 
 
Fiscal Years
 
2019
 
2018
(In millions)
Redeemable
Noncontrolling
Interests
 
Noncontrolling
Interests
 
Redeemable
Noncontrolling
Interests
 
Noncontrolling Interest
Balance at beginning of period
$
11.1

 
$
2.1

 
$
11.2

 
$
—

Net earnings attributable to noncontrolling interests
0.5

 
(0.2
)
 
0.5

 
0.3

Contributions from noncontrolling interests
—

 
1.4

 
—

 
1.8

Dividend distributions
(0.5
)
 
—

 
(0.6
)
 
—

Other
(0.6
)
 
—

 
—

 
—

Balance at end of period
$
10.5

 
$
3.3

 
$
11.1

 
$
2.1
XML 25 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Cover Cover
Sep. 22, 2020
Cover [Abstract]  
Document Type 8-K
Document Period End Date Sep. 22, 2020
Entity Registrant Name VAREX IMAGING CORPORATION
Entity Incorporation, State or Country Code DE
Entity File Number 001-37860
Entity Tax Identification Number 81-3434516
Entity Address, Address Line One 1678 S. Pioneer Road,
Entity Address, City or Town Salt Lake City,
Entity Address, State or Province UT
Entity Address, Postal Zip Code 84104
City Area Code 801
Local Phone Number 972-5000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol VREX
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001681622
Document Fiscal Year Focus 2019
Document Fiscal Period Focus FY
Amendment Flag false
XML 26 R20.htm IDEA: XBRL DOCUMENT v3.20.2
EMPLOYEE STOCK PLANS
 12 Months Ended
Sep. 27, 2019
Share-based Payment Arrangement [Abstract]  
EMPLOYEE STOCK PLANS EMPLOYEE STOCK PLANS
Employee Stock Plans
The Company's employees participate in Varex Imaging Corporation 2017 Omnibus Stock Plan (the “2017 Stock Plan”) and Varex Imaging Corporation 2017 Employee Stock Purchase Plan (the “2017 ESPP”) which allows the grants of stock options, restricted stock units and performance shares among other types of awards.
In January 2017, Varex stockholders approved the 2017 ESPP, which provides eligible employees with an opportunity to purchase shares of Varex common stock at 85% of the lower of its fair market value at the start and end of a six months purchase period. The 2017 ESPP provides for the purchase of up to one million shares of Varex common stock.
Share-Based Compensation Expense
Share-based compensation expense recognized in the consolidated statements of earnings is based on awards ultimately expected to vest. Share-based compensation expense includes expenses related to the Company’s direct employees. Prior to the separation, Varian also charged the Company for the allocated share-based compensation costs of certain employees of Varian who provided selling, general and administrative services on the Company’s behalf.
The table below summarizes the effect of recording share-based compensation expense and for the option component of the employee stock purchase plan shares:
 
Fiscal Year
(In millions)
2019
 
2018
 
2017
Cost of revenues
$
1.2

 
$
1.3

 
$
0.9

Research and development
2.2

 
1.8

 
1.5

Selling, general and administrative (1)
8.3

 
6.9

 
6.0

Total share-based compensation expense
$
11.7

 
$
10.0

 
$
8.4

(1) Includes allocated share-based compensation of $0.8 million for fiscal year 2017 and represents charges by Varian to the Company for certain Varian employees who provided general and administrative services on the Company’s behalf.
The unrecognized share-based compensation cost as of September 27, 2019 was $23.1 million, and is expected to be recognized in the next 3 to 4 fiscal years. As of September 27, 2019, there were approximately 1.2 million and 0.7 million shares of common stock available for future issuances under the 2017 Stock Plan and the 2017 ESPP, respectively.
The Company utilized the Black-Scholes valuation model for estimating the fair value of stock options granted and the option component of ESPP grants. The Company calculated the fair value of option grants and option component of ESPP grants on the respective dates of grant using the following weighted average assumptions:
 
Employee Stock Option Plan
 
Employee Stock Purchase Plans
 
Fiscal Year
 
Fiscal Year
 
2019
 
2018
 
2017
 
2019
 
2018
 
2017
Expected term (in years)
4.6

 
4.8

 
4.2

 
0.5

 
0.5

 
0.5

Risk-free interest rate
2.5
%
 
2.6
%
 
1.6
%
 
2.5
%
 
2.0
%
 
1.0
%
Expected volatility
33.9
%
 
31.8
%
 
23.6
%
 
43.9
%
 
34.1
%
 
28.0
%
Expected dividend
0.0
%
 
0.0
%
 
0.0
%
 
0.0
%
 
0.0
%
 
0.0
%
Weighted average fair value at grant date
$10.19
 
$11.57
 
$8.08
 
$7.81
 
$8.92
 
$7.81

Option valuation methods, including Black-Scholes, require the input of subjective assumptions, which are discussed below.
Risk-Free Interest Rate
The interest rates used are based on the implied yield currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term equal to the expected life of the award.
Expected Term
Options granted generally vest over a period of 36 to 48 months and expire 7 to 10 years from date of grant. Employee stock purchase plan offering periods are 6 months and provides eligible employees with an opportunity to purchase shares of Varex common stock at 85% of the lower of its fair market value at the start and end of a six-month purchase period.
Expected Dividend Yield
The dividend rate used is zero as the Company has never paid any cash dividends on its common stock and does not anticipate doing so in the foreseeable future. The Company is also restricted from paying dividends on common stock under its credit facility.
Expected Volatility
Authoritative accounting guidance on stock-based compensation indicates that companies should consider volatility over a period generally commensurate with the expected or contractual term of the stock option. Adequate Company-specific data does not exist for this time period as the Company began trading in January 2017. The volatility variable used is a blended approach by using the Company's historic data for the years it has been publicly traded and a benchmark of other comparable companies’ volatility rates for the prior years.
Stock Option Activity
The following table summarizes the activity for stock options under Varex’s employee incentive plans for the Company’s employees:
(In thousands, except per share amounts and the remaining term)
Options
 
Price range
 
Weighted Average
Exercise Price
 
Weighted Average Remaining Term (in years)
 
Aggregate Intrinsic Value (1)
Outstanding at September 28, 2018
2,011
 
$22.63 — $37.60
 
$
30.35

 
 
 
 
Granted
297
 
$31.42 — $31.42
 
31.42

 
 
 
 
Canceled, expired or forfeited
(4)
 
$31.08 — $31.08
 
31.08

 
 
 
 
Exercised
(35)
 
$22.84 — $27.77
 
23.38

 
 
 
 
Outstanding at September 27, 2019
2,269
 
$22.63 — $37.60
 
$
30.60

 
4.1
 
$
1,220.3

Exercisable at September 27, 2019
1,477
 
$22.63 — $37.60
 
$
29.67

 
3.4
 
$
1,220.3

(1) The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of Varex common stock of $28.28 as of September 27, 2019, the last trading date of the Company's respective fiscal years, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date.
The weighted-average grant-date fair value of options granted during fiscal years 2019, 2018 and 2017 was $3.0 million, $3.1 million and $9.2 million respectively. The total intrinsic value of the options exercised during the years ended September 27, 2019, September 28, 2018 and September 29, 2017 was $0.2 million, $1.7 million and $1.4 million respectively
Restricted Stock Units, Restricted Stock Awards and Deferred Stock Units
The following table summarizes the activity for restricted stock units, restricted stock awards and deferred stock units under Varex’s employee incentive plans for the Company’s employees:
(In thousands, except per share amounts)
Number of Shares
 
Weighted Average
Grant-Date Fair
Value
Balance at September 28, 2018
641
 
$
33.60

Granted
288
 
31.29

Vested
(201)
 
31.56

Canceled or expired
(50)
 
34.13

Balance at September 27, 2019
678
 
$
33.18

The total grant-date fair value of shares granted in fiscal year was $9.0 million, $10.1 million and $11.4 million for fiscal years 2019, 2018 and 2017, respectively. Shares outstanding at September 27, 2019, September 28, 2018 and September 29, 2017 had an estimated market value of $19.2 million, $18.4 million and $17.8 million, respectively.
XML 27 R21.htm IDEA: XBRL DOCUMENT v3.20.2
TAXES ON EARNINGS
 12 Months Ended
Sep. 27, 2019
Income Tax Disclosure [Abstract]  
TAXES ON EARNINGS TAXES ON EARNINGS
Income tax expense is based on reported income or loss before income taxes. Deferred income taxes reflect the effect of temporary differences between asset and liability amounts that are recognized for financial reporting purposes and the amounts that are recognized for income tax purposes. These deferred taxes are measured by applying currently enacted tax laws. Valuation allowances are recognized to reduce deferred tax assets to the amount that is more likely than not to be realized.
Taxes on earnings were as follows:
 
Fiscal Years
(In millions)
2019
 
2018
 
2017
Current provision:
 
 
 
 
 
Federal
$
9.2

 
$
(2.1
)
 
$
24.8

State and local
1.3

 
(0.3
)
 
1.6

Foreign
6.8

 
7.5

 
5.3

Total current
17.3

 
5.1

 
31.7

Deferred provision (benefit):
 
 
 
 
 
Federal
(10.0
)
 
(7.0
)
 
(7.0
)
State and local
(1.6
)
 
0.7

 
(1.0
)
Foreign
—

 
(1.4
)
 
(0.9
)
Total deferred
(11.6
)
 
(7.7
)
 
(8.9
)
Taxes on earnings
$
5.7

 
$
(2.6
)
 
$
22.8


Earnings before taxes are generated from the following geographic areas:
 
Fiscal Years
(In millions)
2019
 
2018
 
2017
United States
$
5.9

 
$
3.7

 
$
55.5

Foreign
15.6

 
22.0

 
19.3

Earnings before taxes
$
21.5

 
$
25.7

 
$
74.8


The effective tax rate differs from the U.S. federal statutory tax rate as a result of the following:
 
Fiscal Years
 
2019
 
2018
 
2017
Federal statutory income tax rate
21.0
 %
 
24.5
 %
 
35.0
 %
State and local taxes, net of federal tax benefit
(0.9
)%
 
1.1
 %
 
1.3
 %
Revaluation of deferred tax liabilities for US statutory change
—
 %
 
(41.8
)%
 
—
 %
Mandatory repatriation tax on foreign earnings
1.9
 %
 
13.0
 %
 
—
 %
Domestic production activities deduction
—
 %
 
(0.8
)%
 
(2.4
)%
Research and development credit
(10.2
)%
 
(11.1
)%
 
(2.6
)%
Prior year deferred tax adjustments
4.7
 %
 
1.9
 %
 
(4.0
)%
Foreign Rate Difference
6
 %
 
0.8
 %
 
—
 %
Change in valuation allowance
11.2
 %
 
(1.9
)%
 
3.8
 %
US Tax Reform - International Provisions
(4.7
)%
 
—
 %
 
—
 %
Other
(2.5
)%
 
4.2
 %
 
(0.6
)%
Effective tax rate
26.5
 %
 
(10.1
)%
 
30.5
 %

On December 22, 2017, the Tax Cuts and Jobs Act of 2017 (U.S. Tax Reform) was enacted in the U.S. which significantly revised the U.S. corporate income tax structure. Among the revisions impacting our effective tax rate are a lower U.S. corporate statutory rate going from 35% to 21% effective January 1, 2018 and changes to the way foreign earnings are taxed. As a September fiscal year filer, the lower corporate income tax rate is phased in from a U.S. statutory federal rate of 24.5% in fiscal year ending September 28, 2018 to a rate of 21% for the fiscal year ending September 27, 2019.
During fiscal year 2019, the Company’s effective tax rate varied from the U.S. federal statutory rate of 21% primarily because of the favorable impact of changes to the U.S. corporate tax structure resulting from U.S. Tax Reform, and U.S. research and development tax credits. These favorable U.S. tax items are offset by losses in certain foreign jurisdictions for which no benefit is recognized and earnings in other foreign jurisdictions that are taxed at higher rates.
During fiscal year 2018, the Company’s effective tax rate varied from the U.S. federal statutory rate primarily because the favorable impact of changes to the U.S. corporate tax structure resulting from U.S. Tax Reform. During fiscal years 2018 and 2017, the effective tax rate also differs from the U.S. federal statutory rate due to increases resulting from U.S. state income tax expense, losses in certain foreign jurisdictions for which no benefit is recognized, earnings in other foreign jurisdictions that are taxed at higher rates, and limitations on the deductibility of officers' compensation. These are offset by decreases due to U.S. research and development credits, tax windfalls for share-based compensation, and the release of a valuation allowance against loss carryforwards in certain foreign jurisdictions.
The SEC issued guidance under Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (“SAB 118”) that allows for reasonable estimated amounts to be recorded and a measurement period of up to one year from the date of enactment to revise these provisional amounts as new information is obtained and additional guidance is issued. During the three months ended December 28, 2018, the Company completed its analysis of U.S. Tax Reform, and the accounting for the income tax effects has been finalized for the measurement period under SAB 118, with no significant adjustments from the provisional amounts. During fiscal year 2019, additional U.S. Tax Reform provisions, including GILTI (global intangible low-taxed income), BEAT (base-erosion anti-abuse tax), FDII (foreign-derived intangible income), limitations on interest expense deductions (if certain conditions apply), and other components became effective for the Company and, if applicable, have been included in the calculation of the fiscal year 2019 tax provision. The determination of the tax effects of U.S. Tax Reform may change following future legislation or further interpretation of U.S. Tax Reform from U.S. Federal and state tax authorities.
The guidance for accounting for U.S. Tax Reform requires taxpayers to make an election regarding the accounting for GILTI. This policy election is to either: (1) treat GILTI as a period cost if and when incurred, or (2) recognize deferred taxes for basis differences that are expected to reverse as GILTI in future years. During the first quarter of fiscal year 2019, the Company has made the accounting policy election to account for GILTI under the period cost method.
Significant components of deferred tax assets and liabilities are as follows:
(In millions)
September 27, 2019
 
September 28, 2018
Deferred Tax Assets:
 
 
 
Inventory adjustments
$
5.6

 
$
4.2

Share-based compensation
3.1

 
0.8

Product warranty
1.6

 
1.4

Deferred compensation
1.1

 
0.9

Net operating loss carryforwards
24.3

 
3.3

Accrued vacation
1.0

 
1.3

Credit carryforwards
1.9

 
1.8

Other
7.5

 
4.7

 
46.1

 
18.4

Valuation allowance
(18.8
)
 
(4.0
)
Total deferred tax assets
27.3

 
14.4

Deferred Tax Liabilities:
 
 
 
Acquired intangibles
(19.3
)
 
(15.2
)
Property, plant and equipment
(10.6
)
 
(14.3
)
Investments in privately held companies
(3.3
)
 
(4.1
)
Other
(2.3
)
 
(4.0
)
Total deferred tax liabilities
(35.5
)
 
(37.6
)
Net deferred tax liabilities
$
(8.2
)
 
$
(23.2
)
Reported As:
 
 
 
Deferred tax assets
$
27.3

 
$
14.4

Deferred tax liabilities
(35.5
)
 
(37.6
)
Net deferred tax liabilities
$
(8.2
)
 
$
(23.2
)

As a result of the changes to the U.S. taxation of foreign earnings included in U.S. Tax Reform, the Company reevaluated its previous indefinite reinvestment assertion with respect to these earnings during fiscal year 2018, which resulted in the Company revoking its assertion for current and future earnings for all countries, while maintaining the assertion that historic earnings are
indefinitely reinvested outside the U.S. The Company has modified this prior assertion for the year ended September 27, 2019 with respect to the acquisition of Direct Conversion. The modification was to assert that all earnings for Direct Conversion, located primarily in Sweden and Finland, are indefinitely reinvested in those countries. Due to the level of earnings available for repatriation, the treaty benefits applicable to jurisdictions in which those earnings are located, and the now favorable U.S. tax treatment of repatriated foreign earnings, the amount of deferred tax liability recorded related to the potential repatriation is approximately $0.1 million. This estimated liability is for U.S. State income taxes and foreign withholding taxes that would apply if the foreign earnings were actually repatriated in the form of a dividend.
As of September 27, 2019, the Company has net operating loss carryforwards of approximately $24.3 million with $4.4 million expiring between 2020 and 2030 and $19.9 million carried forward indefinitely.
The valuation allowance relates primarily to net operating losses in certain foreign jurisdictions where, based on the weight of available evidence, it is more likely than not that the tax benefit of the net operating losses will not be realized. The valuation allowance increased by $14.8 million during fiscal year 2019 and decreased by $0.3 million during fiscal year 2018. The increase during the current year was primarily related to the acquisition of Direct Conversion that included deferred tax assets subject to a valuation allowance as of acquisition. Changes in the Company's valuation allowance for deferred tax assets were as follows:
 
Fiscal Years
(In millions)
2019
 
2018
 
2017
Valuation allowance balance–beginning of fiscal year
$
4.0

 
$
4.3

 
$
2.5

Increases resulting from business combinations
12.0

 
—

 
—

Other increases
2.8

 
2.2

 
2.5

Other decreases
—

 
(2.5
)
 
(0.7
)
Valuation allowance balance—end of fiscal year
$
18.8

 
$
4.0

 
$
4.3


During fiscal year 2019, the Company paid U.S and foreign taxes of approximately $8.2 million. In fiscal year 2018, the Company paid U.S. and foreign taxes of approximately $13.8 million.
The Company accounts for uncertainty in income taxes following a two-step approach for recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining whether the weight of available evidence indicates that it is more likely than not that, based on the technical merits, the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.
Changes in the Company’s unrecognized tax benefits were as follows:
 
Fiscal Years
(In millions)
2019
 
2018
Unrecognized tax benefits balance–beginning of fiscal year
$
0.6

 
$
0.5

Subtractions based on tax positions related to a prior year
(0.2
)
 
—

Additions based on tax positions related to the current year
0.2

 
0.1

Unrecognized tax benefits balance—end of fiscal year
$
0.6

 
$
0.6


As of September 27, 2019 and September 28, 2018, the total amount of gross unrecognized tax benefits was $0.6 million and $0.6 million, respectively, all of which would affect the effective tax rate if recognized.
The Company includes interest and penalties related to income taxes within taxes on earnings on the Combined Statements of Earnings. For the year ended September 27, 2019, $0.1 million interest and penalties have been included for this period. For the year ended September 28, 2018 any interest or penalties related to unrecognized tax benefits are minimal and have been included in the balance for that period.
The Company files U.S. Federal and state income tax returns and non-U.S. income tax returns in various jurisdictions. All of these returns are subject to examination by their respective taxing jurisdictions from the date of filing through each applicable statute of limitation period. The Company’s significant operations up to the date of separation have historically been included in Varian’s U.S. federal and state income tax returns and non-U.S. jurisdiction tax returns. Material liabilities arising related to the pre-spin operations
would be the responsibility of Varian. Other periods for entities acquired are still open and subject to examination. Generally, periods prior to 2009 are no longer subject to examination.
XML 28 R22.htm IDEA: XBRL DOCUMENT v3.20.2
SEGMENT INFORMATION
 12 Months Ended
Sep. 27, 2019
Segment Reporting [Abstract]  
SEGMENT INFORMATION SEGMENT INFORMATION
The Company has two reportable operating segments Medical and Industrial. The segments align the Company’s products and service offerings with customer use in medical and industrial markets and are consistent with how the Company’s Chief Executive Officer, who is also its CODM, evaluates the business for the allocation of resources. The CODM allocates resources to and evaluates the financial performance of each operating segment primarily based on revenues and gross margin. The operating and reportable segment structure provides alignment between business strategies and operating results.
Description of Segments
The Medical segment designs, manufactures, sells and services X-ray imaging components for use in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy and computer-aided detection. The Company provides a broad range of X-ray imaging components for Medical customers including X-ray tubes, digital flat panel detectors, generators, high voltage connectors, image-processing software and workstations, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, ionization chambers and buckys. The Company’s X-ray imaging components are primarily sold to imaging system OEM customers that incorporate them into their medical diagnostic, radiation therapy, dental, veterinary and industrial imaging systems. The Company also sells its X-ray imaging components to independent service companies, distributors and directly to end-users for replacement purposes.
The Industrial segment designs, manufactures, sells and services products for use in the security and industrial inspection applications, such as airport security, cargo screening at ports and borders and nondestructive examination in a variety of applications. The products include Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high voltage connectors and image processing software that we generally sell to OEM customers that incorporate these products into their inspection systems.
Accordingly, the following information is provided for purposes of achieving an understanding of operations, but it may not be indicative of the financial results of the reported segments were they independent organizations. In addition, comparisons of the Company’s operations to similar operations of other companies may not be meaningful.
Information related to the Company’s segments is as follows:
 
Fiscal Year
(In millions)
2019
 
2018
 
2017
Revenues
 
 
 
 
 
Medical
$
596.8

 
$
602.0

 
$
556.9

Industrial
183.8

 
171.4

 
141.2

Total revenues
780.6

 
773.4

 
698.1

Gross margin
 
 
 
 
 
Medical
188.9

 
190.5

 
193.6

Industrial
67.8

 
63.4

 
59.9

Total gross margin
256.7

 
253.9

 
253.5

Total operating expenses
211.0

 
209.4

 
169.8

Interest and other expenses, net
(24.2
)
 
(18.8
)
 
(8.9
)
Earnings before taxes
21.5

 
25.7

 
74.8

Taxes (benefit) on earnings
5.7

 
(2.6
)
 
22.8

Net earnings
15.8

 
28.3

 
52.0

Less: Net earnings attributable to noncontrolling interests
0.3

 
0.8

 
0.4

Net earnings attributable to Varex
$
15.5

 
$
27.5

 
$
51.6


The following table summarizes the Company’s total assets by its reportable segments:
(In millions)
September 27, 2019
 
September 28, 2018
Identifiable assets:
 
 
 
Medical
$
794.3

 
$
770.6

Industrial
244.6

 
217.3

Total reportable segments
$
1,038.9

 
$
987.9


Geographic Information
 
Revenues
 
Property, plant and equipment, net
 
Fiscal Years
 
Fiscal Years
(In millions)
2019
 
2018
 
2017
 
2019
 
2018
United States
$
275.3

 
$
268.8

 
$
231.9

 
$
122.6

 
$
127.9

Latin America
7.3

 
7.0

 
7.9

 
—

 
—

EMEA
269.0

 
254.5

 
219.5

 
11.4

 
8.7

APAC
229.0

 
243.1

 
238.8

 
8.3

 
8.3

Total company
$
780.6

 
$
773.4

 
$
698.1

 
$
142.3

 
$
144.9


The Company operates various manufacturing and marketing operations outside the United States. Latin America includes Brazil and Mexico. EMEA includes Europe, Russia, the Middle East, India and Africa. APAC includes Asia and Australia. Revenues by region are based on the known final destination of products sold.
XML 29 R23.htm IDEA: XBRL DOCUMENT v3.20.2
EMPLOYEE BENEFIT PLANS
 12 Months Ended
Sep. 27, 2019
Retirement Benefits [Abstract]  
EMPLOYEE BENEFIT PLANS EMPLOYEE BENEFIT PLANS
Varex’s 401(k) plan became effective on January 1, 2017. Varex’s 401(k) plan is intended to be qualified under Section 401(a) of the Code with the 401(k) plan’s related trust intended to be tax exempt under Section 501(a) of the Code and intended for all full-time employees in the United States. This plan allows employees to contribute a portion of their pretax salary up to the maximum dollar limitation prescribed by the Internal Revenue Service. Prior to Varex's 401(k) plan becoming effective, Company employees participated in Varian's 401(k) plan. The Company made matching contributions to the plan totaling $6.7 million, $6.5 million and $4.3 million in fiscal years 2019, 2018 and 2017, respectively.
The Company also maintains defined benefit plans for employees located outside the US. The net pension liability is included in non-current liability on the Company's consolidated balance sheets and totaled $5.5 million and $3.3 million as of September 27, 2019 and September 28, 2018, respectively. The Company’s net periodic benefit costs for the Company’s defined benefit plans was not material for fiscal years 2019, 2018 and 2017.
XML 30 R24.htm IDEA: XBRL DOCUMENT v3.20.2
OTHER COMPREHENSIVE INCOME
 12 Months Ended
Sep. 27, 2019
Equity [Abstract]  
OTHER COMPREHENSIVE INCOME OTHER COMPREHENSIVE INCOME
The following table presents the changes in the accumulated balances for each component of other comprehensive income (loss):
(In millions)
Unrealized Gain (Loss) on Derivative Financial Instruments
 
Unrealized Gain on Defined Benefit Obligations
 
Accumulated Other Comprehensive Income
Balance at September 28, 2018
$
5.8

 
$
—

 
$
5.8

Other comprehensive loss before reclassifications
(8.3
)
 
(1.9
)
 
(10.2
)
Income tax benefit
2.1

 
0.6

 
2.7

Balance at September 27, 2019
$
(0.4
)
 
$
(1.3
)
 
$
(1.7
)
 
 
 
 
 
 

No amounts were reclassified out of accumulated other comprehensive income during fiscal years 2019 and 2018.
XML 31 R25.htm IDEA: XBRL DOCUMENT v3.20.2
REVENUE RECOGNITION
 12 Months Ended
Sep. 27, 2019
Revenue from Contract with Customer [Abstract]  
REVENUE RECOGNITION REVENUE RECOGNITION
The Company adopted ASC 606 on September 29, 2018, using the modified retrospective method for all contracts not completed as of the date of adoption. The reported results for fiscal year 2019 reflect the application of ASC 606 guidance while the reported results for fiscal year 2018 were prepared under the guidance of ASC 605, “Revenue Recognition.” The primary impacts of the adoption include: (1) recording a separate contract liability and contract asset related to the sale of X-ray tubes that were sold with an option for the customer to require the Company to repurchase specific parts of the X‑ray tube at a specific price; and (2) recording a liability related to the deferral of revenue for service type warranties that are provided to certain customers who purchase Linatron® X-ray accelerators.
The Company has made the following accounting policy elections and elected to use certain practical expedients, as permitted by the FASB, in applying ASC 606: (1) the Company accounts for amounts collected from customers for sales and other taxes, net of related amounts remitted to tax authorities; (2) the Company does not adjust the promised amount of consideration for the effects of a significant financing component, if, at contract inception, the Company expects the period between the time when the Company transfers a promised good or service to the customer and the time when the customer pays for that good or service will be one year or less; (3) the Company expenses costs to obtain a contract as they are incurred if the expected period of benefit, and therefore the amortization period, is one year or less; (4) the Company accounts for shipping and handling activities that occur after control transfers to the customer as a fulfillment cost rather than an additional promised service and these fulfillment costs are included as a component of cost of revenues; and (5) the Company does not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.
Transaction price and allocation to performance obligations
Transaction prices of products or services are typically based on contracted rates. To the extent that the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing the expected value method when there is a large number of transactions with similar characteristics or the most likely amount method when there are two possible outcomes, depending on the circumstances of the transaction, to which the Company expects to be entitled. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of the Company’s anticipated performance and all information (historical, current and forecasted) that is reasonably available.
The Company allows customers to return specific parts of purchased X-ray tubes for a partial refund credit, which is identified as variable consideration. ASC 606-10-55-23 requires that for sales with a right of return, revenue is reduced for expected returns, a liability is recorded for expected returns, and an asset is recorded for the right to recover products from customers on settling the liability. The Company recognizes a reduction to revenue and cost of sales at the time of sale and a corresponding contract liability and contract asset. The Company records this estimate based on the historical volume of product returns and adjusts the estimate on a quarterly basis based on the current quarter sales and current quarter returns.
If a contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products or services underlying each performance obligation. The Company determines standalone selling prices based on the price at which the performance obligation is sold separately.
The beginning net cumulative-effect adjustment to the balance sheet for the adoption of ASC 606 is as follows:
 
Balance at
 
Adjustment Due to
 
Balance at
(In millions)
September 28, 2018
 
ASC 606
 
September 29, 2018
Assets:
 
 
 
 
 
Prepaid expenses and other current assets
$
17.1

 
$
6.4

 
$
23.5

Other assets
16.5

 
18.0

 
34.5

Liabilities and Equity:
 
 
 
 
 
Deferred revenues
13.2

 
0.3

 
13.5

Accrued liabilities
47.5

 
7.1

 
54.6

Deferred tax liabilities
23.2

 
(0.8
)
 
22.4

Other long-term liabilities
8.5

 
21.3

 
29.8

Retained earnings
62.4

 
(3.5
)
 
58.9


The following tables compare the reported consolidated balance sheet and statement of operations for fiscal year ended September 27, 2019, to the amounts that would have been reported if ASC 605 had been in effect:
 
September 27, 2019
(In millions)
Balance without Adoption
 
As Reported
Assets:
 
 
 
Prepaid expenses and other current assets
$
13.1

 
$
19.3

Other assets
$
10.0

 
$
27.5

Liabilities and equity:
 
 
 
Deferred revenues
$
9.9

 
$
10.5

Accrued liabilities
$
68.8

 
$
75.7

Deferred tax liabilities
$
9.1

 
$
8.2

Other long-term liabilities
$
12.1

 
$
32.5

Retained earnings
$
77.7

 
$
74.4


 
Twelve Months Ended September 27, 2019
(In millions)
Balance without Adoption
 
As Reported
Revenues
781.2

 
780.6

Cost of revenues
524.7

 
523.9

Taxes on earnings
5.7

 
5.7

Net earnings attributable to Varex
15.3

 
15.5


Contracts and performance obligations
The Company accounts for a contract with a customer when there is an approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of the consideration is probable. The Company's performance obligations consist mainly of transferring control of products and services identified in the contracts or purchase orders. For each contract, the Company considers the obligation to transfer products and services to the customer, which are distinct, to be performance obligations.
Revenue recognition
Revenue is recognized when, or as, obligations under the terms of a contract are satisfied, which occurs when control of the promised products or services is transferred to customers. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or services to a customer.
Product revenue is recognized when the customer obtains control of the Company’s product, which occurs at a point in time, and may be upon shipment or upon delivery based on the contractual shipping terms of a contract.
Service revenue is recognized over time as the services are rendered to the customer based on the extent of progress towards completion of the performance obligation. The Company recognizes service revenue over the term of the service contract. Services are expected to be transferred to the customer throughout the term of the contract and the Company believes recognizing revenue ratably over the term of the contract best depicts the transfer of value to the customer.
Disaggregation of Revenue
Revenue is disaggregated from contracts between geography and by reportable operating segment, which the Company believes best depicts how the nature, amount, timing, and uncertainty of revenues and cash flows are affected by economic factors. Refer to Note 15. Segment Information, included in this report, for the disaggregation of the Company’s revenue based on reportable operating segments and disaggregated by geographic region.    
Contract Balances
Contract assets are included within the prepaid expenses and other current assets, and other assets balances. Contract liabilities, which also includes refund obligations are included within the accrued liabilities, deferred revenues, and other long-term liabilities balances. The following table summarizes the changes in the contract assets and refund liabilities for the twelve months ended September 27, 2019:
(In millions)
Contact Assets
Balance at September 29, 2018
$
24.4

Costs recovered from product returns during the period
(6.4
)
Contract asset from shipments of products, subject to return during the period
5.7

Balance at September 27, 2019
$
23.7

(In millions)
Refund Liabilities
Balance at September 29, 2018
$
27.1

Recognition of revenue included in beginning of year refund liability
(7.0
)
Additions to refund liabilities
6.3

Balance at September 27, 2019
$
26.4


Remaining Performance Obligations
Remaining performance obligations represent the transaction price of firm orders for which revenue has not yet been recognized. As of September 27, 2019, total remaining performance obligations amounted to $265.2 million. The Company expects to recognize a majority of the remaining performance obligations over the next 12 months.
Costs to Obtain or Fulfill a Customer Contract
The Company has certain costs to obtain and fulfill a customer contract, such as commissions and shipping costs. The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the assets that the Company otherwise would have recognized is one year or less. Incremental costs of obtaining contracts that would be recognized over greater than one year are not material. The Company accounts for shipping and handling activities related to contracts with customers as costs to fulfill the promise to transfer the associated products. These costs are included as a component of cost of revenues.
XML 32 R26.htm IDEA: XBRL DOCUMENT v3.20.2
SUBSEQUENT EVENTS
 12 Months Ended
Sep. 27, 2019
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS SUBSEQUENT EVENTS
On October 1, 2019, the Company, in accordance with the terms of the Credit Agreement, provided notice to the administrative agent that effective as of October 8, 2019, the Company was permanently reducing the revolving credit commitment under the Credit Agreement by $25.0 million to $125.0 million. The reduction in the revolving credit commitment will also reduce the fees paid by the Company in connection with such commitment.

Events Subsequent to Original Issuance of Consolidated Financial Statements (Unaudited) 
Existing Credit Facility
In connection with the issuance of the Convertible Notes (defined below), on June 6, 2020, the Company amended the Credit Agreement (“Amendment No. 6”) to revise certain covenants, including covenants that restricted the incurrence of debt and restricted the Company’s ability to enter into the Call Spread Transactions (defined below) and issue the Convertible Notes (defined below). In connection with Amendment No. 6, the Company permanently reduced the total amount available under the Revolving Credit Facility to $100 million.
Convertible Notes
On June 9, 2020, the Company issued $200.0 million in aggregate principal amount of 4.00% unsecured convertible senior notes due 2025 (“Convertible Notes”). The net proceeds from the issuance of the Convertible Notes, after deducting transaction fees and offering expense payable by us, were approximately $193.1 million. The Convertible Notes bear interest at the annual rate of
4.00%, payable semiannually on June 15 and December 15 of each year, beginning on December 15, 2020, and will mature on June 15, 2025, unless earlier converted or repurchased by us.

The Convertible Notes will be convertible into cash, shares of our common stock or a combination thereof, at our election, at an initial conversion rate of 48.05 shares of common stock per $1,000 principal amount of Convertible Notes, which is equivalent to an initial conversion price of approximately $20.81 per share, subject to adjustment pursuant to the terms of the Indenture governing the Convertible Notes (the "Indenture"). The Convertible Notes may be converted at any time after, and including, December 15, 2024 until the close of business on the second scheduled trading day immediately before the maturity date.

The conversion rate of the Convertible Notes may be adjusted in certain circumstances, including in connection with a conversion of the Convertible Notes made following certain fundamental changes and under other circumstances set forth in the Indenture. It is our current intent and policy to settle any conversions of notes through a combination of cash and shares.

Prior to the close of business on the business day immediately preceding December 15, 2024, the Convertible Notes at the option of the holder can be convertible only under the following circumstances:

1.
during any calendar quarter commencing after the calendar quarter ending on September 30, 2020, if the last reported sale price per share of our common stock exceeds 130% of the conversion price for each of at least 20 trading days during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter;
2.
during the five consecutive business days immediately after any five consecutive trading day period (such five consecutive trading day period, the “measurement period”) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of our common stock on such trading day and the conversion rate on such trading day;
3.
upon the occurrence of certain corporate events or distributions on our common stock, as described in the Indenture; or
4.
if we call any notes for redemption (under the conditions specified below).

The Convertible Notes will be redeemable, in whole or in part, at the Company’s option at any time, and from time to time, on or after June 1, 2023 and on or before the 60th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Convertible Notes to be redeemed, plus accrued and unpaid interest, if any, but only if the last reported sale price per share of the Company’s common stock exceeds 130% of the conversion price on (i) each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice; and (ii) the trading day immediately before the date the Company sends such notice. In addition, calling any Convertible Note for redemption will constitute a make-whole fundamental change with respect to that Convertible Note, in which case the conversion rate applicable to the conversion of that Convertible Note will be increased in certain circumstances if it is converted after it is called for redemption. No sinking fund is provided for the Convertible Notes.

Call Spread

On June 4, 2020 and June 5, 2020, in connection with the offering of the Convertible Notes, the Company entered into privately negotiated convertible note hedge transactions (collectively, the “Hedge Transactions”). The Hedge Transactions cover, subject to customary anti-dilution adjustments, the number of shares of our common stock that initially underlie the Convertible Notes. The Hedge Transactions are expected generally to reduce the potential dilution and/or offset any cash payments the Company is required to make in excess of the principal amount due upon conversion of the Convertible Notes in the event that the market price of our common stock is greater than the strike price of the Hedge Transactions, which was initially $20.81 per share (subject to adjustment under the terms of the Hedge Transactions). The strike price of $20.81 corresponds to the initial conversion price of the Convertible Notes. The number of shares underlying the Hedge Transactions is 9.6 million.

On June 4, 2020 and June 5, 2020, the Company also entered into privately negotiated warrant transactions (collectively, the “Warrant Transactions” and, together with the Hedge Transactions, the “Call Spread Transactions”), whereby we sold warrants at a higher strike price relating to the same number of shares of our common stock that initially underlie the Convertible Notes, subject to customary anti-dilution adjustments. The initial strike price of the warrants is $24.975 per share (subject to adjustment under the terms of the Warrant Transactions), which is 50% above the last reported sale price of our common stock on June 4, 2020. The Warrant Transactions could have a dilutive effect to our stockholders to the extent that the market price per share of our common stock, as measured under the terms of the Warrant Transactions, exceeds the applicable strike price of the warrants. The number of shares underlying the Warrant Transactions is 9.6 million.

The Company used $11.2 million of the net proceeds from the issuance of the Convertible Notes and $49.8 million from the Warrant Transactions to pay the cost of the Hedge Transactions, which totaled $61.0 million.

The Hedge Transactions and the Warrant Transactions are separate transactions, in each case, and are not part of the terms of the Convertible Notes and will not affect any holder’s rights under the Convertible Notes. Holders of the Convertible Notes will not have any rights with respect to the Call Spread Transactions.

Accounting Treatment of the Convertible Notes and Related Hedge Transactions and Warrant Transactions

As the Call Spread Transactions meet certain accounting criteria, the Call Spread Transactions will be classified as equity and are not accounted for as derivatives. The proceeds from the offering of the Convertible Notes were separated into liability and equity components. On the date of issuance, the liability and equity components of the Convertible Notes were calculated to be approximately $152.3 million and $47.7 million, respectively. The initial $152.3 million liability component was determined based on the fair value of similar debt instruments excluding the conversion feature assuming a hypothetical interest rate of 10.45%. The initial $47.7 million equity component represents the difference between the fair value of the initial $152.3 million in debt and the $200.0 million of gross proceeds. The equity component will be included in additional paid-in capital in the consolidated balance sheet and will not be subsequently remeasured as long as it continues to meet the conditions for equity classification. The related initial debt discount of $47.7 million will be amortized over the life of the Convertible Notes as non-cash interest expense using the effective interest method at an interest rate of 10.9%.

In connection with the above-noted transactions, we incurred approximately $6.9 million of offering-related costs. These offering fees were allocated to the liability and equity components in proportion to the allocation of proceeds and will be accounted for as debt and equity issuance costs, respectively. We allocated $5.3 million of debt issuance costs to the liability component, which will be capitalized as deferred financing costs within long-term debt. These costs will be amortized as interest expense over the term of the debt using the effective interest method. The remaining $1.6 million of transaction costs allocated to the equity component will be recorded as a reduction of the equity component.
XML 33 R27.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Sep. 27, 2019
Accounting Policies [Abstract]  
Basis of Presentation The accompanying consolidated financial statements are audited and have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). Prior to January 28 2017, the date of separation and distribution, the financial statements were prepared on a stand-alone basis and were derived from Varian’s consolidated financial statements and records as it operated as part of Varian prior to the distribution, in conformity with GAAP.
Consolidation
All transactions between the Company and Varian prior to the separation have been included in the accompanying consolidated financial statements. All intercompany transactions while the Company operated as part of Varian were considered to be effectively settled for cash and are reflected as a component of financing activities as net transfers from (to) Varian in the consolidated statements of cash flows at the time the transactions were recorded.
Prior to the separation, the Company was dependent upon Varian for its working capital and financing requirements, as Varian uses a centralized approach to cash management and financing of its operations. Financial transactions relating to the Company were accounted for through the net parent investment account. Cash and cash equivalents held by Varian were not allocated to the Company.
Net parent investment in the consolidated statements of equity represents Varian’s historical investment in the Company, the net effect of transactions with and allocations from Varian and the Company’s accumulated earnings.
Reclassification
Reclassification
The Company has reclassified $3.0 million from selling, general and administrative expense to impairment of intangible assets for the year ended September 28, 2018, to conform to the current year's presentation. Such reclassifications had no impact on net earnings as previously reported.
Segment Reporting
Segment Reporting
The Company has two reportable operating segments; (i) Medical and (ii) Industrial, which aligns with how its CEO, who is the Company's Chief Operating Decision Maker (“CODM”), reviews the Company’s performance.
Fiscal Year
Fiscal Year
The fiscal years of the Company as reported are the 52 or 53-week period ending on the Friday nearest September 30. Fiscal year 2019 was the 52-week period that ended on September 27, 2019. Fiscal year 2018 was the 52-week period that ended on September 28, 2018. Fiscal year 2017 was the 52-week period that ended on September 29, 2017.
Variable Interest Entities
Variable Interest Entities
For entities in which the Company has variable interests, the Company focuses on identifying which entity has the power to direct the activities that most significantly impact the variable interest entity’s economic performance and which enterprise has the obligation to absorb losses or the right to receive benefits from the variable interest entity. If the Company is the primary beneficiary of a variable interest entity, the assets, liabilities and results of operations of the variable interest entity will be included in the
Company’s consolidated financial statements. As of September 27, 2019, the Company had two variable interest entities neither of which were consolidated.
Use of Estimates
Impact of COVID-19
The coronavirus (“COVID-19”) pandemic and the mitigation efforts by governments to attempt to control its spread created uncertainties and disruptions in the economic and financial markets. The extent to which COVID-19 will continue to impact the Company’s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it will impact worldwide macroeconomic conditions including interest rates and employment rates, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. During the quarter ended July 3, 2020, as a result of the economic downturn resulting from COVID-19, the Company experienced reduced demand in the
Company’s industrial segment and for certain higher end medical products that negatively impacted revenues and gross margin. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the currently estimated future impacts of COVID-19 through the date of reissuance of these consolidated financial statements. The Company’s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material negative impacts to the Company’s consolidated financial statements in future reporting periods. These future developments are highly uncertain, and the outcomes cannot be estimated with certainty. Actual results may differ from those estimates, and such differences may be material to the consolidated financial statements.

The Company’s Credit Agreement, as defined in Note 8, Borrowings, contains financial covenants, including certain leverage ratio covenants. The adverse effects of the COVID-19 pandemic on the Company’s financial condition and results of operations are expected to be more persistent and have been more severe than previously estimated. The Company now believes that reduced demand in the Company’s industrial segment and for certain higher end medical products will continue to negatively impact revenues, gross margin, and the other items used to calculate the Company’s financial covenants contained in its Credit Agreement. Based on the Company’s current forecasts, it is probable that the Company will be in violation of certain leverage ratio covenants contained in its Credit Agreement within the twelve-month period following the reissuance of these consolidated financial statements, including as early as the end of the Company's fiscal year end 2020. Failure to comply with the covenants, if not amended or waived, would result in an event of default under the Credit Agreement and the acceleration of the outstanding balance of the loans thereunder. If an event of default under the Credit Agreement occurs, then pursuant to cross default and/or cross acceleration clauses, substantially all of the Company’s other outstanding debt and derivative contract payables would become due, and all debt and derivative contracts could be terminated, which would have a material adverse impact to the Company’s operations and liquidity as the Company currently does not have the financial resources to satisfy such obligations if they were to become due and payable. These events and conditions raise substantial doubt about the Company’s ability to continue as a going concern within the twelve-month period following the reissuance of these consolidated financial statements.

The Company is actively pursuing various options to prevent an event of default from occurring under the Credit Agreement. The Company is implementing actions to improve its financial results and other items used to calculate the financial covenants, such as accelerating the closure of its Santa Clara facility, the previously announced reduction in force, austerity programs related to outside services, and other appropriate actions. The Company is also taking actions to improve cash flow such as working capital reductions and reduced spending for property, plant and equipment, as well as pursuing potential additional fundraising to modify, supplement, or replace its Credit Agreement. While the Company has and continues to take actions to mitigate the risk of an event of default under the Credit Agreement, there is no assurance that it will be successful in doing so. The Company’s consolidated financial statements have been prepared on a going concern basis and do not reflect any adjustments that might result if the Company is unable to continue as a going concern.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Such estimates include the valuation of inventories, goodwill and intangible assets, impairment on investments, and taxes on earnings. Actual results could differ from these estimates.
Cash and Cash Equivalents and Restricted Cash
Cash and Cash Equivalents
The Company considers currency on hand, demand deposits, time deposits and all highly-liquid investments with an original maturity of three months or less at the date of purchase to be cash and cash equivalents.
Restricted Cash
Restricted cash primarily consists of cash collateral related to certain leases and inventory arrangements. Restricted cash is
included in other assets on the consolidated balance sheet.
Fair Value
Fair Value
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. There is a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:
Level 1—Quoted prices in active markets for identical assets or liabilities.
Level 2—Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or, other inputs that are observable or can be corroborated by observable market data.
Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
Derivative instruments and hedging activities
Derivative instruments and hedging activities
The Company records all derivatives on the balance sheet at fair value. Derivatives designated as a hedge are recorded on the Consolidated Balance Sheets at fair value as of the reporting date. For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative is reported as a component of other comprehensive income or loss and reclassified from accumulated other comprehensive loss into earnings when the hedged transaction affects earnings.  For derivatives that are designated and qualify as net investment hedges, the gain or loss on the derivative is reported as a component of other comprehensive income or loss. Time value is excluded and the cash payments are recognized as an adjustment to interest expense. A qualitative assessment of hedge effectiveness is performed on a quarterly basis, unless facts and circumstances indicate the hedge may no longer be highly effective.
Concentration of Risk
Concentration of Risk
Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash, cash equivalents and trade accounts receivable. Cash held with financial institutions may exceed the Federal Deposit Insurance Corporation insurance limits or similar limits in foreign jurisdictions. The Company has not experienced any losses on its deposits of cash and cash equivalents. The Company performs ongoing credit evaluations of its customers and, except for government tenders, group purchases and orders with a letter of credit, its industrial customers often provide a down payment. The Company maintains an allowance for doubtful accounts based upon the expected collectability of all accounts receivable. The Company obtains some of the components in its products from a limited group of suppliers or from a single-source supplier.
Inventories
Inventories
Inventories are valued at the lower of cost or net realizable value. Costs include materials, labor and manufacturing overhead
and is computed using standard cost (which approximates actual cost) on a first-in-first-out basis. The Company evaluates the carrying
value of its inventories taking into consideration such factors as historical and anticipated future sales compared to quantities on hand
and the prices the Company expects to obtain for products in its various markets. The Company adjust excess and obsolete
inventories to net realizable value and write-downs of excess and obsolete inventories are recorded as a component of cost of revenues.
Property, Plant and Equipment, net
Property, Plant and Equipment, net
Property, plant and equipment are stated at cost, net of accumulated depreciation. Major improvements are capitalized, while repairs and maintenance are expensed as incurred. Depreciation are computed using the straight-line method over the estimated useful lives of the assets. Land is not subject to depreciation, but land improvements are depreciated over fifteen years. Land leasehold rights and leasehold improvements are depreciated over the lesser of their estimated useful lives or remaining lease terms. Buildings are depreciated over twenty years. Machinery and equipment are depreciated over their estimated useful lives, which range from three years to seven years. Assets subject to lease are depreciated over the lesser of their estimated useful lives or remaining lease terms. Estimated useful lives are periodically reviewed and, when appropriate, changes are made prospectively. When certain events or changes in operating conditions occur, asset lives may be adjusted, and an impairment assessment may be performed on the recoverability of the carrying amounts. When assets are retired or otherwise disposed of, the assets and related accumulated depreciation are removed from the accounts.
Investments
Investments
The Company accounts for its equity investments in privately-held companies under the equity method of accounting if the Company has the ability to exercise significant influence in these investments. Distributions received from an equity method investment are classified using the cumulative earnings approach. Under the cumulative earnings approach, distributions up to the amount of cumulative equity in earnings recognized will be treated as returns on investment as operating cash flows and those in excess of that amount will be treated as returns of investment as investing cash flows. The Company monitors these equity investments for impairment and makes appropriate reductions in carrying values if the Company determines that impairment charges are required based primarily on the financial condition and near-term prospects of these companies.
Goodwill and Intangible Assets
Goodwill and Intangible Assets
Goodwill is recorded when the purchase price of an acquisition exceeds the fair value of the net identified tangible and intangible assets acquired. Purchased intangible assets are carried at cost, net of accumulated amortization, and are included in intangible assets in the Company's consolidated balance sheets. Intangible assets with finite lives are amortized over their estimated useful lives of primarily two years to seven years using the straight-line method.
Impairment of Long-lived Assets, Intangible Assets and Goodwill
Impairment of Long-lived Assets, Intangible Assets and Goodwill
The Company reviews long-lived assets and identifiable intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. The Company assesses these assets for impairment based on their estimated undiscounted future cash flows. If the carrying value of the assets exceeds the estimated future undiscounted cash flows, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets.
The Company evaluates goodwill and indefinite lived intangible assets for impairment at least annually at the beginning of the fourth quarter of each fiscal year or whenever an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The Company performs a step one analysis, which consists of a comparison of the fair value of a reporting unit against its carrying amount, including the goodwill allocated to each reporting unit. The Company determines the fair value of its reporting units based on a combination of income and market approaches. The income approach is based on the present value of estimated future cash flows of the reporting units, and the market approach is based on a market multiple calculated for each reporting unit based on market data of other companies engaged in similar business. If the carrying amount of the reporting unit is in excess of its fair value, step two requires the comparison of the implied fair value of the reporting unit’s goodwill against the carrying amount of the reporting unit’s goodwill. Any excess of the carrying value of the reporting unit’s goodwill over the implied fair value of the reporting unit’s goodwill is recorded as an impairment loss. The impairment test for intangible assets with indefinite useful lives, if any, consists of a comparison of fair value to carrying value, with any excess of carrying value over fair value being recorded as an impairment loss.
Loss Contingencies
Loss Contingencies
From time to time, the Company is a party to or otherwise involved in legal proceedings, claims and government inspections or investigations, customs and duties audits and other loss contingency matters, both inside and outside the United States, arising in the ordinary course of its business or otherwise. The Company accrues amounts, to the extent an unfavorable outcome is determined to be probable and the losses can be reasonably estimated, that it believes are adequate to address any liabilities related to legal proceedings and other loss contingencies that it believes will result in a probable loss.
Product Warranty
Product Warranty
The Company warrants most of its products for a specific period of time, usually 12 to 24 months from delivery or acceptance, against material defects. The Company provides for the estimated future costs of warranty obligations in cost of revenues when the related revenues are recognized. The accrued warranty costs represent the best estimate at the time of sale of the total costs that the Company will incur to repair or replace product parts that fail while still under warranty.
The amount of the accrued estimated warranty costs obligation for established products is primarily based on historical experience as to product failures adjusted for current information on repair costs. For new products, estimates include the historical experience of similar products, as well as a reasonable allowance for warranty expenses associated with new products. On a quarterly basis, the Company reviews the accrued warranty costs and updates the historical warranty cost trends, if required.
Allowance for Doubtful Accounts
Allowance for Doubtful Accounts
The Company evaluates the creditworthiness of customers prior to authorizing shipment for all major sale transactions. On a quarterly basis, the Company evaluates aged items in the accounts receivable aging report and provide an allowance in an amount deemed adequate for doubtful accounts. If the evaluation of customers’ financial conditions does not reflect a future ability to collect outstanding receivables, additional provisions may be needed.
Share-Based Compensation Expense
Share-Based Compensation Expense
The Company has an equity-based incentive plan that provides for the grant of nonqualified stock options and restricted stock units to directors, officers and other employees. The Company also permits employees to purchase shares under the Varex employee stock purchase plan. Prior to the separation, the Company’s employees historically participated in Varian’s equity-based incentive plans. Share-based compensation expense through the date of separation included allocations to the Company based on the awards and terms previously granted to its employees as well as an allocation of Varian’s corporate and shared functional employee expenses.
The Company values stock options granted and the option component of the shares of common stock purchased under the equity-based incentive plans and stock purchased under the employee stock purchase plan using the Black-Scholes option-pricing model. Share-based compensation expense for restricted stock units is measured using the fair value of the Company’s stock on the date of grant and is amortized over the award’s respective service period. The Black-Scholes option-pricing model requires the input of certain assumptions, and changes in the assumptions can materially affect the fair value estimates of share-based payment awards.
The Company measures and recognizes expense for all share-based payment awards based on their fair values. Share-based compensation expense recognized in the consolidated statements of earnings includes compensation expense for the share-based payment awards based on the grant date fair value estimated in accordance with the guidance on share-based compensation. Share-based compensation expense recognized is based on the value of the portion of share-based payment awards that is ultimately expected to vest. The Company attributes the value of share-based compensation to expense using the straight-line method. The Company considers only the direct tax impacts of share-based compensation awards when calculating the amount of tax windfalls or shortfalls.
Research and Development
Research and Development
Research and development costs have been expensed as incurred. These costs primarily include employees’ compensation, consulting fees and material costs.
Software Development Costs
Software Development Costs
Costs for the development of new software products and substantial enhancements to existing software products are expensed as incurred until technological feasibility has been established, at which time any additional costs would be capitalized. No costs associated with the development of software have been capitalized, as the Company believes its current software development process is essentially completed concurrent with the establishment of technological feasibility.
Taxes on Earnings
Taxes on Earnings
Current income tax expense is the amount of income taxes expected to be payable for the current year. Deferred income tax liabilities or assets are established for the expected future tax consequences resulting from the differences in financial reporting and tax bases of assets and liabilities. A valuation allowance is provided if it is more likely than not that some or all of the deferred tax assets will not be realized. In addition, we provide reserves for uncertain tax positions when such tax positions do not meet the recognition thresholds or measurement standards prescribed by the authoritative guidance for accounting for income taxes. Amounts
for uncertain tax positions are adjusted in periods when new information becomes available or when positions are effectively settled. Interest and penalties related to uncertain tax positions are recognized as a component of income tax expense.
On December 22, 2017, the U.S. Government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act of 2017 (“U. S. Tax Reform”). U.S. Tax Reform significantly revised the U.S. corporate income tax structure including a lower corporate statutory rate and changes to the way foreign earnings are taxed. U.S. GAAP requires that the impact of tax legislation be recognized in the period in which the law is enacted. In accordance with these rules, we are including the impact of certain provisions of U.S. Tax Reform to the extent they are effective during the current reporting period.
Foreign Currency Translation
Foreign Currency Translation
The Company uses the U.S. Dollar predominately as the functional currency of its foreign operations. Gains and losses from remeasurement of foreign currency balances into U.S. Dollars are included in the consolidated statements of earnings. For the foreign subsidiary where the local currency is the functional currency, translation adjustments of foreign currency financial statements into U.S. dollars are recorded to a separate component of accumulated other comprehensive (loss) earnings.
Accounting Standards Recently Adopted, Recent Accounting Standards Updates Not Yet Effective
Accounting Standards Recently Adopted
In November 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (“ASU 2016-18”), which requires that the statement of cash flows explain the change in the total amount of restricted cash during the period and other additional disclosures. The Company adopted ASU 2016-18 in the first quarter of 2019 using the retrospective transition method and the Company's consolidated statements of cash flows have been retrospectively adjusted to reflect restricted cash balances. Net cash flows for fiscal years 2019, 2018 and 2017 did not change as a result of adopting ASU 2016-18.
The Company adopted ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”), which was issued to reduce the diversity in practice in how certain transactions are classified in the statement of cash flows. The Company adopted ASU 2016-15 in the first quarter of 2019 retrospectively. Net cash flows for fiscal years 2019, 2018 and 2017 did not change as a result of adopting ASU 2016-15.

The Company adopted ASC 606 as of September 29, 2018, using the modified retrospective transition method applied to those contracts which were not completed as of that date. The Company recorded a net reduction to retained earnings of $4.1 million, net of tax, as of September 29, 2018 due to the impact of adopting ASC 606. During the second quarter of 2019 the Company recorded an increase to retained earnings of $0.6 million, net of tax, to correct an error that was not quantitatively or qualitatively material to the current period, related to the adoption of ASC 606. The net cumulative impact of adopting ASC 606 was $3.5 million, net of tax. Refer to Note 18. Revenue Recognition, included in this report report for the detailed impact of adopting ASC 606.

In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities, which amends the application of hedge accounting and improves financial reporting of hedging relationships to more accurately present the economic effects of risk management activities in the financial statements. The ASU is effective for public companies for annual reporting periods beginning after December 15, 2018, with early adoption permitted. The Company early adopted the provisions of ASU 2017-12 during the quarter ended September 27, 2019, using the modified retrospective method. The adoption did not have an impact on the consolidated financial statements.
Recent Accounting Standards Updates Not Yet Effective
In February 2018, the FASB issued ASU 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from U.S. federal tax legislation commonly referred to as the Tax Cuts and Jobs Act, which was enacted in December 2017 (the “2017 Tax Act”). ASU 2018-02 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect that the adoption of this guidance will have a material impact on its consolidated financial statements.
In January 2017, the FASB issued ASU 2017-04 which clarified its guidance to simplify the measurement of goodwill by eliminating the Step 2 impairment test. The new guidance requires companies to perform the goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2021. The amendment is required to be adopted prospectively. The Company is evaluating the impact of adopting this amendment to its consolidated financial statements.
In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Instruments." This ASU replaces the incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. In addition, the ASU requires new disclosures. This standard will be effective for the Company's interim and annual periods beginning with the first quarter of fiscal 2021, and must be applied on a modified retrospective basis. The Company is currently evaluating the potential impact of this standard.
In February 2016, the FASB issued ASU 2016-02 on accounting for leases. The new standard is intended to provide enhanced transparency and comparability by requiring lessees to record right-of-use assets and corresponding lease liabilities on the balance sheet. The new standard will continue to classify leases as either finance or operating, with classification affecting the pattern of expense recognition in the statement of earnings. The new standard is required to be adopted using a modified retrospective method to each prior reporting period presented with various optional practical expedients. The new standard will be effective for the Company beginning in its first quarter of fiscal year 2020 with early adoption permitted. The Company has not completed its assessment of the new standard, but anticipate that the most substantial change to its consolidated financial statements will be a gross-up of its total assets and liabilities. The adoption is not expected to materially impact our results of operations in the upcoming fiscal years and interim periods. The Company will continue to monitor the overall impact of adoption and update our disclosures as appropriate.
Revenue from Contract with Customer
Shipping and Handling Costs
Shipping and handling costs are included as a component of cost of revenues.
Revenue Recognition
Effective September 29, 2018, the Company adopted the requirements of Accounting Standards Update (“ASU”) 2014-09 and related amendments, Revenue from Contracts with Customers (“ASC 606”), which superseded all prior revenue recognition methods and industry-specific guidance. See “Recently Adopted Accounting Pronouncements” below.
The Company’s revenues are derived primarily from the sale of hardware and services. The Company recognizes its revenues net of any value-added or sales tax and net of sales discounts.
The Company sells a high proportion of its X-ray products to a limited number of OEM customers. X-ray tubes, digital detectors and image-processing tools and security and inspection products are generally sold on a stand-alone basis. However, the Company occasionally sells its digital detectors, X-ray tubes and imaging processing tools as a package that is optimized for digital X ray imaging and sells its Linatron ® X-ray accelerators together with its imaging processing software and image detection products to OEM customers that incorporate them into their inspection systems. Service contracts are often sold with certain security and inspection products and computer-aided detection products.
The Company determines revenue recognition through the following steps:
•
Identification of the contract, or contracts, with a customer
•
Identification of the performance obligations in the contract
•
Determination of the transaction price
•
Allocation of the transaction price to the performance obligations in the contract
•
Recognition of revenue when, or as, a performance obligation is satisfied
Deferred Revenues
Deferred revenue primarily represents (i) the amount received applicable to non-software products for which parts
and services under the warranty contracts have not been delivered, and (ii) the amount received for service contracts for
which the services have not been rendered.
The Company adopted ASC 606 on September 29, 2018, using the modified retrospective method for all contracts not completed as of the date of adoption. The reported results for fiscal year 2019 reflect the application of ASC 606 guidance while the reported results for fiscal year 2018 were prepared under the guidance of ASC 605, “Revenue Recognition.” The primary impacts of the adoption include: (1) recording a separate contract liability and contract asset related to the sale of X-ray tubes that were sold with an option for the customer to require the Company to repurchase specific parts of the X‑ray tube at a specific price; and (2) recording a liability related to the deferral of revenue for service type warranties that are provided to certain customers who purchase Linatron® X-ray accelerators.
The Company has made the following accounting policy elections and elected to use certain practical expedients, as permitted by the FASB, in applying ASC 606: (1) the Company accounts for amounts collected from customers for sales and other taxes, net of related amounts remitted to tax authorities; (2) the Company does not adjust the promised amount of consideration for the effects of a significant financing component, if, at contract inception, the Company expects the period between the time when the Company transfers a promised good or service to the customer and the time when the customer pays for that good or service will be one year or less; (3) the Company expenses costs to obtain a contract as they are incurred if the expected period of benefit, and therefore the amortization period, is one year or less; (4) the Company accounts for shipping and handling activities that occur after control transfers to the customer as a fulfillment cost rather than an additional promised service and these fulfillment costs are included as a component of cost of revenues; and (5) the Company does not assess whether promised goods or services are performance obligations if they are immaterial in the context of the contract with the customer.
Transaction price and allocation to performance obligations
Transaction prices of products or services are typically based on contracted rates. To the extent that the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing the expected value method when there is a large number of transactions with similar characteristics or the most likely amount method when there are two possible outcomes, depending on the circumstances of the transaction, to which the Company expects to be entitled. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. Estimates of variable consideration and determination of whether to include estimated amounts in the transaction price are based largely on an assessment of the Company’s anticipated performance and all information (historical, current and forecasted) that is reasonably available.
The Company allows customers to return specific parts of purchased X-ray tubes for a partial refund credit, which is identified as variable consideration. ASC 606-10-55-23 requires that for sales with a right of return, revenue is reduced for expected returns, a liability is recorded for expected returns, and an asset is recorded for the right to recover products from customers on settling the liability. The Company recognizes a reduction to revenue and cost of sales at the time of sale and a corresponding contract liability and contract asset. The Company records this estimate based on the historical volume of product returns and adjusts the estimate on a quarterly basis based on the current quarter sales and current quarter returns.
If a contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products or services underlying each performance obligation. The Company determines standalone selling prices based on the price at which the performance obligation is sold separately.
XML 34 R28.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Sep. 27, 2019
Accounting Policies [Abstract]  
Restrictions on Cash and Cash Equivalents Cash and cash equivalents and restricted cash as reported within
the consolidated statements of cash flows consisted of the following:
 
Twelve Months Ended September 27, 2019
 
Twelve Months Ended September 28, 2018
 
Beginning of Period
 
End of Period
 
Beginning of Period
 
End of Period
Cash and cash equivalents
$
51.9

 
$
29.9

 
$
83.3

 
$
51.9

Restricted cash
1.5

 
1.4

 
0.9

 
1.5

Cash and cash equivalents and restricted cash as reported per statement of cash flows
$
53.4

 
$
31.3

 
$
84.2

 
$
53.4
Schedules of Concentration of Risk, by Risk Factor
Credit is extended to customers based on an evaluation of the customer’s financial condition, and collateral is not required. During the periods presented, one of the Company's Medical segment customers accounted for a significant portion of revenues, which is as follows:
 
Fiscal Year
 
2019
 
2018
 
2017
Canon Medical Systems Corporation
17.3
%
 
18.1
%
 
19.3
%
Schedule of Inventory, Current
The following table summarizes the Company’s inventories, net:
(In millions)
September 27, 2019
 
September 28, 2018
Raw materials and parts
$
160.1

 
$
149.9

Work-in-process
27.9

 
25.4

Finished goods
60.2

 
59.8

Total inventories
$
248.2

 
$
235.1
Property, Plant and Equipment
The following table summarizes the Company’s property, plant and equipment, net:
(In millions)
September 27, 2019
 
September 28, 2018
Land
$
8.3

 
$
8.3

Buildings and leasehold improvements
134.4

 
138.1

Machinery
170.7

 
166.1

Construction in progress
28.5

 
23.1

 
$
341.9

 
$
335.6

Accumulated depreciation and amortization
(199.6
)
 
(190.7
)
Property, plant, and equipment, net
$
142.3

 
$
144.9
Schedule of Product Warranty Liability
The following table reflects the changes in the Company’s accrued product warranty:
 
Fiscal Years
(In millions)
2019
 
2018
Accrued product warranty, at beginning of period
$
7.3

 
$
7.0

Charged to cost of revenues
12.9

 
11.6

Actual product warranty expenditures
(12.1
)
 
(11.3
)
Accrued product warranty, at end of period
$
8.1

 
$
7.3
XML 35 R29.htm IDEA: XBRL DOCUMENT v3.20.2
BUSINESS COMBINATIONS (Tables)
 12 Months Ended
Sep. 27, 2019
Business Combinations [Abstract]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
The following table summarizes the purchase price allocation:
(In millions)
Fair Value
Allocation of the purchase consideration:
 
Accounts Receivable
$
0.2

Inventories
1.0

Other assets
0.2

Intangibles
1.6

Goodwill
1.5

Other liabilities
(0.2
)
Net assets acquired
4.3

Post-closing adjustments
0.5

Total cash consideration
$
4.8


The following table summarizes the preliminary purchase price allocation:
(In millions)
Fair Value
Allocation of the purchase consideration:
 
Accounts receivable
$
2.4

Inventories
5.7

Prepaid expenses and other current assets
0.7

Property, plant, and equipment
0.9

Goodwill
47.2

Intangible assets
32.9

Total assets acquired
89.8

Accounts payable
(1.0
)
Accrued liabilities
(1.5
)
Current maturities of long-term debt
(1.0
)
Deferred revenues
(0.9
)
Long-term debt
(3.5
)
Other long-term liabilities
(1.1
)
Total liabilities assumed
(9.0
)
Noncontrolling interest
(1.4
)
Net assets acquired, less noncontrolling interest
$
79.4

Net cash paid
$
69.5

Deferred consideration
9.9

Total consideration
$
79.4


The following amounts represent the determination of the fair value of identifiable assets acquired and liabilities for the Acquired Detector Business:
(In millions)
Fair Value
Total cash consideration
$
273.2

Allocation of the purchase consideration:
 
Cash
1.4

Accounts Receivable
18.7

Inventory
34.7

Prepaids and other current assets
0.6

Property, plant, and equipment
21.4

Other assets, non-current
2.0

Intangibles
81.1

Goodwill
167.3

Total assets acquired
$
327.2


 
 
Current liabilities
$
(17.2
)
Other liabilities, non-current
(36.8
)
Total liabilities assumed
(54.0
)
Net assets acquired
$
273.2
Schedule of Intangible Assets Acquired
The following amounts represent the determination of the fair value of identifiable intangible assets for the Acquired Detector Business, which are amortized straight-line:
(In millions)
Fair Value
 
Estimated
Useful Life
(In Years)
Favorable leasehold interests
$
3.8

 
16
Backlog
1.2

 
1
Trade names
1.4

 
5
Developed technology
37.7

 
7
In-process research and development
4.0

 
indefinite
Customer relationships
33.0

 
7
Total intangible assets acquired
$
81.1

 
 

The following amounts represent the determination of the fair value and estimated weighted average useful lives of identifiable intangible assets for the Direct Conversion, which are amortized straight-line:
(In millions)
Fair Value
 
Estimated Weighted Average
Useful Life
(In Years)
Backlog
$
0.2

 
1
Trade names
2.5

 
5
Developed technology
18.4

 
10
In-process research and development
2.8

 
indefinite
Customer relationships
9.0

 
10
Total intangible assets acquired
$
32.9

 
 
Schedule of Segment Reporting Information, by Segment
The following amounts represent revenues by reporting segment from Direct Conversion from the acquisition date of April 29, 2019, through September 27, 2019:
(In millions)
Direct Conversion Revenue
Medical
$
4.5

Industrial
1.8

Total Direct Conversion revenues
$
6.3


The following amounts represent revenues by reporting segment from the Acquired Detector Business from the acquisition date of May 1, 2017 through September 29, 2017:
(In millions)
May 1, 2017 through September 29, 2017
Acquired Detector Business
 
Medical
$
41.1

Industrial
20.2

Total Acquired Detector Business revenues
$
61.3


Information related to the Company’s segments is as follows:
 
Fiscal Year
(In millions)
2019
 
2018
 
2017
Revenues
 
 
 
 
 
Medical
$
596.8

 
$
602.0

 
$
556.9

Industrial
183.8

 
171.4

 
141.2

Total revenues
780.6

 
773.4

 
698.1

Gross margin
 
 
 
 
 
Medical
188.9

 
190.5

 
193.6

Industrial
67.8

 
63.4

 
59.9

Total gross margin
256.7

 
253.9

 
253.5

Total operating expenses
211.0

 
209.4

 
169.8

Interest and other expenses, net
(24.2
)
 
(18.8
)
 
(8.9
)
Earnings before taxes
21.5

 
25.7

 
74.8

Taxes (benefit) on earnings
5.7

 
(2.6
)
 
22.8

Net earnings
15.8

 
28.3

 
52.0

Less: Net earnings attributable to noncontrolling interests
0.3

 
0.8

 
0.4

Net earnings attributable to Varex
$
15.5

 
$
27.5

 
$
51.6
Business Acquisition, Pro Forma Information The unaudited pro-forma results do not reflect any operating efficiencies or potential cost savings which may result from the consolidation of the Acquired Detector Business and are not necessarily indicative of what the actual results of operations of the combined company would have been if the acquisition had occurred at the beginning of the period presented nor are they indicative of future results of operations or results that might have been achieved had the acquisition been consummated as of October 3, 2015.
 
Fiscal Year
(In millions)
2017
Revenue
$
777.8

Operating earnings
$
84.7

Net earnings
$
43.1

Net earnings per share, basic
$
1.15

Net earnings per share, diluted
$
1.13
XML 36 R2.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF EARNINGS - USD ($)
shares in Millions
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Income Statement [Abstract]      
Revenues, net $ 780,600,000 $ 773,400,000 $ 698,100,000
Cost of revenues 523,900,000 519,500,000 444,600,000
Gross margin 256,700,000 253,900,000 253,500,000
Operating expenses:      
Research and development 78,100,000 83,000,000.0 67,300,000
Selling, general and administrative 128,100,000 123,400,000 102,500,000
Impairment of intangible assets 4,800,000 3,000,000.0 0
Total operating expenses 211,000,000.0 209,400,000 169,800,000
Operating earnings 45,700,000 44,500,000 83,700,000
Interest income 100,000 200,000 200,000
Interest expense (21,100,000) (21,700,000) (12,300,000)
Other (expense) income, net (3,200,000) 2,700,000 3,200,000
Interest and other expenses, net (24,200,000) (18,800,000) (8,900,000)
Earnings before taxes 21,500,000 25,700,000 74,800,000
Taxes (benefit) on earnings 5,700,000 (2,600,000) 22,800,000
Net earnings 15,800,000 28,300,000 52,000,000.0
Less: Net earnings attributable to noncontrolling interests 300,000 800,000 400,000
Net earnings attributable to Varex $ 15,500,000 $ 27,500,000 $ 51,600,000
Net earnings per common share attributable to Varex      
Basic (in USD per share) $ 0.41 $ 0.73 $ 1.37
Diluted (in USD per share) $ 0.40 $ 0.72 $ 1.36
Weighted average common shares outstanding      
Basic (in shares) 38.2 37.9 37.6
Diluted (in shares) 38.6 38.4 38.0
XML 37 R30.htm IDEA: XBRL DOCUMENT v3.20.2
RESTRUCTURING (Tables)
 12 Months Ended
Sep. 27, 2019
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Charges Below is a detail of restructuring charges incurred during the 2019 and 2018 fiscal years, which predominately relate to the Company's Medical segment:
(In millions)
Location of Restructuring Charges in Consolidated Statements of Earnings
 
September 27, 2019
 
September 28, 2018
Other assets impairment charges
Selling, general and administrative
 
$
—

 
$
1.3

Inventory write downs
Cost of revenues
 
3.1

 
3.1

Intangible assets impairment
Impairment of intangible assets
 
4.8

 
3.0

Accelerated depreciation
Cost of revenues
 
4.5

 
4.2

Severance costs
Selling, general and administrative
 
6.2

 
4.3

Facility closure costs
Selling, general and administrative
 
0.3

 
0.8

Total restructuring charges
 
 
$
18.9

 
$
16.7
XML 38 R31.htm IDEA: XBRL DOCUMENT v3.20.2
OTHER FINANCIAL INFORMATION (Tables)
 12 Months Ended
Sep. 27, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Accrued Liabilities The following table summarizes the Company’s accrued liabilities:
(In millions)
September 27, 2019
 
September 28, 2018
Accrued compensation and benefits
$
32.1

 
$
27.0

Product warranty
8.1

 
7.3

Income taxes payable
10.7

 
1.4

Payable to Varian Medical Systems
—

 
2.3

Right of return liability
6.9

 
—

Deferred consideration
8.9

 
—

Other
9.0

 
9.5

Total accrued liabilities
$
75.7

 
$
47.5
Other Noncurrent Liabilities
The following table summarizes the Company’s other long-term liabilities:
(In millions)
September 27, 2019
 
September 28, 2018
Long-term income tax payable
$
3.9

 
$
3.5

Environment liabilities
0.9

 
1.3

Defined benefit obligation liability
5.5

 
3.3

Long-term right of return liability
19.5

 
—

Long-term other
2.7

 
0.4

Total other long-term liabilities
$
32.5

 
$
8.5
Schedule of Other Nonoperating Income (Expense)
The following table summarizes the Company’s other income (expense), net:
 
Fiscal Years
(In millions)
2019
 
2018
 
2017
Income (loss) from equity method investments
$
(2.3
)
 
$
3.9

 
$
1.3

Change in fair value of deferred consideration
1.0

 
—

 
—

Realized income (loss) on foreign currencies
(1.9
)
 
(1.2
)
 
1.9

Total other income (expense), net
$
(3.2
)
 
$
2.7

 
$
3.2
XML 39 R32.htm IDEA: XBRL DOCUMENT v3.20.2
NET EARNINGS PER SHARE (Tables)
 12 Months Ended
Sep. 27, 2019
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
A reconciliation of the numerator and denominator used in the calculation of basic and diluted net income per common share is as follows:
 
Fiscal Year
(In millions, except per share amounts)
2019
 
2018
 
2017
Net earnings attributable to Varex
$
15.5

 
$
27.5

 
$
51.6

Weighted average shares outstanding - basic
38.2

 
37.9

 
37.6

Dilutive effect of potential common shares
0.4

 
0.5

 
0.4

Weighted average shares outstanding - diluted
38.6

 
38.4

 
38

Net earnings per share attributable to Varex - basic
$
0.41

 
$
0.73

 
$
1.37

Net earnings per share attributable to Varex - diluted
$
0.40

 
$
0.72

 
$
1.36

Anti-dilutive employee shared based awards, excluded
1.9

 
1.2

 
1.0
XML 40 R33.htm IDEA: XBRL DOCUMENT v3.20.2
FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES (Tables)
 12 Months Ended
Sep. 27, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Derivative Instruments
The following table shows the notional amounts of outstanding foreign currency contracts entered into under its balance sheet hedge program as of September 27, 2019:
 
Notional Value of Derivatives not Designated as Hedging Instruments:
In millions
Buy contracts
 
Sell contract
Japanese yen
$
0.9

 
$
—

Swiss franc
—

 
(1.0
)
Chinese renminbi
1.8

 
—

Euro
8.8

 
—

 
$
11.5

 
$
(1.0
)

As of September 27, 2019, the Company had the following outstanding derivatives designated as cash flow hedging instruments:
(In millions, except for number of instruments)
Number of Instruments
 
Notional Value
Interest Rate Swap Contracts
6
 
$
264.4


As of September 27, 2019, the Company had the following outstanding derivatives designated as net investment hedging instruments:
(In millions, except for number of instruments)
Number of Instruments
 
Notional Value
Cross Currency Swap Contracts
4
 
$
77.7
Schedule of Interest Rate Derivative Instruments
The following table summarizes the amount of pre-tax earnings recognized from derivative instruments for the periods indicated and the line items in the accompanying statements of operations where the results are recorded for cash flow hedges:
 
Amount of Gain or (Loss) Recognized in OCI on Derivative
Fiscal Year Ended
 
Location of Gain or (Loss) Reclassified from Accumulated OCI into Income
 
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income
Fiscal Year Ended
(In millions)
2019
 
2018
 
2017
 
 
2019
 
2018
 
2017
Interest Rate Swap Contracts
$
(6.3
)
 
$
6.9

 
$
0.6

 
Interest expense
 
$
1.9

 
$
0.1

 
$
(0.3
)
The Company expects that $0.1 million of the accumulated other comprehensive (loss) income related to cash flow hedges will be realized in pre-tax earnings over the next 12 months, but the amount will vary depending on interest rates.
These derivative instruments are subject to master netting agreements giving effect to rights of offset with each counterparty. None of the balances were eligible for netting. The following table summarizes the gross fair values of derivative instruments as of the periods indicated and the line items in the accompanying consolidated balance sheets where the instruments are recorded.
 
Derivative Assets
 
Derivative Liabilities
(In millions)
 
 
September 27, 2019
 
September 28, 2018
 
 
 
September 27, 2019
 
September 28, 2018
Derivatives designated as cash flow hedges
Balance sheet location
 
 
 
 
 
Balance sheet location
 
 
 
 
Interest rate swap contracts
Other current assets
 
$
—

 
$
2.2

 
Other current liabilities
 
$
—

 
$
—

Interest rate swap contracts
Other non-current assets
 
—

 
5.5

 
Other non-current liabilities
 
(0.5
)
 
—

 
 
 
$
—

 
$
7.7

 
 
 
$
(0.5
)
 
$
—


The following table summarizes the amount of pre-tax earnings recognized from derivative instruments for the periods indicated and the line items in the accompanying statements of operations where the results are recorded for net investment hedges:
 
Amount of Gain or (Loss) Recognized in OCI on Derivative
Fiscal Year Ended
 
Location of Gain or (Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)
 
Amount of Gain or (Loss) Recognized in Income on Derivative (Amount Excluded from Effectiveness Testing)
(In millions)
2019
 
2018
 
2017
 
 
2019
 
2018
 
2017
Cross Currency Swap Contracts
$
(0.2
)
 
$
—

 
$
—

 
Interest expense
 
$
0.2

 
$
—

 
$
—

These derivative instruments are subject to master netting agreements giving effect to rights of offset with each counterparty. None of the balances were eligible for netting. The following table summarizes the gross fair values of derivative instruments as of the periods indicated and the line items in the accompanying consolidated balance sheets where the instruments are recorded:
 
Derivative Assets
 
Derivative Liabilities
(In millions)
 
 
September 27, 2019
 
September 28, 2018
 
 
 
September 27, 2019
 
September 28, 2018
Derivatives designated as net investment hedges
Balance sheet location
 
 
 
 
 
Balance sheet location
 
 
 
 
Cross currency swap contracts
Other current assets
 
—

 
—

 
Other current liabilities
 
(0.2
)
 
—

 
 
 
$
—

 
$
—

 
 
 
$
(0.2
)
 
$
—
XML 41 R34.htm IDEA: XBRL DOCUMENT v3.20.2
BORROWINGS (Tables)
 12 Months Ended
Sep. 27, 2019
Debt Disclosure [Abstract]  
Schedule of Short-Term and Long-Term Debt
The following table summarizes the Company's short-term and long-term debt:
 
September 27, 2019
 
September 28, 2018
(In millions, except for percentages)
Amount
 
Weighted-Average Interest Rate
 
Amount
 
Weighted-Average Interest Rate
Current maturities of long-term debt
 
 
 
 
 
 
 
Term facility
$
29.4

 
5.6
%
 
$
25.0

 
4.2
%
Other debt
1.3

 
 
 
—

 
 
Total current maturities of long-term debt
$
30.7

 
 
 
$
25.0

 
 
 
 
 
 
 
 
 
 
Non-current maturities of long-term debt:
 
 
 
 
 
 
 
Revolving credit facility
$
59.0

 
5.6
%
 
$
28.0

 
4.2
%
Term facility
308.6

 
5.6
%
 
345.0

 
4.2
%
Other debt
2.5

 
 
 
—

 
 
Debt issuance costs
(5.7
)
 
 
 
(8.2
)
 
 
Non-current maturities of long-term debt
364.4

 
 
 
364.8

 
 
Total long-term debt, net
$
395.1

 
 
 
$
389.8

 
 
Schedule of Maturities of Long-term Debt
Future principal payments of the long-term debt outstanding as of September 27, 2019 are as follows:
(In millions)
 
Fiscal years:
 
2020
$
30.7

2021
34.3

2022
335.8

Total debt outstanding
400.8

Less: current maturities of long-term debt
(30.7
)
Non-current portion of long -term debt
$
370.1
XML 42 R35.htm IDEA: XBRL DOCUMENT v3.20.2
FAIR VALUE (Tables)
 12 Months Ended
Sep. 27, 2019
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
At September 28, 2018, the Company determined the following levels of inputs for the following assets or liabilities:
(In millions)
Fair Value Measurements at September 28, 2018
 
Quoted Prices in Active Markets for Identical Assets and Liabilities
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
 
Total
Assets:
 
 
 
 
 
 
 
Cash equivalents - Money market funds
$
—

 
$
18.4

 
$
—

 
$
18.4

Derivative assets
—

 
7.7

 
—

 
7.7

Total assets measured at fair value
$
—

 
$
26.1

 
$
—

 
$
26.1

Liabilities:
 
 
 
 
 
 
 
Derivative liabilities
$
—

 
$
—

 
$
—

 
$
—


In the tables below, the Company has segregated all assets and liabilities that are measured at fair value on a recurring basis into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date.
(In millions)
Fair Value Measurements at September 27, 2019
 
Quoted Prices in Active Markets for Identical Assets and Liabilities
(Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant Unobservable Inputs
(Level 3)
 
Total
Assets:
 
 
 
 
 
 
 
Cash equivalents - money market funds
$
—

 
$
8.8

 
$
—

 
$
8.8

Total assets measured at fair value
$
—

 
$
8.8

 
$
—

 
$
8.8

Liabilities:
 
 
 
 
 
 
 
Derivative liabilities
$
—

 
$
0.7

 
$
—

 
$
0.7

Deferred consideration
8.9

 
—

 
—

 
8.9

Total liabilities measured at fair value
$
8.9

 
$
0.7

 
$
—

 
$
9.6
XML 43 R36.htm IDEA: XBRL DOCUMENT v3.20.2
GOODWILL AND INTANGIBLE ASSETS (Tables)
 12 Months Ended
Sep. 27, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The following table reflects goodwill by reportable operating segment:
(In millions)
Medical
 
Industrial
 
Total
Balance at September 28, 2018
$
147.0

 
$
96.6

 
$
243.6

Business combination
26.0

 
21.2

 
47.2

Balance at September 27, 2019
$
173.0

 
$
117.8

 
$
290.8
Schedule of Finite-Lived Intangible Assets
The following table reflects the gross carrying amount and accumulated amortization of the Company’s finite-lived intangible assets included in other assets in the consolidated balance sheets:
 
September 27, 2019
 
September 28, 2018
(In millions)
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
Acquired existing technology
$
74.1

 
$
(28.4
)
 
$
45.7

 
$
57.9

 
$
(21.8
)
 
$
36.1

Patents, licenses and other
12.7

 
(8.4
)
 
4.3

 
9.9

 
(7.4
)
 
2.5

Customer contracts and supplier relationship
50.7

 
(17.2
)
 
33.5

 
42.6

 
(11.4
)
 
31.2

Total intangible assets with finite lives
137.5

 
(54.0
)
 
83.5

 
110.4

 
(40.6
)
 
69.8

In-process R&D with indefinite lives
2.8

 
0.0

 
2.8

 
4.0

 
0.0

 
4.0

Total intangible assets
$
140.3

 
$
(54.0
)
 
$
86.3

 
$
114.4

 
$
(40.6
)
 
$
73.8

 
 
 
 
 
 
 
 
 
 
 
 
Schedule of Indefinite-Lived Intangible Assets
The following table reflects the gross carrying amount and accumulated amortization of the Company’s finite-lived intangible assets included in other assets in the consolidated balance sheets:
 
September 27, 2019
 
September 28, 2018
(In millions)
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
 
Gross Carrying Amount
 
Accumulated Amortization
 
Net Carrying Amount
Acquired existing technology
$
74.1

 
$
(28.4
)
 
$
45.7

 
$
57.9

 
$
(21.8
)
 
$
36.1

Patents, licenses and other
12.7

 
(8.4
)
 
4.3

 
9.9

 
(7.4
)
 
2.5

Customer contracts and supplier relationship
50.7

 
(17.2
)
 
33.5

 
42.6

 
(11.4
)
 
31.2

Total intangible assets with finite lives
137.5

 
(54.0
)
 
83.5

 
110.4

 
(40.6
)
 
69.8

In-process R&D with indefinite lives
2.8

 
0.0

 
2.8

 
4.0

 
0.0

 
4.0

Total intangible assets
$
140.3

 
$
(54.0
)
 
$
86.3

 
$
114.4

 
$
(40.6
)
 
$
73.8

 
 
 
 
 
 
 
 
 
 
 
 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
As of September 27, 2019, the estimated future amortization expense of intangible assets with finite lives is as follows:
(In millions)
 
Fiscal years:
 
2020
$
17.2

2021
16.3

2022
14.7

2023
13.7

2024
9.1

Thereafter
12.5

Total
$
83.5
XML 44 R37.htm IDEA: XBRL DOCUMENT v3.20.2
REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS (Tables)
 12 Months Ended
Sep. 27, 2019
Noncontrolling Interest [Abstract]  
Changes in Redeemable Noncontrolling Interest
Changes in redeemable noncontrolling interests and noncontrolling interests were as follows: 
 
Fiscal Years
 
2019
 
2018
(In millions)
Redeemable
Noncontrolling
Interests
 
Noncontrolling
Interests
 
Redeemable
Noncontrolling
Interests
 
Noncontrolling Interest
Balance at beginning of period
$
11.1

 
$
2.1

 
$
11.2

 
$
—

Net earnings attributable to noncontrolling interests
0.5

 
(0.2
)
 
0.5

 
0.3

Contributions from noncontrolling interests
—

 
1.4

 
—

 
1.8

Dividend distributions
(0.5
)
 
—

 
(0.6
)
 
—

Other
(0.6
)
 
—

 
—

 
—

Balance at end of period
$
10.5

 
$
3.3

 
$
11.1

 
$
2.1
XML 45 R38.htm IDEA: XBRL DOCUMENT v3.20.2
EMPLOYEE STOCK PLANS (Tables)
 12 Months Ended
Sep. 27, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
The table below summarizes the effect of recording share-based compensation expense and for the option component of the employee stock purchase plan shares:
 
Fiscal Year
(In millions)
2019
 
2018
 
2017
Cost of revenues
$
1.2

 
$
1.3

 
$
0.9

Research and development
2.2

 
1.8

 
1.5

Selling, general and administrative (1)
8.3

 
6.9

 
6.0

Total share-based compensation expense
$
11.7

 
$
10.0

 
$
8.4

(1) Includes allocated share-based compensation of $0.8 million for fiscal year 2017 and represents charges by Varian to the Company for certain Varian employees who provided general and administrative services on the Company’s behalf.
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions
The Company utilized the Black-Scholes valuation model for estimating the fair value of stock options granted and the option component of ESPP grants. The Company calculated the fair value of option grants and option component of ESPP grants on the respective dates of grant using the following weighted average assumptions:
 
Employee Stock Option Plan
 
Employee Stock Purchase Plans
 
Fiscal Year
 
Fiscal Year
 
2019
 
2018
 
2017
 
2019
 
2018
 
2017
Expected term (in years)
4.6

 
4.8

 
4.2

 
0.5

 
0.5

 
0.5

Risk-free interest rate
2.5
%
 
2.6
%
 
1.6
%
 
2.5
%
 
2.0
%
 
1.0
%
Expected volatility
33.9
%
 
31.8
%
 
23.6
%
 
43.9
%
 
34.1
%
 
28.0
%
Expected dividend
0.0
%
 
0.0
%
 
0.0
%
 
0.0
%
 
0.0
%
 
0.0
%
Weighted average fair value at grant date
$10.19
 
$11.57
 
$8.08
 
$7.81
 
$8.92
 
$7.81
Schedule of Share-based Compensation, Stock Options, Activity
The following table summarizes the activity for stock options under Varex’s employee incentive plans for the Company’s employees:
(In thousands, except per share amounts and the remaining term)
Options
 
Price range
 
Weighted Average
Exercise Price
 
Weighted Average Remaining Term (in years)
 
Aggregate Intrinsic Value (1)
Outstanding at September 28, 2018
2,011
 
$22.63 — $37.60
 
$
30.35

 
 
 
 
Granted
297
 
$31.42 — $31.42
 
31.42

 
 
 
 
Canceled, expired or forfeited
(4)
 
$31.08 — $31.08
 
31.08

 
 
 
 
Exercised
(35)
 
$22.84 — $27.77
 
23.38

 
 
 
 
Outstanding at September 27, 2019
2,269
 
$22.63 — $37.60
 
$
30.60

 
4.1
 
$
1,220.3

Exercisable at September 27, 2019
1,477
 
$22.63 — $37.60
 
$
29.67

 
3.4
 
$
1,220.3

(1) The aggregate intrinsic value represents the total pre-tax intrinsic value, which is computed based on the difference between the exercise price and the closing price of Varex common stock of $28.28 as of September 27, 2019, the last trading date of the Company's respective fiscal years, and which represents the amount that would have been received by the option holders had all option holders exercised their options and sold the shares received upon exercise as of that date.
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The following table summarizes the activity for restricted stock units, restricted stock awards and deferred stock units under Varex’s employee incentive plans for the Company’s employees:
(In thousands, except per share amounts)
Number of Shares
 
Weighted Average
Grant-Date Fair
Value
Balance at September 28, 2018
641
 
$
33.60

Granted
288
 
31.29

Vested
(201)
 
31.56

Canceled or expired
(50)
 
34.13

Balance at September 27, 2019
678
 
$
33.18
XML 46 R39.htm IDEA: XBRL DOCUMENT v3.20.2
TAXES ON EARNINGS (Tables)
 12 Months Ended
Sep. 27, 2019
Income Tax Disclosure [Abstract]  
Summary of Valuation Allowance [Table Text Block] Changes in the Company's valuation allowance for deferred tax assets were as follows:
 
Fiscal Years
(In millions)
2019
 
2018
 
2017
Valuation allowance balance–beginning of fiscal year
$
4.0

 
$
4.3

 
$
2.5

Increases resulting from business combinations
12.0

 
—

 
—

Other increases
2.8

 
2.2

 
2.5

Other decreases
—

 
(2.5
)
 
(0.7
)
Valuation allowance balance—end of fiscal year
$
18.8

 
$
4.0

 
$
4.3
Schedule of Components of Income Tax Expense (Benefit)
Taxes on earnings were as follows:
 
Fiscal Years
(In millions)
2019
 
2018
 
2017
Current provision:
 
 
 
 
 
Federal
$
9.2

 
$
(2.1
)
 
$
24.8

State and local
1.3

 
(0.3
)
 
1.6

Foreign
6.8

 
7.5

 
5.3

Total current
17.3

 
5.1

 
31.7

Deferred provision (benefit):
 
 
 
 
 
Federal
(10.0
)
 
(7.0
)
 
(7.0
)
State and local
(1.6
)
 
0.7

 
(1.0
)
Foreign
—

 
(1.4
)
 
(0.9
)
Total deferred
(11.6
)
 
(7.7
)
 
(8.9
)
Taxes on earnings
$
5.7

 
$
(2.6
)
 
$
22.8
Schedule of Income before Income Tax, Domestic and Foreign
Earnings before taxes are generated from the following geographic areas:
 
Fiscal Years
(In millions)
2019
 
2018
 
2017
United States
$
5.9

 
$
3.7

 
$
55.5

Foreign
15.6

 
22.0

 
19.3

Earnings before taxes
$
21.5

 
$
25.7

 
$
74.8
Schedule of Effective Income Tax Rate Reconciliation
The effective tax rate differs from the U.S. federal statutory tax rate as a result of the following:
 
Fiscal Years
 
2019
 
2018
 
2017
Federal statutory income tax rate
21.0
 %
 
24.5
 %
 
35.0
 %
State and local taxes, net of federal tax benefit
(0.9
)%
 
1.1
 %
 
1.3
 %
Revaluation of deferred tax liabilities for US statutory change
—
 %
 
(41.8
)%
 
—
 %
Mandatory repatriation tax on foreign earnings
1.9
 %
 
13.0
 %
 
—
 %
Domestic production activities deduction
—
 %
 
(0.8
)%
 
(2.4
)%
Research and development credit
(10.2
)%
 
(11.1
)%
 
(2.6
)%
Prior year deferred tax adjustments
4.7
 %
 
1.9
 %
 
(4.0
)%
Foreign Rate Difference
6
 %
 
0.8
 %
 
—
 %
Change in valuation allowance
11.2
 %
 
(1.9
)%
 
3.8
 %
US Tax Reform - International Provisions
(4.7
)%
 
—
 %
 
—
 %
Other
(2.5
)%
 
4.2
 %
 
(0.6
)%
Effective tax rate
26.5
 %
 
(10.1
)%
 
30.5
 %
Schedule of Deferred Tax Assets and Liabilities
Significant components of deferred tax assets and liabilities are as follows:
(In millions)
September 27, 2019
 
September 28, 2018
Deferred Tax Assets:
 
 
 
Inventory adjustments
$
5.6

 
$
4.2

Share-based compensation
3.1

 
0.8

Product warranty
1.6

 
1.4

Deferred compensation
1.1

 
0.9

Net operating loss carryforwards
24.3

 
3.3

Accrued vacation
1.0

 
1.3

Credit carryforwards
1.9

 
1.8

Other
7.5

 
4.7

 
46.1

 
18.4

Valuation allowance
(18.8
)
 
(4.0
)
Total deferred tax assets
27.3

 
14.4

Deferred Tax Liabilities:
 
 
 
Acquired intangibles
(19.3
)
 
(15.2
)
Property, plant and equipment
(10.6
)
 
(14.3
)
Investments in privately held companies
(3.3
)
 
(4.1
)
Other
(2.3
)
 
(4.0
)
Total deferred tax liabilities
(35.5
)
 
(37.6
)
Net deferred tax liabilities
$
(8.2
)
 
$
(23.2
)
Reported As:
 
 
 
Deferred tax assets
$
27.3

 
$
14.4

Deferred tax liabilities
(35.5
)
 
(37.6
)
Net deferred tax liabilities
$
(8.2
)
 
$
(23.2
)
Schedule of Unrecognized Tax Benefits Roll Forward
Changes in the Company’s unrecognized tax benefits were as follows:
 
Fiscal Years
(In millions)
2019
 
2018
Unrecognized tax benefits balance–beginning of fiscal year
$
0.6

 
$
0.5

Subtractions based on tax positions related to a prior year
(0.2
)
 
—

Additions based on tax positions related to the current year
0.2

 
0.1

Unrecognized tax benefits balance—end of fiscal year
$
0.6

 
$
0.6
XML 47 R3.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS - USD ($)
$ in Millions
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Statement of Comprehensive Income [Abstract]      
Net earnings $ 15.8 $ 28.3 $ 52.0
Other comprehensive (loss) earnings, net of tax:      
Unrealized (loss) gain on interest rate swap contracts (6.2) 5.2 0.6
Unrealized (loss) gain on defined benefit obligations (1.3) (0.2) 0.2
Other comprehensive (loss) earnings, net of tax (7.5) 5.0 0.8
Comprehensive earnings 8.3 33.3 52.8
Less: Comprehensive earnings attributable to noncontrolling interests 0.3 0.8 0.4
Comprehensive earnings attributable to Varex $ 8.0 $ 32.5 $ 52.4
XML 48 R40.htm IDEA: XBRL DOCUMENT v3.20.2
SEGMENT INFORMATION (Tables)
 12 Months Ended
Sep. 27, 2019
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following amounts represent revenues by reporting segment from Direct Conversion from the acquisition date of April 29, 2019, through September 27, 2019:
(In millions)
Direct Conversion Revenue
Medical
$
4.5

Industrial
1.8

Total Direct Conversion revenues
$
6.3


The following amounts represent revenues by reporting segment from the Acquired Detector Business from the acquisition date of May 1, 2017 through September 29, 2017:
(In millions)
May 1, 2017 through September 29, 2017
Acquired Detector Business
 
Medical
$
41.1

Industrial
20.2

Total Acquired Detector Business revenues
$
61.3


Information related to the Company’s segments is as follows:
 
Fiscal Year
(In millions)
2019
 
2018
 
2017
Revenues
 
 
 
 
 
Medical
$
596.8

 
$
602.0

 
$
556.9

Industrial
183.8

 
171.4

 
141.2

Total revenues
780.6

 
773.4

 
698.1

Gross margin
 
 
 
 
 
Medical
188.9

 
190.5

 
193.6

Industrial
67.8

 
63.4

 
59.9

Total gross margin
256.7

 
253.9

 
253.5

Total operating expenses
211.0

 
209.4

 
169.8

Interest and other expenses, net
(24.2
)
 
(18.8
)
 
(8.9
)
Earnings before taxes
21.5

 
25.7

 
74.8

Taxes (benefit) on earnings
5.7

 
(2.6
)
 
22.8

Net earnings
15.8

 
28.3

 
52.0

Less: Net earnings attributable to noncontrolling interests
0.3

 
0.8

 
0.4

Net earnings attributable to Varex
$
15.5

 
$
27.5

 
$
51.6
Reconciliation of Assets from Segment to Consolidated
The following table summarizes the Company’s total assets by its reportable segments:
(In millions)
September 27, 2019
 
September 28, 2018
Identifiable assets:
 
 
 
Medical
$
794.3

 
$
770.6

Industrial
244.6

 
217.3

Total reportable segments
$
1,038.9

 
$
987.9
Revenue from External Customers by Geographic Areas
Geographic Information
 
Revenues
 
Property, plant and equipment, net
 
Fiscal Years
 
Fiscal Years
(In millions)
2019
 
2018
 
2017
 
2019
 
2018
United States
$
275.3

 
$
268.8

 
$
231.9

 
$
122.6

 
$
127.9

Latin America
7.3

 
7.0

 
7.9

 
—

 
—

EMEA
269.0

 
254.5

 
219.5

 
11.4

 
8.7

APAC
229.0

 
243.1

 
238.8

 
8.3

 
8.3

Total company
$
780.6

 
$
773.4

 
$
698.1

 
$
142.3

 
$
144.9
XML 49 R41.htm IDEA: XBRL DOCUMENT v3.20.2
OTHER COMPREHENSIVE INCOME (Tables)
 12 Months Ended
Sep. 27, 2019
Equity [Abstract]  
Schedule of Changes in Accumulated Other Comprehensive Income (Loss)
The following table presents the changes in the accumulated balances for each component of other comprehensive income (loss):
(In millions)
Unrealized Gain (Loss) on Derivative Financial Instruments
 
Unrealized Gain on Defined Benefit Obligations
 
Accumulated Other Comprehensive Income
Balance at September 28, 2018
$
5.8

 
$
—

 
$
5.8

Other comprehensive loss before reclassifications
(8.3
)
 
(1.9
)
 
(10.2
)
Income tax benefit
2.1

 
0.6

 
2.7

Balance at September 27, 2019
$
(0.4
)
 
$
(1.3
)
 
$
(1.7
)
 
 
 
 
 
 
XML 50 R42.htm IDEA: XBRL DOCUMENT v3.20.2
REVENUE RECOGNITION (Tables)
 12 Months Ended
Sep. 27, 2019
Revenue from Contract with Customer [Abstract]  
Schedule of ASC 606 Adoption Impacts
The beginning net cumulative-effect adjustment to the balance sheet for the adoption of ASC 606 is as follows:
 
Balance at
 
Adjustment Due to
 
Balance at
(In millions)
September 28, 2018
 
ASC 606
 
September 29, 2018
Assets:
 
 
 
 
 
Prepaid expenses and other current assets
$
17.1

 
$
6.4

 
$
23.5

Other assets
16.5

 
18.0

 
34.5

Liabilities and Equity:
 
 
 
 
 
Deferred revenues
13.2

 
0.3

 
13.5

Accrued liabilities
47.5

 
7.1

 
54.6

Deferred tax liabilities
23.2

 
(0.8
)
 
22.4

Other long-term liabilities
8.5

 
21.3

 
29.8

Retained earnings
62.4

 
(3.5
)
 
58.9


The following tables compare the reported consolidated balance sheet and statement of operations for fiscal year ended September 27, 2019, to the amounts that would have been reported if ASC 605 had been in effect:
 
September 27, 2019
(In millions)
Balance without Adoption
 
As Reported
Assets:
 
 
 
Prepaid expenses and other current assets
$
13.1

 
$
19.3

Other assets
$
10.0

 
$
27.5

Liabilities and equity:
 
 
 
Deferred revenues
$
9.9

 
$
10.5

Accrued liabilities
$
68.8

 
$
75.7

Deferred tax liabilities
$
9.1

 
$
8.2

Other long-term liabilities
$
12.1

 
$
32.5

Retained earnings
$
77.7

 
$
74.4


 
Twelve Months Ended September 27, 2019
(In millions)
Balance without Adoption
 
As Reported
Revenues
781.2

 
780.6

Cost of revenues
524.7

 
523.9

Taxes on earnings
5.7

 
5.7

Net earnings attributable to Varex
15.3

 
15.5
Schedule of Changes in Contract With Customer Assets And Liabilities The following table summarizes the changes in the contract assets and refund liabilities for the twelve months ended September 27, 2019:
(In millions)
Contact Assets
Balance at September 29, 2018
$
24.4

Costs recovered from product returns during the period
(6.4
)
Contract asset from shipments of products, subject to return during the period
5.7

Balance at September 27, 2019
$
23.7

(In millions)
Refund Liabilities
Balance at September 29, 2018
$
27.1

Recognition of revenue included in beginning of year refund liability
(7.0
)
Additions to refund liabilities
6.3

Balance at September 27, 2019
$
26.4
XML 51 R43.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Description of Business (Details)
Jan. 28, 2017
Varian Medical Systems, Inc.  
Schedule of Pro Rata Distribution [Line Items]  
Outstanding common stock, percentage distributed 1
XML 52 R44.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reclassification (Details) - USD ($)
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Error Corrections and Prior Period Adjustments Restatement [Line Items]      
Reclassification of selling, general and administrative $ (128,100,000) $ (123,400,000) $ (102,500,000)
Impairment of intangible assets $ 4,800,000 3,000,000.0 $ 0
Restatement Adjustment      
Error Corrections and Prior Period Adjustments Restatement [Line Items]      
Reclassification of selling, general and administrative   3,000,000.0  
Impairment of intangible assets   $ 3,000,000  
XML 53 R45.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Segment Reporting (Details)
 12 Months Ended
Sep. 27, 2019
segment
Accounting Policies [Abstract]  
Number of operating segments 2
XML 54 R46.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Variable Interest Entities (Details)
 12 Months Ended
Sep. 27, 2019
entity
Accounting Policies [Abstract]  
Number of variable interest entities 2
XML 55 R47.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Restricted Cash (Details) - USD ($)
$ in Millions
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Sep. 30, 2016
Accounting Policies [Abstract]        
Cash and cash equivalents $ 29.9 $ 51.9 $ 83.3  
Restricted cash 1.4 1.5 0.9  
Cash and cash equivalents and restricted cash as reported per statement of cash flows $ 31.3 $ 53.4 $ 84.2 $ 36.8
XML 56 R48.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration of Risk (Details) - Canon Medical Systems Corporation - Customer Concentration Risk
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Sales Revenue, Net      
Concentration Risk [Line Items]      
Concentration risk, percentage 17.30% 18.10% 19.30%
Accounts Receivable      
Concentration Risk [Line Items]      
Concentration risk, percentage 10.10% 9.80%  
XML 57 R49.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Details) - USD ($)
$ in Millions
Sep. 27, 2019
Sep. 28, 2018
Accounting Policies [Abstract]    
Raw materials and parts $ 160.1 $ 149.9
Work-in-process 27.9 25.4
Finished goods 60.2 59.8
Total inventories $ 248.2 $ 235.1
XML 58 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 27, 2019
Sep. 28, 2018
Current assets:    
Cash and cash equivalents $ 29.9 $ 51.9
Accounts receivable, net of allowance for doubtful accounts of $1.0 and $0.6 at September 27, 2019 and September 28, 2018, respectively 141.0 154.0
Inventories 248.2 235.1
Prepaid expenses and other current assets 19.3 17.1
Total current assets 438.4 458.1
Property, plant and equipment, net 142.3 144.9
Goodwill 290.8 243.6
Intangibles assets, net 86.3 73.8
Investments in privately-held companies 53.6 51.0
Other assets 27.5 16.5
Total assets 1,038.9 987.9
Current liabilities:    
Accounts payable 58.2 66.3
Accrued liabilities 75.7 47.5
Current maturities of long-term debt 30.7 25.0
Deferred revenues 10.5 13.2
Total current liabilities 175.1 152.0
Long-term debt, net 364.4 364.8
Deferred tax liabilities 8.2 23.2
Other long-term liabilities 32.5 8.5
Total liabilities 580.2 548.5
Commitments and contingencies (Note 11)
Redeemable noncontrolling interests 10.5 11.1
Equity:    
Preferred stock, $.01 par value: 20,000,000 shares authorized, none issued 0.0 0.0
Common stock, $.01 par value: 150,000,000 shares authorized, shares issued and outstanding: 38,371,305 and 38,026,597 at September 27, 2019 and September 28, 2018, respectively 0.4 0.4
Additional paid-in capital 371.8 357.6
Accumulated other comprehensive (loss) income (1.7) 5.8
Retained earnings 74.4 62.4
Total Varex stockholders' equity 444.9 426.2
Noncontrolling interests 3.3 2.1
Total stockholders' equity 448.2 428.3
Total liabilities, redeemable noncontrolling interests and stockholders' equity $ 1,038.9 $ 987.9
XML 59 R50.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property Plant and Equipment (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross $ 341.9 $ 335.6  
Accumulated depreciation and amortization (199.6) (190.7)  
Property, plant, and equipment, net 142.3 144.9  
Depreciation 23.5 26.0 $ 16.9
Accelerated depreciation $ 4.5 4.2  
Land Improvements      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, useful lives 15 years    
Building      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, useful lives 20 years    
Land      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross $ 8.3 8.3  
Buildings and leasehold improvements      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 134.4 138.1  
Machinery      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross 170.7 166.1  
Construction in progress      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, gross $ 28.5 $ 23.1  
Minimum | Machinery      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, useful lives 3 years    
Maximum | Machinery      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment, useful lives 7 years    
XML 60 R51.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Details)
 12 Months Ended
Sep. 27, 2019
Minimum  
Finite-Lived Intangible Assets [Line Items]  
Finite-lived intangible asset, useful life 2 years
Maximum  
Finite-Lived Intangible Assets [Line Items]  
Finite-lived intangible asset, useful life 7 years
XML 61 R52.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Impairment of Long-Lived Assets, Intangible Assets and Goodwill (Details) - USD ($)
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Accounting Policies [Abstract]      
Impairment of intangible assets $ 4,800,000 $ 3,000,000.0 $ 0
Goodwill, impairment loss   $ 0 $ 0
XML 62 R53.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Product Warranty (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Movement in Standard Product Warranty Accrual [Roll Forward]    
Accrued product warranty, at beginning of period $ 7.3 $ 7.0
Charged to cost of revenues 12.9 11.6
Actual product warranty expenditures (12.1) (11.3)
Accrued product warranty, at end of period $ 8.1 $ 7.3
Minimum    
Product Warranty Liability [Line Items]    
Warranty term (in months) 12 months  
Maximum    
Product Warranty Liability [Line Items]    
Warranty term (in months) 24 months  
XML 63 R54.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Allowance for Doubtful Accounts (Details) - USD ($)
$ in Millions
Sep. 27, 2019
Sep. 28, 2018
Accounting Policies [Abstract]    
Allowance for doubtful accounts $ 1.0 $ 0.6
XML 64 R55.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounting Standards Recently Adopted (Details) - USD ($)
$ in Millions
Sep. 27, 2019
Mar. 29, 2019
Dec. 28, 2018
Sep. 29, 2018
Sep. 28, 2018
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
(Decrease) increase to retained earnings for adoption of new accounting guidance $ 74.4     $ 58.9 $ 62.4
ASU 2014-09 | Difference between Revenue Guidance in Effect before and after Topic 606          
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]          
(Decrease) increase to retained earnings for adoption of new accounting guidance $ (3.5) $ 0.6 $ (4.1) $ (3.5)  
XML 65 R56.htm IDEA: XBRL DOCUMENT v3.20.2
BUSINESS COMBINATIONS - Direct Conversion Narrative (Details) - Direct Conversion AB - USD ($)
$ in Millions
Apr. 29, 2019
Apr. 30, 2019
Business Acquisition [Line Items]    
Percentage of voting interests acquired   98.20%
Net cash paid $ 69.5  
Debt assumed 4.5  
Deferred payment, value assigned $ 9.9  
Deferred payment (in shares) 300,000  
XML 66 R57.htm IDEA: XBRL DOCUMENT v3.20.2
BUSINESS COMBINATIONS - Fair Value of Identifiable Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Millions
Apr. 29, 2019
Aug. 31, 2018
May 01, 2017
Sep. 27, 2019
Sep. 28, 2018
Allocation of the purchase consideration:          
Goodwill       $ 290.8 $ 243.6
Direct Conversion AB          
Allocation of the purchase consideration:          
Accounts Receivable $ 2.4        
Inventory 5.7        
Prepaids and other current assets 0.7        
Property, plant, and equipment 0.9        
Intangibles 32.9        
Goodwill 47.2        
Total assets acquired 89.8        
Accounts payable (1.0)        
Accrued liabilities (1.5)        
Current maturities of long-term debt (1.0)        
Deferred revenues (0.9)        
Long-term debt (3.5)        
Other liabilities, non-current (1.1)        
Total liabilities assumed (9.0)        
Noncontrolling interest (1.4)        
Net assets acquired, less noncontrolling interest 79.4        
Net cash paid 69.5        
Deferred consideration 9.9        
Total cash consideration $ 79.4        
Virtual Media Integration, Ltd.          
Allocation of the purchase consideration:          
Accounts Receivable   $ 0.2      
Inventory   1.0      
Other assets   0.2      
Intangibles   1.6      
Goodwill   1.5      
Other liabilities   (0.2)      
Net assets acquired   4.3      
Post-closing adjustments   0.5      
Total cash consideration   $ 4.8      
PerkinElmer, Inc.          
Allocation of the purchase consideration:          
Cash     $ 1.4    
Accounts Receivable     18.7    
Inventory     34.7    
Prepaids and other current assets     0.6    
Property, plant, and equipment     21.4    
Other assets, non-current     2.0    
Intangibles     81.1    
Goodwill     167.3    
Total assets acquired     327.2    
Current liabilities     (17.2)    
Other liabilities, non-current     (36.8)    
Total liabilities assumed     (54.0)    
Net assets acquired     273.2    
Net cash paid     277.4    
Total cash consideration     $ 273.2    
XML 67 R58.htm IDEA: XBRL DOCUMENT v3.20.2
BUSINESS COMBINATIONS - Intangibles Acquired (Details) - USD ($)
$ in Millions
Apr. 29, 2019
May 01, 2017
Direct Conversion AB    
Intangible Assets Acquired as Part of Business Combination [Table] [Line Items]    
Intangibles $ 32.9  
Direct Conversion AB | In-process research and development    
Intangible Assets Acquired as Part of Business Combination [Table] [Line Items]    
Intangibles 2.8  
Direct Conversion AB | Backlog    
Intangible Assets Acquired as Part of Business Combination [Table] [Line Items]    
Intangibles $ 0.2  
Estimated useful life 1 year  
Direct Conversion AB | Trade names    
Intangible Assets Acquired as Part of Business Combination [Table] [Line Items]    
Intangibles $ 2.5  
Estimated useful life 5 years  
Direct Conversion AB | Developed technology    
Intangible Assets Acquired as Part of Business Combination [Table] [Line Items]    
Intangibles $ 18.4  
Estimated useful life 10 years  
Direct Conversion AB | Customer relationships    
Intangible Assets Acquired as Part of Business Combination [Table] [Line Items]    
Intangibles $ 9.0  
Estimated useful life 10 years  
PerkinElmer, Inc.    
Intangible Assets Acquired as Part of Business Combination [Table] [Line Items]    
Intangibles   $ 81.1
PerkinElmer, Inc. | In-process research and development    
Intangible Assets Acquired as Part of Business Combination [Table] [Line Items]    
Intangibles   4.0
PerkinElmer, Inc. | Favorable leasehold interests    
Intangible Assets Acquired as Part of Business Combination [Table] [Line Items]    
Intangibles   $ 3.8
Estimated useful life   16 years
PerkinElmer, Inc. | Backlog    
Intangible Assets Acquired as Part of Business Combination [Table] [Line Items]    
Intangibles   $ 1.2
Estimated useful life   1 year
PerkinElmer, Inc. | Trade names    
Intangible Assets Acquired as Part of Business Combination [Table] [Line Items]    
Intangibles   $ 1.4
Estimated useful life   5 years
PerkinElmer, Inc. | Developed technology    
Intangible Assets Acquired as Part of Business Combination [Table] [Line Items]    
Intangibles   $ 37.7
Estimated useful life   7 years
PerkinElmer, Inc. | Customer relationships    
Intangible Assets Acquired as Part of Business Combination [Table] [Line Items]    
Intangibles   $ 33.0
Estimated useful life   7 years
XML 68 R59.htm IDEA: XBRL DOCUMENT v3.20.2
BUSINESS COMBINATIONS - Revenues by Segment (Details) - USD ($)
$ in Millions
 5 Months Ended
Sep. 27, 2019
Sep. 29, 2017
Direct Conversion AB    
Segment Reporting Information [Line Items]    
Revenues $ 6.3  
Direct Conversion AB | Medical    
Segment Reporting Information [Line Items]    
Revenues 4.5  
Direct Conversion AB | Industrial    
Segment Reporting Information [Line Items]    
Revenues $ 1.8  
PerkinElmer, Inc.    
Segment Reporting Information [Line Items]    
Revenues   $ 61.3
PerkinElmer, Inc. | Medical    
Segment Reporting Information [Line Items]    
Revenues   41.1
PerkinElmer, Inc. | Industrial    
Segment Reporting Information [Line Items]    
Revenues   $ 20.2
XML 69 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) - USD ($)
$ in Millions
Sep. 27, 2019
Sep. 28, 2018
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 1.0 $ 0.6
Preferred stock, par value per share (usd per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 20,000,000 20,000,000
Preferred stock, shares issued (in shares) 0 0
Common stock, par value per share (usd per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 150,000,000 150,000,000
Common stock, shares, issued (in shares) 38,371,305 38,026,597
Common stock, shares, outstanding (in shares) 38,371,305 38,026,597
XML 70 R60.htm IDEA: XBRL DOCUMENT v3.20.2
BUSINESS COMBINATIONS - Virtual Media Narrative (Details)
$ in Millions
Aug. 31, 2018
USD ($)
Virtual Media Integration, Ltd.  
Business Acquisition [Line Items]  
Total cash consideration $ 4.8
XML 71 R61.htm IDEA: XBRL DOCUMENT v3.20.2
BUSINESS COMBINATIONS - PerkinElmer's Medical Imaging Narrative (Details) - PerkinElmer, Inc.
$ in Millions
May 01, 2017
USD ($)
employee
Business Acquisition [Line Items]  
Net cash paid $ 277.4
Total cash consideration $ 273.2
Business combination, number of employees | employee 280
Deferred tax liabilities noncurrent $ 31.0
Foreign Tax Authority  
Business Acquisition [Line Items]  
Goodwill expected tax deductible amount $ 35.0
XML 72 R62.htm IDEA: XBRL DOCUMENT v3.20.2
BUSINESS COMBINATIONS - Pro Forma (Details) - PerkinElmer, Inc.
$ / shares in Units, $ in Millions
 12 Months Ended
Sep. 29, 2017
USD ($)
$ / shares
Business Acquisition [Line Items]  
Revenue $ 777.8
Operating earnings 84.7
Net earnings $ 43.1
Net earnings per share, basic (in USD per share) | $ / shares $ 1.15
Net earnings per share, diluted (in USD per share) | $ / shares $ 1.13
XML 73 R63.htm IDEA: XBRL DOCUMENT v3.20.2
RELATED-PARTY TRANSACTIONS - Investment in Privately Held Companies (Details)
$ in Millions
 1 Months Ended 11 Months Ended 12 Months Ended
Dec. 17, 2019
USD ($)
Oct. 31, 2013
Sep. 27, 2019
USD ($)
member
Sep. 27, 2019
USD ($)
member
Sep. 28, 2018
USD ($)
Sep. 29, 2017
USD ($)
Related Party Transaction [Line Items]            
Income (loss) from equity method investments       $ (2.3) $ 3.9 $ 1.3
Contributions to equity method investments       $ 3.9 0.0 0.0
dpiX Holding            
Related Party Transaction [Line Items]            
Equity method investment, ownership percentage     40.00% 40.00%    
Number of consortium members | member     4 4    
Income (loss) from equity method investments       $ (1.1) 3.4 0.8
Equity method investments     $ 48.1 48.1 48.9  
dpiX Holding | Equity Method Investee            
Related Party Transaction [Line Items]            
Purchases from related party       23.5 19.3 $ 24.7
Accounts payable, related parties     $ 3.6 $ 3.6 $ 3.7  
Percentage of manufacturing capacity   50.00%        
Percentage of fixed costs   50.00%        
dpiX LLC            
Related Party Transaction [Line Items]            
Equity method investment, ownership percentage     100.00% 100.00%    
VEC Imaging            
Related Party Transaction [Line Items]            
Equity method investment, ownership percentage     50.00% 50.00%    
Equity method investments     $ 2.0 $ 2.0    
Contributions to equity method investments     $ 2.9      
Fixed Cost Commitments | dpiX Holding            
Related Party Transaction [Line Items]            
Related party transaction, expected fixed cost       $ 3.7    
CETTEEN GmbH | VEC Imaging            
Related Party Transaction [Line Items]            
Equity method investment, ownership percentage     50.00% 50.00%    
Forecast | VEC Imaging            
Related Party Transaction [Line Items]            
Contributions to equity method investments $ 2.2          
XML 74 R64.htm IDEA: XBRL DOCUMENT v3.20.2
RESTRUCTURING - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Restructuring Cost and Reserve [Line Items]    
Restructuring and impairment charges $ 18.9 $ 16.7
Other unrelated restructuring costs 2.8 0.8
London Facility Closing    
Restructuring Cost and Reserve [Line Items]    
Restructuring charges   1.7
Santa Clara Facility Relocation    
Restructuring Cost and Reserve [Line Items]    
Restructuring and impairment charges 16.1 $ 14.2
Minimum | Santa Clara Facility Relocation    
Restructuring Cost and Reserve [Line Items]    
Expected additional costs to be incurred 8.1  
Maximum | Santa Clara Facility Relocation    
Restructuring Cost and Reserve [Line Items]    
Expected additional costs to be incurred $ 12.1  
XML 75 R65.htm IDEA: XBRL DOCUMENT v3.20.2
RESTRUCTURING - Restructuring Charges Incurred (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Restructuring and Related Activities [Abstract]      
Other assets impairment charges $ 0.0 $ 1.3 $ 0.0
Inventory write-down 3.1 3.1 $ 0.0
Intangible assets impairment 4.8 3.0  
Accelerated depreciation 4.5 4.2  
Severance costs 6.2 4.3  
Facility closure costs 0.3 0.8  
Total restructuring charges $ 18.9 $ 16.7  
XML 76 R66.htm IDEA: XBRL DOCUMENT v3.20.2
OTHER FINANCIAL INFORMATION - (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Sep. 29, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Accrued compensation and benefits $ 32.1 $ 27.0    
Product warranty 8.1 7.3    
Income taxes payable 10.7 1.4    
Payable to Varian Medical Systems 0.0 2.3    
Right of return liability 6.9 0.0    
Deferred consideration 8.9 0.0    
Other 9.0 9.5    
Total accrued liabilities 75.7 47.5   $ 54.6
Long-term income tax payable 3.9 3.5    
Environment liabilities 0.9 1.3    
Defined benefit obligation liability 5.5 3.3    
Long-term right of return liability 19.5 0.0    
Long-term other 2.7 0.4    
Total other long-term liabilities 32.5 8.5   $ 29.8
Income (loss) from equity method investments (2.3) 3.9 $ 1.3  
Change in fair value of deferred consideration 1.0 0.0 0.0  
Realized income (loss) on foreign currencies (1.9) (1.2) 1.9  
Total other income (expense), net $ (3.2) $ 2.7 $ 3.2  
XML 77 R67.htm IDEA: XBRL DOCUMENT v3.20.2
NET EARNINGS PER SHARE - (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Earnings Per Share [Abstract]      
Net earnings attributable to Varex $ 15.5 $ 27.5 $ 51.6
Weighted average shares outstanding - basic (in shares) 38.2 37.9 37.6
Dilutive effect of potential common shares (in shares) 0.4 0.5 0.4
Weighted average shares outstanding - diluted (in shares) 38.6 38.4 38.0
Net earnings per share attributable to Varex - basic (in USD per share) $ 0.41 $ 0.73 $ 1.37
Net earnings per share attributable to Varex - diluted (in USD per share) $ 0.40 $ 0.72 $ 1.36
Anti-dilutive employee shared based awards, excluded (in shares) 1.9 1.2 1.0
XML 78 R68.htm IDEA: XBRL DOCUMENT v3.20.2
FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivative Instruments (Details) - Derivatives designated as cash flow hedges - Designated as Hedging Instrument
$ in Millions
Sep. 27, 2019
USD ($)
derivative
Interest Rate Swap Contracts  
Derivative [Line Items]  
Number of Instruments | derivative 6
Notional Value | $ $ 264.4
Cross Currency Swap Contracts  
Derivative [Line Items]  
Number of Instruments | derivative 4
Notional Value | $ $ 77.7
XML 79 R69.htm IDEA: XBRL DOCUMENT v3.20.2
FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Narrative (Details)
$ in Millions
 12 Months Ended
Sep. 27, 2019
USD ($)
Derivative [Line Items]  
Loss on derivative instruments not designated as cash flow hedges $ 1.5
Derivatives designated as cash flow hedges | Interest Rate Swap Contracts  
Derivative [Line Items]  
Recorded component of accumulated other comprehensive income (loss) that will be reclassified in the statements of comprehensive earnings over the next 12 months $ 0.1
XML 80 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Cash flows from operating activities:      
Net earnings $ 15,800,000 $ 28,300,000 $ 52,000,000.0
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Share-based compensation expense 11,700,000 10,000,000.0 8,400,000
Depreciation 23,500,000 26,000,000.0 16,900,000
Amortization of intangible assets 15,700,000 16,200,000 10,500,000
Impairment of intangible assets 4,800,000 3,000,000.0 0
Other assets impairment charges 0 1,300,000 0
Inventory write-down 3,100,000 3,100,000 0
Deferred taxes (12,900,000) (7,700,000) (8,900,000)
Amortization of deferred loan costs 2,400,000 2,300,000 1,800,000
Loss (gain) from equity method investments, net of dividends received 2,300,000 (3,900,000) (1,300,000)
Other, net 800,000 700,000 1,800,000
Changes in assets and liabilities, net of effects of acquisitions:      
Accounts receivable 14,800,000 9,000,000.0 (23,100,000)
Inventories (11,100,000) (2,400,000) (4,200,000)
Prepaid expenses and other assets 4,300,000 2,000,000.0 (10,100,000)
Accounts payable (9,000,000.0) 5,200,000 4,900,000
Accrued operating liabilities and other long-term operating liabilities 10,900,000 (10,200,000) 28,100,000
Deferred revenues (5,200,000) 2,400,000 (1,600,000)
Net cash provided by operating activities 71,900,000 85,300,000 75,200,000
Cash flows from investing activities:      
Purchases of property, plant and equipment (19,800,000) (20,400,000) (20,200,000)
Acquisitions of businesses, net of cash acquired (69,500,000) (4,800,000) (271,800,000)
Investments in privately-held companies (3,900,000) 0 0
Net cash used in investing activities (93,200,000) (25,200,000) (292,000,000.0)
Cash flows from financing activities:      
Net transfers from parent 0 0 5,000,000.0
Distributions to Varian Medical Systems, Inc. 0 0 (227,100,000)
Taxes related to net share settlement of equity awards (2,100,000) (2,300,000) (1,900,000)
Borrowings under credit agreements 85,400,000 10,000,000.0 749,000,000.0
Repayments of borrowing under credit agreements (87,000,000.0) (106,000,000.0) (255,000,000.0)
Proceeds from exercise of stock options 800,000 3,800,000 2,800,000
Proceeds from shares issued under employee stock purchase plan 3,800,000 3,300,000 0
Excess tax benefits from share-based compensation 0 0 2,400,000
Payment of debt issuance costs (500,000) (400,000) (11,900,000)
Contributions from noncontrolling partner 0 1,800,000 0
Dividends paid to redeemable noncontrolling interest (500,000) (600,000) 0
Net cash (used in) provided by financing activities (100,000) (90,400,000) 263,300,000
Effects of exchange rate changes on cash and cash equivalents and restricted cash (700,000) (500,000) 900,000
Net (decrease) increase in cash and cash equivalents and restricted cash (22,100,000) (30,800,000) 47,400,000
Cash and cash equivalents and restricted cash at beginning of period 53,400,000 84,200,000 36,800,000
Cash and cash equivalents and restricted cash at end of period 31,300,000 53,400,000 84,200,000
Supplemental cash flow information:      
Cash paid for interest 19,900,000 19,300,000 9,800,000
Cash paid for income tax 8,200,000 13,800,000 6,000,000.0
Supplemental non-cash activities:      
Purchases of property, plant and equipment financed through accounts payable 1,800,000 2,000,000.0 4,000,000.0
Transfers of property, plant and equipment from Varian Medical Systems, Inc. 0 0 15,000,000.0
Other non-cash transfers to Varian Medical Systems, Inc. $ 0 $ 0 $ 1,600,000
XML 81 R70.htm IDEA: XBRL DOCUMENT v3.20.2
FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Income Recognized From Derivative Instruments (Details) - Designated as Hedging Instrument - Derivatives designated as cash flow hedges - USD ($)
$ in Millions
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Interest Rate Swap Contracts      
Derivative [Line Items]      
Amount of Gain or (Loss) Recognized in OCI on Derivative Fiscal Year Ended $ (6.3) $ 6.9 $ 0.6
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income Fiscal Year Ended 1.9 0.1 (0.3)
Cross Currency Swap Contracts      
Derivative [Line Items]      
Amount of Gain or (Loss) Recognized in OCI on Derivative Fiscal Year Ended (0.2) 0.0 0.0
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income Fiscal Year Ended $ 0.2 $ 0.0 $ 0.0
XML 82 R71.htm IDEA: XBRL DOCUMENT v3.20.2
FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivatives at Fair Value (Details) - Derivatives designated as cash flow hedges - Designated as Hedging Instrument - USD ($)
$ in Millions
Sep. 27, 2019
Sep. 28, 2018
Interest Rate Swap Contracts    
Derivative [Line Items]    
Derivative Assets $ 0.0 $ 7.7
Derivative Liabilities (0.5) 0.0
Cross Currency Swap Contracts    
Derivative [Line Items]    
Derivative Assets 0.0 0.0
Derivative Liabilities (0.2) 0.0
Other current assets | Interest Rate Swap Contracts    
Derivative [Line Items]    
Derivative Assets 0.0 2.2
Other current assets | Cross Currency Swap Contracts    
Derivative [Line Items]    
Derivative Assets 0.0 0.0
Other non-current assets | Interest Rate Swap Contracts    
Derivative [Line Items]    
Derivative Assets 0.0 5.5
Other current liabilities | Interest Rate Swap Contracts    
Derivative [Line Items]    
Derivative Liabilities 0.0 0.0
Other current liabilities | Cross Currency Swap Contracts    
Derivative [Line Items]    
Derivative Liabilities (0.2) 0.0
Other non-current liabilities | Interest Rate Swap Contracts    
Derivative [Line Items]    
Derivative Liabilities $ (0.5) $ 0.0
XML 83 R72.htm IDEA: XBRL DOCUMENT v3.20.2
FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Foreign Currency Contracts (Details) - Foreign Exchange Contract - Designated as Hedging Instrument
$ in Millions
Sep. 27, 2019
USD ($)
Buy contracts  
Derivatives, Fair Value [Line Items]  
Notional Value $ 11.5
Buy contracts | Japanese yen  
Derivatives, Fair Value [Line Items]  
Notional Value 0.9
Buy contracts | Swiss franc  
Derivatives, Fair Value [Line Items]  
Notional Value 0.0
Buy contracts | Chinese renminbi  
Derivatives, Fair Value [Line Items]  
Notional Value 1.8
Buy contracts | Euro  
Derivatives, Fair Value [Line Items]  
Notional Value 8.8
Sell contract  
Derivatives, Fair Value [Line Items]  
Notional Value (1.0)
Sell contract | Japanese yen  
Derivatives, Fair Value [Line Items]  
Notional Value 0.0
Sell contract | Swiss franc  
Derivatives, Fair Value [Line Items]  
Notional Value (1.0)
Sell contract | Chinese renminbi  
Derivatives, Fair Value [Line Items]  
Notional Value 0.0
Sell contract | Euro  
Derivatives, Fair Value [Line Items]  
Notional Value $ 0.0
XML 84 R73.htm IDEA: XBRL DOCUMENT v3.20.2
BORROWINGS - Schedule of Short-Term and Long-Term Debt (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Current maturities of long-term debt    
Current maturities of long-term debt $ 30.7 $ 25.0
Non-current maturities of long-term debt:    
Long-term debt excluding current maturities, gross 370.1  
Debt issuance costs (5.7) (8.2)
Long-term debt outstanding 364.4 364.8
Long-term Debt 395.1 389.8
Other Debt    
Current maturities of long-term debt    
Current maturities of long-term debt 1.3 0.0
Non-current maturities of long-term debt:    
Long-term debt excluding current maturities, gross 2.5 0.0
Secured Debt    
Current maturities of long-term debt    
Current maturities of long-term debt 29.4 25.0
Non-current maturities of long-term debt:    
Long-term debt excluding current maturities, gross $ 308.6 $ 345.0
Weighted-average interest rate, short-term debt 5.60% 4.20%
Weighted-average interest rate, long-term debt 5.60% 4.20%
Revolving Credit Facility | Revolving Credit Facility    
Non-current maturities of long-term debt:    
Long-term debt excluding current maturities, gross $ 59.0 $ 28.0
Weighted-average interest rate, long-term debt 5.60% 4.20%
XML 85 R74.htm IDEA: XBRL DOCUMENT v3.20.2
BORROWINGS - Narrative (Details) - USD ($)
Oct. 08, 2019
Oct. 10, 2018
May 01, 2017
Jan. 25, 2017
Jun. 06, 2020
Sep. 27, 2019
Sep. 28, 2018
Line of Credit Facility [Line Items]              
Long-term debt, net           $ 364,400,000 $ 364,800,000
Debt issuance costs           5,700,000 8,200,000
Current maturities of long-term debt           30,700,000 25,000,000.0
Secured Debt              
Line of Credit Facility [Line Items]              
Current maturities of long-term debt           $ 29,400,000 $ 25,000,000.0
Revolving Credit Facility              
Line of Credit Facility [Line Items]              
Maximum borrowing capacity     $ 400,000,000.0        
Revolving Credit Facility | Revolving Credit Facility              
Line of Credit Facility [Line Items]              
Maximum borrowing capacity   $ 150,000,000.0 $ 200,000,000.0        
Debt instrument, term     5 years        
Used capacity, commitment fee percentage     0.125%        
Permanent reduction in the revolving credit commitment   $ (50,000,000.0)          
Revolving Credit Facility | Secured Debt              
Line of Credit Facility [Line Items]              
Debt instrument, term     5 years        
Proceeds from lines of credit     $ 97,000,000.0        
Revolving Credit Facility | Federal Funds Effective Swap Rate | Revolving Credit Facility              
Line of Credit Facility [Line Items]              
Basis spread on variable rate     0.50%        
Revolving Credit Facility | London Interbank Offered Rate (LIBOR) | Revolving Credit Facility              
Line of Credit Facility [Line Items]              
Basis spread on variable rate     1.00%        
Revolving Credit Facility | Minimum | Revolving Credit Facility              
Line of Credit Facility [Line Items]              
Unused capacity, commitment fee percentage     0.25%        
Revolving Credit Facility | Minimum | London Interbank Offered Rate (LIBOR) | Revolving Credit Facility              
Line of Credit Facility [Line Items]              
Basis spread on variable rate     1.75%        
Revolving Credit Facility | Minimum | Base Rate | Revolving Credit Facility              
Line of Credit Facility [Line Items]              
Basis spread on variable rate     0.75%        
Revolving Credit Facility | Maximum | Revolving Credit Facility              
Line of Credit Facility [Line Items]              
Unused capacity, commitment fee percentage     0.40%        
Revolving Credit Facility | Maximum | London Interbank Offered Rate (LIBOR) | Revolving Credit Facility              
Line of Credit Facility [Line Items]              
Basis spread on variable rate     2.75%        
Revolving Credit Facility | Maximum | Base Rate | Revolving Credit Facility              
Line of Credit Facility [Line Items]              
Basis spread on variable rate     1.75%        
Revolving Credit Facility | Debt Instrument, Repayment, Period One | Secured Debt              
Line of Credit Facility [Line Items]              
Repayment percentage     5.00%        
Revolving Credit Facility | Debt Instrument, Repayment, Period Two | Secured Debt              
Line of Credit Facility [Line Items]              
Repayment percentage     5.00% 7.50%      
Revolving Credit Facility | Debt Instrument, Repayment, Period Three | Secured Debt              
Line of Credit Facility [Line Items]              
Repayment percentage     7.50%        
Revolving Credit Facility | Debt Instrument, Repayment, Period Four | Secured Debt              
Line of Credit Facility [Line Items]              
Repayment percentage     7.50% 10.00%      
Revolving Credit Facility | Debt Instrument, Repayment, Period Five | Secured Debt              
Line of Credit Facility [Line Items]              
Repayment percentage     10.00%        
Subsequent Event | Revolving Credit Facility              
Line of Credit Facility [Line Items]              
Maximum borrowing capacity $ 125,000,000.0            
Permanent reduction in the revolving credit commitment (25,000,000.0)            
Subsequent Event | Revolving Credit Facility | Revolving Credit Facility              
Line of Credit Facility [Line Items]              
Maximum borrowing capacity 125,000,000.0       $ 100,000,000    
Permanent reduction in the revolving credit commitment $ 25,000,000.0            
XML 86 R75.htm IDEA: XBRL DOCUMENT v3.20.2
BORROWINGS - Schedule of Debt Maturities (Details) - USD ($)
$ in Millions
Sep. 27, 2019
Sep. 28, 2018
Debt Disclosure [Abstract]    
2020 $ 30.7  
2021 34.3  
2022 335.8  
Total debt outstanding 400.8  
Less: current maturities of long-term debt (30.7) $ (25.0)
Non-current portion of long -term debt $ 370.1  
XML 87 R76.htm IDEA: XBRL DOCUMENT v3.20.2
FAIR VALUE - (Details) - USD ($)
$ in Millions
Sep. 27, 2019
Sep. 28, 2018
Liabilities:    
Long-term debt, fair value $ 395.1  
Fair Value, Measurements, Recurring    
Assets:    
Cash equivalents - money market funds 8.8 $ 18.4
Derivative assets   7.7
Total assets measured at fair value 8.8 26.1
Liabilities:    
Derivative liabilities 0.7 0.0
Deferred consideration 8.9  
Total liabilities measured at fair value 9.6  
Fair Value, Measurements, Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)    
Assets:    
Cash equivalents - money market funds 0.0 0.0
Derivative assets   0.0
Total assets measured at fair value 0.0 0.0
Liabilities:    
Derivative liabilities 0.0 0.0
Deferred consideration 8.9  
Total liabilities measured at fair value 8.9  
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2)    
Assets:    
Cash equivalents - money market funds 8.8 18.4
Derivative assets   7.7
Total assets measured at fair value 8.8 26.1
Liabilities:    
Derivative liabilities 0.7 0.0
Deferred consideration 0.0  
Total liabilities measured at fair value 0.7  
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3)    
Assets:    
Cash equivalents - money market funds 0.0 0.0
Derivative assets   0.0
Total assets measured at fair value 0.0 0.0
Liabilities:    
Derivative liabilities 0.0 $ 0.0
Deferred consideration 0.0  
Total liabilities measured at fair value $ 0.0  
XML 88 R77.htm IDEA: XBRL DOCUMENT v3.20.2
GOODWILL AND INTANGIBLE ASSETS - Summary of Goowill (Details)
$ in Millions
 12 Months Ended
Sep. 27, 2019
USD ($)
Goodwill [Roll Forward]  
Balance at September 28, 2018 $ 243.6
Business combination 47.2
Balance at September 27, 2019 290.8
Medical  
Goodwill [Roll Forward]  
Balance at September 28, 2018 147.0
Business combination 26.0
Balance at September 27, 2019 173.0
Industrial  
Goodwill [Roll Forward]  
Balance at September 28, 2018 96.6
Business combination 21.2
Balance at September 27, 2019 $ 117.8
XML 89 R78.htm IDEA: XBRL DOCUMENT v3.20.2
GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details) - USD ($)
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount $ 137,500,000 $ 110,400,000  
Accumulated Amortization (54,000,000.0) (40,600,000)  
Net Carrying Amount 83,500,000 69,800,000  
In-process R&D with indefinite lives 2,800,000 4,000,000.0  
Total intangible assets, gross 140,300,000 114,400,000  
Total intangible assets, net 86,300,000 73,800,000  
Amortization of intangible assets 15,700,000 16,200,000 $ 10,500,000
Impairment of intangible assets 4,800,000 3,000,000.0 $ 0
Developed technology      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 74,100,000 57,900,000  
Accumulated Amortization (28,400,000) (21,800,000)  
Net Carrying Amount 45,700,000 36,100,000  
Patents, licenses and other      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 12,700,000 9,900,000  
Accumulated Amortization (8,400,000) (7,400,000)  
Net Carrying Amount 4,300,000 2,500,000  
Customer contracts and supplier relationship      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 50,700,000 42,600,000  
Accumulated Amortization (17,200,000) (11,400,000)  
Net Carrying Amount $ 33,500,000 $ 31,200,000  
XML 90 R79.htm IDEA: XBRL DOCUMENT v3.20.2
GOODWILL AND INTANGIBLE ASSETS - Amortization Schedule (Details) - USD ($)
$ in Millions
Sep. 27, 2019
Sep. 28, 2018
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]    
2020 $ 17.2  
2021 16.3  
2022 14.7  
2023 13.7  
2024 9.1  
Thereafter 12.5  
Net Carrying Amount $ 83.5 $ 69.8
XML 91 R7.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Net Parent Investment
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Total Varex Equity
Noncontrolling Interests
Shares outstanding, beginning of period (in shares) at Sep. 30, 2016   0            
Balance at beginning of period at Sep. 30, 2016 $ 526.0 $ 0.0 $ 0.0 $ 526.0   $ 0.0 $ 526.0 $ 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net earnings 51.6     16.5   35.1 51.6  
Net transfers to parent 18.4     18.4     18.4  
Other (0.2)   (0.2)       (0.2)  
Distribution to Varian Medical Systems (227.1)     (227.1)     (227.1)  
Conversion of net parent investment into common stock (in shares)   37,400,000            
Conversion of net parent investment into common stock 0.0 $ 0.4 333.4 (333.8)        
Exercise of stock options (in shares)   100,000            
Exercise of stock options 2.8   2.8       2.8  
Common stock issued upon vesting of restricted shares (in shares)   200,000            
Shares withheld on vesting of restricted stock (in shares)   (100,000)            
Shares withheld on vesting of restricted stock (1.9)   (1.9)       (1.9)  
Share-based compensation 6.2   6.2       6.2  
Unrealized gain on interest rate swap contracts, net of tax 0.6       $ 0.6   0.6  
Unrealized gain (loss) on defined benefit obligations 0.2       0.2   0.2  
Tax impacts to APIC related to share-based award activity 2.4   2.4       2.4  
Shares outstanding, end of period (in shares) at Sep. 29, 2017   37,600,000            
Ending balance at Sep. 29, 2017 379.0 $ 0.4 342.7 0.0 0.8 35.1 379.0 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net earnings 27.8         27.5 27.5 0.3
Other (0.2)         (0.2) (0.2)  
Exercise of stock options (in shares)   200,000            
Exercise of stock options 3.8   3.8       3.8  
Common stock issued upon vesting of restricted shares (in shares)   200,000            
Shares withheld on vesting of restricted stock (in shares)   (100,000)            
Shares withheld on vesting of restricted stock (2.2)   (2.2)       (2.2)  
Share-based compensation 10.0   10.0       10.0  
Unrealized gain on interest rate swap contracts, net of tax 5.2       5.2   5.2  
Unrealized gain (loss) on defined benefit obligations (0.2)       (0.2)   (0.2)  
Common stock issued under employee stock purchase plan (in shares)   100,000            
Common stock issued under employee stock purchase plan 3.3   3.3       3.3  
Capital contribution by noncontrolling interest $ 1.8             1.8
Shares outstanding, end of period (in shares) at Sep. 28, 2018 38,026,597 38,000,000.0            
Ending balance at Sep. 28, 2018 $ 428.3 $ 0.4 357.6 0.0 5.8 62.4 426.2 2.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net earnings $ 15.3         15.5 15.5 (0.2)
Exercise of stock options (in shares) 35,000 0            
Exercise of stock options $ 0.8   0.8       0.8  
Common stock issued upon vesting of restricted shares (in shares)   200,000            
Shares withheld on vesting of restricted stock (in shares)   0            
Shares withheld on vesting of restricted stock (2.1)   (2.1)       (2.1)  
Share-based compensation 11.7   11.7       11.7  
Unrealized gain on interest rate swap contracts, net of tax (6.2)       (6.2)   (6.2)  
Unrealized gain (loss) on defined benefit obligations (1.3)       (1.3)   (1.3)  
Common stock issued under employee stock purchase plan (in shares)   200,000            
Common stock issued under employee stock purchase plan 3.8   3.8       3.8  
Noncontrolling interest acquired/consolidated $ 1.4             1.4
Shares outstanding, end of period (in shares) at Sep. 27, 2019 38,371,305 38,400,000            
Ending balance at Sep. 27, 2019 $ 448.2 $ 0.4 $ 371.8 $ 0.0 $ (1.7) 74.4 444.9 $ 3.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Effect of adoption of ASC 606 $ (3.5)         $ (3.5) $ (3.5)  
XML 92 R80.htm IDEA: XBRL DOCUMENT v3.20.2
COMMITMENTS AND CONTINGENCIES - (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Commitments and Contingencies Disclosure [Abstract]      
Future minimum payments due, next twelve months $ 7.5    
Future minimum payments, due in two years 5.4    
Future minimum payments, due in three years 4.7    
Future minimum payments, due in four years 1.8    
Future minimum payments, due in five years 0.9    
Future minimum payments, due thereafter 0.2    
Operating leases, rent expense 5.1 $ 5.3 $ 4.0
Environment liabilities $ 0.9 $ 1.3  
XML 93 R81.htm IDEA: XBRL DOCUMENT v3.20.2
REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS - Narrative (Details)
shares in Millions, $ in Millions
 1 Months Ended
Oct. 31, 2015
€ / shares
Sep. 27, 2019
USD ($)
shares
Apr. 30, 2019
Sep. 28, 2018
USD ($)
Sep. 29, 2017
USD ($)
Apr. 30, 2015
Noncontrolling Interest [Line Items]            
Redeemable noncontrolling interest, equity, redemption value | $   $ 10.5   $ 11.1 $ 11.2  
Joint Venture In Saudi Arabia            
Noncontrolling Interest [Line Items]            
Noncontrolling interest, ownership percentage by parent       75.00%    
Noncontrolling interest, ownership percentage by noncontrolling owners       25.00%    
Direct Conversion AB            
Noncontrolling Interest [Line Items]            
Percentage of voting interests acquired     98.20%      
MeVis Medical Solutions AG (MeVis)            
Noncontrolling Interest [Line Items]            
Percentage of voting interests acquired           73.50%
Annual recurring compensation (in euros per share) | € / shares € 0.95          
Temporary equity, redemption price per share (in eur per share) | € / shares € 19.77          
Redeemable noncontrolling interest, equity, redemption value | $   $ 10.5        
Temporary equity, shares outstanding (in shares) | shares   0.5        
MeVis Medical Solutions AG (MeVis) | MeVis Medical Solutions AG (MeVis)            
Noncontrolling Interest [Line Items]            
Noncontrolling interest, ownership percentage by noncontrolling owners   26.30%        
XML 94 R82.htm IDEA: XBRL DOCUMENT v3.20.2
REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS - Summary of Changes in Redeemable Noncontrolling Interests & Noncontrolling INterets (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Noncontrolling Interest [Line Items]      
Balance at beginning of period $ 11.1 $ 11.2  
Net earnings attributable to noncontrolling interests 0.5 0.5  
Dividends paid to redeemable noncontrolling interest (0.5) (0.6) $ 0.0
Other (0.6) 0.0  
Balance at end of period 10.5 11.1 11.2
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]      
Balance at beginning of period 428.3 379.0 526.0
Contributions from noncontrolling interests 1.4    
Contributions from noncontrolling interests   1.8  
Balance at end of period 3.3 2.1  
Noncontrolling Interests      
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]      
Balance at beginning of period 2.1 0.0 $ 0.0
Net earnings attributable to noncontrolling interests (0.2) 0.3  
Contributions from noncontrolling interests $ 1.4    
Contributions from noncontrolling interests   $ 1.8  
XML 95 R83.htm IDEA: XBRL DOCUMENT v3.20.2
EMPLOYEE STOCK PLANS - Narrative (Details) - USD ($)
$ in Millions
 1 Months Ended 12 Months Ended
Jan. 31, 2017
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Options exercised, intrinsic value   $ 0.2 $ 1.7 $ 1.4
Options, grants in period, grant date fair value   3.0 3.1 9.2
Grant-date fair value of shares granted in the period   9.0 10.1 11.4
Shares outstanding, market value   19.2 $ 18.4 $ 17.8
Employee Stock Option        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Compensation cost not yet recognized   $ 23.1    
2017 ESPP | Employee Stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Purchase price of common stock, percent 85.00% 85.00%    
Stock plan offering period (in months) 6 months 6 months    
Number of shares authorized (in shares) 1,000,000,000,000      
2017 ESPP | Employee Stock Option        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares available for grant (in shares)   700,000    
2017 Omnibus Stock Plan | Employee Stock Option        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares available for grant (in shares)   1,200,000    
Minimum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting period (in months)   36 months    
Award expiration period (in years)   7 years    
Minimum | Employee Stock Option        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Compensation cost period for recognition (in years)   3 years    
Maximum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting period (in months)   48 months    
Award expiration period (in years)   10 years    
Maximum | Employee Stock Option        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Compensation cost period for recognition (in years)   4 years    
XML 96 R84.htm IDEA: XBRL DOCUMENT v3.20.2
EMPLOYEE STOCK PLANS - Share-based Compensation Expense (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Allocated share-based compensation expense $ 11.7 $ 10.0 $ 8.4
Cost of revenues      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Allocated share-based compensation expense 1.2 1.3 0.9
Research and development      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Allocated share-based compensation expense 2.2 1.8 1.5
Selling, general and administrative      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Allocated share-based compensation expense $ 8.3 $ 6.9 6.0
Varian | General and administrative      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Allocated share-based compensation expense     $ 0.8
XML 97 R85.htm IDEA: XBRL DOCUMENT v3.20.2
EMPLOYEE STOCK PLANS - Valuation Assumptions (Details) - $ / shares
 3 Months Ended 12 Months Ended
Dec. 28, 2018
Dec. 29, 2017
Sep. 27, 2019
Employee Stock Option      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected term (in years) 4 years 9 months 18 days 4 years 2 months 12 days 4 years 7 months 6 days
Risk-free interest rate 2.60% 1.60% 2.50%
Expected volatility 31.80% 23.60% 33.90%
Expected dividend 0.00% 0.00% 0.00%
Weighted average fair value at grant date (in USD per share) $ 11.57 $ 8.08 $ 10.19
Employee Stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected term (in years) 6 months 6 months 6 months
Risk-free interest rate 2.00% 1.00% 2.50%
Expected volatility 34.10% 28.00% 43.90%
Expected dividend 0.00% 0.00% 0.00%
Weighted average fair value at grant date (in USD per share) $ 8.92 $ 7.81 $ 7.81
XML 98 R86.htm IDEA: XBRL DOCUMENT v3.20.2
EMPLOYEE STOCK PLANS - Stock Option Activity (Details)
$ / shares in Units, shares in Thousands
 12 Months Ended
Sep. 27, 2019
USD ($)
$ / shares
shares
Options  
Options, outstanding, beginning balance (in shares) | shares 2,011
Options, grants in period (in shares) | shares 297
Options, forfeitures and expirations in period (in shares) | shares (4)
Options, exercises in period, value (in shares) | shares (35)
Options, outstanding, ending balance (in shares) | shares 2,269
Options, exercisable (in shares) | shares 1,477
Weighted Average Exercise Price  
Options, outstanding, weighted average exercise price, beginning (in USD per share) $ 30.35
Options, grants in period, weighted average exercise price (in USD per share) 31.42
Options, forfeitures and expirations in period, weighted average exercise price (in USD per share) 31.08
Options, exercises in period, weighted average exercise price (in USD per share) 23.38
Options, outstanding, weighted average exercise price, ending (in USD per share) 30.60
Options, exercisable, weighted average exercise price (in USD per share) $ 29.67
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]  
Options, outstanding, weighted average remaining contractual term (in years) 4 years 1 month 6 days
Options, exercisable, weighted average remaining contractual term (in years) 3 years 4 months 24 days
Options, outstanding, intrinsic value | $ $ 1,220,300
Options, exercisable, intrinsic value | $ $ 1,220,300
Share price (in usd per share) $ 28.28
Minimum  
Price Range  
Options, outstanding, price, beginning (in USD per share) 22.63
Options, grants in period, price (in USD per share) 31.42
Options, forfeitures and expirations in period, price (in USD per share) 31.08
Options, exercises in period, price (in USD per share) 22.84
Options, outstanding, price, ending (in USD per share) 22.63
Options, exercisable, price (in USD per share) 22.63
Maximum  
Price Range  
Options, outstanding, price, beginning (in USD per share) 37.60
Options, grants in period, price (in USD per share) 31.42
Options, forfeitures and expirations in period, price (in USD per share) 31.08
Options, exercises in period, price (in USD per share) 27.77
Options, outstanding, price, ending (in USD per share) 37.60
Options, exercisable, price (in USD per share) $ 37.60
XML 99 R87.htm IDEA: XBRL DOCUMENT v3.20.2
EMPLOYEE STOCK PLANS - Restricted Stock and Performance Stock (Details)
shares in Thousands
 12 Months Ended
Sep. 27, 2019
$ / shares
shares
Number of Shares  
Restricted Stock Units and Performance Stock Units, nonvested, beginning balance (in shares) | shares 641
Restricted Stock Units and Performance Stock Units, grants in period (in shares) | shares 288
Restricted Stock Units and Performance Stock Units, vested in period (in shares) | shares (201)
Restricted Stock Units and Performance Stock Units, forfeited in period (in shares) | shares (50)
Restricted Stock Units and Performance Stock Units, nonvested, ending balance (in shares) | shares 678
Weighted Average Grant-Date Fair Value  
Restricted Stock Units and Performance Stock Units, nonvested, beginning of period, weighted average grant date fair value (in USD per share) | $ / shares $ 33.60
Restricted Stock Units and Performance Stock Units, grants in period, weighted average grant date fair value (in USD per share) | $ / shares 31.29
Restricted Stock Units and Performance Stock Units, vested in period, weighted average grant date fair value (in USD per share) | $ / shares 31.56
Restricted Stock Units and Performance Stock Units, forfeitures, weighted average grant date fair value (in USD per share) | $ / shares 34.13
Restricted Stock Units and Performance Stock Units, nonvested, end of period, weighted average grant date fair value (in USD per share) | $ / shares $ 33.18
XML 100 R88.htm IDEA: XBRL DOCUMENT v3.20.2
TAXES ON EARNINGS - Summary of Taxes by Jurisdiction and Classification (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Current provision:      
Federal $ 9.2 $ (2.1) $ 24.8
State and local 1.3 (0.3) 1.6
Foreign 6.8 7.5 5.3
Total current 17.3 5.1 31.7
Deferred provision (benefit):      
Federal (10.0) (7.0) (7.0)
State and local (1.6) 0.7 (1.0)
Foreign 0.0 (1.4) (0.9)
Total deferred (11.6) (7.7) (8.9)
Taxes on earnings 5.7 (2.6) 22.8
United States 5.9 3.7 55.5
Foreign 15.6 22.0 19.3
Earnings before taxes $ 21.5 $ 25.7 $ 74.8
XML 101 R89.htm IDEA: XBRL DOCUMENT v3.20.2
TAXES ON EARNINGS - Income Tax Rate Reconciliation (Details)
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Income Tax Disclosure [Abstract]      
Federal statutory income tax rate 21.00% 24.50% 35.00%
State and local taxes, net of federal tax benefit (0.90%) 1.10% 1.30%
Revaluation of deferred tax liabilities for US statutory change 0.00% (41.80%) 0.00%
Mandatory repatriation tax on foreign earnings 1.90% 13.00% 0.00%
Domestic production activities deduction 0.00% (0.80%) (2.40%)
Research and development credit (10.20%) (11.10%) (2.60%)
Prior year deferred tax adjustments 4.70% 1.90% (4.00%)
Foreign Rate Difference 6.00% 0.80% 0.00%
Change in valuation allowance 11.20% (1.90%) 3.80%
US Tax Reform - International Provisions (0.047) 0 0
Other (2.50%) 4.20% (0.60%)
Effective tax rate 26.50% (10.10%) 30.50%
XML 102 R8.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Sep. 27, 2019
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Description of Business
Varex Imaging Corporation (the “Company,” “Varex” or “Varex Imaging”) designs, manufactures, sells and services a broad range of Medical products, which include X-ray imaging components, including X-ray tubes, digital detectors and accessories, high voltage connectors, image processing software and workstations, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, ionization chambers and buckys, for use in a range of applications, including radiographic or fluoroscopic imaging, mammography, computed tomography, oncology and computer-aided detection. The Company sells its products to imaging system original equipment manufacturer (“OEM”) customers for incorporation into new medical diagnostic, radiation therapy, dental, and veterinary, to independent service companies, distributors and directly to end-users for replacement purposes.
The Company also designs, manufacturers, sells and services industrial products, which include Linatron® X-ray accelerators, imaging processing software and image detection products for security and inspection purposes, such as cargo screening at ports and borders and nondestructive examination in a variety of applications. The Company generally sells security and inspection products to OEM customers who incorporate Varex’s products into their inspection systems. The Company conducts an active research and development program to focus on new technology and applications in both the medical and industrial X-ray imaging markets.
Varex Imaging Corporation was incorporated in Delaware on July 18, 2016 for the purpose of holding the assets and liabilities associated with the Company's business and separated from Varian Medical Systems, Inc. (“Varian”) on January 28, 2017, upon which Varian completed the distribution of 100% of the outstanding common stock of Varex to Varian stockholders. Following the separation and distribution, Varex became an independent publicly-traded company and is listed on the NASDAQ Global Select Market under the ticker “VREX.”
Basis of Presentation and Principle of Consolidation
The accompanying consolidated financial statements are audited and have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). Prior to January 28 2017, the date of separation and distribution, the financial statements were prepared on a stand-alone basis and were derived from Varian’s consolidated financial statements and records as it operated as part of Varian prior to the distribution, in conformity with GAAP. Prior to the separation and distribution, the consolidated financial statements included allocations of certain Varian corporate expenses these costs were allocated to the Company on the basis of direct usage when identifiable or other systematic measures that reflect utilization of services provided to or benefits received by the Company.
All transactions between the Company and Varian prior to the separation have been included in the accompanying consolidated financial statements. All intercompany transactions while the Company operated as part of Varian were considered to be effectively settled for cash and are reflected as a component of financing activities as net transfers from (to) Varian in the consolidated statements of cash flows at the time the transactions were recorded.
Prior to the separation, the Company was dependent upon Varian for its working capital and financing requirements, as Varian uses a centralized approach to cash management and financing of its operations. Financial transactions relating to the Company were accounted for through the net parent investment account. Cash and cash equivalents held by Varian were not allocated to the Company.
Net parent investment in the consolidated statements of equity represents Varian’s historical investment in the Company, the net effect of transactions with and allocations from Varian and the Company’s accumulated earnings.
Impact of COVID-19
The coronavirus (“COVID-19”) pandemic and the mitigation efforts by governments to attempt to control its spread created uncertainties and disruptions in the economic and financial markets. The extent to which COVID-19 will continue to impact the Company’s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it will impact worldwide macroeconomic conditions including interest rates and employment rates, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. During the quarter ended July 3, 2020, as a result of the economic downturn resulting from COVID-19, the Company experienced reduced demand in the
Company’s industrial segment and for certain higher end medical products that negatively impacted revenues and gross margin. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the currently estimated future impacts of COVID-19 through the date of reissuance of these consolidated financial statements. The Company’s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material negative impacts to the Company’s consolidated financial statements in future reporting periods. These future developments are highly uncertain, and the outcomes cannot be estimated with certainty. Actual results may differ from those estimates, and such differences may be material to the consolidated financial statements.

The Company’s Credit Agreement, as defined in Note 8, Borrowings, contains financial covenants, including certain leverage ratio covenants. The adverse effects of the COVID-19 pandemic on the Company’s financial condition and results of operations are expected to be more persistent and have been more severe than previously estimated. The Company now believes that reduced demand in the Company’s industrial segment and for certain higher end medical products will continue to negatively impact revenues, gross margin, and the other items used to calculate the Company’s financial covenants contained in its Credit Agreement. Based on the Company’s current forecasts, it is probable that the Company will be in violation of certain leverage ratio covenants contained in its Credit Agreement within the twelve-month period following the reissuance of these consolidated financial statements, including as early as the end of the Company's fiscal year end 2020. Failure to comply with the covenants, if not amended or waived, would result in an event of default under the Credit Agreement and the acceleration of the outstanding balance of the loans thereunder. If an event of default under the Credit Agreement occurs, then pursuant to cross default and/or cross acceleration clauses, substantially all of the Company’s other outstanding debt and derivative contract payables would become due, and all debt and derivative contracts could be terminated, which would have a material adverse impact to the Company’s operations and liquidity as the Company currently does not have the financial resources to satisfy such obligations if they were to become due and payable. These events and conditions raise substantial doubt about the Company’s ability to continue as a going concern within the twelve-month period following the reissuance of these consolidated financial statements.

The Company is actively pursuing various options to prevent an event of default from occurring under the Credit Agreement. The Company is implementing actions to improve its financial results and other items used to calculate the financial covenants, such as accelerating the closure of its Santa Clara facility, the previously announced reduction in force, austerity programs related to outside services, and other appropriate actions. The Company is also taking actions to improve cash flow such as working capital reductions and reduced spending for property, plant and equipment, as well as pursuing potential additional fundraising to modify, supplement, or replace its Credit Agreement. While the Company has and continues to take actions to mitigate the risk of an event of default under the Credit Agreement, there is no assurance that it will be successful in doing so. The Company’s consolidated financial statements have been prepared on a going concern basis and do not reflect any adjustments that might result if the Company is unable to continue as a going concern.
Reclassification
The Company has reclassified $3.0 million from selling, general and administrative expense to impairment of intangible assets for the year ended September 28, 2018, to conform to the current year's presentation. Such reclassifications had no impact on net earnings as previously reported.
Segment Reporting
The Company has two reportable operating segments; (i) Medical and (ii) Industrial, which aligns with how its CEO, who is the Company's Chief Operating Decision Maker (“CODM”), reviews the Company’s performance. See Note 15. Segment Information, included in this report, for further information on the Company’s segments.
Fiscal Year
The fiscal years of the Company as reported are the 52 or 53-week period ending on the Friday nearest September 30. Fiscal year 2019 was the 52-week period that ended on September 27, 2019. Fiscal year 2018 was the 52-week period that ended on September 28, 2018. Fiscal year 2017 was the 52-week period that ended on September 29, 2017.
Variable Interest Entities
For entities in which the Company has variable interests, the Company focuses on identifying which entity has the power to direct the activities that most significantly impact the variable interest entity’s economic performance and which enterprise has the obligation to absorb losses or the right to receive benefits from the variable interest entity. If the Company is the primary beneficiary of a variable interest entity, the assets, liabilities and results of operations of the variable interest entity will be included in the
Company’s consolidated financial statements. As of September 27, 2019, the Company had two variable interest entities neither of which were consolidated.
 Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Such estimates include the valuation of inventories, goodwill and intangible assets, impairment on investments, and taxes on earnings. Actual results could differ from these estimates.
Cash and Cash Equivalents
The Company considers currency on hand, demand deposits, time deposits and all highly-liquid investments with an original maturity of three months or less at the date of purchase to be cash and cash equivalents.
Restricted Cash
Restricted cash primarily consists of cash collateral related to certain leases and inventory arrangements. Restricted cash is
included in other assets on the consolidated balance sheet. Cash and cash equivalents and restricted cash as reported within
the consolidated statements of cash flows consisted of the following:
 
Twelve Months Ended September 27, 2019
 
Twelve Months Ended September 28, 2018
 
Beginning of Period
 
End of Period
 
Beginning of Period
 
End of Period
Cash and cash equivalents
$
51.9

 
$
29.9

 
$
83.3

 
$
51.9

Restricted cash
1.5

 
1.4

 
0.9

 
1.5

Cash and cash equivalents and restricted cash as reported per statement of cash flows
$
53.4

 
$
31.3

 
$
84.2

 
$
53.4


Fair Value
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. There is a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:
Level 1—Quoted prices in active markets for identical assets or liabilities.
Level 2—Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or, other inputs that are observable or can be corroborated by observable market data.
Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
Derivative instruments and hedging activities
The Company records all derivatives on the balance sheet at fair value. Derivatives designated as a hedge are recorded on the Consolidated Balance Sheets at fair value as of the reporting date. For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative is reported as a component of other comprehensive income or loss and reclassified from accumulated other comprehensive loss into earnings when the hedged transaction affects earnings.  For derivatives that are designated and qualify as net investment hedges, the gain or loss on the derivative is reported as a component of other comprehensive income or loss. Time value is excluded and the cash payments are recognized as an adjustment to interest expense. A qualitative assessment of hedge effectiveness is performed on a quarterly basis, unless facts and circumstances indicate the hedge may no longer be highly effective.
Concentration of Risk
Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash, cash equivalents and trade accounts receivable. Cash held with financial institutions may exceed the Federal Deposit Insurance Corporation insurance limits or similar limits in foreign jurisdictions. The Company has not experienced any losses on its deposits of cash and cash equivalents. The Company performs ongoing credit evaluations of its customers and, except for government tenders, group purchases and orders with a letter of credit, its industrial customers often provide a down payment. The Company maintains an allowance for doubtful accounts based upon the expected collectability of all accounts receivable. The Company obtains some of the components in its products from a limited group of suppliers or from a single-source supplier. The Company has neither experienced nor expects any significant disruptions to its operations due to supplier concentration.
Credit is extended to customers based on an evaluation of the customer’s financial condition, and collateral is not required. During the periods presented, one of the Company's Medical segment customers accounted for a significant portion of revenues, which is as follows:
 
Fiscal Year
 
2019
 
2018
 
2017
Canon Medical Systems Corporation
17.3
%
 
18.1
%
 
19.3
%

Canon Medical Systems Corporation accounted for 10.1% and 9.8% of the Company’s accounts receivable as of September 27, 2019 and September 28, 2018, respectively.
Inventories
Inventories are valued at the lower of cost or net realizable value. Costs include materials, labor and manufacturing overhead
and is computed using standard cost (which approximates actual cost) on a first-in-first-out basis. The Company evaluates the carrying
value of its inventories taking into consideration such factors as historical and anticipated future sales compared to quantities on hand
and the prices the Company expects to obtain for products in its various markets. The Company adjust excess and obsolete
inventories to net realizable value and write-downs of excess and obsolete inventories are recorded as a component of cost of revenues.
The following table summarizes the Company’s inventories, net:
(In millions)
September 27, 2019
 
September 28, 2018
Raw materials and parts
$
160.1

 
$
149.9

Work-in-process
27.9

 
25.4

Finished goods
60.2

 
59.8

Total inventories
$
248.2

 
$
235.1


Property, Plant and Equipment, net
Property, plant and equipment are stated at cost, net of accumulated depreciation. Major improvements are capitalized, while repairs and maintenance are expensed as incurred. Depreciation are computed using the straight-line method over the estimated useful lives of the assets. Land is not subject to depreciation, but land improvements are depreciated over fifteen years. Land leasehold rights and leasehold improvements are depreciated over the lesser of their estimated useful lives or remaining lease terms. Buildings are depreciated over twenty years. Machinery and equipment are depreciated over their estimated useful lives, which range from three years to seven years. Assets subject to lease are depreciated over the lesser of their estimated useful lives or remaining lease terms. Estimated useful lives are periodically reviewed and, when appropriate, changes are made prospectively. When certain events or changes in operating conditions occur, asset lives may be adjusted, and an impairment assessment may be performed on the recoverability of the carrying amounts. When assets are retired or otherwise disposed of, the assets and related accumulated depreciation are removed from the accounts.
The following table summarizes the Company’s property, plant and equipment, net:
(In millions)
September 27, 2019
 
September 28, 2018
Land
$
8.3

 
$
8.3

Buildings and leasehold improvements
134.4

 
138.1

Machinery
170.7

 
166.1

Construction in progress
28.5

 
23.1

 
$
341.9

 
$
335.6

Accumulated depreciation and amortization
(199.6
)
 
(190.7
)
Property, plant, and equipment, net
$
142.3

 
$
144.9


The Company recorded depreciation expense of $23.5 million, $26.0 million and $16.9 million, in fiscal years 2019, 2018 and 2017, respectively. During fiscal year 2019 the company recorded accelerated depreciation of $4.5 million on the machinery and equipment used in the fabrication of amorphous silicon glass at its facility in Santa Clara, CA. See Note 4. Restructuring, included in this report, for further information. During fiscal year 2018 the company recorded accelerated depreciation of $4.2 million on the machinery and equipment used in the fabrication of amorphous silicon glass at its facility in Santa Clara, CA. See Note 4. Restructuring, included in this report, for further information.
Investments
The Company accounts for its equity investments in privately-held companies under the equity method of accounting if the Company has the ability to exercise significant influence in these investments. Distributions received from an equity method investment are classified using the cumulative earnings approach. Under the cumulative earnings approach, distributions up to the amount of cumulative equity in earnings recognized will be treated as returns on investment as operating cash flows and those in excess of that amount will be treated as returns of investment as investing cash flows. The Company monitors these equity investments for impairment and makes appropriate reductions in carrying values if the Company determines that impairment charges are required based primarily on the financial condition and near-term prospects of these companies.
Goodwill and Intangible Assets
Goodwill is recorded when the purchase price of an acquisition exceeds the fair value of the net identified tangible and intangible assets acquired. Purchased intangible assets are carried at cost, net of accumulated amortization, and are included in intangible assets in the Company's consolidated balance sheets. Intangible assets with finite lives are amortized over their estimated useful lives of primarily two years to seven years using the straight-line method.
Impairment of Long-lived Assets, Intangible Assets and Goodwill
The Company reviews long-lived assets and identifiable intangible assets with finite lives for impairment whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable. The Company assesses these assets for impairment based on their estimated undiscounted future cash flows. If the carrying value of the assets exceeds the estimated future undiscounted cash flows, the Company recognizes an impairment loss based on the excess of the carrying amount over the fair value of the assets.
The Company evaluates goodwill and indefinite lived intangible assets for impairment at least annually at the beginning of the fourth quarter of each fiscal year or whenever an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The Company performs a step one analysis, which consists of a comparison of the fair value of a reporting unit against its carrying amount, including the goodwill allocated to each reporting unit. The Company determines the fair value of its reporting units based on a combination of income and market approaches. The income approach is based on the present value of estimated future cash flows of the reporting units, and the market approach is based on a market multiple calculated for each reporting unit based on market data of other companies engaged in similar business. If the carrying amount of the reporting unit is in excess of its fair value, step two requires the comparison of the implied fair value of the reporting unit’s goodwill against the carrying amount of the reporting unit’s goodwill. Any excess of the carrying value of the reporting unit’s goodwill over the implied fair value of the reporting unit’s goodwill is recorded as an impairment loss. The impairment test for intangible assets with indefinite useful lives, if any, consists of a comparison of fair value to carrying value, with any excess of carrying value over fair value being recorded as an impairment loss.
During the fiscal year ended September 27, 2019 and 2018, the Company recognized $4.8 million and $3.0 million of impairments of intangible assets related to the restructuring activities see Note 4. Restructuring, included in this report. No goodwill impairment charges were recognized for any of the prior periods presented. No impairment charges were recognized in fiscal year 2017.
Loss Contingencies
From time to time, the Company is a party to or otherwise involved in legal proceedings, claims and government inspections or investigations, customs and duties audits and other loss contingency matters, both inside and outside the United States, arising in the ordinary course of its business or otherwise. The Company accrues amounts, to the extent an unfavorable outcome is determined to be probable and the losses can be reasonably estimated, that it believes are adequate to address any liabilities related to legal proceedings and other loss contingencies that it believes will result in a probable loss.
Product Warranty
The Company warrants most of its products for a specific period of time, usually 12 to 24 months from delivery or acceptance, against material defects. The Company provides for the estimated future costs of warranty obligations in cost of revenues when the related revenues are recognized. The accrued warranty costs represent the best estimate at the time of sale of the total costs that the Company will incur to repair or replace product parts that fail while still under warranty.
The amount of the accrued estimated warranty costs obligation for established products is primarily based on historical experience as to product failures adjusted for current information on repair costs. For new products, estimates include the historical experience of similar products, as well as a reasonable allowance for warranty expenses associated with new products. On a quarterly basis, the Company reviews the accrued warranty costs and updates the historical warranty cost trends, if required.
The following table reflects the changes in the Company’s accrued product warranty:
 
Fiscal Years
(In millions)
2019
 
2018
Accrued product warranty, at beginning of period
$
7.3

 
$
7.0

Charged to cost of revenues
12.9

 
11.6

Actual product warranty expenditures
(12.1
)
 
(11.3
)
Accrued product warranty, at end of period
$
8.1

 
$
7.3


Revenue Recognition
Effective September 29, 2018, the Company adopted the requirements of Accounting Standards Update (“ASU”) 2014-09 and related amendments, Revenue from Contracts with Customers (“ASC 606”), which superseded all prior revenue recognition methods and industry-specific guidance. See “Recently Adopted Accounting Pronouncements” below.
The Company’s revenues are derived primarily from the sale of hardware and services. The Company recognizes its revenues net of any value-added or sales tax and net of sales discounts.
The Company sells a high proportion of its X-ray products to a limited number of OEM customers. X-ray tubes, digital detectors and image-processing tools and security and inspection products are generally sold on a stand-alone basis. However, the Company occasionally sells its digital detectors, X-ray tubes and imaging processing tools as a package that is optimized for digital X ray imaging and sells its Linatron ® X-ray accelerators together with its imaging processing software and image detection products to OEM customers that incorporate them into their inspection systems. Service contracts are often sold with certain security and inspection products and computer-aided detection products.
The Company determines revenue recognition through the following steps:
•
Identification of the contract, or contracts, with a customer
•
Identification of the performance obligations in the contract
•
Determination of the transaction price
•
Allocation of the transaction price to the performance obligations in the contract
•
Recognition of revenue when, or as, a performance obligation is satisfied
Deferred Revenues
Deferred revenue primarily represents (i) the amount received applicable to non-software products for which parts
and services under the warranty contracts have not been delivered, and (ii) the amount received for service contracts for
which the services have not been rendered.
Allowance for Doubtful Accounts
The Company evaluates the creditworthiness of customers prior to authorizing shipment for all major sale transactions. On a quarterly basis, the Company evaluates aged items in the accounts receivable aging report and provide an allowance in an amount deemed adequate for doubtful accounts. If the evaluation of customers’ financial conditions does not reflect a future ability to collect outstanding receivables, additional provisions may be needed. We had an allowance for doubtful accounts of $1.0 million and $0.6 million as of September 27, 2019 and September 28, 2018, respectively.
Share-Based Compensation Expense
The Company has an equity-based incentive plan that provides for the grant of nonqualified stock options and restricted stock units to directors, officers and other employees. The Company also permits employees to purchase shares under the Varex employee stock purchase plan. Prior to the separation, the Company’s employees historically participated in Varian’s equity-based incentive plans. Share-based compensation expense through the date of separation included allocations to the Company based on the awards and terms previously granted to its employees as well as an allocation of Varian’s corporate and shared functional employee expenses.
The Company values stock options granted and the option component of the shares of common stock purchased under the equity-based incentive plans and stock purchased under the employee stock purchase plan using the Black-Scholes option-pricing model. Share-based compensation expense for restricted stock units is measured using the fair value of the Company’s stock on the date of grant and is amortized over the award’s respective service period. The Black-Scholes option-pricing model requires the input of certain assumptions, and changes in the assumptions can materially affect the fair value estimates of share-based payment awards.
The Company measures and recognizes expense for all share-based payment awards based on their fair values. Share-based compensation expense recognized in the consolidated statements of earnings includes compensation expense for the share-based payment awards based on the grant date fair value estimated in accordance with the guidance on share-based compensation. Share-based compensation expense recognized is based on the value of the portion of share-based payment awards that is ultimately expected to vest. The Company attributes the value of share-based compensation to expense using the straight-line method. The Company considers only the direct tax impacts of share-based compensation awards when calculating the amount of tax windfalls or shortfalls. For additional information, see Note 13. Employee Stock Plans, included in this report.
Shipping and Handling Costs
Shipping and handling costs are included as a component of cost of revenues.
Research and Development
Research and development costs have been expensed as incurred. These costs primarily include employees’ compensation, consulting fees and material costs.
Software Development Costs
Costs for the development of new software products and substantial enhancements to existing software products are expensed as incurred until technological feasibility has been established, at which time any additional costs would be capitalized. No costs associated with the development of software have been capitalized, as the Company believes its current software development process is essentially completed concurrent with the establishment of technological feasibility.
Taxes on Earnings
Current income tax expense is the amount of income taxes expected to be payable for the current year. Deferred income tax liabilities or assets are established for the expected future tax consequences resulting from the differences in financial reporting and tax bases of assets and liabilities. A valuation allowance is provided if it is more likely than not that some or all of the deferred tax assets will not be realized. In addition, we provide reserves for uncertain tax positions when such tax positions do not meet the recognition thresholds or measurement standards prescribed by the authoritative guidance for accounting for income taxes. Amounts
for uncertain tax positions are adjusted in periods when new information becomes available or when positions are effectively settled. Interest and penalties related to uncertain tax positions are recognized as a component of income tax expense.
On December 22, 2017, the U.S. Government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act of 2017 (“U. S. Tax Reform”). U.S. Tax Reform significantly revised the U.S. corporate income tax structure including a lower corporate statutory rate and changes to the way foreign earnings are taxed. U.S. GAAP requires that the impact of tax legislation be recognized in the period in which the law is enacted. In accordance with these rules, we are including the impact of certain provisions of U.S. Tax Reform to the extent they are effective during the current reporting period.
Foreign Currency Translation
The Company uses the U.S. Dollar predominately as the functional currency of its foreign operations. Gains and losses from remeasurement of foreign currency balances into U.S. Dollars are included in the consolidated statements of earnings. For the foreign subsidiary where the local currency is the functional currency, translation adjustments of foreign currency financial statements into U.S. dollars are recorded to a separate component of accumulated other comprehensive (loss) earnings.
Accounting Standards Recently Adopted
In November 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (“ASU 2016-18”), which requires that the statement of cash flows explain the change in the total amount of restricted cash during the period and other additional disclosures. The Company adopted ASU 2016-18 in the first quarter of 2019 using the retrospective transition method and the Company's consolidated statements of cash flows have been retrospectively adjusted to reflect restricted cash balances. Net cash flows for fiscal years 2019, 2018 and 2017 did not change as a result of adopting ASU 2016-18.
The Company adopted ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (“ASU 2016-15”), which was issued to reduce the diversity in practice in how certain transactions are classified in the statement of cash flows. The Company adopted ASU 2016-15 in the first quarter of 2019 retrospectively. Net cash flows for fiscal years 2019, 2018 and 2017 did not change as a result of adopting ASU 2016-15.

The Company adopted ASC 606 as of September 29, 2018, using the modified retrospective transition method applied to those contracts which were not completed as of that date. The Company recorded a net reduction to retained earnings of $4.1 million, net of tax, as of September 29, 2018 due to the impact of adopting ASC 606. During the second quarter of 2019 the Company recorded an increase to retained earnings of $0.6 million, net of tax, to correct an error that was not quantitatively or qualitatively material to the current period, related to the adoption of ASC 606. The net cumulative impact of adopting ASC 606 was $3.5 million, net of tax. Refer to Note 18. Revenue Recognition, included in this report report for the detailed impact of adopting ASC 606.

In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities, which amends the application of hedge accounting and improves financial reporting of hedging relationships to more accurately present the economic effects of risk management activities in the financial statements. The ASU is effective for public companies for annual reporting periods beginning after December 15, 2018, with early adoption permitted. The Company early adopted the provisions of ASU 2017-12 during the quarter ended September 27, 2019, using the modified retrospective method. The adoption did not have an impact on the consolidated financial statements.
Recent Accounting Standards Updates Not Yet Effective
In February 2018, the FASB issued ASU 2018-02, Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income, which allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from U.S. federal tax legislation commonly referred to as the Tax Cuts and Jobs Act, which was enacted in December 2017 (the “2017 Tax Act”). ASU 2018-02 is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted. The Company does not expect that the adoption of this guidance will have a material impact on its consolidated financial statements.
In January 2017, the FASB issued ASU 2017-04 which clarified its guidance to simplify the measurement of goodwill by eliminating the Step 2 impairment test. The new guidance requires companies to perform the goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. The amendment will be effective for the Company beginning in its first quarter of fiscal year 2021. The amendment is required to be adopted prospectively. The Company is evaluating the impact of adopting this amendment to its consolidated financial statements.
In June 2016, the FASB issued ASU 2016-13, "Measurement of Credit Losses on Financial Instruments." This ASU replaces the incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. In addition, the ASU requires new disclosures. This standard will be effective for the Company's interim and annual periods beginning with the first quarter of fiscal 2021, and must be applied on a modified retrospective basis. The Company is currently evaluating the potential impact of this standard.
In February 2016, the FASB issued ASU 2016-02 on accounting for leases. The new standard is intended to provide enhanced transparency and comparability by requiring lessees to record right-of-use assets and corresponding lease liabilities on the balance sheet. The new standard will continue to classify leases as either finance or operating, with classification affecting the pattern of expense recognition in the statement of earnings. The new standard is required to be adopted using a modified retrospective method to each prior reporting period presented with various optional practical expedients. The new standard will be effective for the Company beginning in its first quarter of fiscal year 2020 with early adoption permitted. The Company has not completed its assessment of the new standard, but anticipate that the most substantial change to its consolidated financial statements will be a gross-up of its total assets and liabilities. The adoption is not expected to materially impact our results of operations in the upcoming fiscal years and interim periods. The Company will continue to monitor the overall impact of adoption and update our disclosures as appropriate.
XML 103 R90.htm IDEA: XBRL DOCUMENT v3.20.2
TAXES ON EARNINGS - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Income Tax Disclosure [Abstract]      
Federal statutory income tax rate 21.00% 24.50% 35.00%
Deferred tax liabilities of undistributed foreign earnings $ 0.1    
Net operating loss carryforwards 24.3 $ 3.3  
Operating loss carryforwards, that expire 4.4    
Operating loss carryforwards, that do not expire 19.9    
Operating loss carryforwards, valuation allowance increase (decrease) 14.8 (0.3)  
Cash paid for income tax 8.2 13.8 $ 6.0
Unrecognized tax benefits 0.6 0.6 $ 0.5
Income tax penalties and interest expense 0.1 0.0  
Unrecognized tax benefits, income tax penalties and interest accrued $ 0.1 $ 0.0  
XML 104 R91.htm IDEA: XBRL DOCUMENT v3.20.2
TAXES ON EARNINGS - Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Millions
Sep. 27, 2019
Sep. 29, 2018
Sep. 28, 2018
Sep. 29, 2017
Sep. 30, 2016
Deferred Tax Assets:          
Inventory adjustments $ 5.6   $ 4.2    
Share-based compensation 3.1   0.8    
Product warranty 1.6   1.4    
Deferred compensation 1.1   0.9    
Net operating loss carryforwards 24.3   3.3    
Accrued vacation 1.0   1.3    
Credit carryforwards 1.9   1.8    
Other 7.5   4.7    
Deferred tax assets, gross 46.1   18.4    
Valuation allowance (18.8)   (4.0) $ (4.3) $ (2.5)
Total deferred tax assets 27.3   14.4    
Deferred Tax Liabilities:          
Acquired intangibles (19.3)   (15.2)    
Property, plant and equipment (10.6)   (14.3)    
Investments in privately held companies (3.3)   (4.1)    
Other (2.3)   (4.0)    
Total deferred tax liabilities (35.5)   (37.6)    
Net deferred tax liabilities (8.2)   (23.2)    
Deferred tax assets 27.3   14.4    
Deferred tax liabilities (35.5)   (37.6)    
Net deferred tax liabilities $ 8.2 $ 22.4 $ 23.2    
XML 105 R92.htm IDEA: XBRL DOCUMENT v3.20.2
TAXES ON EARNINGS - Valuation Allowance (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Deferred Tax Assets Valuation Allowance [Roll Forward]      
Valuation allowance balance–beginning of fiscal year $ 4.0 $ 4.3 $ 2.5
Increases resulting from business combinations 12.0 0.0 0.0
Other increases 2.8 2.2 2.5
Other decreases 0.0 (2.5) (0.7)
Valuation allowance balance—end of fiscal year $ 18.8 $ 4.0 $ 4.3
XML 106 R93.htm IDEA: XBRL DOCUMENT v3.20.2
TAXES ON EARNINGS - Income Tax Contingency (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]    
Unrecognized tax benefits balance–beginning of fiscal year $ 0.6 $ 0.5
Subtractions based on tax positions related to a prior year (0.2) 0.0
Additions based on tax positions related to the current year 0.2 0.1
Unrecognized tax benefits balance—end of fiscal year $ 0.6 $ 0.6
XML 107 R94.htm IDEA: XBRL DOCUMENT v3.20.2
SEGMENT INFORMATION - Narrative (Details)
 12 Months Ended
Sep. 27, 2019
segment
Segment Reporting [Abstract]  
Number of operating segments 2
XML 108 R95.htm IDEA: XBRL DOCUMENT v3.20.2
SEGMENT INFORMATION - Summary of Segment Information (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Segment Reporting Information [Line Items]      
Revenues, net $ 780.6 $ 773.4 $ 698.1
Gross margin 256.7 253.9 253.5
Total operating expenses 211.0 209.4 169.8
Interest and other expenses, net (24.2) (18.8) (8.9)
Earnings before taxes 21.5 25.7 74.8
Taxes (benefit) on earnings 5.7 (2.6) 22.8
Net earnings 15.8 28.3 52.0
Less: Net earnings attributable to noncontrolling interests 0.3 0.8 0.4
Net earnings attributable to Varex 15.5 27.5 51.6
Medical      
Segment Reporting Information [Line Items]      
Revenues, net 596.8 602.0 556.9
Gross margin 188.9 190.5 193.6
Industrial      
Segment Reporting Information [Line Items]      
Revenues, net 183.8 171.4 141.2
Gross margin $ 67.8 $ 63.4 $ 59.9
XML 109 R96.htm IDEA: XBRL DOCUMENT v3.20.2
SEGMENT INFORMATION - Assets (Details) - USD ($)
$ in Millions
Sep. 27, 2019
Sep. 28, 2018
Segment Reporting Information [Line Items]    
Assets $ 1,038.9 $ 987.9
Operating Segments    
Segment Reporting Information [Line Items]    
Assets 1,038.9 987.9
Medical | Operating Segments    
Segment Reporting Information [Line Items]    
Assets 794.3 770.6
Industrial | Operating Segments    
Segment Reporting Information [Line Items]    
Assets $ 244.6 $ 217.3
XML 110 R97.htm IDEA: XBRL DOCUMENT v3.20.2
SEGMENT INFORMATION - Geographic (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues, net $ 780.6 $ 773.4 $ 698.1
Property, plant and equipment, net 142.3 144.9  
United States      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues, net 275.3 268.8 231.9
Property, plant and equipment, net 122.6 127.9  
Latin America      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues, net 7.3 7.0 7.9
Property, plant and equipment, net 0.0 0.0  
EMEA      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues, net 269.0 254.5 219.5
Property, plant and equipment, net 11.4 8.7  
APAC      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues, net 229.0 243.1 $ 238.8
Property, plant and equipment, net $ 8.3 $ 8.3  
XML 111 R98.htm IDEA: XBRL DOCUMENT v3.20.2
EMPLOYEE BENEFIT PLANS - (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Sep. 29, 2017
Retirement Benefits [Abstract]      
Employer discretionary contribution amount $ 6.7 $ 6.5 $ 4.3
Defined benefit pension plan liability $ 5.5 $ 3.3  
XML 112 R99.htm IDEA: XBRL DOCUMENT v3.20.2
OTHER COMPREHENSIVE INCOME - (Details) - USD ($)
 12 Months Ended
Sep. 27, 2019
Sep. 28, 2018
Changes In Accumulated Other Comprehensive Income (Loss) [Roll Forward]    
Balance at beginning of period $ 428,300,000 $ 379,000,000.0
Other comprehensive loss before reclassifications (10,200,000)  
Income tax benefit 2,700,000  
Ending balance 448,200,000 428,300,000
Amount reclassified out of accumulated other comprehensive income 0 0
Unrealized Gain (Loss) on Derivative Financial Instruments    
Changes In Accumulated Other Comprehensive Income (Loss) [Roll Forward]    
Balance at beginning of period 5,800,000  
Other comprehensive loss before reclassifications (8,300,000)  
Income tax benefit 2,100,000  
Ending balance (400,000) 5,800,000
Unrealized Gain on Defined Benefit Obligations    
Changes In Accumulated Other Comprehensive Income (Loss) [Roll Forward]    
Balance at beginning of period 0  
Other comprehensive loss before reclassifications (1,900,000)  
Income tax benefit 600,000  
Ending balance (1,300,000) 0
Accumulated Other Comprehensive Income    
Changes In Accumulated Other Comprehensive Income (Loss) [Roll Forward]    
Balance at beginning of period 5,800,000  
Ending balance $ (1,700,000) $ 5,800,000
XML 113 R9.htm IDEA: XBRL DOCUMENT v3.20.2
BUSINESS COMBINATIONS
 12 Months Ended
Sep. 27, 2019
Business Combinations [Abstract]  
BUSINESS COMBINATIONS BUSINESS COMBINATIONS
Acquisition of Direct Conversion AB (publ)
On April 29, 2019, Varex completed the acquisition of 98.2% of the outstanding shares of common stock of Direct Conversion AB (publ) (“Direct Conversion”) for $69.5 million in cash, net of cash acquired, the assumption of Direct Conversion's debt of $4.5 million and deferred consideration equal to $9.9 million or 0.3 million shares of the Company’s common stock (subject to reduction to settle indemnity claims) to be paid on the first anniversary of the closing with a mixture of cash and shares of Varex common stock. The acquisition of Direct Conversion expands our detector product portfolio to include photon counting technology.  This technology will allow Varex to expand its range of imaging applications and offer new solutions to both Medical and Industrial customers.
The following table summarizes the preliminary purchase price allocation:
(In millions)
Fair Value
Allocation of the purchase consideration:
 
Accounts receivable
$
2.4

Inventories
5.7

Prepaid expenses and other current assets
0.7

Property, plant, and equipment
0.9

Goodwill
47.2

Intangible assets
32.9

Total assets acquired
89.8

Accounts payable
(1.0
)
Accrued liabilities
(1.5
)
Current maturities of long-term debt
(1.0
)
Deferred revenues
(0.9
)
Long-term debt
(3.5
)
Other long-term liabilities
(1.1
)
Total liabilities assumed
(9.0
)
Noncontrolling interest
(1.4
)
Net assets acquired, less noncontrolling interest
$
79.4

Net cash paid
$
69.5

Deferred consideration
9.9

Total consideration
$
79.4



The Company recorded the assets acquired and liabilities assumed at their preliminary estimated fair values. Intangibles were valued primarily using a discounted cash flow, which included estimated revenue growth and discount rate. Due to the complexity of this transaction as of September 27, 2019, the Company had not finalized the determination of the fair values allocated to various assets and liabilities, including, but not limited to, inventory; deferred tax assets and liabilities; intangible assets and the residual amount allocated to goodwill. The fair value assigned to goodwill is primarily attributable to expected synergies. The goodwill related to the Direct Conversion acquisition is not tax deductible.
The following amounts represent the determination of the fair value and estimated weighted average useful lives of identifiable intangible assets for the Direct Conversion, which are amortized straight-line:
(In millions)
Fair Value
 
Estimated Weighted Average
Useful Life
(In Years)
Backlog
$
0.2

 
1
Trade names
2.5

 
5
Developed technology
18.4

 
10
In-process research and development
2.8

 
indefinite
Customer relationships
9.0

 
10
Total intangible assets acquired
$
32.9

 
 

The following amounts represent revenues by reporting segment from Direct Conversion from the acquisition date of April 29, 2019, through September 27, 2019:
(In millions)
Direct Conversion Revenue
Medical
$
4.5

Industrial
1.8

Total Direct Conversion revenues
$
6.3



The acquisition of Direct Conversion did not have a significant impact on our consolidated results of operations on a pro forma basis for the current or prior years.
Acquisition of Virtual Media Integration
On August 31, 2018, the Company completed the acquisition of Virtual Media Integration, Ltd. (“VMI”) from MISTRAS Group, Inc for $4.8 million. VMI is a provider of computed and digital radiography and X-ray film digitizer systems for industrial non-destructive testing. The acquired assets and liabilities of the VMI business were allocated to the Industrial reporting segment. The acquisition related costs were included in the consolidated statements of earnings under selling, general and administrative expenses.
The following table summarizes the purchase price allocation:
(In millions)
Fair Value
Allocation of the purchase consideration:
 
Accounts Receivable
$
0.2

Inventories
1.0

Other assets
0.2

Intangibles
1.6

Goodwill
1.5

Other liabilities
(0.2
)
Net assets acquired
4.3

Post-closing adjustments
0.5

Total cash consideration
$
4.8


Acquisition of PerkinElmer’s Medical Imaging Business
On May 1, 2017, the Company completed the acquisition of the medical imaging business (“Acquired Detector Business”) of PerkinElmer, Inc. (“PKI”) for $277.4 million, or $273.2 million after post-closing working capital adjustments. The acquisition consisted of PerkinElmer Medical Holdings, Inc. and Dexela Limited, together with certain assets of PKI and its direct and indirect subsidiaries relating to digital flat panel X-ray detectors that serve as components for industrial, medical, dental and veterinary X-ray imaging systems. The Acquired Detector Business included about 280 employees, with operations in Santa Clara, California as well as operations in Germany, the Netherlands, China and the United Kingdom. The acquisition of the Acquired Detector Business was pursuant to the Master Purchase and Sale Agreement, dated December 21, 2016 (the “Purchase Agreement”), by and between PKI and Varian and the subsequent Assignment and Assumption Agreement, dated January 27, 2017, by and between Varian and Varex, pursuant to which Varian assigned and conveyed all of its rights, obligations, title and interest in the Purchase Agreement to Varex.
The following amounts represent the determination of the fair value of identifiable assets acquired and liabilities for the Acquired Detector Business:
(In millions)
Fair Value
Total cash consideration
$
273.2

Allocation of the purchase consideration:
 
Cash
1.4

Accounts Receivable
18.7

Inventory
34.7

Prepaids and other current assets
0.6

Property, plant, and equipment
21.4

Other assets, non-current
2.0

Intangibles
81.1

Goodwill
167.3

Total assets acquired
$
327.2


 
 
Current liabilities
$
(17.2
)
Other liabilities, non-current
(36.8
)
Total liabilities assumed
(54.0
)
Net assets acquired
$
273.2


The fair value assigned to goodwill is attributable to expected cost synergy opportunities. Included in the goodwill recorded for the Acquired Detector Business is approximately $35 million that will be deductible for income tax purposes in Germany, China and the Netherlands. The remaining goodwill related to the stock acquisition in the United States is not tax deductible. Also, as a result of the acquisition, non-current deferred income tax liability increased by approximately $31 million related to basis differences for both tangible and intangible assets acquired as part of the stock purchases in the United States and the United Kingdom, and asset purchases in Germany, the Netherlands and China.
The following amounts represent the determination of the fair value of identifiable intangible assets for the Acquired Detector Business, which are amortized straight-line:
(In millions)
Fair Value
 
Estimated
Useful Life
(In Years)
Favorable leasehold interests
$
3.8

 
16
Backlog
1.2

 
1
Trade names
1.4

 
5
Developed technology
37.7

 
7
In-process research and development
4.0

 
indefinite
Customer relationships
33.0

 
7
Total intangible assets acquired
$
81.1

 
 

The following amounts represent revenues by reporting segment from the Acquired Detector Business from the acquisition date of May 1, 2017 through September 29, 2017:
(In millions)
May 1, 2017 through September 29, 2017
Acquired Detector Business
 
Medical
$
41.1

Industrial
20.2

Total Acquired Detector Business revenues
$
61.3


Unaudited Pro Forma Information
The unaudited pro-forma amounts presented below for the fiscal year 2017 are presented for informational purposes only. In addition to the Company's results for the periods presented, the amounts below also include effects of the Acquired Detector Business as if it had been consummated on October 1, 2016. These unaudited pro-forma results include effects that are directly attributable to the acquisition which include the amortization of intangible assets, interest expense, and other adjustments, including estimated tax effects. The unaudited pro-forma results do not reflect any operating efficiencies or potential cost savings which may result from the consolidation of the Acquired Detector Business and are not necessarily indicative of what the actual results of operations of the combined company would have been if the acquisition had occurred at the beginning of the period presented nor are they indicative of future results of operations or results that might have been achieved had the acquisition been consummated as of October 3, 2015.
 
Fiscal Year
(In millions)
2017
Revenue
$
777.8

Operating earnings
$
84.7

Net earnings
$
43.1

Net earnings per share, basic
$
1.15

Net earnings per share, diluted
$
1.13
EXCEL 114 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end

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�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 116 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 117 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 306 585 1 false 102 0 false 12 false false R1.htm 0004000 - Document - Cover Cover Sheet http://www.vareximaging.com/role/CoverCover Cover Cover Cover 1 false false R2.htm 1001000 - Statement - CONSOLIDATED STATEMENTS OF EARNINGS Sheet http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings CONSOLIDATED STATEMENTS OF EARNINGS Statements 2 false false R3.htm 1002000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS Sheet http://www.vareximaging.com/role/ConsolidatedStatementsOfComprehensiveEarnings CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS Statements 3 false false R4.htm 1003000 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.vareximaging.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 4 false false R5.htm 1003501 - Statement - CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) Sheet http://www.vareximaging.com/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) Statements 5 false false R6.htm 1004000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 1005000 - Statement - CONSOLIDATED STATEMENTS OF EQUITY Sheet http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity CONSOLIDATED STATEMENTS OF EQUITY Statements 7 false false R8.htm 2101100 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.vareximaging.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 2102100 - Disclosure - BUSINESS COMBINATIONS Sheet http://www.vareximaging.com/role/BusinessCombinations BUSINESS COMBINATIONS Notes 9 false false R10.htm 2103100 - Disclosure - RELATED-PARTY TRANSACTIONS Sheet http://www.vareximaging.com/role/RelatedPartyTransactions RELATED-PARTY TRANSACTIONS Notes 10 false false R11.htm 2104100 - Disclosure - RESTRUCTURING Sheet http://www.vareximaging.com/role/Restructuring RESTRUCTURING Notes 11 false false R12.htm 2105100 - Disclosure - OTHER FINANCIAL INFORMATION Sheet http://www.vareximaging.com/role/OtherFinancialInformation OTHER FINANCIAL INFORMATION Notes 12 false false R13.htm 2106100 - Disclosure - NET EARNINGS PER SHARE Sheet http://www.vareximaging.com/role/NetEarningsPerShare NET EARNINGS PER SHARE Notes 13 false false R14.htm 2107100 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES Sheet http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivities FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES Notes 14 false false R15.htm 2108100 - Disclosure - BORROWINGS Sheet http://www.vareximaging.com/role/Borrowings BORROWINGS Notes 15 false false R16.htm 2109100 - Disclosure - FAIR VALUE Sheet http://www.vareximaging.com/role/FairValue FAIR VALUE Notes 16 false false R17.htm 2110100 - Disclosure - GOODWILL AND INTANGIBLE ASSETS Sheet http://www.vareximaging.com/role/GoodwillAndIntangibleAssets GOODWILL AND INTANGIBLE ASSETS Notes 17 false false R18.htm 2111100 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.vareximaging.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 18 false false R19.htm 2112100 - Disclosure - REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS Sheet http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterests REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS Notes 19 false false R20.htm 2113100 - Disclosure - EMPLOYEE STOCK PLANS Sheet http://www.vareximaging.com/role/EmployeeStockPlans EMPLOYEE STOCK PLANS Notes 20 false false R21.htm 2114100 - Disclosure - TAXES ON EARNINGS Sheet http://www.vareximaging.com/role/TaxesOnEarnings TAXES ON EARNINGS Notes 21 false false R22.htm 2115100 - Disclosure - SEGMENT INFORMATION Sheet http://www.vareximaging.com/role/SegmentInformation SEGMENT INFORMATION Notes 22 false false R23.htm 2116100 - Disclosure - EMPLOYEE BENEFIT PLANS Sheet http://www.vareximaging.com/role/EmployeeBenefitPlans EMPLOYEE BENEFIT PLANS Notes 23 false false R24.htm 2117100 - Disclosure - OTHER COMPREHENSIVE INCOME Sheet http://www.vareximaging.com/role/OtherComprehensiveIncome OTHER COMPREHENSIVE INCOME Notes 24 false false R25.htm 2118100 - Disclosure - REVENUE RECOGNITION Sheet http://www.vareximaging.com/role/RevenueRecognition REVENUE RECOGNITION Notes 25 false false R26.htm 2119100 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.vareximaging.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 26 false false R27.htm 2201201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 27 false false R28.htm 2301302 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.vareximaging.com/role/SummaryOfSignificantAccountingPolicies 28 false false R29.htm 2302301 - Disclosure - BUSINESS COMBINATIONS (Tables) Sheet http://www.vareximaging.com/role/BusinessCombinationsTables BUSINESS COMBINATIONS (Tables) Tables http://www.vareximaging.com/role/BusinessCombinations 29 false false R30.htm 2304301 - Disclosure - RESTRUCTURING (Tables) Sheet http://www.vareximaging.com/role/RestructuringTables RESTRUCTURING (Tables) Tables http://www.vareximaging.com/role/Restructuring 30 false false R31.htm 2305301 - Disclosure - OTHER FINANCIAL INFORMATION (Tables) Sheet http://www.vareximaging.com/role/OtherFinancialInformationTables OTHER FINANCIAL INFORMATION (Tables) Tables http://www.vareximaging.com/role/OtherFinancialInformation 31 false false R32.htm 2306301 - Disclosure - NET EARNINGS PER SHARE (Tables) Sheet http://www.vareximaging.com/role/NetEarningsPerShareTables NET EARNINGS PER SHARE (Tables) Tables http://www.vareximaging.com/role/NetEarningsPerShare 32 false false R33.htm 2307301 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES (Tables) Sheet http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesTables FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES (Tables) Tables http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivities 33 false false R34.htm 2308301 - Disclosure - BORROWINGS (Tables) Sheet http://www.vareximaging.com/role/BorrowingsTables BORROWINGS (Tables) Tables http://www.vareximaging.com/role/Borrowings 34 false false R35.htm 2309301 - Disclosure - FAIR VALUE (Tables) Sheet http://www.vareximaging.com/role/FairValueTables FAIR VALUE (Tables) Tables http://www.vareximaging.com/role/FairValue 35 false false R36.htm 2310301 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) Sheet http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsTables GOODWILL AND INTANGIBLE ASSETS (Tables) Tables http://www.vareximaging.com/role/GoodwillAndIntangibleAssets 36 false false R37.htm 2312301 - Disclosure - REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS (Tables) Sheet http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsTables REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS (Tables) Tables http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterests 37 false false R38.htm 2313301 - Disclosure - EMPLOYEE STOCK PLANS (Tables) Sheet http://www.vareximaging.com/role/EmployeeStockPlansTables EMPLOYEE STOCK PLANS (Tables) Tables http://www.vareximaging.com/role/EmployeeStockPlans 38 false false R39.htm 2314301 - Disclosure - TAXES ON EARNINGS (Tables) Sheet http://www.vareximaging.com/role/TaxesOnEarningsTables TAXES ON EARNINGS (Tables) Tables http://www.vareximaging.com/role/TaxesOnEarnings 39 false false R40.htm 2315301 - Disclosure - SEGMENT INFORMATION (Tables) Sheet http://www.vareximaging.com/role/SegmentInformationTables SEGMENT INFORMATION (Tables) Tables http://www.vareximaging.com/role/SegmentInformation 40 false false R41.htm 2317301 - Disclosure - OTHER COMPREHENSIVE INCOME (Tables) Sheet http://www.vareximaging.com/role/OtherComprehensiveIncomeTables OTHER COMPREHENSIVE INCOME (Tables) Tables http://www.vareximaging.com/role/OtherComprehensiveIncome 41 false false R42.htm 2318301 - Disclosure - REVENUE RECOGNITION (Tables) Sheet http://www.vareximaging.com/role/RevenueRecognitionTables REVENUE RECOGNITION (Tables) Tables http://www.vareximaging.com/role/RevenueRecognition 42 false false R43.htm 2401403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Description of Business (Details) Sheet http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesDescriptionOfBusinessDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Description of Business (Details) Details 43 false false R44.htm 2401404 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reclassification (Details) Sheet http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesReclassificationDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reclassification (Details) Details 44 false false R45.htm 2401405 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Segment Reporting (Details) Sheet http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesSegmentReportingDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Segment Reporting (Details) Details 45 false false R46.htm 2401406 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Variable Interest Entities (Details) Sheet http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesVariableInterestEntitiesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Variable Interest Entities (Details) Details 46 false false R47.htm 2401407 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Restricted Cash (Details) Sheet http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesRestrictedCashDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Restricted Cash (Details) Details 47 false false R48.htm 2401408 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration of Risk (Details) Sheet http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesConcentrationOfRiskDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration of Risk (Details) Details 48 false false R49.htm 2401409 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Details) Sheet http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesInventoriesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Details) Details 49 false false R50.htm 2401410 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property Plant and Equipment (Details) Sheet http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property Plant and Equipment (Details) Details 50 false false R51.htm 2401411 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Details) Sheet http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesGoodwillAndIntangibleAssetsDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Details) Details 51 false false R52.htm 2401412 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Impairment of Long-Lived Assets, Intangible Assets and Goodwill (Details) Sheet http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesImpairmentOfLongLivedAssetsIntangibleAssetsAndGoodwillDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Impairment of Long-Lived Assets, Intangible Assets and Goodwill (Details) Details 52 false false R53.htm 2401413 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Product Warranty (Details) Sheet http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesProductWarrantyDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Product Warranty (Details) Details 53 false false R54.htm 2401414 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Allowance for Doubtful Accounts (Details) Sheet http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesAllowanceForDoubtfulAccountsDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Allowance for Doubtful Accounts (Details) Details 54 false false R55.htm 2401415 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounting Standards Recently Adopted (Details) Sheet http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesAccountingStandardsRecentlyAdoptedDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounting Standards Recently Adopted (Details) Details 55 false false R56.htm 2402402 - Disclosure - BUSINESS COMBINATIONS - Direct Conversion Narrative (Details) Sheet http://www.vareximaging.com/role/BusinessCombinationsDirectConversionNarrativeDetails BUSINESS COMBINATIONS - Direct Conversion Narrative (Details) Details 56 false false R57.htm 2402403 - Disclosure - BUSINESS COMBINATIONS - Fair Value of Identifiable Assets Acquired and Liabilities Assumed (Details) Sheet http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails BUSINESS COMBINATIONS - Fair Value of Identifiable Assets Acquired and Liabilities Assumed (Details) Details 57 false false R58.htm 2402404 - Disclosure - BUSINESS COMBINATIONS - Intangibles Acquired (Details) Sheet http://www.vareximaging.com/role/BusinessCombinationsIntangiblesAcquiredDetails BUSINESS COMBINATIONS - Intangibles Acquired (Details) Details 58 false false R59.htm 2402405 - Disclosure - BUSINESS COMBINATIONS - Revenues by Segment (Details) Sheet http://www.vareximaging.com/role/BusinessCombinationsRevenuesBySegmentDetails BUSINESS COMBINATIONS - Revenues by Segment (Details) Details 59 false false R60.htm 2402406 - Disclosure - BUSINESS COMBINATIONS - Virtual Media Narrative (Details) Sheet http://www.vareximaging.com/role/BusinessCombinationsVirtualMediaNarrativeDetails BUSINESS COMBINATIONS - Virtual Media Narrative (Details) Details 60 false false R61.htm 2402407 - Disclosure - BUSINESS COMBINATIONS - PerkinElmer's Medical Imaging Narrative (Details) Sheet http://www.vareximaging.com/role/BusinessCombinationsPerkinelmersMedicalImagingNarrativeDetails BUSINESS COMBINATIONS - PerkinElmer's Medical Imaging Narrative (Details) Details 61 false false R62.htm 2402408 - Disclosure - BUSINESS COMBINATIONS - Pro Forma (Details) Sheet http://www.vareximaging.com/role/BusinessCombinationsProFormaDetails BUSINESS COMBINATIONS - Pro Forma (Details) Details 62 false false R63.htm 2403401 - Disclosure - RELATED-PARTY TRANSACTIONS - Investment in Privately Held Companies (Details) Sheet http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails RELATED-PARTY TRANSACTIONS - Investment in Privately Held Companies (Details) Details 63 false false R64.htm 2404402 - Disclosure - RESTRUCTURING - Narrative (Details) Sheet http://www.vareximaging.com/role/RestructuringNarrativeDetails RESTRUCTURING - Narrative (Details) Details 64 false false R65.htm 2404403 - Disclosure - RESTRUCTURING - Restructuring Charges Incurred (Details) Sheet http://www.vareximaging.com/role/RestructuringRestructuringChargesIncurredDetails RESTRUCTURING - Restructuring Charges Incurred (Details) Details 65 false false R66.htm 2405402 - Disclosure - OTHER FINANCIAL INFORMATION - (Details) Sheet http://www.vareximaging.com/role/OtherFinancialInformationDetails OTHER FINANCIAL INFORMATION - (Details) Details http://www.vareximaging.com/role/OtherFinancialInformationTables 66 false false R67.htm 2406402 - Disclosure - NET EARNINGS PER SHARE - (Details) Sheet http://www.vareximaging.com/role/NetEarningsPerShareDetails NET EARNINGS PER SHARE - (Details) Details http://www.vareximaging.com/role/NetEarningsPerShareTables 67 false false R68.htm 2407402 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivative Instruments (Details) Sheet http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativeInstrumentsDetails FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivative Instruments (Details) Details 68 false false R69.htm 2407403 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Narrative (Details) Sheet http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesNarrativeDetails FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Narrative (Details) Details 69 false false R70.htm 2407404 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Income Recognized From Derivative Instruments (Details) Sheet http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfIncomeRecognizedFromDerivativeInstrumentsDetails FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Income Recognized From Derivative Instruments (Details) Details 70 false false R71.htm 2407405 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivatives at Fair Value (Details) Sheet http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivatives at Fair Value (Details) Details 71 false false R72.htm 2407406 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Foreign Currency Contracts (Details) Sheet http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfForeignCurrencyContractsDetails FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Foreign Currency Contracts (Details) Details 72 false false R73.htm 2408402 - Disclosure - BORROWINGS - Schedule of Short-Term and Long-Term Debt (Details) Sheet http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails BORROWINGS - Schedule of Short-Term and Long-Term Debt (Details) Details 73 false false R74.htm 2408403 - Disclosure - BORROWINGS - Narrative (Details) Sheet http://www.vareximaging.com/role/BorrowingsNarrativeDetails BORROWINGS - Narrative (Details) Details 74 false false R75.htm 2408404 - Disclosure - BORROWINGS - Schedule of Debt Maturities (Details) Sheet http://www.vareximaging.com/role/BorrowingsScheduleOfDebtMaturitiesDetails BORROWINGS - Schedule of Debt Maturities (Details) Details 75 false false R76.htm 2409402 - Disclosure - FAIR VALUE - (Details) Sheet http://www.vareximaging.com/role/FairValueDetails FAIR VALUE - (Details) Details http://www.vareximaging.com/role/FairValueTables 76 false false R77.htm 2410402 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Summary of Goowill (Details) Sheet http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsSummaryOfGoowillDetails GOODWILL AND INTANGIBLE ASSETS - Summary of Goowill (Details) Details 77 false false R78.htm 2410403 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details) Sheet http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details) Details 78 false false R79.htm 2410404 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Amortization Schedule (Details) Sheet http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsAmortizationScheduleDetails GOODWILL AND INTANGIBLE ASSETS - Amortization Schedule (Details) Details 79 false false R80.htm 2411401 - Disclosure - COMMITMENTS AND CONTINGENCIES - (Details) Sheet http://www.vareximaging.com/role/CommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES - (Details) Details http://www.vareximaging.com/role/CommitmentsAndContingencies 80 false false R81.htm 2412402 - Disclosure - REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS - Narrative (Details) Sheet http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsNarrativeDetails REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS - Narrative (Details) Details http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsTables 81 false false R82.htm 2412403 - Disclosure - REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS - Summary of Changes in Redeemable Noncontrolling Interests & Noncontrolling INterets (Details) Sheet http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsSummaryOfChangesInRedeemableNoncontrollingInterestsNoncontrollingInteretsDetails REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS - Summary of Changes in Redeemable Noncontrolling Interests & Noncontrolling INterets (Details) Details 82 false false R83.htm 2413402 - Disclosure - EMPLOYEE STOCK PLANS - Narrative (Details) Sheet http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails EMPLOYEE STOCK PLANS - Narrative (Details) Details 83 false false R84.htm 2413403 - Disclosure - EMPLOYEE STOCK PLANS - Share-based Compensation Expense (Details) Sheet http://www.vareximaging.com/role/EmployeeStockPlansShareBasedCompensationExpenseDetails EMPLOYEE STOCK PLANS - Share-based Compensation Expense (Details) Details 84 false false R85.htm 2413404 - Disclosure - EMPLOYEE STOCK PLANS - Valuation Assumptions (Details) Sheet http://www.vareximaging.com/role/EmployeeStockPlansValuationAssumptionsDetails EMPLOYEE STOCK PLANS - Valuation Assumptions (Details) Details 85 false false R86.htm 2413405 - Disclosure - EMPLOYEE STOCK PLANS - Stock Option Activity (Details) Sheet http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails EMPLOYEE STOCK PLANS - Stock Option Activity (Details) Details 86 false false R87.htm 2413406 - Disclosure - EMPLOYEE STOCK PLANS - Restricted Stock and Performance Stock (Details) Sheet http://www.vareximaging.com/role/EmployeeStockPlansRestrictedStockAndPerformanceStockDetails EMPLOYEE STOCK PLANS - Restricted Stock and Performance Stock (Details) Details 87 false false R88.htm 2414402 - Disclosure - TAXES ON EARNINGS - Summary of Taxes by Jurisdiction and Classification (Details) Sheet http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails TAXES ON EARNINGS - Summary of Taxes by Jurisdiction and Classification (Details) Details 88 false false R89.htm 2414403 - Disclosure - TAXES ON EARNINGS - Income Tax Rate Reconciliation (Details) Sheet http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails TAXES ON EARNINGS - Income Tax Rate Reconciliation (Details) Details 89 false false R90.htm 2414404 - Disclosure - TAXES ON EARNINGS - Narrative (Details) Sheet http://www.vareximaging.com/role/TaxesOnEarningsNarrativeDetails TAXES ON EARNINGS - Narrative (Details) Details 90 false false R91.htm 2414405 - Disclosure - TAXES ON EARNINGS - Deferred Tax Assets and Liabilities (Details) Sheet http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails TAXES ON EARNINGS - Deferred Tax Assets and Liabilities (Details) Details 91 false false R92.htm 2414406 - Disclosure - TAXES ON EARNINGS - Valuation Allowance (Details) Sheet http://www.vareximaging.com/role/TaxesOnEarningsValuationAllowanceDetails TAXES ON EARNINGS - Valuation Allowance (Details) Details 92 false false R93.htm 2414407 - Disclosure - TAXES ON EARNINGS - Income Tax Contingency (Details) Sheet http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxContingencyDetails TAXES ON EARNINGS - Income Tax Contingency (Details) Details 93 false false R94.htm 2415402 - Disclosure - SEGMENT INFORMATION - Narrative (Details) Sheet http://www.vareximaging.com/role/SegmentInformationNarrativeDetails SEGMENT INFORMATION - Narrative (Details) Details 94 false false R95.htm 2415403 - Disclosure - SEGMENT INFORMATION - Summary of Segment Information (Details) Sheet http://www.vareximaging.com/role/SegmentInformationSummaryOfSegmentInformationDetails SEGMENT INFORMATION - Summary of Segment Information (Details) Details 95 false false R96.htm 2415404 - Disclosure - SEGMENT INFORMATION - Assets (Details) Sheet http://www.vareximaging.com/role/SegmentInformationAssetsDetails SEGMENT INFORMATION - Assets (Details) Details 96 false false R97.htm 2415405 - Disclosure - SEGMENT INFORMATION - Geographic (Details) Sheet http://www.vareximaging.com/role/SegmentInformationGeographicDetails SEGMENT INFORMATION - Geographic (Details) Details 97 false false R98.htm 2416401 - Disclosure - EMPLOYEE BENEFIT PLANS - (Details) Sheet http://www.vareximaging.com/role/EmployeeBenefitPlansDetails EMPLOYEE BENEFIT PLANS - (Details) Details http://www.vareximaging.com/role/EmployeeBenefitPlans 98 false false R99.htm 2417402 - Disclosure - OTHER COMPREHENSIVE INCOME - (Details) Sheet http://www.vareximaging.com/role/OtherComprehensiveIncomeDetails OTHER COMPREHENSIVE INCOME - (Details) Details http://www.vareximaging.com/role/OtherComprehensiveIncomeTables 99 false false R100.htm 2418402 - Disclosure - REVENUE RECOGNITION - Schedule of Balance Sheet Adjustment for ASC 606 Adoption (Details) Sheet http://www.vareximaging.com/role/RevenueRecognitionScheduleOfBalanceSheetAdjustmentForAsc606AdoptionDetails REVENUE RECOGNITION - Schedule of Balance Sheet Adjustment for ASC 606 Adoption (Details) Details 100 false false R101.htm 2418403 - Disclosure - REVENUE RECOGNITION - Schedule of ASC 606 Adoption Impact On Income Statement (Details) Sheet http://www.vareximaging.com/role/RevenueRecognitionScheduleOfAsc606AdoptionImpactOnIncomeStatementDetails REVENUE RECOGNITION - Schedule of ASC 606 Adoption Impact On Income Statement (Details) Details 101 false false R102.htm 2418404 - Disclosure - REVENUE RECOGNITION - Schedule of Changes in Contract Balances (Details) Sheet http://www.vareximaging.com/role/RevenueRecognitionScheduleOfChangesInContractBalancesDetails REVENUE RECOGNITION - Schedule of Changes in Contract Balances (Details) Details 102 false false R103.htm 2418405 - Disclosure - REVENUE RECOGNITION - Remaining Performance Obligations (Details) Sheet http://www.vareximaging.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails REVENUE RECOGNITION - Remaining Performance Obligations (Details) Details 103 false false R104.htm 2419401 - Disclosure - SUBSEQUENT EVENTS - (Details) Sheet http://www.vareximaging.com/role/SubsequentEventsDetails SUBSEQUENT EVENTS - (Details) Details http://www.vareximaging.com/role/SubsequentEvents 104 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption in us-gaap/2019 used in 3 facts was deprecated in us-gaap/2020 as of 2020-01-31 and should not be used. exhibit991-financialst.htm line 12, exhibit991-financialst.htm line 12, exhibit991-financialst.htm line 12 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 42 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:CommonStockParOrStatedValuePerShare, us-gaap:CommonStockSharesAuthorized, us-gaap:CommonStockSharesIssued, us-gaap:CommonStockSharesOutstanding, us-gaap:DebtInstrumentConvertibleConversionRatio1, us-gaap:DebtInstrumentTerm, us-gaap:GoodwillImpairmentLoss, us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill, us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense, us-gaap:PreferredStockParOrStatedValuePerShare, us-gaap:PreferredStockSharesAuthorized, us-gaap:PreferredStockSharesIssued, us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax, us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1, us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued, vrex:DebtInstrumentConvertibleConsecutiveBusinessDays, vrex:DebtInstrumentConvertibleConsecutiveTradingDayMeasurementPeriod, vrex:DebtInstrumentPeriodicPaymentPercentage, vrex:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice, vrex:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice, vrex:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice, vrex:SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsExercisesinPeriodPrice, vrex:SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice form8-kcoverxreissued2.htm exhibit991-financialst.htm exhibit231-auditorcons.htm vrex-20200922.xsd vrex-20200922_cal.xml vrex-20200922_def.xml vrex-20200922_lab.xml vrex-20200922_pre.xml http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/country/2017-01-31 http://xbrl.sec.gov/currency/2019-01-31 http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true JSON 118 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form8-kcoverxreissued2.htm exhibit991-financialst.htm": { "axisCustom": 1, "axisStandard": 40, "contextCount": 306, "dts": { "calculationLink": { "local": [ "vrex-20200922_cal.xml" ] }, "definitionLink": { "local": [ "us-gaap-eedm-def-2019-01-31.xml", "srt-eedm1-def-2019-01-31.xml", "vrex-20200922_def.xml" ] }, "inline": { "local": [ "form8-kcoverxreissued2.htm", "exhibit991-financialst.htm" ] }, "labelLink": { "local": [ "vrex-20200922_lab.xml", "us-gaap-doc-2019-01-31.xml", "dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "vrex-20200922_pre.xml" ] }, "referenceLink": { "local": [ "us-gaap-ref-2019-01-31.xml", "dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "vrex-20200922.xsd", "srt-types-2019-01-31.xsd", "xbrl-instance-2003-12-31.xsd", "xbrl-linkbase-2003-12-31.xsd", "xl-2003-12-31.xsd", "xlink-2003-12-31.xsd", "numeric-2009-12-16.xsd", "nonNumeric-2009-12-16.xsd", "ref-2006-02-27.xsd", "srt-2019-01-31.xsd", "xbrldt-2005.xsd", "us-gaap-2019-01-31.xsd", "us-roles-2019-01-31.xsd", "srt-roles-2019-01-31.xsd", "country-2017-01-31.xsd", "us-types-2019-01-31.xsd", "factExplanatory-2009-12-16.xsd", "negated-2009-12-16.xsd", "net-2009-12-16.xsd", "currency-2019-01-31.xsd", "dei-2019-01-31.xsd", "exch-2019-01-31.xsd", "naics-2017-01-31.xsd", "sic-2011-01-31.xsd", "stpr-2018-01-31.xsd", "deprecated-2009-12-16.xsd", "reference-2009-12-16.xsd", "us-parts-codification-2019-01-31.xsd" ] } }, "elementCount": 812, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2019-01-31": 24, "http://www.vareximaging.com/20200922": 18, "http://xbrl.sec.gov/dei/2019-01-31": 4, "total": 46 }, "keyCustom": 47, "keyStandard": 538, "memberCustom": 29, "memberStandard": 72, "nsprefix": "vrex", "nsuri": "http://www.vareximaging.com/20200922", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "form8-kcoverxreissued2.htm", "contextRef": "D2020Q4Sep222020-Sep222020", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0004000 - Document - Cover Cover", "role": "http://www.vareximaging.com/role/CoverCover", "shortName": "Cover Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "form8-kcoverxreissued2.htm", "contextRef": "D2020Q4Sep222020-Sep222020", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2103100 - Disclosure - RELATED-PARTY TRANSACTIONS", "role": "http://www.vareximaging.com/role/RelatedPartyTransactions", "shortName": "RELATED-PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418402 - Disclosure - REVENUE RECOGNITION - Schedule of Balance Sheet Adjustment for ASC 606 Adoption (Details)", "role": "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfBalanceSheetAdjustmentForAsc606AdoptionDetails", "shortName": "REVENUE RECOGNITION - Schedule of Balance Sheet Adjustment for ASC 606 Adoption (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "I2019Q1Sep29", "decimals": "-5", "lang": null, "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R101": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418403 - Disclosure - REVENUE RECOGNITION - Schedule of ASC 606 Adoption Impact On Income Statement (Details)", "role": "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfAsc606AdoptionImpactOnIncomeStatementDetails", "shortName": "REVENUE RECOGNITION - Schedule of ASC 606 Adoption Impact On Income Statement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD_us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member", "decimals": "-5", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R102": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2018Q4", "decimals": "-5", "first": true, "lang": null, "name": "vrex:ContractWithCustomerAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418404 - Disclosure - REVENUE RECOGNITION - Schedule of Changes in Contract Balances (Details)", "role": "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfChangesInContractBalancesDetails", "shortName": "REVENUE RECOGNITION - Schedule of Changes in Contract Balances (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2018Q4", "decimals": "-5", "first": true, "lang": null, "name": "vrex:ContractWithCustomerAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R103": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418405 - Disclosure - REVENUE RECOGNITION - Remaining Performance Obligations (Details)", "role": "http://www.vareximaging.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails", "shortName": "REVENUE RECOGNITION - Remaining Performance Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R104": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:PaymentsOfDebtIssuanceCosts", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2419401 - Disclosure - SUBSEQUENT EVENTS - (Details)", "role": "http://www.vareximaging.com/role/SubsequentEventsDetails", "shortName": "SUBSEQUENT EVENTS - (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "D2020Q3Jun042020-Jun052020_us-gaap_SubsequentEventTypeAxis_us-gaap_SubsequentEventMember", "decimals": "-5", "lang": null, "name": "vrex:PaymentOfHedgeTransactionsFromProceedsOfConvertibleDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2104100 - Disclosure - RESTRUCTURING", "role": "http://www.vareximaging.com/role/Restructuring", "shortName": "RESTRUCTURING", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2105100 - Disclosure - OTHER FINANCIAL INFORMATION", "role": "http://www.vareximaging.com/role/OtherFinancialInformation", "shortName": "OTHER FINANCIAL INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2106100 - Disclosure - NET EARNINGS PER SHARE", "role": "http://www.vareximaging.com/role/NetEarningsPerShare", "shortName": "NET EARNINGS PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2107100 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES", "role": "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivities", "shortName": "FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2108100 - Disclosure - BORROWINGS", "role": "http://www.vareximaging.com/role/Borrowings", "shortName": "BORROWINGS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2109100 - Disclosure - FAIR VALUE", "role": "http://www.vareximaging.com/role/FairValue", "shortName": "FAIR VALUE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2110100 - Disclosure - GOODWILL AND INTANGIBLE ASSETS", "role": "http://www.vareximaging.com/role/GoodwillAndIntangibleAssets", "shortName": "GOODWILL AND INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2111100 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://www.vareximaging.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2112100 - Disclosure - REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS", "role": "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterests", "shortName": "REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001000 - Statement - CONSOLIDATED STATEMENTS OF EARNINGS", "role": "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings", "shortName": "CONSOLIDATED STATEMENTS OF EARNINGS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "lang": null, "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2113100 - Disclosure - EMPLOYEE STOCK PLANS", "role": "http://www.vareximaging.com/role/EmployeeStockPlans", "shortName": "EMPLOYEE STOCK PLANS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2114100 - Disclosure - TAXES ON EARNINGS", "role": "http://www.vareximaging.com/role/TaxesOnEarnings", "shortName": "TAXES ON EARNINGS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2115100 - Disclosure - SEGMENT INFORMATION", "role": "http://www.vareximaging.com/role/SegmentInformation", "shortName": "SEGMENT INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2116100 - Disclosure - EMPLOYEE BENEFIT PLANS", "role": "http://www.vareximaging.com/role/EmployeeBenefitPlans", "shortName": "EMPLOYEE BENEFIT PLANS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2117100 - Disclosure - OTHER COMPREHENSIVE INCOME", "role": "http://www.vareximaging.com/role/OtherComprehensiveIncome", "shortName": "OTHER COMPREHENSIVE INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2118100 - Disclosure - REVENUE RECOGNITION", "role": "http://www.vareximaging.com/role/RevenueRecognition", "shortName": "REVENUE RECOGNITION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2119100 - Disclosure - SUBSEQUENT EVENTS", "role": "http://www.vareximaging.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2201201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2301302 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2302301 - Disclosure - BUSINESS COMBINATIONS (Tables)", "role": "http://www.vareximaging.com/role/BusinessCombinationsTables", "shortName": "BUSINESS COMBINATIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002000 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS", "role": "http://www.vareximaging.com/role/ConsolidatedStatementsOfComprehensiveEarnings", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2304301 - Disclosure - RESTRUCTURING (Tables)", "role": "http://www.vareximaging.com/role/RestructuringTables", "shortName": "RESTRUCTURING (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2305301 - Disclosure - OTHER FINANCIAL INFORMATION (Tables)", "role": "http://www.vareximaging.com/role/OtherFinancialInformationTables", "shortName": "OTHER FINANCIAL INFORMATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2306301 - Disclosure - NET EARNINGS PER SHARE (Tables)", "role": "http://www.vareximaging.com/role/NetEarningsPerShareTables", "shortName": "NET EARNINGS PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2307301 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES (Tables)", "role": "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesTables", "shortName": "FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2308301 - Disclosure - BORROWINGS (Tables)", "role": "http://www.vareximaging.com/role/BorrowingsTables", "shortName": "BORROWINGS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2309301 - Disclosure - FAIR VALUE (Tables)", "role": "http://www.vareximaging.com/role/FairValueTables", "shortName": "FAIR VALUE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2310301 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)", "role": "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsTables", "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2312301 - Disclosure - REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS (Tables)", "role": "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsTables", "shortName": "REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RedeemableNoncontrollingInterestTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2313301 - Disclosure - EMPLOYEE STOCK PLANS (Tables)", "role": "http://www.vareximaging.com/role/EmployeeStockPlansTables", "shortName": "EMPLOYEE STOCK PLANS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SummaryOfValuationAllowanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2314301 - Disclosure - TAXES ON EARNINGS (Tables)", "role": "http://www.vareximaging.com/role/TaxesOnEarningsTables", "shortName": "TAXES ON EARNINGS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SummaryOfValuationAllowanceTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003000 - Statement - CONSOLIDATED BALANCE SHEETS", "role": "http://www.vareximaging.com/role/ConsolidatedBalanceSheets", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2315301 - Disclosure - SEGMENT INFORMATION (Tables)", "role": "http://www.vareximaging.com/role/SegmentInformationTables", "shortName": "SEGMENT INFORMATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "lang": "en-US", "name": "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2317301 - Disclosure - OTHER COMPREHENSIVE INCOME (Tables)", "role": "http://www.vareximaging.com/role/OtherComprehensiveIncomeTables", "shortName": "OTHER COMPREHENSIVE INCOME (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2318301 - Disclosure - REVENUE RECOGNITION (Tables)", "role": "http://www.vareximaging.com/role/RevenueRecognitionTables", "shortName": "REVENUE RECOGNITION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "I2017Q1Jan28_srt_CounterpartyNameAxis_vrex_VarianMedicalSystemsInc.Member", "decimals": "INF", "first": true, "lang": null, "name": "vrex:OutstandingCommonStockPercentageDistributed", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2401403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Description of Business (Details)", "role": "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesDescriptionOfBusinessDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Description of Business (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "I2017Q1Jan28_srt_CounterpartyNameAxis_vrex_VarianMedicalSystemsInc.Member", "decimals": "INF", "first": true, "lang": null, "name": "vrex:OutstandingCommonStockPercentageDistributed", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:SellingGeneralAndAdministrativeExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2401404 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reclassification (Details)", "role": "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesReclassificationDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reclassification (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:PriorPeriodReclassificationAdjustmentDescription", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2018Q4YTD_srt_RestatementAxis_srt_RestatementAdjustmentMember", "decimals": "-5", "lang": null, "name": "us-gaap:SellingGeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2401405 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Segment Reporting (Details)", "role": "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesSegmentReportingDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Segment Reporting (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "INF", "first": true, "lang": null, "name": "vrex:NumberofVariableInterestEntities", "reportCount": 1, "unique": true, "unitRef": "entity", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2401406 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Variable Interest Entities (Details)", "role": "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesVariableInterestEntitiesDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Variable Interest Entities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "INF", "first": true, "lang": null, "name": "vrex:NumberofVariableInterestEntities", "reportCount": 1, "unique": true, "unitRef": "entity", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2401407 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Restricted Cash (Details)", "role": "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesRestrictedCashDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Restricted Cash (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2017Q4", "decimals": "-5", "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD_srt_MajorCustomersAxis_vrex_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2401408 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration of Risk (Details)", "role": "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesConcentrationOfRiskDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration of Risk (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD_srt_MajorCustomersAxis_vrex_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_SalesRevenueNetMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2401409 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Details)", "role": "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesInventoriesDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003501 - Statement - CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)", "role": "http://www.vareximaging.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (PARENTHETICAL)", "subGroupType": "", "uniqueAnchor": null }, "R50": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2401410 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property Plant and Equipment (Details)", "role": "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property Plant and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2401411 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Details)", "role": "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesGoodwillAndIntangibleAssetsDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Goodwill and Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD_srt_RangeAxis_srt_MinimumMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2401412 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Impairment of Long-Lived Assets, Intangible Assets and Goodwill (Details)", "role": "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesImpairmentOfLongLivedAssetsIntangibleAssetsAndGoodwillDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Impairment of Long-Lived Assets, Intangible Assets and Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2017Q4YTD", "decimals": "INF", "lang": null, "name": "us-gaap:GoodwillImpairmentLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2018Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:StandardProductWarrantyAccrual", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2401413 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Product Warranty (Details)", "role": "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesProductWarrantyDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Product Warranty (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2017Q4", "decimals": "-5", "lang": null, "name": "us-gaap:StandardProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2401414 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Allowance for Doubtful Accounts (Details)", "role": "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesAllowanceForDoubtfulAccountsDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Allowance for Doubtful Accounts (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R55": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2401415 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounting Standards Recently Adopted (Details)", "role": "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesAccountingStandardsRecentlyAdoptedDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounting Standards Recently Adopted (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R56": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "I2019Q3Apr302019_us-gaap_BusinessAcquisitionAxis_vrex_DirectConversionABMember", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2402402 - Disclosure - BUSINESS COMBINATIONS - Direct Conversion Narrative (Details)", "role": "http://www.vareximaging.com/role/BusinessCombinationsDirectConversionNarrativeDetails", "shortName": "BUSINESS COMBINATIONS - Direct Conversion Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "D2019Q2Apr29_us-gaap_BusinessAcquisitionAxis_vrex_DirectConversionABMember", "decimals": "-5", "lang": null, "name": "us-gaap:NoncashOrPartNoncashAcquisitionDebtAssumed1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2402403 - Disclosure - BUSINESS COMBINATIONS - Fair Value of Identifiable Assets Acquired and Liabilities Assumed (Details)", "role": "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails", "shortName": "BUSINESS COMBINATIONS - Fair Value of Identifiable Assets Acquired and Liabilities Assumed (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "I2019Q2Apr29_us-gaap_BusinessAcquisitionAxis_vrex_DirectConversionABMember", "decimals": "-5", "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "I2019Q2Apr29_us-gaap_BusinessAcquisitionAxis_vrex_DirectConversionABMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2402404 - Disclosure - BUSINESS COMBINATIONS - Intangibles Acquired (Details)", "role": "http://www.vareximaging.com/role/BusinessCombinationsIntangiblesAcquiredDetails", "shortName": "BUSINESS COMBINATIONS - Intangibles Acquired (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "I2019Q2Apr29_us-gaap_BusinessAcquisitionAxis_vrex_DirectConversionABMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember", "decimals": "-5", "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "D2019Q4Apr30-Sep27_us-gaap_BusinessAcquisitionAxis_vrex_DirectConversionABMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2402405 - Disclosure - BUSINESS COMBINATIONS - Revenues by Segment (Details)", "role": "http://www.vareximaging.com/role/BusinessCombinationsRevenuesBySegmentDetails", "shortName": "BUSINESS COMBINATIONS - Revenues by Segment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "D2019Q4Apr30-Sep27_us-gaap_BusinessAcquisitionAxis_vrex_DirectConversionABMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "D2018Q4Aug312018-Aug312018_us-gaap_BusinessAcquisitionAxis_vrex_VirtualMediaIntegrationLtd.Member", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2402406 - Disclosure - BUSINESS COMBINATIONS - Virtual Media Narrative (Details)", "role": "http://www.vareximaging.com/role/BusinessCombinationsVirtualMediaNarrativeDetails", "shortName": "BUSINESS COMBINATIONS - Virtual Media Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R61": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "D2017Q2May1_us-gaap_BusinessAcquisitionAxis_vrex_PerkinElmerInc.Member", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2402407 - Disclosure - BUSINESS COMBINATIONS - PerkinElmer's Medical Imaging Narrative (Details)", "role": "http://www.vareximaging.com/role/BusinessCombinationsPerkinelmersMedicalImagingNarrativeDetails", "shortName": "BUSINESS COMBINATIONS - PerkinElmer's Medical Imaging Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "I2017Q2May1_us-gaap_BusinessAcquisitionAxis_vrex_PerkinElmerInc.Member", "decimals": "0", "lang": null, "name": "vrex:BusinessCombinationNumberofEmployees", "reportCount": 1, "unique": true, "unitRef": "employee", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2017Q4YTD_us-gaap_BusinessAcquisitionAxis_vrex_PerkinElmerInc.Member", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2402408 - Disclosure - BUSINESS COMBINATIONS - Pro Forma (Details)", "role": "http://www.vareximaging.com/role/BusinessCombinationsProFormaDetails", "shortName": "BUSINESS COMBINATIONS - Pro Forma (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2017Q4YTD_us-gaap_BusinessAcquisitionAxis_vrex_PerkinElmerInc.Member", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403401 - Disclosure - RELATED-PARTY TRANSACTIONS - Investment in Privately Held Companies (Details)", "role": "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails", "shortName": "RELATED-PARTY TRANSACTIONS - Investment in Privately Held Companies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_vrex_DpiXHoldingMember", "decimals": "-5", "lang": null, "name": "us-gaap:IncomeLossFromEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RestructuringCostsAndAssetImpairmentCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404402 - Disclosure - RESTRUCTURING - Narrative (Details)", "role": "http://www.vareximaging.com/role/RestructuringNarrativeDetails", "shortName": "RESTRUCTURING - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "lang": null, "name": "us-gaap:OtherRestructuringCosts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OtherAssetImpairmentCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404403 - Disclosure - RESTRUCTURING - Restructuring Charges Incurred (Details)", "role": "http://www.vareximaging.com/role/RestructuringRestructuringChargesIncurredDetails", "shortName": "RESTRUCTURING - Restructuring Charges Incurred (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "lang": null, "name": "us-gaap:ImpairmentOfIntangibleAssetsFinitelived", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AccruedEmployeeBenefitsCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405402 - Disclosure - OTHER FINANCIAL INFORMATION - (Details)", "role": "http://www.vareximaging.com/role/OtherFinancialInformationDetails", "shortName": "OTHER FINANCIAL INFORMATION - (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AccruedEmployeeBenefitsCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406402 - Disclosure - NET EARNINGS PER SHARE - (Details)", "role": "http://www.vareximaging.com/role/NetEarningsPerShareDetails", "shortName": "NET EARNINGS PER SHARE - (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "lang": null, "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DerivativeNumberOfInstrumentsHeld", "reportCount": 1, "unique": true, "unitRef": "derivative", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407402 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivative Instruments (Details)", "role": "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativeInstrumentsDetails", "shortName": "FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivative Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DerivativeNumberOfInstrumentsHeld", "reportCount": 1, "unique": true, "unitRef": "derivative", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407403 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Narrative (Details)", "role": "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesNarrativeDetails", "shortName": "FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005000 - Statement - CONSOLIDATED STATEMENTS OF EQUITY", "role": "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity", "shortName": "CONSOLIDATED STATEMENTS OF EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2016Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407404 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Income Recognized From Derivative Instruments (Details)", "role": "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfIncomeRecognizedFromDerivativeInstrumentsDetails", "shortName": "FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Income Recognized From Derivative Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407405 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivatives at Fair Value (Details)", "role": "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails", "shortName": "FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Derivatives at Fair Value (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_InterestRateSwapMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_CashFlowHedgingMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_PositionAxis_us-gaap_LongMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407406 - Disclosure - FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Foreign Currency Contracts (Details)", "role": "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfForeignCurrencyContractsDetails", "shortName": "FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES - Summary of Foreign Currency Contracts (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember_us-gaap_PositionAxis_us-gaap_LongMember", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LongTermDebtCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408402 - Disclosure - BORROWINGS - Schedule of Short-Term and Long-Term Debt (Details)", "role": "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails", "shortName": "BORROWINGS - Schedule of Short-Term and Long-Term Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LongTermDebtNoncurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408403 - Disclosure - BORROWINGS - Narrative (Details)", "role": "http://www.vareximaging.com/role/BorrowingsNarrativeDetails", "shortName": "BORROWINGS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "D2017Q2May1_us-gaap_CreditFacilityAxis_us-gaap_RevolvingCreditFacilityMember_us-gaap_DebtInstrumentAxis_vrex_RevolvingCreditFacilityMay2017Member", "decimals": "INF", "lang": null, "name": "us-gaap:LineOfCreditFacilityCommitmentFeePercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408404 - Disclosure - BORROWINGS - Schedule of Debt Maturities (Details)", "role": "http://www.vareximaging.com/role/BorrowingsScheduleOfDebtMaturitiesDetails", "shortName": "BORROWINGS - Schedule of Debt Maturities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LongTermDebtFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409402 - Disclosure - FAIR VALUE - (Details)", "role": "http://www.vareximaging.com/role/FairValueDetails", "shortName": "FAIR VALUE - (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LongTermDebtFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2018Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410402 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Summary of Goowill (Details)", "role": "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsSummaryOfGoowillDetails", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Summary of Goowill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "lang": null, "name": "us-gaap:GoodwillAcquiredDuringPeriod", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410403 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details)", "role": "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410404 - Disclosure - GOODWILL AND INTANGIBLE ASSETS - Amortization Schedule (Details)", "role": "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsAmortizationScheduleDetails", "shortName": "GOODWILL AND INTANGIBLE ASSETS - Amortization Schedule (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101100 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411401 - Disclosure - COMMITMENTS AND CONTINGENCIES - (Details)", "role": "http://www.vareximaging.com/role/CommitmentsAndContingenciesDetails", "shortName": "COMMITMENTS AND CONTINGENCIES - (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:RedeemableNoncontrollingInterestTableTextBlock", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412402 - Disclosure - REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS - Narrative (Details)", "role": "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsNarrativeDetails", "shortName": "REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2018Q4_srt_OwnershipAxis_vrex_JointVentureInSaudiArabiaMember", "decimals": "2", "lang": null, "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:RedeemableNoncontrollingInterestTableTextBlock", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2018Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412403 - Disclosure - REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS - Summary of Changes in Redeemable Noncontrolling Interests & Noncontrolling INterets (Details)", "role": "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsSummaryOfChangesInRedeemableNoncontrollingInterestsNoncontrollingInteretsDetails", "shortName": "REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS - Summary of Changes in Redeemable Noncontrolling Interests & Noncontrolling INterets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:RedeemableNoncontrollingInterestTableTextBlock", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "lang": null, "name": "us-gaap:TemporaryEquityNetIncome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413402 - Disclosure - EMPLOYEE STOCK PLANS - Narrative (Details)", "role": "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails", "shortName": "EMPLOYEE STOCK PLANS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413403 - Disclosure - EMPLOYEE STOCK PLANS - Share-based Compensation Expense (Details)", "role": "http://www.vareximaging.com/role/EmployeeStockPlansShareBasedCompensationExpenseDetails", "shortName": "EMPLOYEE STOCK PLANS - Share-based Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q1YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413404 - Disclosure - EMPLOYEE STOCK PLANS - Valuation Assumptions (Details)", "role": "http://www.vareximaging.com/role/EmployeeStockPlansValuationAssumptionsDetails", "shortName": "EMPLOYEE STOCK PLANS - Valuation Assumptions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q1YTD_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413405 - Disclosure - EMPLOYEE STOCK PLANS - Stock Option Activity (Details)", "role": "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails", "shortName": "EMPLOYEE STOCK PLANS - Stock Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413406 - Disclosure - EMPLOYEE STOCK PLANS - Restricted Stock and Performance Stock (Details)", "role": "http://www.vareximaging.com/role/EmployeeStockPlansRestrictedStockAndPerformanceStockDetails", "shortName": "EMPLOYEE STOCK PLANS - Restricted Stock and Performance Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2018Q4", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414402 - Disclosure - TAXES ON EARNINGS - Summary of Taxes by Jurisdiction and Classification (Details)", "role": "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails", "shortName": "TAXES ON EARNINGS - Summary of Taxes by Jurisdiction and Classification (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414403 - Disclosure - TAXES ON EARNINGS - Income Tax Rate Reconciliation (Details)", "role": "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails", "shortName": "TAXES ON EARNINGS - Income Tax Rate Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "3", "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2102100 - Disclosure - BUSINESS COMBINATIONS", "role": "http://www.vareximaging.com/role/BusinessCombinations", "shortName": "BUSINESS COMBINATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414404 - Disclosure - TAXES ON EARNINGS - Narrative (Details)", "role": "http://www.vareximaging.com/role/TaxesOnEarningsNarrativeDetails", "shortName": "TAXES ON EARNINGS - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "lang": null, "name": "us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsInventory", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414405 - Disclosure - TAXES ON EARNINGS - Deferred Tax Assets and Liabilities (Details)", "role": "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails", "shortName": "TAXES ON EARNINGS - Deferred Tax Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsInventory", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2018Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsValuationAllowance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414406 - Disclosure - TAXES ON EARNINGS - Valuation Allowance (Details)", "role": "http://www.vareximaging.com/role/TaxesOnEarningsValuationAllowanceDetails", "shortName": "TAXES ON EARNINGS - Valuation Allowance (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "lang": null, "name": "vrex:ValuationAllowanceDeferredTaxAssetIncreaseFromBusinessCombinationAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2018Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414407 - Disclosure - TAXES ON EARNINGS - Income Tax Contingency (Details)", "role": "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxContingencyDetails", "shortName": "TAXES ON EARNINGS - Income Tax Contingency (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "lang": null, "name": "us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415402 - Disclosure - SEGMENT INFORMATION - Narrative (Details)", "role": "http://www.vareximaging.com/role/SegmentInformationNarrativeDetails", "shortName": "SEGMENT INFORMATION - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R95": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415403 - Disclosure - SEGMENT INFORMATION - Summary of Segment Information (Details)", "role": "http://www.vareximaging.com/role/SegmentInformationSummaryOfSegmentInformationDetails", "shortName": "SEGMENT INFORMATION - Summary of Segment Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD_us-gaap_StatementBusinessSegmentsAxis_vrex_MedicalMember", "decimals": "-5", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Assets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415404 - Disclosure - SEGMENT INFORMATION - Assets (Details)", "role": "http://www.vareximaging.com/role/SegmentInformationAssetsDetails", "shortName": "SEGMENT INFORMATION - Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2019Q4_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember", "decimals": "-5", "lang": null, "name": "us-gaap:Assets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415405 - Disclosure - SEGMENT INFORMATION - Geographic (Details)", "role": "http://www.vareximaging.com/role/SegmentInformationGeographicDetails", "shortName": "SEGMENT INFORMATION - Geographic (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD_srt_StatementGeographicalAxis_country_US", "decimals": "-5", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanCostRecognized", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2416401 - Disclosure - EMPLOYEE BENEFIT PLANS - (Details)", "role": "http://www.vareximaging.com/role/EmployeeBenefitPlansDetails", "shortName": "EMPLOYEE BENEFIT PLANS - (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanCostRecognized", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FI2018Q4", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417402 - Disclosure - OTHER COMPREHENSIVE INCOME - (Details)", "role": "http://www.vareximaging.com/role/OtherComprehensiveIncomeDetails", "shortName": "OTHER COMPREHENSIVE INCOME - (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "exhibit991-financialst.htm", "contextRef": "FD2019Q4YTD", "decimals": "-5", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } } }, "segmentCount": 102, "tag": { "country_US": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://www.vareximaging.com/role/SegmentInformationGeographicDetails" ], "xbrltype": "domainItemType" }, "currency_AllCurrenciesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "All Currencies [Domain]", "terseLabel": "All Currencies [Domain]" } } }, "localname": "AllCurrenciesDomain", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfForeignCurrencyContractsDetails" ], "xbrltype": "domainItemType" }, "currency_CHF": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Switzerland, Francs", "terseLabel": "Swiss franc" } } }, "localname": "CHF", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfForeignCurrencyContractsDetails" ], "xbrltype": "domainItemType" }, "currency_CNY": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "China, Yuan Renminbi", "terseLabel": "Chinese renminbi" } } }, "localname": "CNY", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfForeignCurrencyContractsDetails" ], "xbrltype": "domainItemType" }, "currency_EUR": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Euro Member Countries, Euro", "terseLabel": "Euro" } } }, "localname": "EUR", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfForeignCurrencyContractsDetails" ], "xbrltype": "domainItemType" }, "currency_JPY": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Japan, Yen", "terseLabel": "Japanese yen" } } }, "localname": "JPY", "nsuri": "http://xbrl.sec.gov/currency/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfForeignCurrencyContractsDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r591" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r591" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r591" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r591" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r588" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r589" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r586" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r587" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r590" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r592" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CoverCover" ], "xbrltype": "booleanItemType" }, "srt_AsiaPacificMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Asia Pacific [Member]", "terseLabel": "APAC" } } }, "localname": "AsiaPacificMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SegmentInformationGeographicDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r186", "r198" ], "lang": { "en-US": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SegmentInformationAssetsDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SegmentInformationAssetsDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r69", "r136" ], "lang": { "en-US": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesDescriptionOfBusinessDetails" ], "xbrltype": "stringItemType" }, "srt_CurrencyAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Currency [Axis]", "terseLabel": "Currency [Axis]" } } }, "localname": "CurrencyAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfForeignCurrencyContractsDetails" ], "xbrltype": "stringItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Investment, Name [Domain]", "terseLabel": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "domainItemType" }, "srt_LatinAmericaMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Latin America [Member]", "terseLabel": "Latin America" } } }, "localname": "LatinAmericaMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SegmentInformationGeographicDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r202", "r301", "r307", "r578" ], "lang": { "en-US": { "role": { "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesConcentrationOfRiskDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails", "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails", "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails", "http://www.vareximaging.com/role/RestructuringNarrativeDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesGoodwillAndIntangibleAssetsDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesProductWarrantyDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails", "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails", "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails", "http://www.vareximaging.com/role/RestructuringNarrativeDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesGoodwillAndIntangibleAssetsDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesProductWarrantyDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Ownership [Axis]", "terseLabel": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Ownership [Domain]", "terseLabel": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails", "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails", "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails", "http://www.vareximaging.com/role/RestructuringNarrativeDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesGoodwillAndIntangibleAssetsDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesProductWarrantyDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails", "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails", "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails", "http://www.vareximaging.com/role/RestructuringNarrativeDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesGoodwillAndIntangibleAssetsDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesProductWarrantyDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesDescriptionOfBusinessDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAdjustmentMember": { "auth_ref": [ "r149", "r151", "r152", "r153" ], "lang": { "en-US": { "role": { "label": "Restatement Adjustment [Member]", "terseLabel": "Restatement Adjustment" } } }, "localname": "RestatementAdjustmentMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesReclassificationDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Restatement [Axis]", "terseLabel": "Restatement [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesReclassificationDetails" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Restatement [Domain]", "terseLabel": "Restatement [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesReclassificationDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Forecast [Member]", "terseLabel": "Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r211" ], "lang": { "en-US": { "role": { "label": "Investment, Name [Axis]", "terseLabel": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SegmentInformationGeographicDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r201", "r301", "r306", "r577", "r580", "r584" ], "lang": { "en-US": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SegmentInformationGeographicDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r268", "r521" ], "lang": { "en-US": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201409Member": { "auth_ref": [ "r309" ], "lang": { "en-US": { "role": { "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).", "label": "Accounting Standards Update 2014-09 [Member]", "terseLabel": "ASU 2014-09" } } }, "localname": "AccountingStandardsUpdate201409Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfBalanceSheetAdjustmentForAsc606AdoptionDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesAccountingStandardsRecentlyAdoptedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r49" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r143", "r513", "r551", "r571" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount for accounts payable to related parties.", "label": "Accounts Payable, Related Parties", "terseLabel": "Accounts payable, related parties" } } }, "localname": "AccountsPayableRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]", "terseLabel": "Accounts Receivable" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r4", "r25", "r204", "r205", "r302" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net of allowance for doubtful accounts of $1.0 and $0.6 at September 27, 2019 and September 28, 2018, respectively" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedEmployeeBenefitsCurrent": { "auth_ref": [ "r8", "r9", "r53" ], "calculation": { "http://www.vareximaging.com/role/OtherFinancialInformationDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Employee Benefits, Current", "terseLabel": "Accrued compensation and benefits" } } }, "localname": "AccruedEmployeeBenefitsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedEnvironmentalLossContingenciesNoncurrent": { "auth_ref": [ "r58", "r255", "r256", "r267" ], "calculation": { "http://www.vareximaging.com/role/OtherFinancialInformationDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value of the obligation (known or estimated) arising from requirements to perform activities to remediate one or more sites, payable after twelve months or beyond the next operating cycle if longer.", "label": "Accrued Environmental Loss Contingencies, Noncurrent", "terseLabel": "Environment liabilities" } } }, "localname": "AccruedEnvironmentalLossContingenciesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CommitmentsAndContingenciesDetails", "http://www.vareximaging.com/role/OtherFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r17", "r545", "r562" ], "calculation": { "http://www.vareximaging.com/role/OtherFinancialInformationDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "terseLabel": "Income taxes payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesNoncurrent": { "auth_ref": [ "r19", "r545", "r562" ], "calculation": { "http://www.vareximaging.com/role/OtherFinancialInformationDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.", "label": "Accrued Income Taxes, Noncurrent", "terseLabel": "Long-term income tax payable" } } }, "localname": "AccruedIncomeTaxesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r53" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.vareximaging.com/role/OtherFinancialInformationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued liabilities", "totalLabel": "Total accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets", "http://www.vareximaging.com/role/OtherFinancialInformationDetails", "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfBalanceSheetAdjustmentForAsc606AdoptionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": { "auth_ref": [ "r72", "r78", "r79", "r318", "r445" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans including the portion attributable to the noncontrolling interest.", "label": "Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member]", "terseLabel": "Unrealized Gain on Defined Benefit Obligations" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r46", "r250" ], "calculation": { "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedTerseLabel": "Accumulated depreciation and amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember": { "auth_ref": [ "r78", "r444" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, including portion attributable to noncontrolling interest.", "label": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]", "terseLabel": "Unrealized Gain (Loss) on Derivative Financial Instruments" } } }, "localname": "AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r75", "r77", "r78" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive (loss) income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r74", "r78", "r79", "r445" ], "lang": { "en-US": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r232" ], "lang": { "en-US": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Estimated useful life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsIntangiblesAcquiredDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.", "label": "Additional Financial Information Disclosure [Text Block]", "terseLabel": "OTHER FINANCIAL INFORMATION" } } }, "localname": "AdditionalFinancialInformationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherFinancialInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r26" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from a tax benefit (deficiency) associated with an share-based compensation plan other than an employee stock ownership plan (ESOP).", "label": "Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net", "terseLabel": "Tax impacts to APIC related to share-based award activity" } } }, "localname": "AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r148" ], "lang": { "en-US": { "role": { "documentation": "Information by new accounting pronouncement.", "label": "Adjustments for New Accounting Pronouncements [Axis]", "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfBalanceSheetAdjustmentForAsc606AdoptionDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesAccountingStandardsRecentlyAdoptedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation", "negatedTerseLabel": "Shares withheld on vesting of restricted stock" } } }, "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r323", "r325", "r361", "r362" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Share-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net earnings to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r325", "r355", "r360" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Allocated share-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansShareBasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r31", "r206", "r213" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesAllowanceForDoubtfulAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r96", "r123", "r509" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Amortization of deferred loan costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r123", "r230", "r239" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows", "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r162" ], "lang": { "en-US": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Anti-dilutive employee shared based awards, excluded (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/NetEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": { "auth_ref": [ "r74", "r78", "r79", "r445" ], "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]", "terseLabel": "Accumulated Other Comprehensive Income" } } }, "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r191", "r543", "r561" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets", "http://www.vareximaging.com/role/SegmentInformationAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets", "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfBalanceSheetAdjustmentForAsc606AdoptionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r6", "r65" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r490" ], "calculation": { "http://www.vareximaging.com/role/FairValueDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "totalLabel": "Total assets measured at fair value" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]", "terseLabel": "Assets:" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r326", "r357" ], "lang": { "en-US": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails", "http://www.vareximaging.com/role/EmployeeStockPlansValuationAssumptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r465", "r469" ], "lang": { "en-US": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Minimum rate investor will accept.", "label": "Base Rate [Member]", "terseLabel": "Base Rate" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingMember": { "auth_ref": [ "r249" ], "lang": { "en-US": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building [Member]", "terseLabel": "Building" } } }, "localname": "BuildingMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsDirectConversionNarrativeDetails", "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.vareximaging.com/role/BusinessCombinationsIntangiblesAcquiredDetails", "http://www.vareximaging.com/role/BusinessCombinationsPerkinelmersMedicalImagingNarrativeDetails", "http://www.vareximaging.com/role/BusinessCombinationsProFormaDetails", "http://www.vareximaging.com/role/BusinessCombinationsRevenuesBySegmentDetails", "http://www.vareximaging.com/role/BusinessCombinationsVirtualMediaNarrativeDetails", "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r409", "r410" ], "lang": { "en-US": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsDirectConversionNarrativeDetails", "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.vareximaging.com/role/BusinessCombinationsIntangiblesAcquiredDetails", "http://www.vareximaging.com/role/BusinessCombinationsPerkinelmersMedicalImagingNarrativeDetails", "http://www.vareximaging.com/role/BusinessCombinationsProFormaDetails", "http://www.vareximaging.com/role/BusinessCombinationsRevenuesBySegmentDetails", "http://www.vareximaging.com/role/BusinessCombinationsVirtualMediaNarrativeDetails", "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsDirectConversionNarrativeDetails", "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.vareximaging.com/role/BusinessCombinationsPerkinelmersMedicalImagingNarrativeDetails", "http://www.vareximaging.com/role/BusinessCombinationsProFormaDetails", "http://www.vareximaging.com/role/BusinessCombinationsVirtualMediaNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r405" ], "lang": { "en-US": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Percentage of voting interests acquired" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsDirectConversionNarrativeDetails", "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": { "auth_ref": [ "r407", "r408" ], "lang": { "en-US": { "role": { "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Earnings Per Share, Basic", "terseLabel": "Net earnings per share, basic (in USD per share)" } } }, "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsProFormaDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": { "auth_ref": [ "r407", "r408" ], "lang": { "en-US": { "role": { "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Earnings Per Share, Diluted", "terseLabel": "Net earnings per share, diluted (in USD per share)" } } }, "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsProFormaDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r407", "r408" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Business Acquisition, Pro Forma Information [Table Text Block]", "terseLabel": "Business Acquisition, Pro Forma Information" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": { "auth_ref": [ "r429" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.", "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount", "terseLabel": "Goodwill expected tax deductible amount" } } }, "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsPerkinelmersMedicalImagingNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax": { "auth_ref": [ "r407", "r408" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax", "terseLabel": "Operating earnings" } } }, "localname": "BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsProFormaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [ "r407", "r408" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Net Income (Loss)", "terseLabel": "Net earnings" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsProFormaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r407", "r408" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business Acquisition, Pro Forma Revenue", "terseLabel": "Revenue" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsProFormaDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": { "auth_ref": [ "r413" ], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.", "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value", "negatedLabel": "Noncontrolling interest" } } }, "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r422", "r423", "r426" ], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Total cash consideration", "totalLabel": "Total cash consideration" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.vareximaging.com/role/BusinessCombinationsPerkinelmersMedicalImagingNarrativeDetails", "http://www.vareximaging.com/role/BusinessCombinationsVirtualMediaNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": { "auth_ref": [ "r422", "r423" ], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.", "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable", "terseLabel": "Deferred consideration" } } }, "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": { "auth_ref": [ "r122", "r430" ], "calculation": { "http://www.vareximaging.com/role/OtherFinancialInformationDetails": { "order": 2.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.", "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability", "negatedTerseLabel": "Change in fair value of deferred consideration" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r421", "r424", "r428" ], "calculation": { "http://www.vareximaging.com/role/FairValueDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination, Contingent Consideration, Liability", "terseLabel": "Deferred consideration" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": { "auth_ref": [ "r421", "r425" ], "calculation": { "http://www.vareximaging.com/role/OtherFinancialInformationDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.", "label": "Business Combination, Contingent Consideration, Liability, Current", "terseLabel": "Deferred consideration" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r431" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "BUSINESS COMBINATIONS" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinations" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": { "auth_ref": [ "r406" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.", "label": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual", "terseLabel": "Revenues" } } }, "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsRevenuesBySegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]", "terseLabel": "Allocation of the purchase consideration:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r412" ], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "vrex_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsandGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Cash" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": { "auth_ref": [ "r412" ], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 9.0, "parentTag": "vrex_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsandGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other", "terseLabel": "Other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [ "r412" ], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 4.0, "parentTag": "vrex_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsandGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets", "terseLabel": "Prepaids and other current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r412" ], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "vrex_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsandGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "terseLabel": "Accounts Receivable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": { "auth_ref": [ "r412" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities", "negatedLabel": "Current liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r412" ], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "negatedLabel": "Accounts payable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt": { "auth_ref": [ "r412" ], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt", "negatedLabel": "Current maturities of long-term debt" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "auth_ref": [ "r412" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other", "negatedLabel": "Other liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r372", "r412" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "terseLabel": "Deferred tax liabilities noncurrent" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsPerkinelmersMedicalImagingNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r412" ], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 7.0, "parentTag": "vrex_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsandGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Intangibles" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.vareximaging.com/role/BusinessCombinationsIntangiblesAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r411", "r412" ], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "vrex_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsandGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventory" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r412" ], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "negatedTotalLabel": "Total liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": { "auth_ref": [ "r412" ], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt", "negatedLabel": "Long-term debt" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "auth_ref": [ "r412" ], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other", "negatedLabel": "Other liabilities, non-current" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": { "auth_ref": [ "r412" ], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 6.0, "parentTag": "vrex_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsandGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets", "terseLabel": "Other assets, non-current" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r411", "r412" ], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 5.0, "parentTag": "vrex_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsandGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Property, plant, and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": { "auth_ref": [ "r412" ], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest", "totalLabel": "Net assets acquired, less noncontrolling interest" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r412" ], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "totalLabel": "Net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessExitCosts1": { "auth_ref": [ "r123", "r257", "r261", "r263" ], "calculation": { "http://www.vareximaging.com/role/RestructuringRestructuringChargesIncurredDetails": { "order": 6.0, "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.", "label": "Business Exit Costs", "terseLabel": "Facility closure costs" } } }, "localname": "BusinessExitCosts1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RestructuringRestructuringChargesIncurredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member": { "auth_ref": [ "r308" ], "lang": { "en-US": { "role": { "documentation": "Calculated under guidance for revenue recognition in effect prior to change to new guidance for revenue from contract with customer when using transition method for cumulative effect in period including initial date of application.", "label": "Calculated under Revenue Guidance in Effect before Topic 606 [Member]", "terseLabel": "Balance without Adoption" } } }, "localname": "CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfAsc606AdoptionImpactOnIncomeStatementDetails", "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfBalanceSheetAdjustmentForAsc606AdoptionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r128", "r129", "r130" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred but Not yet Paid", "terseLabel": "Purchases of property, plant and equipment financed through accounts payable" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r42", "r125" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesRestrictedCashDetails": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "calculation": { "http://www.vareximaging.com/role/FairValueDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash equivalents - money market funds" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r13", "r126", "r132", "r542" ], "lang": { "en-US": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents and Restricted Cash" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r117", "r125", "r131" ], "calculation": { "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesRestrictedCashDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents and restricted cash at end of period", "periodStartLabel": "Cash and cash equivalents and restricted cash at beginning of period", "totalLabel": "Cash and cash equivalents and restricted cash as reported per statement of cash flows" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r117", "r505" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net (decrease) increase in cash and cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": { "auth_ref": [ "r488" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.", "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months", "terseLabel": "Recorded component of accumulated other comprehensive income (loss) that will be reclassified in the statements of comprehensive earnings over the next 12 months" } } }, "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r462" ], "lang": { "en-US": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Derivatives designated as cash flow hedges" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesNarrativeDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativeInstrumentsDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfIncomeRecognizedFromDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ChangeInContractWithCustomerAssetAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Change in Contract with Customer, Asset [Abstract]", "terseLabel": "Change in Contract with Customer, Asset [Abstract]" } } }, "localname": "ChangeInContractWithCustomerAssetAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfChangesInContractBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Change in Contract with Customer, Liability [Abstract]", "terseLabel": "Change in Contract with Customer, Liability [Abstract]" } } }, "localname": "ChangeInContractWithCustomerLiabilityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfChangesInContractBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r142" ], "lang": { "en-US": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price of warrants (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r59", "r267", "r552", "r570" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 11)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r266", "r269" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "auth_ref": [ "r132", "r272", "r581", "r582" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.", "label": "Commitments and Contingencies, Policy [Policy Text Block]", "terseLabel": "Loss Contingencies" } } }, "localname": "CommitmentsAndContingenciesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r24" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value per share (usd per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r24" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r24" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares, issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r24", "r290" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Shares outstanding, end of period (in shares)", "periodStartLabel": "Shares outstanding, beginning of period (in shares)", "terseLabel": "Common stock, shares, outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r24" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $.01 par value: 150,000,000 shares authorized, shares issued and outstanding: 38,371,305 and 38,026,597 at September 27, 2019 and September 28, 2018, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "auth_ref": [ "r311", "r312", "r322", "r364" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.", "label": "Compensation and Employee Benefit Plans [Text Block]", "terseLabel": "EMPLOYEE BENEFIT PLANS" } } }, "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeBenefitPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r82", "r84", "r85" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfComprehensiveEarnings": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive earnings attributable to Varex" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfComprehensiveEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r82", "r84", "r436", "r437", "r452" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfComprehensiveEarnings": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "terseLabel": "Less: Comprehensive earnings attributable to noncontrolling interests" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfComprehensiveEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r82", "r84", "r435", "r452" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfComprehensiveEarnings": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Comprehensive earnings" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfComprehensiveEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r105" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "OTHER COMPREHENSIVE INCOME" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherComprehensiveIncome" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r177", "r178", "r499", "r500" ], "lang": { "en-US": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r177", "r178", "r499", "r500", "r579" ], "lang": { "en-US": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesConcentrationOfRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r177", "r178", "r499", "r500", "r579" ], "lang": { "en-US": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesConcentrationOfRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r172", "r558" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]", "terseLabel": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesConcentrationOfRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r177", "r178", "r499", "r500" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesConcentrationOfRiskDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r175", "r177", "r178", "r179", "r499", "r501" ], "lang": { "en-US": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]", "terseLabel": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesConcentrationOfRiskDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r177", "r178", "r499", "r500" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r132", "r439", "r454", "r456" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationVariableInterestEntityPolicy": { "auth_ref": [ "r132", "r447", "r448", "r449" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).", "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]", "terseLabel": "Variable Interest Entities" } } }, "localname": "ConsolidationVariableInterestEntityPolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress [Member]", "terseLabel": "Construction in progress" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r298" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of contract balances and changes in contract balances.", "label": "Contract with Customer, Asset and Liability [Table Text Block]", "terseLabel": "Schedule of Changes in Contract With Customer Assets And Liabilities" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r296", "r297", "r302" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "periodEndLabel": "Balance at September 27, 2019", "periodStartLabel": "Balance at September 29, 2018" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfChangesInContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r296", "r297", "r302" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Deferred revenues" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets", "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfBalanceSheetAdjustmentForAsc606AdoptionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r303" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Recognition of revenue included in beginning of year refund liability" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfChangesInContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerRefundLiabilityCurrent": { "auth_ref": [ "r304" ], "calculation": { "http://www.vareximaging.com/role/OtherFinancialInformationDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current.", "label": "Contract with Customer, Refund Liability, Current", "terseLabel": "Right of return liability" } } }, "localname": "ContractWithCustomerRefundLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerRefundLiabilityNoncurrent": { "auth_ref": [ "r304" ], "calculation": { "http://www.vareximaging.com/role/OtherFinancialInformationDetails": { "order": 4.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as noncurrent.", "label": "Contract with Customer, Refund Liability, Noncurrent", "terseLabel": "Long-term right of return liability" } } }, "localname": "ContractWithCustomerRefundLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebt": { "auth_ref": [ "r18", "r548", "r564" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.", "label": "Convertible Debt", "terseLabel": "Convertible debt" } } }, "localname": "ConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r277" ], "lang": { "en-US": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]", "terseLabel": "Convertible Debt" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r99" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "terseLabel": "Cost of revenues" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings", "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfAsc606AdoptionImpactOnIncomeStatementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of revenues" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansShareBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails", "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails", "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails", "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails", "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CrossCurrencyInterestRateContractMember": { "auth_ref": [ "r316", "r477" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.", "label": "Cross Currency Interest Rate Contract [Member]", "terseLabel": "Cross Currency Swap Contracts" } } }, "localname": "CrossCurrencyInterestRateContractMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesNarrativeDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativeInstrumentsDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfIncomeRecognizedFromDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) to equity or (increase) decrease to net assets, resulting from the cumulative effect adjustment of a new accounting principle applied in the period of adoption.", "label": "Cumulative Effect of New Accounting Principle in Period of Adoption", "terseLabel": "Effect of adoption of ASC 606" } } }, "localname": "CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r134", "r393", "r398" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails": { "order": 1.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Federal Tax Expense (Benefit)", "terseLabel": "Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r141", "r395" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails": { "order": 3.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense (Benefit)", "terseLabel": "Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r134", "r393", "r398" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "totalLabel": "Total current" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Current provision:" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r134", "r393", "r398" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails": { "order": 2.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current State and Local Tax Expense (Benefit)", "terseLabel": "State and local" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r176" ], "lang": { "en-US": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r417" ], "lang": { "en-US": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsIntangiblesAcquiredDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r283" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "BORROWINGS" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/Borrowings" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r16", "r17", "r18", "r544", "r548", "r560" ], "lang": { "en-US": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails", "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails", "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Basis spread on variable rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r18", "r279", "r548", "r560" ], "calculation": { "http://www.vareximaging.com/role/BorrowingsScheduleOfDebtMaturitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "totalLabel": "Total debt outstanding" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsScheduleOfDebtMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": { "auth_ref": [ "r278" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.", "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component", "terseLabel": "Debt instrument, convertible, carrying amount of equity component" } } }, "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r281" ], "lang": { "en-US": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Debt instrument, convertible, conversion price (in dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleConversionRatio1": { "auth_ref": [ "r56", "r291", "r292", "r293" ], "lang": { "en-US": { "role": { "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.", "label": "Debt Instrument, Convertible, Conversion Ratio", "terseLabel": "Debt instrument, convertible, conversion ratio" } } }, "localname": "DebtInstrumentConvertibleConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "pureItemType" }, "us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments": { "auth_ref": [ "r56", "r291", "r292", "r293" ], "lang": { "en-US": { "role": { "documentation": "The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.", "label": "Debt Instrument, Convertible, Number of Equity Instruments", "terseLabel": "Debt instrument, convertible, number of equity instruments (in shares)" } } }, "localname": "DebtInstrumentConvertibleNumberOfEquityInstruments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days", "terseLabel": "Debt instrument, convertible, threshold consecutive trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.", "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger", "terseLabel": "Debt instrument, convertible, threshold percentage of stock price trigger" } } }, "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Trading Days", "terseLabel": "Debt instrument, convertible, threshold trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdTradingDays", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r508", "r510" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt instrument, face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r55", "r282", "r508" ], "lang": { "en-US": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Debt instrument, interest rate, effective percentage" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r55" ], "lang": { "en-US": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Debt instrument, interest rate, stated percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r57" ], "lang": { "en-US": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails", "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails", "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Debt instrument, term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r134", "r394", "r398" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal Income Tax Expense (Benefit)", "terseLabel": "Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r48", "r509" ], "calculation": { "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebtNoncurrent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "negatedTerseLabel": "Debt issuance costs", "terseLabel": "Debt issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails", "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r134", "r394", "r398" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense (Benefit)", "terseLabel": "Foreign" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r123", "r134", "r394", "r398" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "totalLabel": "Total deferred" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Deferred provision (benefit):" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r20", "r21", "r384", "r546", "r559" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r373", "r388" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred tax liabilities", "totalLabel": "Net deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets", "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfBalanceSheetAdjustmentForAsc606AdoptionDetails", "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r134", "r394", "r398" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "terseLabel": "State and local" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r385" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Deferred tax assets, gross" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInventory": { "auth_ref": [ "r367", "r391", "r392" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.", "label": "Deferred Tax Assets, Inventory", "terseLabel": "Inventory adjustments" } } }, "localname": "DeferredTaxAssetsInventory", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r386" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Total deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Deferred Tax Assets, Net [Abstract]", "terseLabel": "Deferred Tax Assets:" } } }, "localname": "DeferredTaxAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r366", "r391", "r392" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails", "http://www.vareximaging.com/role/TaxesOnEarningsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration", "terseLabel": "Operating loss carryforwards, that do not expire" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration", "terseLabel": "Operating loss carryforwards, that expire" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r367", "r391", "r392" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets, Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsForeign": { "auth_ref": [ "r390", "r391", "r392" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards, Foreign", "terseLabel": "Credit carryforwards" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsForeign", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences": { "auth_ref": [ "r366", "r391", "r392" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensated absences (includes, but not limited to, sick and personal days).", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Compensated Absences", "terseLabel": "Accrued vacation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": { "auth_ref": [ "r366", "r391", "r392" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation", "terseLabel": "Deferred compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r366", "r391", "r392" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost", "terseLabel": "Share-based compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves": { "auth_ref": [ "r366", "r391", "r392" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from warranty reserves.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Warranty Reserves", "terseLabel": "Product warranty" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r387" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedTerseLabel": "Valuation allowance", "periodEndLabel": "Valuation allowance balance\u2014end of fiscal year", "periodStartLabel": "Valuation allowance balance\u2013beginning of fiscal year" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails", "http://www.vareximaging.com/role/TaxesOnEarningsValuationAllowanceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r373", "r388" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "negatedTotalLabel": "Net deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": { "auth_ref": [ "r367", "r391", "r392" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.", "label": "Deferred Tax Liabilities, Intangible Assets", "negatedTerseLabel": "Acquired intangibles" } } }, "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates": { "auth_ref": [ "r367", "r391", "r392" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from investments in unconsolidated subsidiaries and investments in other affiliates which are not controlled nor consolidated.", "label": "Deferred Tax Liabilities, Investment in Noncontrolled Affiliates", "negatedTerseLabel": "Investments in privately held companies" } } }, "localname": "DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesNetAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Deferred Tax Liabilities, Net [Abstract]", "terseLabel": "Deferred Tax Liabilities:" } } }, "localname": "DeferredTaxLiabilitiesNetAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r367", "r391", "r392" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities, Other", "negatedTerseLabel": "Other" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "auth_ref": [ "r367", "r391", "r392" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.", "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "negatedTerseLabel": "Property, plant and equipment" } } }, "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": { "auth_ref": [ "r391" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.", "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings", "terseLabel": "Deferred tax liabilities of undistributed foreign earnings" } } }, "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": { "auth_ref": [ "r19", "r313", "r314", "r315" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.", "label": "Liability, Defined Benefit Pension Plan, Noncurrent", "terseLabel": "Defined benefit pension plan liability" } } }, "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanCostRecognized": { "auth_ref": [ "r321" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost for defined contribution plan.", "label": "Defined Contribution Plan, Cost", "terseLabel": "Employer discretionary contribution amount" } } }, "localname": "DefinedContributionPlanCostRecognized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeBenefitPlansDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r123", "r248" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r67", "r68", "r498" ], "calculation": { "http://www.vareximaging.com/role/FairValueDetails": { "order": 2.0, "parentTag": "us-gaap_AssetsFairValueDisclosure", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative assets" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesNarrativeDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativeInstrumentsDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfForeignCurrencyContractsDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfIncomeRecognizedFromDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "auth_ref": [ "r66", "r70", "r467", "r527" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.", "label": "Derivative Asset, Fair Value, Gross Asset", "terseLabel": "Derivative Assets" } } }, "localname": "DerivativeFairValueOfDerivativeAsset", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r66", "r70", "r467", "r527" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Fair Value, Gross Liability", "negatedTerseLabel": "Derivative Liabilities" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r466", "r468", "r473", "r479" ], "lang": { "en-US": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesNarrativeDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativeInstrumentsDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfForeignCurrencyContractsDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfIncomeRecognizedFromDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r489" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "FINANCIAL DERIVATIVES AND HEDGING ACTIVITIES" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r463", "r466", "r473" ], "lang": { "en-US": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesNarrativeDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativeInstrumentsDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfIncomeRecognizedFromDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": { "auth_ref": [ "r471", "r478" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net", "terseLabel": "Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income Fiscal Year Ended" } } }, "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfIncomeRecognizedFromDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLoss": { "auth_ref": [ "r472", "r474" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of realized and unrealized loss of derivative instruments not designated or qualifying as hedging instruments.", "label": "Derivative Instruments Not Designated as Hedging Instruments, Loss", "terseLabel": "Loss on derivative instruments not designated as cash flow hedges" } } }, "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r67", "r68", "r498" ], "calculation": { "http://www.vareximaging.com/role/FairValueDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesFairValueDisclosure", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivative liabilities" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesNarrativeDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativeInstrumentsDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfIncomeRecognizedFromDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r459", "r461" ], "lang": { "en-US": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Notional Value" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativeInstrumentsDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfForeignCurrencyContractsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeNumberOfInstrumentsHeld": { "auth_ref": [ "r459", "r461" ], "lang": { "en-US": { "role": { "documentation": "The number of derivative instruments of a particular group held by the entity.", "label": "Derivative, Number of Instruments Held", "terseLabel": "Number of Instruments" } } }, "localname": "DerivativeNumberOfInstrumentsHeld", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativeInstrumentsDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r144", "r458", "r460", "r461", "r463", "r464", "r470", "r473", "r481", "r483", "r486" ], "lang": { "en-US": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesNarrativeDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativeInstrumentsDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfIncomeRecognizedFromDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]", "terseLabel": "Derivatives, Fair Value [Line Items]" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfForeignCurrencyContractsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r132", "r145", "r458", "r460", "r463", "r464", "r482" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Derivative instruments and hedging activities" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r463" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Designated as Hedging Instrument" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativeInstrumentsDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfForeignCurrencyContractsDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfIncomeRecognizedFromDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r419" ], "lang": { "en-US": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "terseLabel": "Developed technology" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsIntangiblesAcquiredDetails", "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member": { "auth_ref": [ "r308" ], "lang": { "en-US": { "role": { "documentation": "Effect in current period from application of guidance for revenue from contract with customer compared with guidance for revenue recognition applicable prior to change when using transition method for cumulative effect in period including initial date of application.", "label": "Difference between Revenue Guidance in Effect before and after Topic 606 [Member]", "terseLabel": "Difference between Revenue Guidance in Effect before and after Topic 606", "verboseLabel": "Adjustment Due to ASC 606" } } }, "localname": "DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfBalanceSheetAdjustmentForAsc606AdoptionDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesAccountingStandardsRecentlyAdoptedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r364" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "terseLabel": "EMPLOYEE STOCK PLANS" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlans" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r49", "r143", "r513" ], "calculation": { "http://www.vareximaging.com/role/OtherFinancialInformationDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties, Current", "terseLabel": "Payable to Varian Medical Systems" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EMEAMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Regions of Europe, Middle East and Africa.", "label": "EMEA [Member]", "terseLabel": "EMEA" } } }, "localname": "EMEAMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SegmentInformationGeographicDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Net earnings per common share attributable to Varex" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r94", "r149", "r157", "r159", "r160", "r161", "r164", "r556", "r574" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic (in USD per share)", "verboseLabel": "Net earnings per share attributable to Varex - basic (in USD per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings", "http://www.vareximaging.com/role/NetEarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r94", "r149", "r157", "r159", "r160", "r161", "r164", "r556", "r574" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted (in USD per share)", "verboseLabel": "Net earnings per share attributable to Varex - diluted (in USD per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings", "http://www.vareximaging.com/role/NetEarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r165" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "NET EARNINGS PER SHARE" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/NetEarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r505" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effects of exchange rate changes on cash and cash equivalents and restricted cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r140", "r374", "r375" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-US": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "totalLabel": "Effective tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r374", "r375", "r397" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails": { "order": 1.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Federal statutory income tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails", "http://www.vareximaging.com/role/TaxesOnEarningsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r374", "r375", "r397" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails": { "order": 9.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "terseLabel": "Change in valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r374", "r375", "r397" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails": { "order": 3.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.", "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent", "terseLabel": "Revaluation of deferred tax liabilities for US statutory change" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities": { "auth_ref": [ "r374", "r375", "r397" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails": { "order": 5.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for qualified production activity.", "label": "Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent", "negatedTerseLabel": "Domestic production activities deduction" } } }, "localname": "EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r374", "r375", "r397" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails": { "order": 8.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent", "terseLabel": "Foreign Rate Difference" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "auth_ref": [ "r374", "r375", "r397" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails": { "order": 7.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent", "terseLabel": "Prior year deferred tax adjustments" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": { "auth_ref": [], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails": { "order": 10.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.", "label": "Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent", "terseLabel": "Other" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings": { "auth_ref": [ "r374", "r375", "r397" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails": { "order": 4.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings.", "label": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent", "terseLabel": "Mandatory repatriation tax on foreign earnings" } } }, "localname": "EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r374", "r375", "r397" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails": { "order": 2.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "terseLabel": "State and local taxes, net of federal tax benefit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": { "auth_ref": [ "r374", "r375", "r397" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails": { "order": 6.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent", "negatedTerseLabel": "Research and development credit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsPercent": { "auth_ref": [ "r374" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails": { "order": 11.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations, attributable to increase (decrease) from transition tax on accumulated earnings of controlled foreign corporation deemed repatriated pursuant to Tax Cuts and Jobs Act.", "label": "Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Transition Tax on Accumulated Foreign Earnings, Percent", "terseLabel": "US Tax Reform - International Provisions" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxCutsAndJobsActOf2017TransitionTaxOnAccumulatedForeignEarningsPercent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxRateReconciliationDetails" ], "xbrltype": "pureItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansShareBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r356" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Compensation cost not yet recognized" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r356" ], "lang": { "en-US": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Compensation cost period for recognition (in years)" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "Employee Stock" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails", "http://www.vareximaging.com/role/EmployeeStockPlansValuationAssumptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r353" ], "lang": { "en-US": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Employee Stock Option" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails", "http://www.vareximaging.com/role/EmployeeStockPlansValuationAssumptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r290" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity", "http://www.vareximaging.com/role/OtherComprehensiveIncomeDetails", "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsSummaryOfChangesInRedeemableNoncontrollingInterestsNoncontrollingInteretsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvesteeMember": { "auth_ref": [ "r209", "r530", "r532", "r534", "r536", "r538", "r540" ], "lang": { "en-US": { "role": { "documentation": "An entity that issued voting stock held by an investor and that is accounted for under the equity method of accounting by the investor.", "label": "Equity Method Investee [Member]", "terseLabel": "Equity Method Investee" } } }, "localname": "EquityMethodInvesteeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r211" ], "lang": { "en-US": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity method investment, ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r43", "r192", "r210" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Equity method investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]", "terseLabel": "Error Corrections and Prior Period Adjustments Restatement [Line Items]" } } }, "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesReclassificationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities": { "auth_ref": [ "r363" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.", "label": "Excess Tax Benefit from Share-based Compensation, Financing Activities", "terseLabel": "Excess tax benefits from share-based compensation" } } }, "localname": "ExcessTaxBenefitFromShareBasedCompensationFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r490", "r491", "r492", "r496" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r316", "r317", "r320", "r491", "r523" ], "lang": { "en-US": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r490", "r491", "r493", "r494", "r497" ], "lang": { "en-US": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r495" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "FAIR VALUE" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FairValue" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r316", "r317", "r320", "r491", "r524" ], "lang": { "en-US": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1)" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r316", "r317", "r320", "r491", "r525" ], "lang": { "en-US": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Significant Other Observable Inputs (Level 2)" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r316", "r317", "r320", "r491", "r526" ], "lang": { "en-US": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Significant Unobservable Inputs (Level 3)" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r495", "r497" ], "lang": { "en-US": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Measurements, Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r465", "r470", "r484" ], "lang": { "en-US": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfForeignCurrencyContractsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FederalFundsEffectiveSwapRateMember": { "auth_ref": [ "r485" ], "lang": { "en-US": { "role": { "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.", "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]", "terseLabel": "Federal Funds Effective Swap Rate" } } }, "localname": "FederalFundsEffectiveSwapRateMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.", "label": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]", "terseLabel": "Schedule of Intangible Assets Acquired" } } }, "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Finite-lived intangible asset, useful life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r238" ], "calculation": { "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedTerseLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsAmortizationScheduleDetails": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsAmortizationScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r240" ], "calculation": { "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsAmortizationScheduleDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months", "terseLabel": "2020" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsAmortizationScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r240" ], "calculation": { "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsAmortizationScheduleDetails": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Five", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsAmortizationScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r240" ], "calculation": { "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsAmortizationScheduleDetails": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsAmortizationScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r240" ], "calculation": { "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsAmortizationScheduleDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three", "terseLabel": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsAmortizationScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r240" ], "calculation": { "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsAmortizationScheduleDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two", "terseLabel": "2021" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsAmortizationScheduleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r231", "r234", "r238", "r242", "r528" ], "lang": { "en-US": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsIntangiblesAcquiredDetails", "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]", "terseLabel": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsAmortizationScheduleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r238", "r528" ], "calculation": { "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Gross Carrying Amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r231", "r237" ], "lang": { "en-US": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsIntangiblesAcquiredDetails", "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r238" ], "calculation": { "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsAmortizationScheduleDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Net Carrying Amount" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsAmortizationScheduleDetails", "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiscalPeriod": { "auth_ref": [ "r432", "r453", "r455" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.", "label": "Fiscal Period, Policy [Policy Text Block]", "terseLabel": "Fiscal Year" } } }, "localname": "FiscalPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]", "terseLabel": "Foreign Tax Authority" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsPerkinelmersMedicalImagingNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r502", "r503", "r504" ], "calculation": { "http://www.vareximaging.com/role/OtherFinancialInformationDetails": { "order": 3.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "terseLabel": "Realized income (loss) on foreign currencies" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r132", "r504", "r506" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r316", "r476" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign Exchange Contract" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfForeignCurrencyContractsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r95" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]", "verboseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansShareBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r220", "r222" ], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 8.0, "parentTag": "vrex_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsandGoodwill", "weight": 1.0 }, "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Balance at September 27, 2019", "periodStartLabel": "Balance at September 28, 2018", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.vareximaging.com/role/ConsolidatedBalanceSheets", "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsSummaryOfGoowillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r223" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Business combination" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsSummaryOfGoowillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r247" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "GOODWILL AND INTANGIBLE ASSETS" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r132", "r226", "r235" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Goodwill and Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r123", "r221", "r224", "r227" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impairment Loss", "terseLabel": "Goodwill, impairment loss" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesImpairmentOfLongLivedAssetsIntangibleAssetsAndGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsSummaryOfGoowillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillPurchaseAccountingAdjustments": { "auth_ref": [ "r225", "r404" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from adjustments after acquisition date under purchase accounting of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Purchase Accounting Adjustments", "verboseLabel": "Post-closing adjustments" } } }, "localname": "GoodwillPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsSummaryOfGoowillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r97" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "terseLabel": "Gross margin", "totalLabel": "Gross margin" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings", "http://www.vareximaging.com/role/SegmentInformationSummaryOfSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r463", "r480" ], "lang": { "en-US": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativeInstrumentsDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfForeignCurrencyContractsDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfIncomeRecognizedFromDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r463" ], "lang": { "en-US": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativeInstrumentsDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfForeignCurrencyContractsDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfIncomeRecognizedFromDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r463" ], "lang": { "en-US": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesNarrativeDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativeInstrumentsDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfIncomeRecognizedFromDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r123", "r243" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.", "label": "Impairment of Intangible Assets (Excluding Goodwill)", "terseLabel": "Impairment of intangible assets", "verboseLabel": "Impairment of intangible assets" } } }, "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows", "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings", "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesImpairmentOfLongLivedAssetsIntangibleAssetsAndGoodwillDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesReclassificationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "auth_ref": [ "r123", "r243" ], "calculation": { "http://www.vareximaging.com/role/RestructuringRestructuringChargesIncurredDetails": { "order": 3.0, "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.", "label": "Impairment of Intangible Assets, Finite-lived", "verboseLabel": "Intangible assets impairment" } } }, "localname": "ImpairmentOfIntangibleAssetsFinitelived", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RestructuringRestructuringChargesIncurredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Impairment of Long-lived Assets, Intangible Assets and Goodwill" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InProcessResearchAndDevelopmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.", "label": "In Process Research and Development [Member]", "terseLabel": "In-process research and development" } } }, "localname": "InProcessResearchAndDevelopmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsIntangiblesAcquiredDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r139" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "terseLabel": "United States" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r91", "r149", "r541", "r554", "r575" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 }, "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Earnings before taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings", "http://www.vareximaging.com/role/SegmentInformationSummaryOfSegmentInformationDetails", "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r139" ], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "terseLabel": "Foreign" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r92", "r123", "r189", "r210", "r553", "r572" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.vareximaging.com/role/OtherFinancialInformationDetails": { "order": 1.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "negatedTerseLabel": "Loss (gain) from equity method investments, net of dividends received", "terseLabel": "Income (loss) from equity method investments" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows", "http://www.vareximaging.com/role/OtherFinancialInformationDetails", "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r253" ], "lang": { "en-US": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansShareBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansShareBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r377" ], "lang": { "en-US": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsPerkinelmersMedicalImagingNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsPerkinelmersMedicalImagingNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r403" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "TAXES ON EARNINGS" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarnings" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": { "auth_ref": [ "r376" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.", "label": "Income Tax Examination, Penalties and Interest Expense", "terseLabel": "Income tax penalties and interest expense" } } }, "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r134", "r190", "r400" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 }, "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Taxes (benefit) on earnings", "totalLabel": "Taxes on earnings" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings", "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfAsc606AdoptionImpactOnIncomeStatementDetails", "http://www.vareximaging.com/role/SegmentInformationSummaryOfSegmentInformationDetails", "http://www.vareximaging.com/role/TaxesOnEarningsSummaryOfTaxesByJurisdictionAndClassificationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r86", "r132", "r370", "r371", "r382", "r383", "r389", "r402", "r583" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Taxes on Earnings" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r119", "r127" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Cash paid for income tax" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows", "http://www.vareximaging.com/role/TaxesOnEarningsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r122" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r122" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedTerseLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r122" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued operating liabilities and other long-term operating liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r122" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "terseLabel": "Deferred revenues" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r122" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedTerseLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in assets and liabilities, net of effects of acquisitions:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r122" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedTerseLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r158", "r163" ], "calculation": { "http://www.vareximaging.com/role/NetEarningsPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "terseLabel": "Dilutive effect of potential common shares (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/NetEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r233", "r241" ], "lang": { "en-US": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsIntangiblesAcquiredDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r241" ], "calculation": { "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)", "terseLabel": "In-process R&D with indefinite lives" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r233", "r241" ], "lang": { "en-US": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsIntangiblesAcquiredDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis": { "auth_ref": [ "r308" ], "lang": { "en-US": { "role": { "documentation": "Information about effect of transition method for cumulative effect in initial period of application.", "label": "Initial Application Period Cumulative Effect Transition [Axis]", "terseLabel": "Initial Application Period Cumulative Effect Transition [Axis]" } } }, "localname": "InitialApplicationPeriodCumulativeEffectTransitionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfAsc606AdoptionImpactOnIncomeStatementDetails", "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfBalanceSheetAdjustmentForAsc606AdoptionDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesAccountingStandardsRecentlyAdoptedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Effect of transition method for cumulative effect in initial period of application.", "label": "Initial Application Period Cumulative Effect Transition [Domain]", "terseLabel": "Initial Application Period Cumulative Effect Transition [Domain]" } } }, "localname": "InitialApplicationPeriodCumulativeEffectTransitionDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfAsc606AdoptionImpactOnIncomeStatementDetails", "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfBalanceSheetAdjustmentForAsc606AdoptionDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesAccountingStandardsRecentlyAdoptedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [], "calculation": { "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "totalLabel": "Total intangible assets, gross" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r229", "r236" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangibles assets, net", "totalLabel": "Total intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets", "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntellectualPropertyMember": { "auth_ref": [ "r420" ], "lang": { "en-US": { "role": { "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.", "label": "Intellectual Property [Member]", "terseLabel": "Patents, licenses and other" } } }, "localname": "IntellectualPropertyMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r89", "r188", "r507", "r509", "r557" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedTerseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r115", "r118", "r127" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r475" ], "lang": { "en-US": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "terseLabel": "Interest Rate Swap Contracts" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesNarrativeDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativeInstrumentsDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails", "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfIncomeRecognizedFromDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r33", "r219" ], "calculation": { "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesInventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r3", "r63", "r215" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories", "totalLabel": "Total inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r11", "r64", "r132", "r168", "r216", "r218" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": { "auth_ref": [ "r35", "r36", "r219" ], "calculation": { "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.", "label": "Inventory, Raw Materials and Supplies, Net of Reserves", "terseLabel": "Raw materials and parts" } } }, "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r34", "r219" ], "calculation": { "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesInventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work-in-process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r217" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.vareximaging.com/role/RestructuringRestructuringChargesIncurredDetails": { "order": 2.0, "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory Write-down", "terseLabel": "Inventory write-down" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows", "http://www.vareximaging.com/role/RestructuringRestructuringChargesIncurredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r101", "r187" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r212" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Investments" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": { "auth_ref": [ "r43" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.", "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures", "terseLabel": "Investments in privately-held companies" } } }, "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandImprovementsMember": { "auth_ref": [ "r7" ], "lang": { "en-US": { "role": { "documentation": "Additions or improvements to real estate held.", "label": "Land Improvements [Member]", "terseLabel": "Land Improvements" } } }, "localname": "LandImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r305" ], "lang": { "en-US": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]", "terseLabel": "Land" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseAgreementsMember": { "auth_ref": [ "r418" ], "lang": { "en-US": { "role": { "documentation": "Contractual agreement that stipulates the lessee pay the lessor for use of an asset.", "label": "Lease Agreements [Member]", "terseLabel": "Favorable leasehold interests" } } }, "localname": "LeaseAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsIntangiblesAcquiredDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseAndRentalExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "Operating Leases, Rent Expense", "terseLabel": "Operating leases, rent expense" } } }, "localname": "LeaseAndRentalExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r52" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r30", "r550", "r568" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities, redeemable noncontrolling interests and stockholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities, redeemable noncontrolling interests and stockholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets", "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfBalanceSheetAdjustmentForAsc606AdoptionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r54" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r490" ], "calculation": { "http://www.vareximaging.com/role/FairValueDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure", "totalLabel": "Total liabilities measured at fair value" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities, Fair Value Disclosure [Abstract]", "terseLabel": "Liabilities:" } } }, "localname": "LiabilitiesFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage", "terseLabel": "Used capacity, commitment fee percentage" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": { "auth_ref": [ "r138" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) of the credit facility.", "label": "Line of Credit Facility, Increase (Decrease), Net", "negatedTerseLabel": "Permanent reduction in the revolving credit commitment" } } }, "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails", "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]", "terseLabel": "Line of Credit Facility [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r50" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum borrowing capacity", "verboseLabel": "Revolving credit commitment" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails", "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r50", "r137" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]", "terseLabel": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.", "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage", "terseLabel": "Unused capacity, commitment fee percentage" } } }, "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "London Interbank Offered Rate (LIBOR)" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicates an ownership position in, or purchase of, a security.", "label": "Long [Member]", "terseLabel": "Buy contracts" } } }, "localname": "LongMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfForeignCurrencyContractsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r18", "r280", "r548", "r564" ], "calculation": { "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "totalLabel": "Long-term Debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r51" ], "calculation": { "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 }, "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Current Maturities", "negatedLabel": "Less: current maturities of long-term debt", "terseLabel": "Current maturities of long-term debt" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails", "http://www.vareximaging.com/role/BorrowingsScheduleOfDebtMaturitiesDetails", "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails", "http://www.vareximaging.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Long-term Debt, Current Maturities [Abstract]", "terseLabel": "Current maturities of long-term debt" } } }, "localname": "LongTermDebtCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long-term Debt, Fair Value", "terseLabel": "Long-term debt, fair value" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r146", "r275" ], "calculation": { "http://www.vareximaging.com/role/BorrowingsScheduleOfDebtMaturitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months", "terseLabel": "2020" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsScheduleOfDebtMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r146", "r275" ], "calculation": { "http://www.vareximaging.com/role/BorrowingsScheduleOfDebtMaturitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long-term Debt, Maturities, Repayments of Principal in Year Three", "terseLabel": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsScheduleOfDebtMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r146", "r275" ], "calculation": { "http://www.vareximaging.com/role/BorrowingsScheduleOfDebtMaturitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Long-term Debt, Maturities, Repayments of Principal in Year Two", "terseLabel": "2021" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsScheduleOfDebtMaturitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r57" ], "calculation": { "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 }, "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt, net", "totalLabel": "Long-term debt outstanding" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails", "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails", "http://www.vareximaging.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Long-term Debt, Excluding Current Maturities [Abstract]", "terseLabel": "Non-current maturities of long-term debt:" } } }, "localname": "LongTermDebtNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtWeightedAverageInterestRateOverTime": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average interest rate of long-term debt outstanding calculated over time.", "label": "Long-term Debt, Weighted Average Interest Rate, over Time", "terseLabel": "Weighted-average interest rate, long-term debt" } } }, "localname": "LongTermDebtWeightedAverageInterestRateOverTime", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r57" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r57", "r276" ], "lang": { "en-US": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MajorityShareholderMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Owner that controls more than 50 percent of the voting interest in the entity through direct or indirect ownership.", "label": "Majority Shareholder [Member]", "terseLabel": "Varian" } } }, "localname": "MajorityShareholderMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansShareBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r62", "r549", "r567" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "periodEndLabel": "Balance at end of period", "terseLabel": "Noncontrolling interests" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets", "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsSummaryOfChangesInRedeemableNoncontrollingInterestsNoncontrollingInteretsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDisclosureTextBlock": { "auth_ref": [ "r457" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.", "label": "Noncontrolling Interest Disclosure [Text Block]", "verboseLabel": "REDEEMABLE NONCONTROLLING INTERESTS & NONCONTROLLING INTERESTS" } } }, "localname": "MinorityInterestDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterests" ], "xbrltype": "textBlockItemType" }, "us-gaap_MinorityInterestLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Noncontrolling Interest [Line Items]", "terseLabel": "Noncontrolling Interest [Line Items]" } } }, "localname": "MinorityInterestLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsNarrativeDetails", "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsSummaryOfChangesInRedeemableNoncontrollingInterestsNoncontrollingInteretsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.", "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners", "terseLabel": "Noncontrolling interest, ownership percentage by noncontrolling owners" } } }, "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Noncontrolling Interest, Ownership Percentage by Parent", "terseLabel": "Noncontrolling interest, ownership percentage by parent" } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_MinorityInterestTable": { "auth_ref": [ "r62", "r98", "r434", "r446" ], "lang": { "en-US": { "role": { "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.", "label": "Noncontrolling Interest [Table]", "terseLabel": "Noncontrolling Interest [Table]" } } }, "localname": "MinorityInterestTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsNarrativeDetails", "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsSummaryOfChangesInRedeemableNoncontrollingInterestsNoncontrollingInteretsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MovementInMinorityInterestRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]", "terseLabel": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]" } } }, "localname": "MovementInMinorityInterestRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsSummaryOfChangesInRedeemableNoncontrollingInterestsNoncontrollingInteretsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Movement in Standard Product Warranty Accrual [Roll Forward]", "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]" } } }, "localname": "MovementInStandardProductWarrantyAccrualRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesProductWarrantyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r117" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash (used in) provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r117" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r117", "r120", "r124" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r80", "r83", "r93", "r124", "r163", "r555", "r573" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net earnings attributable to Varex", "totalLabel": "Net earnings attributable to Varex" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings", "http://www.vareximaging.com/role/NetEarningsPerShareDetails", "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfAsc606AdoptionImpactOnIncomeStatementDetails", "http://www.vareximaging.com/role/SegmentInformationSummaryOfSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r80", "r83", "r441", "r451" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Less: Net earnings attributable to noncontrolling interests" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings", "http://www.vareximaging.com/role/SegmentInformationSummaryOfSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest": { "auth_ref": [ "r98" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Portion of net income (loss) attributable to nonredeemable noncontrolling interest.", "label": "Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest", "verboseLabel": "Net earnings attributable to noncontrolling interests" } } }, "localname": "NetIncomeLossAttributableToNonredeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsSummaryOfChangesInRedeemableNoncontrollingInterestsNoncontrollingInteretsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": { "auth_ref": [ "r287", "r441", "r442" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.", "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest", "terseLabel": "Net earnings" } } }, "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Accounting Standards Recently Adopted, Recent Accounting Standards Updates Not Yet Effective" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "terseLabel": "Supplemental non-cash activities:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionDebtAssumed1": { "auth_ref": [ "r128", "r129", "r130" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of debt that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Noncash or Part Noncash Acquisition, Debt Assumed", "terseLabel": "Debt assumed" } } }, "localname": "NoncashOrPartNoncashAcquisitionDebtAssumed1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsDirectConversionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Noncontrolling Interest [Abstract]" } } }, "localname": "NoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": { "auth_ref": [ "r295", "r438", "r443" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.", "label": "Noncontrolling Interest, Increase from Sale of Parent Equity Interest", "terseLabel": "Noncontrolling interest acquired/consolidated", "verboseLabel": "Contributions from noncontrolling interests" } } }, "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity", "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsSummaryOfChangesInRedeemableNoncontrollingInterestsNoncontrollingInteretsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r433" ], "lang": { "en-US": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interests" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity", "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsSummaryOfChangesInRedeemableNoncontrollingInterestsNoncontrollingInteretsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r102" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "terseLabel": "Interest and other expenses, net", "totalLabel": "Interest and other expenses, net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings", "http://www.vareximaging.com/role/SegmentInformationSummaryOfSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SegmentInformationNarrativeDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesSegmentReportingDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "terseLabel": "Total operating expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings", "http://www.vareximaging.com/role/SegmentInformationSummaryOfSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating earnings" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r511", "r512" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments Due, Next Twelve Months", "terseLabel": "Future minimum payments due, next twelve months" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": { "auth_ref": [ "r511", "r512" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Five Years", "terseLabel": "Future minimum payments, due in five years" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": { "auth_ref": [ "r511", "r512" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Four Years", "terseLabel": "Future minimum payments, due in four years" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": { "auth_ref": [ "r511", "r512" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Three Years", "terseLabel": "Future minimum payments, due in three years" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": { "auth_ref": [ "r511", "r512" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due in Two Years", "terseLabel": "Future minimum payments, due in two years" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": { "auth_ref": [ "r511", "r512" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases, Future Minimum Payments, Due Thereafter", "terseLabel": "Future minimum payments, due thereafter" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/CommitmentsAndContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r186", "r198" ], "lang": { "en-US": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SegmentInformationAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrderOrProductionBacklogMember": { "auth_ref": [ "r416" ], "lang": { "en-US": { "role": { "documentation": "Orders, production or production backlog arising from contracts such as purchase or sales orders acquired in a business combination.", "label": "Order or Production Backlog [Member]", "terseLabel": "Backlog" } } }, "localname": "OrderOrProductionBacklogMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsIntangiblesAcquiredDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r147", "r154", "r183", "r457" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r8", "r9", "r10", "r53" ], "calculation": { "http://www.vareximaging.com/role/OtherFinancialInformationDetails": { "order": 7.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetImpairmentCharges": { "auth_ref": [ "r123", "r252" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.vareximaging.com/role/RestructuringRestructuringChargesIncurredDetails": { "order": 1.0, "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value.", "label": "Other Asset Impairment Charges", "terseLabel": "Other assets impairment charges" } } }, "localname": "OtherAssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows", "http://www.vareximaging.com/role/RestructuringRestructuringChargesIncurredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r48" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets", "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfBalanceSheetAdjustmentForAsc606AdoptionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "auth_ref": [ "r78" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax", "terseLabel": "Other comprehensive loss before reclassifications" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax": { "auth_ref": [ "r71" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfComprehensiveEarnings": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax", "terseLabel": "Unrealized (loss) gain on interest rate swap contracts", "verboseLabel": "Unrealized gain on interest rate swap contracts, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfComprehensiveEarnings", "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r81", "r84", "r87", "r290" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfComprehensiveEarnings": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Other comprehensive (loss) earnings, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfComprehensiveEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive (loss) earnings, net of tax:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfComprehensiveEarnings" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r73", "r75" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfComprehensiveEarnings": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedLabel": "Unrealized gain (loss) on defined benefit obligations", "negatedTerseLabel": "Unrealized (loss) gain on defined benefit obligations" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfComprehensiveEarnings", "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTax": { "auth_ref": [ "r76", "r399", "r401" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Tax", "negatedTerseLabel": "Income tax benefit" } } }, "localname": "OtherComprehensiveIncomeLossTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": { "auth_ref": [ "r71", "r75", "r487" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax", "terseLabel": "Amount of Gain or (Loss) Recognized in OCI on Derivative Fiscal Year Ended" } } }, "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfIncomeRecognizedFromDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentAssetsMember": { "auth_ref": [ "r465", "r484" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other current assets.", "label": "Other Current Assets [Member]", "terseLabel": "Other current assets" } } }, "localname": "OtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other current liabilities.", "label": "Other Current Liabilities [Member]", "terseLabel": "Other current liabilities" } } }, "localname": "OtherCurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r58" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.vareximaging.com/role/OtherFinancialInformationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities", "totalLabel": "Total other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets", "http://www.vareximaging.com/role/OtherFinancialInformationDetails", "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfBalanceSheetAdjustmentForAsc606AdoptionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r124" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedTerseLabel": "Other, net" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentAssetsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent assets.", "label": "Other Noncurrent Assets [Member]", "terseLabel": "Other non-current assets" } } }, "localname": "OtherNoncurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]", "terseLabel": "Other non-current liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfDerivativesAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Table Text Block]", "terseLabel": "Other Noncurrent Liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherFinancialInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r103" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 }, "http://www.vareximaging.com/role/OtherFinancialInformationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other (expense) income, net", "totalLabel": "Total other income (expense), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings", "http://www.vareximaging.com/role/OtherFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherRestructuringCosts": { "auth_ref": [ "r123", "r257", "r261", "r263" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.", "label": "Other Restructuring Costs", "terseLabel": "Other unrelated restructuring costs" } } }, "localname": "OtherRestructuringCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RestructuringNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSundryLiabilitiesNoncurrent": { "auth_ref": [ "r19", "r547", "r563" ], "calculation": { "http://www.vareximaging.com/role/OtherFinancialInformationDetails": { "order": 5.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.", "label": "Other Sundry Liabilities, Noncurrent", "terseLabel": "Long-term other" } } }, "localname": "OtherSundryLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ParentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.", "label": "Parent [Member]", "terseLabel": "Total Varex Equity" } } }, "localname": "ParentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentOfFinancingAndStockIssuanceCosts": { "auth_ref": [ "r114" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities.", "label": "Payment of Financing and Stock Issuance Costs", "terseLabel": "Payment of financing and stock issuance costs" } } }, "localname": "PaymentOfFinancingAndStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForHedgeFinancingActivities": { "auth_ref": [ "r114", "r121" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.", "label": "Payments for Hedge, Financing Activities", "terseLabel": "Payments for hedge, financing activities" } } }, "localname": "PaymentsForHedgeFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r113" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedTerseLabel": "Payment of debt issuance costs", "terseLabel": "Payments of debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows", "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDistributionsToAffiliates": { "auth_ref": [ "r111" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.", "label": "Payments of Distributions to Affiliates", "negatedTerseLabel": "Distributions to Varian Medical Systems, Inc." } } }, "localname": "PaymentsOfDistributionsToAffiliates", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsMinorityInterest": { "auth_ref": [ "r111" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.", "label": "Payments of Ordinary Dividends, Noncontrolling Interest", "negatedTerseLabel": "Dividends paid to redeemable noncontrolling interest" } } }, "localname": "PaymentsOfDividendsMinorityInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows", "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsSummaryOfChangesInRedeemableNoncontrollingInterestsNoncontrollingInteretsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r114" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "terseLabel": "Payments of stock issuance costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r111" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-based Payment Arrangement", "negatedTerseLabel": "Taxes related to net share settlement of equity awards" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r106", "r427" ], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Net cash paid" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsDirectConversionNarrativeDetails", "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.vareximaging.com/role/BusinessCombinationsPerkinelmersMedicalImagingNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r106" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedTerseLabel": "Acquisitions of businesses, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "auth_ref": [ "r106" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "Payments to Acquire Equity Method Investments", "negatedLabel": "Investments in privately-held companies", "terseLabel": "Contributions to equity method investments" } } }, "localname": "PaymentsToAcquireEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows", "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r107" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedTerseLabel": "Purchases of property, plant and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": { "auth_ref": [ "r19", "r313", "r314", "r315" ], "calculation": { "http://www.vareximaging.com/role/OtherFinancialInformationDetails": { "order": 3.0, "parentTag": "us-gaap_OtherLiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.", "label": "Liability, Defined Benefit Plan, Noncurrent", "terseLabel": "Defined benefit obligation liability" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r326", "r357" ], "lang": { "en-US": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PositionAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by position taken for a security.", "label": "Position [Axis]", "terseLabel": "Position [Axis]" } } }, "localname": "PositionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfForeignCurrencyContractsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PositionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicates position taken for a security.", "label": "Position [Domain]", "terseLabel": "Position [Domain]" } } }, "localname": "PositionDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfForeignCurrencyContractsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r23" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value per share (usd per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r23" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r23" ], "lang": { "en-US": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r23" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $.01 par value: 20,000,000 shares authorized, none issued" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r5", "r40", "r41" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets", "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfBalanceSheetAdjustmentForAsc606AdoptionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.", "label": "Reclassification, Policy [Policy Text Block]", "terseLabel": "Reclassification" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromContributionsFromParent": { "auth_ref": [ "r110" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from parent as a source of financing that is recorded as additional paid in capital.", "label": "Proceeds from Contributions from Parent", "terseLabel": "Net transfers from parent" } } }, "localname": "ProceedsFromContributionsFromParent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r109" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from Convertible Debt", "terseLabel": "Proceeds from convertible debt" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLinesOfCredit": { "auth_ref": [ "r109", "r138" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Proceeds from Lines of Credit", "terseLabel": "Proceeds from lines of credit" } } }, "localname": "ProceedsFromLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLongTermLinesOfCredit": { "auth_ref": [ "r109" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.", "label": "Proceeds from Long-term Lines of Credit", "terseLabel": "Borrowings under credit agreements" } } }, "localname": "ProceedsFromLongTermLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromMinorityShareholders": { "auth_ref": [ "r110" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.", "label": "Proceeds from Noncontrolling Interests", "terseLabel": "Contributions from noncontrolling partner" } } }, "localname": "ProceedsFromMinorityShareholders", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r108", "r358" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockPlans": { "auth_ref": [ "r108" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow associated with the amount received from the stock plan during the period.", "label": "Proceeds from Stock Plans", "terseLabel": "Proceeds from shares issued under employee stock purchase plan" } } }, "localname": "ProceedsFromStockPlans", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyLiabilityLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Warranty Liability [Line Items]", "terseLabel": "Product Warranty Liability [Line Items]" } } }, "localname": "ProductWarrantyLiabilityLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesProductWarrantyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductWarrantyLiabilityTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about product warranty liability, including, but not limited to, reductions in the liability for payments made under the warranty, changes in the liability for accruals related to product warranties issued, and changes in the liability for accruals related to preexisting warranties.", "label": "Product Warranty Liability [Table]", "terseLabel": "Product Warranty Liability [Table]" } } }, "localname": "ProductWarrantyLiabilityTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesProductWarrantyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r80", "r83", "r116", "r191", "r199", "r435", "r440", "r442", "r451", "r452" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.vareximaging.com/role/ConsolidatedStatementsOfComprehensiveEarnings": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net earnings", "totalLabel": "Net earnings" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows", "http://www.vareximaging.com/role/ConsolidatedStatementsOfComprehensiveEarnings", "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings", "http://www.vareximaging.com/role/SegmentInformationSummaryOfSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r46", "r251" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property, Plant and Equipment, Type [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r45", "r249" ], "calculation": { "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Property, plant and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r14", "r15", "r251", "r569" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, plant and equipment, net", "totalLabel": "Property, plant, and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets", "http://www.vareximaging.com/role/SegmentInformationGeographicDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r44", "r132", "r251" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property, Plant and Equipment, net" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r14", "r251" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Property, Plant and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r14", "r249" ], "lang": { "en-US": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property, Plant and Equipment, Type [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Property, plant and equipment, useful lives" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": { "auth_ref": [ "r32", "r132", "r207" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.", "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]", "terseLabel": "Allowance for Doubtful Accounts" } } }, "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r78", "r79", "r87" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "terseLabel": "Amount reclassified out of accumulated other comprehensive income" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]", "terseLabel": "Changes In Accumulated Other Comprehensive Income (Loss) [Roll Forward]" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": { "auth_ref": [ "r194", "r196" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.", "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]", "terseLabel": "Reconciliation of Assets from Segment to Consolidated" } } }, "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]" } } }, "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxContingencyDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": { "auth_ref": [ "r285", "r286", "r288", "r289" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.", "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount", "terseLabel": "Redeemable noncontrolling interests" } } }, "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RedeemableNoncontrollingInterestTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.", "label": "Redeemable Noncontrolling Interest [Table Text Block]", "terseLabel": "Changes in Redeemable Noncontrolling Interest" } } }, "localname": "RedeemableNoncontrollingInterestTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r519" ], "lang": { "en-US": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansShareBasedCompensationExpenseDetails", "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r319", "r514", "r515" ], "lang": { "en-US": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]", "terseLabel": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Purchases from Related Party", "terseLabel": "Purchases from related party" } } }, "localname": "RelatedPartyTransactionPurchasesFromRelatedParty", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r319", "r514", "r515", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540" ], "lang": { "en-US": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansShareBasedCompensationExpenseDetails", "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r519" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "RELATED-PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLongTermLinesOfCredit": { "auth_ref": [ "r112" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.", "label": "Repayments of Long-term Lines of Credit", "negatedTerseLabel": "Repayments of borrowing under credit agreements" } } }, "localname": "RepaymentsOfLongTermLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r365", "r585" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansShareBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r132", "r365" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Expense, Policy [Policy Text Block]", "terseLabel": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": { "auth_ref": [ "r47", "r132", "r245", "r246", "r585" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.", "label": "Research, Development, and Computer Software, Policy [Policy Text Block]", "terseLabel": "Software Development Costs" } } }, "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r131", "r542", "r565" ], "calculation": { "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesRestrictedCashDetails": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Restructuring and Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r265" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring and Related Activities Disclosure [Text Block]", "terseLabel": "RESTRUCTURING" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/Restructuring" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringAndRelatedCostExpectedCostRemaining1": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expected cost remaining for the specified restructuring cost.", "label": "Restructuring and Related Cost, Expected Cost Remaining", "terseLabel": "Expected additional costs to be incurred" } } }, "localname": "RestructuringAndRelatedCostExpectedCostRemaining1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RestructuringNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r123", "r257", "r261", "r263" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Charges", "terseLabel": "Restructuring charges" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RestructuringNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RestructuringNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostsAndAssetImpairmentCharges": { "auth_ref": [ "r123" ], "calculation": { "http://www.vareximaging.com/role/RestructuringRestructuringChargesIncurredDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.", "label": "Restructuring Costs and Asset Impairment Charges", "terseLabel": "Restructuring and impairment charges", "totalLabel": "Total restructuring charges" } } }, "localname": "RestructuringCostsAndAssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RestructuringNarrativeDetails", "http://www.vareximaging.com/role/RestructuringRestructuringChargesIncurredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]", "terseLabel": "Restructuring Plan [Axis]" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RestructuringNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]", "terseLabel": "Restructuring Plan [Domain]" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RestructuringNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringReserveAcceleratedDepreciation": { "auth_ref": [], "calculation": { "http://www.vareximaging.com/role/RestructuringRestructuringChargesIncurredDetails": { "order": 4.0, "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of accelerated depreciation charged against earnings associated with exit from or disposal of business activities or restructuring plan.", "label": "Restructuring and Related Cost, Accelerated Depreciation", "terseLabel": "Accelerated depreciation" } } }, "localname": "RestructuringReserveAcceleratedDepreciation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RestructuringRestructuringChargesIncurredDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r27", "r294", "r566" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings", "verboseLabel": "(Decrease) increase to retained earnings for adoption of new accounting guidance" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets", "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfBalanceSheetAdjustmentForAsc606AdoptionDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesAccountingStandardsRecentlyAdoptedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r133", "r310" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue from Contract with Customer" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r310" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "REVENUE RECOGNITION" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognition" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "auth_ref": [ "r200" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.", "label": "Revenue from External Customers by Geographic Areas [Table Text Block]", "terseLabel": "Revenue from External Customers by Geographic Areas" } } }, "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]", "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Line Items]" } } }, "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfAsc606AdoptionImpactOnIncomeStatementDetails", "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfBalanceSheetAdjustmentForAsc606AdoptionDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesAccountingStandardsRecentlyAdoptedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information when using transition method for cumulative effect in initial period of application for revenue from contract with customer.", "label": "Revenue, Initial Application Period Cumulative Effect Transition [Table]", "terseLabel": "Revenue, Initial Application Period Cumulative Effect Transition [Table]" } } }, "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfAsc606AdoptionImpactOnIncomeStatementDetails", "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfBalanceSheetAdjustmentForAsc606AdoptionDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesAccountingStandardsRecentlyAdoptedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r299" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Revenue, remaining performance obligation, amount" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r300" ], "lang": { "en-US": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction, period" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r300" ], "lang": { "en-US": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r90", "r185", "r186", "r197" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Revenues, net" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings", "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfAsc606AdoptionImpactOnIncomeStatementDetails", "http://www.vareximaging.com/role/SegmentInformationGeographicDetails", "http://www.vareximaging.com/role/SegmentInformationSummaryOfSegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenues from External Customers and Long-Lived Assets [Line Items]", "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]" } } }, "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SegmentInformationGeographicDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails", "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails", "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r177" ], "lang": { "en-US": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Sales Revenue, Net" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of Accrued Liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherFinancialInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r78" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Changes in Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherComprehensiveIncomeTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r409", "r410" ], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsDirectConversionNarrativeDetails", "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.vareximaging.com/role/BusinessCombinationsPerkinelmersMedicalImagingNarrativeDetails", "http://www.vareximaging.com/role/BusinessCombinationsProFormaDetails", "http://www.vareximaging.com/role/BusinessCombinationsVirtualMediaNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r395" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Schedule of Short-Term and Long-Term Debt" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r388" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Schedule of Deferred Tax Assets and Liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": { "auth_ref": [ "r144", "r458", "r460", "r461", "r463", "r464", "r470", "r473", "r481", "r483" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Schedule of Derivative Instruments [Table Text Block]", "terseLabel": "Schedule of Derivative Instruments" } } }, "localname": "ScheduleOfDerivativeInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r163" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/NetEarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r374" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r325", "r354", "r360" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansShareBasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r325", "r354", "r360" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": { "auth_ref": [ "r151", "r152", "r153" ], "lang": { "en-US": { "role": { "documentation": "Schedule of prior period adjustments to correct an error in previously issued financial statements. The disclosure may include, but is not limited to: (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustment (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. This table can be used to disclose the amounts as previously reported and the effect of the correction or other adjustment on per line item or per share amount basis. This table uses as its line items financial statement line items that are affected by prior period adjustments.", "label": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]", "terseLabel": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]" } } }, "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesReclassificationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r490", "r491" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FairValueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r231", "r237" ], "lang": { "en-US": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r231", "r237" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r226", "r228" ], "lang": { "en-US": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsSummaryOfGoowillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r226", "r228" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r139" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "terseLabel": "Schedule of Income before Income Tax, Domestic and Foreign" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r241", "r244" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.", "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Indefinite-Lived Intangible Assets" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock": { "auth_ref": [ "r473" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of interest rate derivatives, including, but not limited to, the fair value of the derivatives, statement of financial position location, and statement of financial performance location of these instruments.", "label": "Schedule of Interest Rate Derivatives [Table Text Block]", "terseLabel": "Schedule of Interest Rate Derivative Instruments" } } }, "localname": "ScheduleOfInterestRateDerivativesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r11", "r37", "r38", "r39" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "terseLabel": "Schedule of Inventory, Current" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r275" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.", "label": "Schedule of Maturities of Long-term Debt [Table Text Block]", "terseLabel": "Schedule of Maturities of Long-term Debt" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r148", "r150", "r166", "r167", "r169" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.", "label": "Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]", "terseLabel": "Schedule of ASC 606 Adoption Impacts" } } }, "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.", "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]", "terseLabel": "Schedule of Other Nonoperating Income (Expense)" } } }, "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherFinancialInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r274" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Schedule of Product Warranty Liability" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r46", "r251" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r414" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r135", "r514", "r515", "r516", "r517", "r518" ], "lang": { "en-US": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": { "auth_ref": [ "r13", "r131", "r542", "r565" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.", "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Restrictions on Cash and Cash Equivalents" } } }, "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r259", "r260", "r262" ], "lang": { "en-US": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RestructuringNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "auth_ref": [ "r259", "r260", "r262" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.", "label": "Restructuring and Related Costs [Table Text Block]", "terseLabel": "Schedule of Restructuring Charges" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RestructuringTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "auth_ref": [ "r88", "r90", "r201" ], "lang": { "en-US": { "role": { "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SegmentInformationGeographicDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r184", "r191", "r193", "r195", "r226" ], "lang": { "en-US": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsRevenuesBySegmentDetails", "http://www.vareximaging.com/role/SegmentInformationAssetsDetails", "http://www.vareximaging.com/role/SegmentInformationSummaryOfSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r184", "r191", "r193", "r195", "r226" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Segment Reporting Information, by Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsTables", "http://www.vareximaging.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r326", "r357" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails", "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails", "http://www.vareximaging.com/role/EmployeeStockPlansValuationAssumptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r332", "r343", "r346" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of Share-based Compensation, Stock Options, Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": { "auth_ref": [ "r348" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [ "r381", "r396" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits.", "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]", "terseLabel": "Schedule of Unrecognized Tax Benefits Roll Forward" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r237" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "auth_ref": [ "r175", "r177", "r178", "r179", "r499", "r501" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]", "terseLabel": "Schedules of Concentration of Risk, by Risk Factor" } } }, "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredDebtMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.", "label": "Secured Debt [Member]", "terseLabel": "Secured Debt" } } }, "localname": "SecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails", "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsRevenuesBySegmentDetails", "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsSummaryOfGoowillDetails", "http://www.vareximaging.com/role/SegmentInformationAssetsDetails", "http://www.vareximaging.com/role/SegmentInformationSummaryOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r203" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "SEGMENT INFORMATION" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsRevenuesBySegmentDetails", "http://www.vareximaging.com/role/SegmentInformationAssetsDetails", "http://www.vareximaging.com/role/SegmentInformationSummaryOfSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r132" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting, Policy [Policy Text Block]", "terseLabel": "Segment Reporting" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r100", "r214" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "negatedLabel": "Reclassification of selling, general and administrative", "terseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesReclassificationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [ "r104" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "verboseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansShareBasedCompensationExpenseDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeveranceCosts1": { "auth_ref": [ "r123", "r257", "r261", "r263" ], "calculation": { "http://www.vareximaging.com/role/RestructuringRestructuringChargesIncurredDetails": { "order": 5.0, "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.", "label": "Severance Costs", "terseLabel": "Severance costs" } } }, "localname": "SeveranceCosts1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RestructuringRestructuringChargesIncurredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r122" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Share-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r327" ], "lang": { "en-US": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Award vesting period (in months)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r337" ], "lang": { "en-US": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Restricted Stock Units and Performance Stock Units, forfeited in period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansRestrictedStockAndPerformanceStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r342" ], "lang": { "en-US": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Restricted Stock Units and Performance Stock Units, forfeitures, weighted average grant date fair value (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansRestrictedStockAndPerformanceStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r340" ], "lang": { "en-US": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Restricted Stock Units and Performance Stock Units, grants in period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansRestrictedStockAndPerformanceStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r340" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Restricted Stock Units and Performance Stock Units, grants in period, weighted average grant date fair value (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansRestrictedStockAndPerformanceStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r339" ], "lang": { "en-US": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Restricted Stock Units and Performance Stock Units, nonvested, ending balance (in shares)", "periodStartLabel": "Restricted Stock Units and Performance Stock Units, nonvested, beginning balance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansRestrictedStockAndPerformanceStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansRestrictedStockAndPerformanceStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r339" ], "lang": { "en-US": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Restricted Stock Units and Performance Stock Units, nonvested, end of period, weighted average grant date fair value (in USD per share)", "periodStartLabel": "Restricted Stock Units and Performance Stock Units, nonvested, beginning of period, weighted average grant date fair value (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansRestrictedStockAndPerformanceStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted Average Grant-Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansRestrictedStockAndPerformanceStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r341" ], "lang": { "en-US": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedTerseLabel": "Restricted Stock Units and Performance Stock Units, vested in period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansRestrictedStockAndPerformanceStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r341" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Restricted Stock Units and Performance Stock Units, vested in period, weighted average grant date fair value (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansRestrictedStockAndPerformanceStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r351" ], "lang": { "en-US": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Expected dividend" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansValuationAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r350" ], "lang": { "en-US": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansValuationAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r352" ], "lang": { "en-US": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansValuationAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails", "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails", "http://www.vareximaging.com/role/EmployeeStockPlansValuationAssumptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r329" ], "lang": { "en-US": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized", "terseLabel": "Number of shares authorized (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r357" ], "lang": { "en-US": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant", "terseLabel": "Number of shares available for grant (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r335" ], "lang": { "en-US": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "terseLabel": "Options, exercisable (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r335" ], "lang": { "en-US": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Options, exercisable, weighted average exercise price (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r345" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value", "terseLabel": "Options exercised, intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r338" ], "lang": { "en-US": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period", "negatedTerseLabel": "Options, forfeitures and expirations in period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r338" ], "lang": { "en-US": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Options, forfeitures and expirations in period, weighted average exercise price (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Options, grants in period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r344" ], "lang": { "en-US": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average fair value at grant date (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansValuationAssumptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r357" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Options, outstanding, intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r334", "r357" ], "lang": { "en-US": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Options, outstanding, ending balance (in shares)", "periodStartLabel": "Options, outstanding, beginning balance (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r333" ], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Options, outstanding, weighted average exercise price, ending (in USD per share)", "periodStartLabel": "Options, outstanding, weighted average exercise price, beginning (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r324", "r330" ], "lang": { "en-US": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails", "http://www.vareximaging.com/role/EmployeeStockPlansValuationAssumptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Options, exercises in period, weighted average exercise price (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Options, grants in period, weighted average exercise price (in USD per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r132", "r326", "r331" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-based Payment Arrangement [Policy Text Block]", "terseLabel": "Share-Based Compensation Expense" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price (in usd per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r328" ], "lang": { "en-US": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period", "terseLabel": "Award expiration period (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r349", "r359" ], "lang": { "en-US": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansValuationAssumptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r357" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "terseLabel": "Options, exercisable, intrinsic value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r357" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Options, exercisable, weighted average remaining contractual term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r347" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Options, outstanding, weighted average remaining contractual term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent", "terseLabel": "Purchase price of common stock, percent" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation", "negatedTerseLabel": "Shares withheld on vesting of restricted stock (in shares)" } } }, "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicates the sale of a borrowed security or written option.", "label": "Short [Member]", "terseLabel": "Sell contract" } } }, "localname": "ShortMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/FinancialDerivativesAndHedgingActivitiesSummaryOfForeignCurrencyContractsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShortTermDebtWeightedAverageInterestRateOverTime": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average interest rate of short-term debt outstanding calculated over time.", "label": "Short-term Debt, Weighted Average Interest Rate, over Time", "terseLabel": "Weighted-average interest rate, short-term debt" } } }, "localname": "ShortTermDebtWeightedAverageInterestRateOverTime", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_StandardProductWarrantyAccrual": { "auth_ref": [ "r273" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.", "label": "Standard Product Warranty Accrual", "periodEndLabel": "Accrued product warranty, at end of period", "periodStartLabel": "Accrued product warranty, at beginning of period" } } }, "localname": "StandardProductWarrantyAccrual", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesProductWarrantyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyAccrualCurrent": { "auth_ref": [], "calculation": { "http://www.vareximaging.com/role/OtherFinancialInformationDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability that is expected to be paid within one year or the normal operating cycle, if longer. Does not include the balance for the extended product warranty liability.", "label": "Standard Product Warranty Accrual, Current", "terseLabel": "Product warranty" } } }, "localname": "StandardProductWarrantyAccrualCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/OtherFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyAccrualPayments": { "auth_ref": [ "r270" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.", "label": "Standard Product Warranty Accrual, Decrease for Payments", "negatedTerseLabel": "Actual product warranty expenditures" } } }, "localname": "StandardProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesProductWarrantyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r271" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.", "label": "Standard Product Warranty Accrual, Increase for Warranties Issued", "terseLabel": "Charged to cost of revenues" } } }, "localname": "StandardProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesProductWarrantyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyPolicy": { "auth_ref": [ "r132", "r272" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.", "label": "Standard Product Warranty, Policy [Policy Text Block]", "terseLabel": "Product Warranty" } } }, "localname": "StandardProductWarrantyPolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r1", "r191", "r226", "r254", "r258", "r264", "r576" ], "lang": { "en-US": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsRevenuesBySegmentDetails", "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsSummaryOfGoowillDetails", "http://www.vareximaging.com/role/SegmentInformationAssetsDetails", "http://www.vareximaging.com/role/SegmentInformationSummaryOfSegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r61", "r290" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity", "http://www.vareximaging.com/role/OtherComprehensiveIncomeDetails", "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsSummaryOfChangesInRedeemableNoncontrollingInterestsNoncontrollingInteretsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": { "auth_ref": [ "r23", "r24", "r290", "r291", "r294" ], "lang": { "en-US": { "role": { "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Stock Issued During Period, Shares, Conversion of Units", "terseLabel": "Conversion of net parent investment into common stock (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r23", "r24", "r290", "r294" ], "lang": { "en-US": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "terseLabel": "Common stock issued under employee stock purchase plan (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r290", "r294" ], "lang": { "en-US": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross", "terseLabel": "Common stock issued upon vesting of restricted shares (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r23", "r24", "r290", "r294", "r336" ], "lang": { "en-US": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedTerseLabel": "Options, exercises in period, value (in shares)", "terseLabel": "Exercise of stock options (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity", "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": { "auth_ref": [ "r61", "r290", "r294" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).", "label": "Stock Issued During Period, Value, Conversion of Units", "terseLabel": "Conversion of net parent investment into common stock" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfUnits", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r23", "r24", "r290", "r294" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "terseLabel": "Common stock issued under employee stock purchase plan" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r61", "r290", "r294" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r24", "r28", "r29", "r208" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Varex stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r433", "r434", "r450" ], "calculation": { "http://www.vareximaging.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending balance", "periodStartLabel": "Balance at beginning of period", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedBalanceSheets", "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity", "http://www.vareximaging.com/role/OtherComprehensiveIncomeDetails", "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsSummaryOfChangesInRedeemableNoncontrollingInterestsNoncontrollingInteretsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.", "label": "Stockholders' Equity, Other", "negatedLabel": "Other" } } }, "localname": "StockholdersEquityOther", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails", "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r520" ], "lang": { "en-US": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r520" ], "lang": { "en-US": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails", "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r520" ], "lang": { "en-US": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails", "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r522" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SummaryOfValuationAllowanceTextBlock": { "auth_ref": [ "r387" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.", "label": "Summary of Valuation Allowance [Table Text Block]", "terseLabel": "Summary of Valuation Allowance [Table Text Block]" } } }, "localname": "SummaryOfValuationAllowanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": { "auth_ref": [ "r60" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests", "periodEndLabel": "Balance at end of period", "periodStartLabel": "Balance at beginning of period", "terseLabel": "Redeemable noncontrolling interest, equity, redemption value" } } }, "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsNarrativeDetails", "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsSummaryOfChangesInRedeemableNoncontrollingInterestsNoncontrollingInteretsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityNetIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of net income or loss attributable to temporary equity interest.", "label": "Temporary Equity, Net Income", "terseLabel": "Net earnings attributable to noncontrolling interests" } } }, "localname": "TemporaryEquityNetIncome", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsSummaryOfChangesInRedeemableNoncontrollingInterestsNoncontrollingInteretsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityOtherChanges": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in temporary equity from changes classified as other.", "label": "Temporary Equity, Other Changes", "terseLabel": "Other" } } }, "localname": "TemporaryEquityOtherChanges", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsSummaryOfChangesInRedeemableNoncontrollingInterestsNoncontrollingInteretsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityRedemptionPricePerShare": { "auth_ref": [ "r12", "r284" ], "lang": { "en-US": { "role": { "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Redemption Price Per Share", "terseLabel": "Temporary equity, redemption price per share (in eur per share)" } } }, "localname": "TemporaryEquityRedemptionPricePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r22" ], "lang": { "en-US": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "terseLabel": "Temporary equity, shares outstanding (in shares)" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r415" ], "lang": { "en-US": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Trade names" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsIntangiblesAcquiredDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Adoption and early adoption of sources of change to generally accepted accounting principles (GAAP) in the United States. The FASB released the FASB Accounting Standards Codification as the authoritative source of literature effective for interim and annual periods ending after September 15, 2009. As part of the Codification process, the FASB issues Accounting Standards Updates to amend the Codification but otherwise the Accounting Standards Updates are not authoritative in their own right. All previous accounting standards (such as FASB Statements of Financial Accounting Standards, FASB Interpretations, FASB Staff Positions, Emerging Issues Task Force Consensuses, other pronouncements of the FASB or other designated bodies, or other forms of GAAP are considered accounting pronouncements) were superseded upon the adoption of the Codification. For an interim period, references to the superseded standards are included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.", "label": "Type of Adoption [Domain]", "terseLabel": "Type of Adoption [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfBalanceSheetAdjustmentForAsc606AdoptionDetails", "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesAccountingStandardsRecentlyAdoptedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r368", "r378" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Unrecognized tax benefits balance\u2014end of fiscal year", "periodStartLabel": "Unrecognized tax benefits balance\u2013beginning of fiscal year", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxContingencyDetails", "http://www.vareximaging.com/role/TaxesOnEarningsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r379" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "negatedTerseLabel": "Subtractions based on tax positions related to a prior year" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxContingencyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r376" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Unrecognized tax benefits, income tax penalties and interest accrued" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r380" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "terseLabel": "Additions based on tax positions related to the current year" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsIncomeTaxContingencyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r170", "r171", "r173", "r174", "r180", "r181", "r182" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r369" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "terseLabel": "Operating loss carryforwards, valuation allowance increase (decrease)" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r156", "r161" ], "calculation": { "http://www.vareximaging.com/role/NetEarningsPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-US": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average shares outstanding - diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings", "http://www.vareximaging.com/role/NetEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted average common shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r155", "r161" ], "calculation": { "http://www.vareximaging.com/role/NetEarningsPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average shares outstanding - basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEarnings", "http://www.vareximaging.com/role/NetEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "vrex_A2017ESPPMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2017 ESPP [Member]", "label": "2017 ESPP [Member]", "terseLabel": "2017 ESPP" } } }, "localname": "A2017ESPPMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "vrex_A2017OmnibusStockPlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2017 Omnibus Stock Plan [Member]", "label": "2017 Omnibus Stock Plan [Member]", "terseLabel": "2017 Omnibus Stock Plan" } } }, "localname": "A2017OmnibusStockPlanMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails" ], "xbrltype": "domainItemType" }, "vrex_BuildingsandLeaseholdImprovementsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Buildings and Leasehold Improvements [Member]", "label": "Buildings and Leasehold Improvements [Member]", "terseLabel": "Buildings and leasehold improvements" } } }, "localname": "BuildingsandLeaseholdImprovementsMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesPropertyPlantAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "vrex_BusinessAcquisitionAnnualRecurringCompensation": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Business Acquisition, Annual Recurring Compensation", "label": "Business Acquisition, Annual Recurring Compensation", "terseLabel": "Annual recurring compensation (in euros per share)" } } }, "localname": "BusinessAcquisitionAnnualRecurringCompensation", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "vrex_BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationValueAssigned": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Business Acquisition, Equity Interest Issued Or Issuable, Contingent Consideration, Value Assigned", "label": "Business Acquisition, Equity Interest Issued Or Issuable, Contingent Consideration, Value Assigned", "terseLabel": "Deferred payment, value assigned" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableContingentConsiderationValueAssigned", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsDirectConversionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "vrex_BusinessAcquisitionEquityInterestIssuedorIssuableContingentConsideration": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Contingent Consideration", "label": "Business Acquisition, Equity Interest Issued or Issuable, Contingent Consideration", "terseLabel": "Deferred payment (in shares)" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedorIssuableContingentConsideration", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsDirectConversionNarrativeDetails" ], "xbrltype": "sharesItemType" }, "vrex_BusinessCombinationNumberofEmployees": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Business Combination, Number of Employees", "label": "Business Combination, Number of Employees", "terseLabel": "Business combination, number of employees" } } }, "localname": "BusinessCombinationNumberofEmployees", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsPerkinelmersMedicalImagingNarrativeDetails" ], "xbrltype": "integerItemType" }, "vrex_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities": { "auth_ref": [], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accrued Liabilities", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accrued Liabilities", "negatedLabel": "Accrued liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "vrex_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesRevenueFromContractWithCustomerLiability": { "auth_ref": [], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Revenue From Contract With Customer, Liability", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Revenue From Contract With Customer, Liability", "negatedLabel": "Deferred revenues" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesRevenueFromContractWithCustomerLiability", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "vrex_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsandGoodwill": { "auth_ref": [], "calculation": { "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets and Goodwill", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets and Goodwill", "totalLabel": "Total assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAssetsandGoodwill", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "vrex_CETTEENGmbHMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "CETTEEN GmbH [Member]", "label": "CETTEEN GmbH [Member]", "terseLabel": "CETTEEN GmbH" } } }, "localname": "CETTEENGmbHMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "domainItemType" }, "vrex_CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Canon Medical Systems Corporation (Formerly Toshiba Medical Systems) [Member]", "label": "Canon Medical Systems Corporation (Formerly Toshiba Medical Systems) [Member]", "terseLabel": "Canon Medical Systems Corporation" } } }, "localname": "CanonMedicalSystemsCorporationFormerlyToshibaMedicalSystemsMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesConcentrationOfRiskDetails" ], "xbrltype": "domainItemType" }, "vrex_ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Class Of Warrant Or Right, Percent Increase Of Strike Price Over Sale Price", "label": "Class Of Warrant Or Right, Percent Increase Of Strike Price Over Sale Price", "terseLabel": "Percent increase of strike price over sale price" } } }, "localname": "ClassOfWarrantOrRightPercentIncreaseOfStrikePriceOverSalePrice", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "vrex_ContractWithCustomerAsset": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Contract With Customer, Asset", "label": "Contract With Customer, Asset", "periodEndLabel": "Balance at September 27, 2019", "periodStartLabel": "Balance at September 29, 2018" } } }, "localname": "ContractWithCustomerAsset", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfChangesInContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "vrex_ContractWithCustomerLiabilityAdditions": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Contract With Customer, Liability, Additions", "label": "Contract With Customer, Liability, Additions", "terseLabel": "Additions to refund liabilities" } } }, "localname": "ContractWithCustomerLiabilityAdditions", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfChangesInContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "vrex_ConvertibleNotesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Convertible Notes [Member]", "label": "Convertible Notes [Member]", "terseLabel": "Convertible Notes" } } }, "localname": "ConvertibleNotesMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "vrex_CustomerContractsandSupplierRelationshipsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Customer Contracts and Supplier Relationships [Member]", "label": "Customer Contracts and Supplier Relationships [Member]", "terseLabel": "Customer contracts and supplier relationship" } } }, "localname": "CustomerContractsandSupplierRelationshipsMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "vrex_DebtInstrumentConvertibleConsecutiveBusinessDays": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Convertible, Consecutive Business Days", "label": "Debt Instrument, Convertible, Consecutive Business Days", "terseLabel": "Debt instrument, convertible, consecutive business days" } } }, "localname": "DebtInstrumentConvertibleConsecutiveBusinessDays", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "integerItemType" }, "vrex_DebtInstrumentConvertibleConsecutiveTradingDayMeasurementPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Convertible, Consecutive Trading Day Measurement Period", "label": "Debt Instrument, Convertible, Consecutive Trading Day Measurement Period", "terseLabel": "Debt instrument, convertible, consecutive trading day measurement period" } } }, "localname": "DebtInstrumentConvertibleConsecutiveTradingDayMeasurementPeriod", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "integerItemType" }, "vrex_DebtInstrumentConvertibleHypotheticalInterestRate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Convertible, Hypothetical Interest Rate", "label": "Debt Instrument, Convertible, Hypothetical Interest Rate", "terseLabel": "Debt instrument, convertible, hypothetical interest rate" } } }, "localname": "DebtInstrumentConvertibleHypotheticalInterestRate", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "vrex_DebtInstrumentConvertibleThresholdForMeasurementPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Convertible, Threshold For Measurement Period", "label": "Debt Instrument, Convertible, Threshold For Measurement Period", "terseLabel": "Debt instrument, convertible, threshold for measurement period" } } }, "localname": "DebtInstrumentConvertibleThresholdForMeasurementPeriod", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "vrex_DebtInstrumentPeriodicPaymentPercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Periodic Payment, Percentage", "label": "Debt Instrument, Periodic Payment, Percentage", "terseLabel": "Repayment percentage" } } }, "localname": "DebtInstrumentPeriodicPaymentPercentage", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails" ], "xbrltype": "percentItemType" }, "vrex_DebtInstrumentRepaymentPeriodFiveMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Repayment, Period Five [Member]", "label": "Debt Instrument, Repayment, Period Five [Member]", "terseLabel": "Debt Instrument, Repayment, Period Five" } } }, "localname": "DebtInstrumentRepaymentPeriodFiveMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails" ], "xbrltype": "domainItemType" }, "vrex_DebtInstrumentRepaymentPeriodFourMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Repayment, Period Four [Member]", "label": "Debt Instrument, Repayment, Period Four [Member]", "terseLabel": "Debt Instrument, Repayment, Period Four" } } }, "localname": "DebtInstrumentRepaymentPeriodFourMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails" ], "xbrltype": "domainItemType" }, "vrex_DebtInstrumentRepaymentPeriodOneMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Repayment, Period One [Member]", "label": "Debt Instrument, Repayment, Period One [Member]", "terseLabel": "Debt Instrument, Repayment, Period One" } } }, "localname": "DebtInstrumentRepaymentPeriodOneMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails" ], "xbrltype": "domainItemType" }, "vrex_DebtInstrumentRepaymentPeriodThreeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Repayment, Period Three [Member]", "label": "Debt Instrument, Repayment, Period Three [Member]", "terseLabel": "Debt Instrument, Repayment, Period Three" } } }, "localname": "DebtInstrumentRepaymentPeriodThreeMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails" ], "xbrltype": "domainItemType" }, "vrex_DebtInstrumentRepaymentPeriodTwoMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Repayment, Period Two [Member]", "label": "Debt Instrument, Repayment, Period Two [Member]", "terseLabel": "Debt Instrument, Repayment, Period Two" } } }, "localname": "DebtInstrumentRepaymentPeriodTwoMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails" ], "xbrltype": "domainItemType" }, "vrex_DebtRepaymentPeriodAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Repayment Period [Axis]", "label": "Debt Repayment Period [Axis]", "terseLabel": "Debt Repayment Period [Axis]" } } }, "localname": "DebtRepaymentPeriodAxis", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails" ], "xbrltype": "stringItemType" }, "vrex_DebtRepaymentPeriodDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Domain] for Debt Repayment Period [Axis]", "label": "Debt Repayment Period [Domain]", "terseLabel": "Debt Repayment Period [Domain]" } } }, "localname": "DebtRepaymentPeriodDomain", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails" ], "xbrltype": "domainItemType" }, "vrex_DeferredIncomeTaxExpenseBenefitExcludingPortiontoAPIC": { "auth_ref": [], "calculation": { "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Deferred Income Tax Expense (Benefit) Excluding Portion to APIC", "label": "Deferred Income Tax Expense (Benefit) Excluding Portion to APIC", "terseLabel": "Deferred taxes" } } }, "localname": "DeferredIncomeTaxExpenseBenefitExcludingPortiontoAPIC", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "vrex_DeferredTaxAssetsJurisdictionalAmountGross": { "auth_ref": [], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilitiesNet", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Deferred Tax Assets, Jurisdictional Amount, Gross", "label": "Deferred Tax Assets, Jurisdictional Amount, Gross", "terseLabel": "Deferred tax assets" } } }, "localname": "DeferredTaxAssetsJurisdictionalAmountGross", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "vrex_DeferredTaxAssetsValuationAllowanceRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Deferred Tax Assets Valuation Allowance [Roll Forward]", "label": "Deferred Tax Assets Valuation Allowance [Roll Forward]", "terseLabel": "Deferred Tax Assets Valuation Allowance [Roll Forward]" } } }, "localname": "DeferredTaxAssetsValuationAllowanceRollForward", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsValuationAllowanceDetails" ], "xbrltype": "stringItemType" }, "vrex_DeferredTaxLiabilityJurisdictionalAmountGross": { "auth_ref": [], "calculation": { "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilitiesNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Deferred Tax Liability, Jurisdictional Amount, Gross", "label": "Deferred Tax Liability, Jurisdictional Amount, Gross", "negatedTerseLabel": "Deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilityJurisdictionalAmountGross", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "vrex_DirectConversionABMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Direct Conversion AB [Member]", "label": "Direct Conversion AB [Member]", "terseLabel": "Direct Conversion AB" } } }, "localname": "DirectConversionABMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsDirectConversionNarrativeDetails", "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.vareximaging.com/role/BusinessCombinationsIntangiblesAcquiredDetails", "http://www.vareximaging.com/role/BusinessCombinationsRevenuesBySegmentDetails", "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsNarrativeDetails" ], "xbrltype": "domainItemType" }, "vrex_DistributionstoParent": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Distributions to Parent", "label": "Distributions to Parent", "negatedTerseLabel": "Distribution to Varian Medical Systems" } } }, "localname": "DistributionstoParent", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "vrex_DpiXHoldingMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "dpiX Holding [Member]", "label": "dpiX Holding [Member]", "terseLabel": "dpiX Holding" } } }, "localname": "DpiXHoldingMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "domainItemType" }, "vrex_DpiXLLCMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "dpiX LLC [Member]", "label": "dpiX LLC [Member]", "terseLabel": "dpiX LLC" } } }, "localname": "DpiXLLCMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "domainItemType" }, "vrex_EquityMethodInvestmentsNumberofFullOwnershipMembers": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equity Method Investments, Number of Full Ownership Members", "label": "Equity Method Investments, Number of Full Ownership Members", "terseLabel": "Number of consortium members" } } }, "localname": "EquityMethodInvestmentsNumberofFullOwnershipMembers", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "integerItemType" }, "vrex_FixedCostCommitmentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fixed Cost Commitments [Member]", "label": "Fixed Cost Commitments [Member]", "terseLabel": "Fixed Cost Commitments" } } }, "localname": "FixedCostCommitmentsMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "domainItemType" }, "vrex_IncreaseDecreaseInContractwithCustomerAssetCostsRecoveredFromProductReturns": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Increase (Decrease) In Contract with Customer, Asset, Costs Recovered From Product Returns", "label": "Increase (Decrease) In Contract with Customer, Asset, Costs Recovered From Product Returns", "terseLabel": "Costs recovered from product returns during the period" } } }, "localname": "IncreaseDecreaseInContractwithCustomerAssetCostsRecoveredFromProductReturns", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfChangesInContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "vrex_IncreaseDecreaseInContractwithCustomerAssetShipmentOfProductSubjectToReturn": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Increase (Decrease) In Contract with Customer, Asset, Shipment Of Product Subject To Return", "label": "Increase (Decrease) In Contract with Customer, Asset, Shipment Of Product Subject To Return", "terseLabel": "Contract asset from shipments of products, subject to return during the period" } } }, "localname": "IncreaseDecreaseInContractwithCustomerAssetShipmentOfProductSubjectToReturn", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/RevenueRecognitionScheduleOfChangesInContractBalancesDetails" ], "xbrltype": "monetaryItemType" }, "vrex_IndustrialMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Industrial [Member]", "label": "Industrial [Member]", "terseLabel": "Industrial" } } }, "localname": "IndustrialMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsRevenuesBySegmentDetails", "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsSummaryOfGoowillDetails", "http://www.vareximaging.com/role/SegmentInformationAssetsDetails", "http://www.vareximaging.com/role/SegmentInformationSummaryOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "vrex_IntangibleAssetsAcquiredasPartofBusinessCombinationTableLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Line Items] for Intangible Assets Acquired as Part of Business Combination [Table] [Table]", "label": "Intangible Assets Acquired as Part of Business Combination [Table] [Line Items]", "terseLabel": "Intangible Assets Acquired as Part of Business Combination [Table] [Line Items]" } } }, "localname": "IntangibleAssetsAcquiredasPartofBusinessCombinationTableLineItems", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsIntangiblesAcquiredDetails" ], "xbrltype": "stringItemType" }, "vrex_IntangibleAssetsAcquiredasPartofBusinessCombinationTableTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Intangible Assets Acquired as Part of Business Combination [Table] [Table]", "label": "Intangible Assets Acquired as Part of Business Combination [Table] [Table]", "terseLabel": "Intangible Assets Acquired as Part of Business Combination [Table] [Table]" } } }, "localname": "IntangibleAssetsAcquiredasPartofBusinessCombinationTableTable", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsIntangiblesAcquiredDetails" ], "xbrltype": "stringItemType" }, "vrex_JointVentureInSaudiArabiaMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Joint Venture In Saudi Arabia [Member]", "label": "Joint Venture In Saudi Arabia [Member]", "terseLabel": "Joint Venture In Saudi Arabia" } } }, "localname": "JointVentureInSaudiArabiaMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsNarrativeDetails" ], "xbrltype": "domainItemType" }, "vrex_LondonFacilityClosingMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "London Facility Closing [Member]", "label": "London Facility Closing [Member]", "terseLabel": "London Facility Closing" } } }, "localname": "LondonFacilityClosingMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/RestructuringNarrativeDetails" ], "xbrltype": "domainItemType" }, "vrex_LongtermDebtExcludingCurrentMaturitiesGross": { "auth_ref": [], "calculation": { "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebtNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Long-term Debt Excluding Current Maturities, Gross", "label": "Long-term Debt Excluding Current Maturities, Gross", "terseLabel": "Long-term debt excluding current maturities, gross", "verboseLabel": "Non-current portion of long -term debt" } } }, "localname": "LongtermDebtExcludingCurrentMaturitiesGross", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BorrowingsScheduleOfDebtMaturitiesDetails", "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails" ], "xbrltype": "monetaryItemType" }, "vrex_MeVisMedicalSolutionsAGMeVisMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "MeVis Medical Solutions AG (MeVis) [Member]", "label": "MeVis Medical Solutions AG (MeVis) [Member]", "terseLabel": "MeVis Medical Solutions AG (MeVis)" } } }, "localname": "MeVisMedicalSolutionsAGMeVisMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsNarrativeDetails" ], "xbrltype": "domainItemType" }, "vrex_MedicalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Medical [Member]", "label": "Medical [Member]", "terseLabel": "Medical" } } }, "localname": "MedicalMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsRevenuesBySegmentDetails", "http://www.vareximaging.com/role/GoodwillAndIntangibleAssetsSummaryOfGoowillDetails", "http://www.vareximaging.com/role/SegmentInformationAssetsDetails", "http://www.vareximaging.com/role/SegmentInformationSummaryOfSegmentInformationDetails" ], "xbrltype": "domainItemType" }, "vrex_NetParentInvestmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Net Parent Investment [Member]", "label": "Net Parent Investment [Member]", "terseLabel": "Net Parent Investment" } } }, "localname": "NetParentInvestmentMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "domainItemType" }, "vrex_NetTransfersFromToParent": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Net Transfers from Parent", "label": "Net Transfers From (To) Parent", "terseLabel": "Net transfers to parent" } } }, "localname": "NetTransfersFromToParent", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "vrex_NoncashTransferstoParent": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Noncash Transfers to Parent", "label": "Noncash Transfers to Parent", "terseLabel": "Other non-cash transfers to Varian Medical Systems, Inc." } } }, "localname": "NoncashTransferstoParent", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "vrex_NoncontrollingInterestIncreaseFromCapitalContribution": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Noncontrolling Interest, Increase From Capital Contribution", "label": "Noncontrolling Interest, Increase From Capital Contribution", "terseLabel": "Capital contribution by noncontrolling interest", "verboseLabel": "Contributions from noncontrolling interests" } } }, "localname": "NoncontrollingInterestIncreaseFromCapitalContribution", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfEquity", "http://www.vareximaging.com/role/RedeemableNoncontrollingInterestsNoncontrollingInterestsSummaryOfChangesInRedeemableNoncontrollingInterestsNoncontrollingInteretsDetails" ], "xbrltype": "monetaryItemType" }, "vrex_NumberofVariableInterestEntities": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of Variable Interest Entities", "label": "Number of Variable Interest Entities", "terseLabel": "Number of variable interest entities" } } }, "localname": "NumberofVariableInterestEntities", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesVariableInterestEntitiesDetails" ], "xbrltype": "integerItemType" }, "vrex_OtherDebtMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Other Debt [Member]", "label": "Other Debt [Member]", "terseLabel": "Other Debt" } } }, "localname": "OtherDebtMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails" ], "xbrltype": "domainItemType" }, "vrex_OutstandingCommonStockPercentageDistributed": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Outstanding Common Stock, Percentage Distributed", "label": "Outstanding Common Stock, Percentage Distributed", "terseLabel": "Outstanding common stock, percentage distributed" } } }, "localname": "OutstandingCommonStockPercentageDistributed", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesDescriptionOfBusinessDetails" ], "xbrltype": "pureItemType" }, "vrex_PaymentOfHedgeTransactionsFromProceedsOfConvertibleDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Payment Of Hedge Transactions From Proceeds Of Convertible Debt", "label": "Payment Of Hedge Transactions From Proceeds Of Convertible Debt", "terseLabel": "Payment of hedge transactions from proceeds of convertible debt" } } }, "localname": "PaymentOfHedgeTransactionsFromProceedsOfConvertibleDebt", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "vrex_PaymentOfHedgeTransactionsFromProceedsOfWarrantTransactions": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Payment Of Hedge Transactions From Proceeds Of Warrant Transactions", "label": "Payment Of Hedge Transactions From Proceeds Of Warrant Transactions", "terseLabel": "Payment of hedge transactions from proceeds of warrant transactions" } } }, "localname": "PaymentOfHedgeTransactionsFromProceedsOfWarrantTransactions", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "vrex_PercentageOfFixedCosts": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The percentage of fixed costs as defined in the agreement and determined at the beginning of each calendar year that the entity is required to pay.", "label": "Percentage Of Fixed Costs", "terseLabel": "Percentage of fixed costs" } } }, "localname": "PercentageOfFixedCosts", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "percentItemType" }, "vrex_PercentageOfManufacturingCapacity": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The percentage of manufacturing capacity that the entity has the guaranteed right to purchase up to.", "label": "Percentage Of Manufacturing Capacity", "terseLabel": "Percentage of manufacturing capacity" } } }, "localname": "PercentageOfManufacturingCapacity", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "percentItemType" }, "vrex_PerkinElmerInc.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "PerkinElmer, Inc. [Member]", "label": "PerkinElmer, Inc. [Member]", "terseLabel": "PerkinElmer, Inc." } } }, "localname": "PerkinElmerInc.Member", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.vareximaging.com/role/BusinessCombinationsIntangiblesAcquiredDetails", "http://www.vareximaging.com/role/BusinessCombinationsPerkinelmersMedicalImagingNarrativeDetails", "http://www.vareximaging.com/role/BusinessCombinationsProFormaDetails", "http://www.vareximaging.com/role/BusinessCombinationsRevenuesBySegmentDetails" ], "xbrltype": "domainItemType" }, "vrex_ReceiptofProperty": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Receipt of Property", "label": "Receipt of Property", "terseLabel": "Transfers of property, plant and equipment from Varian Medical Systems, Inc." } } }, "localname": "ReceiptofProperty", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "vrex_RelatedPartyTransactionExpectedFixedCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Related Party Transaction, Expected Fixed Cost", "label": "Related Party Transaction, Expected Fixed Cost", "terseLabel": "Related party transaction, expected fixed cost" } } }, "localname": "RelatedPartyTransactionExpectedFixedCost", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "monetaryItemType" }, "vrex_RevolvingCreditFacilityMay2017Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revolving Credit Facility May 2017 [Member]", "label": "Revolving Credit Facility May 2017 [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMay2017Member", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BorrowingsNarrativeDetails", "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails", "http://www.vareximaging.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "vrex_SantaClaraFacilityRelocationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Santa Clara Facility Relocation [Member]", "label": "Santa Clara Facility Relocation [Member]", "terseLabel": "Santa Clara Facility Relocation" } } }, "localname": "SantaClaraFacilityRelocationMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/RestructuringNarrativeDetails" ], "xbrltype": "domainItemType" }, "vrex_ScheduleOfShortTermAndLongTermDebtLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Line Items] for Schedule Of Short-Term And Long-Term Debt [Table]", "label": "Schedule Of Short-Term And Long-Term Debt [Line Items]", "terseLabel": "Schedule Of Short-Term And Long-Term Debt [Line Items]" } } }, "localname": "ScheduleOfShortTermAndLongTermDebtLineItems", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails" ], "xbrltype": "stringItemType" }, "vrex_ScheduleOfShortTermAndLongTermDebtTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule Of Short-Term And Long-Term Debt [Table]", "label": "Schedule Of Short-Term And Long-Term Debt [Table]", "terseLabel": "Schedule Of Short-Term And Long-Term Debt [Table]" } } }, "localname": "ScheduleOfShortTermAndLongTermDebtTable", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BorrowingsScheduleOfShortTermAndLongTermDebtDetails" ], "xbrltype": "stringItemType" }, "vrex_ScheduleofProRataDistributionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Line Items] for Schedule of Pro Rata Distribution [Table]", "label": "Schedule of Pro Rata Distribution [Line Items]", "terseLabel": "Schedule of Pro Rata Distribution [Line Items]" } } }, "localname": "ScheduleofProRataDistributionLineItems", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesDescriptionOfBusinessDetails" ], "xbrltype": "stringItemType" }, "vrex_ScheduleofProRataDistributionTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of Pro Rata Distribution [Table]", "label": "Schedule of Pro Rata Distribution [Table]", "terseLabel": "Schedule of Pro Rata Distribution [Table]" } } }, "localname": "ScheduleofProRataDistributionTable", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesDescriptionOfBusinessDetails" ], "xbrltype": "stringItemType" }, "vrex_SharebasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsGrantsInPeriodGrantDateFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement By Share-Based Payment Award, Other Than Options, Grants In Period, Grant Date Fair Value", "label": "Share-based Compensation Arrangement By Share-Based Payment Award, Other Than Options, Grants In Period, Grant Date Fair Value", "terseLabel": "Grant-date fair value of shares granted in the period" } } }, "localname": "SharebasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsGrantsInPeriodGrantDateFairValue", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "vrex_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Options, Outstanding, Price", "label": "Share-based Compensation Arrangement By Share-based Payment Award, Options, Outstanding, Price", "periodEndLabel": "Options, outstanding, price, ending (in USD per share)", "periodStartLabel": "Options, outstanding, price, beginning (in USD per share)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingPrice", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "vrex_SharebasedCompensationArrangementBySharebasedPaymentAwardStockPlanOfferingPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Stock Plan Offering Period", "label": "Share-based Compensation Arrangement By Share-based Payment Award, Stock Plan Offering Period", "terseLabel": "Stock plan offering period (in months)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardStockPlanOfferingPeriod", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails" ], "xbrltype": "durationItemType" }, "vrex_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Price", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Price", "terseLabel": "Options, exercisable, price (in USD per share)" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisablePrice", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "vrex_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePriceRangeRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercise Price Range [Roll Forward]", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercise Price Range [Roll Forward]", "terseLabel": "Price Range" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisePriceRangeRollForward", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "vrex_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Price", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Price", "terseLabel": "Options, forfeitures and expirations in period, price (in USD per share)" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresandExpirationsinPeriodPrice", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "vrex_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsGrantsinPeriodGrantDateFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Grant Date Fair Value", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Fair Value", "terseLabel": "Options, grants in period, grant date fair value" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsGrantsinPeriodGrantDateFairValue", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "vrex_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsExercisesinPeriodPrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Price", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Price", "terseLabel": "Options, exercises in period, price (in USD per share)" } } }, "localname": "SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsExercisesinPeriodPrice", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "vrex_SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Price", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Price", "terseLabel": "Options, grants in period, price (in USD per share)" } } }, "localname": "SharebasedCompensationArrangementsbySharebasedPaymentAwardOptionsGrantsinPeriodPrice", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "vrex_SharebasedCompensationbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsSharesOutstandingMarketValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Share-based Compensation by Share- based Payment Award, Shares Outstanding, Market Value", "label": "Share-based Compensation by Share-based Payment Award, Equity Instruments Other than Options, Shares Outstanding, Market Value", "terseLabel": "Shares outstanding, market value" } } }, "localname": "SharebasedCompensationbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsSharesOutstandingMarketValue", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/EmployeeStockPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "vrex_VECImagingGmbHCo.KGMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "VEC Imaging GmbH & Co. KG [Member]", "label": "VEC Imaging GmbH & Co. KG [Member]", "terseLabel": "VEC Imaging" } } }, "localname": "VECImagingGmbHCo.KGMember", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/RelatedPartyTransactionsInvestmentInPrivatelyHeldCompaniesDetails" ], "xbrltype": "domainItemType" }, "vrex_ValuationAllowanceDeferredTaxAssetDecreaseAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Valuation Allowance, Deferred Tax Asset, Decrease, Amount", "label": "Valuation Allowance, Deferred Tax Asset, Decrease, Amount", "negatedTerseLabel": "Other decreases" } } }, "localname": "ValuationAllowanceDeferredTaxAssetDecreaseAmount", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsValuationAllowanceDetails" ], "xbrltype": "monetaryItemType" }, "vrex_ValuationAllowanceDeferredTaxAssetIncreaseAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Valuation Allowance, Deferred Tax Asset, Increase, Amount", "label": "Valuation Allowance, Deferred Tax Asset, Increase, Amount", "terseLabel": "Other increases" } } }, "localname": "ValuationAllowanceDeferredTaxAssetIncreaseAmount", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsValuationAllowanceDetails" ], "xbrltype": "monetaryItemType" }, "vrex_ValuationAllowanceDeferredTaxAssetIncreaseFromBusinessCombinationAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Valuation Allowance, Deferred Tax Asset, Increase From Business Combination, Amount", "label": "Valuation Allowance, Deferred Tax Asset, Increase From Business Combination, Amount", "terseLabel": "Increases resulting from business combinations" } } }, "localname": "ValuationAllowanceDeferredTaxAssetIncreaseFromBusinessCombinationAmount", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/TaxesOnEarningsValuationAllowanceDetails" ], "xbrltype": "monetaryItemType" }, "vrex_VarianMedicalSystemsInc.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Varian Medical Systems, Inc. [Member]", "label": "Varian Medical Systems, Inc. [Member]", "terseLabel": "Varian Medical Systems, Inc." } } }, "localname": "VarianMedicalSystemsInc.Member", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesDescriptionOfBusinessDetails" ], "xbrltype": "domainItemType" }, "vrex_VirtualMediaIntegrationLtd.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Virtual Media Integration, Ltd. [Member]", "label": "Virtual Media Integration, Ltd. [Member]", "terseLabel": "Virtual Media Integration, Ltd." } } }, "localname": "VirtualMediaIntegrationLtd.Member", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/BusinessCombinationsFairValueOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails", "http://www.vareximaging.com/role/BusinessCombinationsVirtualMediaNarrativeDetails" ], "xbrltype": "domainItemType" }, "vrex_WarrantyTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Warranty Term", "label": "Warranty Term", "terseLabel": "Warranty term (in months)" } } }, "localname": "WarrantyTerm", "nsuri": "http://www.vareximaging.com/20200922", "presentation": [ "http://www.vareximaging.com/role/SummaryOfSignificantAccountingPoliciesProductWarrantyDetails" ], "xbrltype": "durationItemType" } }, "unitCount": 12 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e7018-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r105": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "http://asc.fasb.org/topic&trid=2134417" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3581-108585" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4273-108586" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(i)(4))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(n)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(n))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04.(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690" }, "r147": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r154": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1500-109256" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258" }, "r165": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e725-108305" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e765-108305" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.10-01.(b)(6))", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r183": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "a", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9054-108599" }, "r203": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5074-111524" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5144-111524" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=117311354&loc=d3e32014-111567" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955202&loc=SL82895884-210446" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "40", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=16397303&loc=d3e19347-109286" }, "r247": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)(1)", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "410", "URI": "http://asc.fasb.org/extlink&oid=6393242&loc=d3e13207-110859" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r265": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "http://asc.fasb.org/topic&trid=2175745" }, "r266": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14615-108349" }, "r269": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1),(c)(5)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031898-161870" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870" }, "r283": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(12)(c)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(16)(c)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(3)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "14", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "15", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130531-203044" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944033&loc=SL49130532-203044" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130551-203045" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130611-203046-203046" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r311": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "710", "URI": "http://asc.fasb.org/topic&trid=2127225" }, "r312": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "712", "URI": "http://asc.fasb.org/topic&trid=2197446" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r322": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116855982&loc=d3e4534-113899" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)-(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=SL79508275-113901" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11149-113907" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11178-113907" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11374-113907" }, "r364": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28680-109314" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28680-109314" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=SL37586934-109318" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32123-109318" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32247-109318" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32280-109318" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31917-109318" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31931-109318" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=117331294&loc=d3e36027-109320" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e39076-109324" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "05", "SubTopic": "30", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=65884525&loc=d3e40913-109327" }, "r403": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e961-128460" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868840&loc=d3e2207-128464" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5333-128473" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5333-128473" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5419-128473" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5504-128473" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "44", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5558-128473" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "b", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479" }, "r431": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=d3e5291-111683" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569655-111683" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "2AA", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "a", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=SL6759068-111685" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=d3e5728-111685" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=118582676&loc=SL6759159-111685" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3A-02(b))", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355033-122828" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3A-02)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355033-122828" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3A-03(b))", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355100-122828" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3A-03)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116822174&loc=d3e355100-122828" }, "r457": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.15)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "4CC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL109998890-113959" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(6)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41675-113959" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=116861445&loc=SL5629052-113961" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=118875152&loc=SL5864739-113975" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109978405&loc=d3e80720-113993" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=112277219&loc=d3e80748-113994" }, "r489": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13433-108611" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13531-108611" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30700-110894" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39678-107864" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r519": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r522": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=SL51823488-111719" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6052-115624" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r586": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r587": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r588": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r589": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r590": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r591": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r592": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.27(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6812-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e640-108580" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6911-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-03(e))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868656-224227" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6935-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.19)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" } }, "version": "2.1" } ZIP 119 0001681622-20-000091-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001681622-20-000091-xbrl.zip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